
<html lang="en"     class="pb-page"  data-request-id="b2d63d3d-b1b3-4c56-9721-e54e8920dd73"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.7b00098;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2017.60.issue-6"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Potent Human Glutaminyl Cyclase Inhibitors as Anti-Alzheimer’s Agents Based on Rational Design" /></meta><meta name="dc.Creator" content="Van-Hai  Hoang" /></meta><meta name="dc.Creator" content="Phuong-Thao  Tran" /></meta><meta name="dc.Creator" content="Minghua  Cui" /></meta><meta name="dc.Creator" content="Van T. H.  Ngo" /></meta><meta name="dc.Creator" content="Jihyae  Ann" /></meta><meta name="dc.Creator" content="Jongmi  Park" /></meta><meta name="dc.Creator" content="Jiyoun  Lee" /></meta><meta name="dc.Creator" content="Kwanghyun  Choi" /></meta><meta name="dc.Creator" content="Hanyang  Cho" /></meta><meta name="dc.Creator" content="Hee  Kim" /></meta><meta name="dc.Creator" content="Hee-Jin  Ha" /></meta><meta name="dc.Creator" content="Hyun-Seok  Hong" /></meta><meta name="dc.Creator" content="Sun  Choi" /></meta><meta name="dc.Creator" content="Young-Ho  Kim" /></meta><meta name="dc.Creator" content="Jeewoo  Lee" /></meta><meta name="dc.Description" content="Glutaminyl cyclase (QC) has been implicated in the formation of toxic amyloid plaques by generating the N-terminal pyroglutamate of β-amyloid peptides (pGlu-Aβ) and thus may participate in the path..." /></meta><meta name="Description" content="Glutaminyl cyclase (QC) has been implicated in the formation of toxic amyloid plaques by generating the N-terminal pyroglutamate of β-amyloid peptides (pGlu-Aβ) and thus may participate in the path..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 13, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00098" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00098" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00098" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00098" /></link>
        
    
    

<title>Discovery of Potent Human Glutaminyl Cyclase Inhibitors as Anti-Alzheimer’s Agents Based on Rational Design | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00098" /></meta><meta property="og:title" content="Discovery of Potent Human Glutaminyl Cyclase Inhibitors as Anti-Alzheimer’s Agents Based on Rational Design" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0015.jpeg" /></meta><meta property="og:description" content="Glutaminyl cyclase (QC) has been implicated in the formation of toxic amyloid plaques by generating the N-terminal pyroglutamate of β-amyloid peptides (pGlu-Aβ) and thus may participate in the pathogenesis of Alzheimer’s disease (AD). We designed a library of glutamyl cyclase (QC) inhibitors based on the proposed binding mode of the preferred substrate, Aβ3E−42. An in vitro structure–activity relationship study identified several excellent QC inhibitors demonstrating 5- to 40-fold increases in potency compared to a known QC inhibitor. When tested in mouse models of AD, compound 212 significantly reduced the brain concentrations of pyroform Aβ and total Aβ and restored cognitive functions. This potent Aβ-lowering effect was achieved by incorporating an additional binding region into our previously established pharmacophoric model, resulting in strong interactions with the carboxylate group of Glu327 in the QC binding site. Our study offers useful insights in designing novel QC inhibitors as a potential treatment option for AD." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00098"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00098">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00098&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00098&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00098&amp;href=/doi/10.1021/acs.jmedchem.7b00098" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2573-2590</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00070" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b01717" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Potent Human Glutaminyl Cyclase Inhibitors as Anti-Alzheimer’s Agents Based on Rational Design</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Van-Hai++Hoang">Van-Hai Hoang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Phuong-Thao++Tran">Phuong-Thao Tran</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Minghua++Cui">Minghua Cui</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Van+T.+H.++Ngo">Van T. H. Ngo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jihyae++Ann">Jihyae Ann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jongmi++Park">Jongmi Park</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jiyoun++Lee">Jiyoun Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kwanghyun++Choi">Kwanghyun Choi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hanyang++Cho">Hanyang Cho</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hee++Kim">Hee Kim</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hee-Jin++Ha">Hee-Jin Ha</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hyun-Seok++Hong">Hyun-Seok Hong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sun++Choi">Sun Choi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-7669-7954" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Young-Ho++Kim">Young-Ho Kim</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeewoo++Lee">Jeewoo Lee</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-7832-6719" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Laboratory of Medicinal Chemistry, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">National Leading Research Laboratory of Molecular Modeling & Drug Design, College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic of Korea</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Medifron DBT, Sandanro 349, Danwon-Gu, Ansan-City, Gyeonggi-Do 15426, Republic of Korea</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Department of Global Medical Science, Sungshin University, Seoul 01133, Republic of Korea</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Department of Pharmaceutical Chemistry, Hanoi University of Pharmacy, Hanoi, Vietnam</span></div><div class="corresp-info"><strong>*</strong>Phone: 82-2-880-7846. Fax: 82-2-888-0649. E-mail: <a href="/cdn-cgi/l/email-protection#5d3738382a32321d2e3328733c3e73362f"><span class="__cf_email__" data-cfemail="a5cfc0c0d2cacae5d6cbd08bc4c68bced7">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00098&amp;href=/doi/10.1021%2Facs.jmedchem.7b00098" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2573–2590</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 24, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>19 January 2017</li><li><span class="item_label"><b>Published</b> online</span>13 March 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 March 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00098" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00098</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2573%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DVan-Hai%2BHoang%252C%2BPhuong-Thao%2BTran%252C%2BMinghua%2BCui%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D6%26contentID%3Dacs.jmedchem.7b00098%26title%3DDiscovery%2Bof%2BPotent%2BHuman%2BGlutaminyl%2BCyclase%2BInhibitors%2Bas%2BAnti-Alzheimer%25E2%2580%2599s%2BAgents%2BBased%2Bon%2BRational%2BDesign%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2590%26publicationDate%3DMarch%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00098"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2736</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">22</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00098" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Potent Human Glutaminyl Cyclase Inhibitors as Anti-Alzheimer’s Agents Based on Rational Design&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Van-Hai&quot;,&quot;last_name&quot;:&quot;Hoang&quot;},{&quot;first_name&quot;:&quot;Phuong-Thao&quot;,&quot;last_name&quot;:&quot;Tran&quot;},{&quot;first_name&quot;:&quot;Minghua&quot;,&quot;last_name&quot;:&quot;Cui&quot;},{&quot;first_name&quot;:&quot;Van&quot;,&quot;last_name&quot;:&quot;T. H. Ngo&quot;},{&quot;first_name&quot;:&quot;Jihyae&quot;,&quot;last_name&quot;:&quot;Ann&quot;},{&quot;first_name&quot;:&quot;Jongmi&quot;,&quot;last_name&quot;:&quot;Park&quot;},{&quot;first_name&quot;:&quot;Jiyoun&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Kwanghyun&quot;,&quot;last_name&quot;:&quot;Choi&quot;},{&quot;first_name&quot;:&quot;Hanyang&quot;,&quot;last_name&quot;:&quot;Cho&quot;},{&quot;first_name&quot;:&quot;Hee&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Hee-Jin&quot;,&quot;last_name&quot;:&quot;Ha&quot;},{&quot;first_name&quot;:&quot;Hyun-Seok&quot;,&quot;last_name&quot;:&quot;Hong&quot;},{&quot;first_name&quot;:&quot;Sun&quot;,&quot;last_name&quot;:&quot;Choi&quot;},{&quot;first_name&quot;:&quot;Young-Ho&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Jeewoo&quot;,&quot;last_name&quot;:&quot;Lee&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;2573-2590&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00098&quot;},&quot;abstract&quot;:&quot;Glutaminyl cyclase (QC) has been implicated in the formation of toxic amyloid plaques by generating the N-terminal pyroglutamate of β-amyloid peptides (pGlu-Aβ) and thus may participate in the pathogenesis of Alzheimer’s disease (AD). We designed a library of glutamyl cyclase (QC) inhibitors based on the proposed binding mode of the preferred substrate, Aβ3E−42. An in vitro structure–activity relationship study identified several excellent QC inhibitors demonstrating 5- to 40-fold increases in potency compared to a known QC inhibitor. When tested in mouse models of AD, compound 212 significantly reduced the brain concentrations of pyroform Aβ and total Aβ and restored cognitive functions. This potent Aβ-lowering effect was achieved by incorporating an additional binding region into our previously established pharmacophoric model, resulting in strong interactions with the carboxylate group of Glu327 in the QC binding site. Our study offers useful insights in designing novel QC inhibitors as a potential treatme&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00098&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00098" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00098&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00098" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00098&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00098" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00098&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00098&amp;href=/doi/10.1021/acs.jmedchem.7b00098" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00098" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00098" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00098%26sid%3Dliteratum%253Aachs%26pmid%3D28234463%26genre%3Darticle%26aulast%3DHoang%26date%3D2017%26atitle%3DDiscovery%2Bof%2BPotent%2BHuman%2BGlutaminyl%2BCyclase%2BInhibitors%2Bas%2BAnti-Alzheimer%25E2%2580%2599s%2BAgents%2BBased%2Bon%2BRational%2BDesign%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D6%26spage%3D2573%26epage%3D2590%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/jmcmar.2017.60.issue-6/20170323/jmcmar.2017.60.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/medium/jm-2017-00098k_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00098&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Glutaminyl cyclase (QC) has been implicated in the formation of toxic amyloid plaques by generating the <i>N</i>-terminal pyroglutamate of β-amyloid peptides (pGlu-Aβ) and thus may participate in the pathogenesis of Alzheimer’s disease (AD). We designed a library of glutamyl cyclase (QC) inhibitors based on the proposed binding mode of the preferred substrate, Aβ<sub>3E−42</sub>. An <i>in vitro</i> structure–activity relationship study identified several excellent QC inhibitors demonstrating 5- to 40-fold increases in potency compared to a known QC inhibitor. When tested in mouse models of AD, compound <b>212</b> significantly reduced the brain concentrations of pyroform Aβ and total Aβ and restored cognitive functions. This potent Aβ-lowering effect was achieved by incorporating an additional binding region into our previously established pharmacophoric model, resulting in strong interactions with the carboxylate group of Glu327 in the QC binding site. Our study offers useful insights in designing novel QC inhibitors as a potential treatment option for AD.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56530" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56530" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) and related dementias are the leading cause of disabilities in old age and have become enormous socioeconomic burdens to many countries with rapidly growing elderly populations. The currently available treatment options for AD, such as acetylcholinesterase inhibitors (AChEI) and <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate (NMDA) receptor antagonists, offer only limited symptomatic relief, rather than modifying the disease course. Among the various alternatives that have been extensively investigated, β-amyloid (Aβ)-targeted therapies have been the center of attention because many research findings indicate that elevated levels of Aβ peptides in the brain promote the formation of amyloid plaques and neuronal death.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> What causes the elevated levels of Aβ peptides is still under debate, but either facilitating the clearance or suppressing the formation of Aβ is likely to reduce amyloid burdens in the brain, possibly slowing down the neurodegenerative process. Unfortunately, several Aβ-lowering drugs based on this premise, such as bapineuzumab, solanezumab, and semagacestat, have failed to provide significant therapeutic benefits in clinical trials. One possible explanation for this recent failure is that the brain Aβ peptides are a heterogeneous mixture of peptides, each form of which displays different structural and functional features.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> Given that Aβ peptides participate in such diverse physiological processes including neurogenesis,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> neuronal survival,<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5-7)</a> oxidative stress,<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> and innate immunity,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> targeting specific forms of Aβ peptides that are prone to aggregation and are neurotoxic may provide a more effective therapy.</div><div class="NLM_p">Aβ peptides are generated by the proteolytic cleavage of the amyloid precursor protein (APP), a transmembrane glycoprotein. Depending on the sequential cleavage sites, Aβ peptides with 30–51 amino acid residues are produced. Aβ<sub>1–40</sub> and Aβ<sub>1–42</sub> are the most abundant isoforms in the human brain and are thought to be the major initiators of AD pathogenesis. The brains of AD patients also contain a significant amount of <i>N</i>-terminally truncated species, such as Aβ<sub>n-40/42</sub>, where <i>n</i> ranges from 2 to 11.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11-13)</a> Many studies have found that these <i>N</i>-terminally truncated species are further cyclized to form pyroglutamate (pGlu)-Aβ. Because of their increased hydrophobicity, pGlu-Aβ peptides are prone to rapid aggregation and are much more resistant to proteolytic degradation. In fact, Aβ<sub>3(pE)-42</sub> constitutes approximately 15–20% of the total Aβ<sub>42</sub> and is deposited in the center of senile plaques in the brains of AD patients.<a onclick="showRef(event, 'ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16">(14-16)</a> It has been reported that pGlu-Aβ peptides are more neurotoxic than Aβ<sub>1–40</sub> and Aβ<sub>1–42</sub> and act as a seed for amyloid and tau plaques.<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17-19)</a></div><div class="NLM_p">The pGlu-Aβ peptides are generated by glutaminyl cyclase (QC). Mammalian QC is mainly found in the pituitary, hypothalamus, and brain and participates in the maturation of neuropeptides and hormones.<a onclick="showRef(event, 'ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22">(20-22)</a> Notably, QC is overexpressed in the brains of AD patients and animal models,<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> and the knockout of QC rescued the cognitive function in AD model mice.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Small molecule QC inhibitors also reduced brain pGlu-Aβ levels and Aβ plaques,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> in addition to decreasing gliosis and restoring memory deficits in AD mice.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In addition, the results from a recent phase I trial indicate that QC inhibitors are well tolerated and metabolically safe for both young and elderly patients,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> suggesting that the inhibition of QC offers an alternative approach to conventional Aβ-lowering agents.</div><div class="NLM_p">In contrast to the emerging importance of QC in AD pathogenesis, relatively few QC inhibitors have been reported so far.<a onclick="showRef(event, 'ref28 ref29 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30 ref31 ref32">(28-32)</a> In general, these inhibitors share two distinct structural features: first, a zinc-binding moiety, such as imidazole, that can bind to the active site zinc ion and second, a large hydrophobic residue that can occupy the penultimate position to the <i>N</i>-terminal glutamine. Previously, our group designed a series of QC inhibitors based on this general scaffold, which we divided into three pharmacophoric regions: A-region representing the zinc-binding group, B-region containing a hydrogen bond donor, and C-region mimicking the aromatic ring of the phenylalanine side chain.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> We studied the structure–activity relationship specifically focused on the C-region, while having 5-methylimidazole in the A-region and a propylthiourea moiety in the B-region, based on the structure of the previously reported QC inhibitor, compound <b>1</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Although we found a promising candidate with an IC<sub>50</sub> value of 58 nM in our previous study, we wanted to further expand our library of QC inhibitors and to study their SAR as well as their <i>in vivo</i> activity. To identify an additional pharmacophore, we turned our attention to the antepenultimate Arg of Aβ<sub>3E−42</sub>. While the substrate specificity of this specific position has not been clearly elucidated, we speculated that the additional side chain might be able to act as a positional anchor to provide enhanced binding interactions. Therefore, we designed a novel scaffold that has an additional pharmacophoric region D, as described in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>. These new series of compounds contain various amine-type functional groups in the D-region, which mimic the guanidine moiety of Arg. In this work, we synthesized newly designed QC inhibitors focused on the D-region and investigated their SAR based on <i>in vitro</i> inhibition for human QC. Furthermore, we evaluated the efficacy of the selected inhibitors by measuring their ability to reduce the formation of Aβ<sub>3(pE)-42</sub> and to prevent memory impairment in AD model mice. Finally, we analyzed the specific binding interactions between the selected inhibitors and the QC active site by performing molecular docking studies.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/medium/jm-2017-00098k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Newly designed scaffold for QC inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00098&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83726" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83726" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">To synthesize compounds with the newly designed scaffold that includes the D-region, we first synthesized a library of 1-alkyloxy-2-methoxy-4-nitrobenzene fragments, as shown in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<a class="ref internalNav" href="#sch3" aria-label="3">3</a>. The syntheses of 1-acyclic and cyclic aminoalkyloxy-2-methoxy-4-nitrobenzene derivatives are described in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The Williamson reaction of 4-nitroguaialcol <b>2</b> with dibromoalkanes followed by N-alkylation provided piperidine, morpholine, and piperazine derivatives <b>6</b>–<b>17</b>. 4-Substituted piperidinyl derivatives, <b>18</b>–<b>20</b>, were synthesized by the Mitsunobu reaction of <b>2</b> with corresponding 4-(hydroxyalkyl)piperidine fragments,<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> followed by an <i>N</i>-Boc deprotection reaction to afford <b>21</b> and <b>23</b>. Compounds <b>21</b> and <b>23</b> were then reductively methylated to provide <b>22</b> and <b>24</b>. Acyclic aminoalkyl derivatives, <b>25</b>–<b>28</b>, were synthesized by Williamson or Mitsunobu reactions with <b>2</b>. Alkyl phthalimide intermediates, <b>29</b> and <b>30</b>, were prepared from <b>2</b> and deprotected to give primary amines <b>31</b> and <b>32</b>, which were converted to compound <b>33</b> by reductive amination and to compounds <b>38</b>–<b>41</b> by monoalkylation using 2-nitrobenzenesulfonamide<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> as a protecting group, respectively. 1-Heteroarylalkyloxy-2-methoxy-4-nitrobenzene fragments were prepared as described in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. The Sonogashira reaction of aryl bromides <b>42</b>–<b>45</b> and <b>47</b><a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> with corresponding terminal alkynes provided the alkyne intermediates <b>50</b>–<b>58</b>, which were further reduced and underwent a Mitsunobu reaction to afford <b>70</b>–<b>74</b> and <b>76</b>–<b>79</b>. Compound <b>75</b> was prepared from commercially available <b>48</b> by reduction and protection followed by the Williamson reaction. 1-Pyridinylalkoxy-2-methoxy-4-nitrobenzene fragments were synthesized as described in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. The C-alkylation of picolines and aminopicolines with bromoalkane derivatives or diethylcarbonate provided chloroethyl, TBS-protected hydroxyalkyl, and ethoxycarbonyl intermediates (<b>85</b>–<b>89</b>, <b>92</b>, and <b>93</b>). Chloroalkyl intermediates (<b>85</b>–<b>87</b>) were conjugated with 4-nitroguaiacol via the Williamson reaction to produce compounds <b>96</b>–<b>98</b>, while TBS-protected hydroxyalkyl intermediates (<b>88</b>, <b>89</b>) were first deprotected with TBAF and subsequently conjugated with 4-nitroguaiacol via the Mitsunobu reaction to yield compounds <b>99</b> and <b>100</b>. The ethoxycarbonyl group in compounds <b>92</b>–<b>93</b> was first reduced to an ethylalcohol group (<b>94</b>–<b>95</b>) by using LAH and further conjugated with 4-nitroguaiacol via the Mitsunobu reaction to generate compounds <b>101</b> and <b>102</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/medium/jm-2017-00098k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the Alkyl D-Region<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00098&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) bromoalkyl derivatives, K<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C, 1 h for <b>25</b>, <b>26</b>, and <b>28</b>; (b) DMF, base (piperidine, morpholine, 1-methylpiperazine, or <i>N</i>-Boc piperazine), heat; (c) 4-(hydroxyalkyl)piperidine, DEAD, PPh<sub>3</sub>, DCM, r.t., 2 h; (d) TFA, DCM, r.t., overnight; (e) (HCHO)<sub>n</sub>, ZnCl<sub>2</sub>, DCM, r.t., 1 h; then NaBH<sub>4</sub>, reflux, overnight; (f) N<sub>2</sub>H<sub>4</sub>·H<sub>2</sub>O, EtOH, r.t., overnight; (g) 2-nitrobenzenesulfonyl chloride, TEA, DCM, r.t., 5 h; (h) CH<sub>3</sub>I, NaH, THF, r.t., overnight; (i) thiophenol, K<sub>2</sub>CO<sub>3</sub>, MeCN, r.t., overnight; (j) Boc<sub>2</sub>O, Et<sub>3</sub>N, DCM, r.t., 2 h; (k) HO(CH)<sub>2</sub>N(CH<sub>3</sub>)Boc, DEAD, PPh<sub>3</sub>, DCM, r.t., 2 h for <b>27</b>.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/medium/jm-2017-00098k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the Aryl D-Region<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00098&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CuI, Pd(PPh<sub>3</sub>)<sub>4</sub>, Et<sub>3</sub>N, DCM, 50 °C, overnight or alkyn-1-ol, DMF, Et<sub>3</sub>N, (Ph<sub>3</sub>P)<sub>2</sub>PdCl<sub>2</sub>, CuI, r.t., 15 h; (b) Pd/C, MeOH, H<sub>2</sub>, r.t., overnight; (c) 4-nitroguaiacol, DEAD, PPh<sub>3</sub>, DCM, r.t., 2 h; (d) HCOONH<sub>4</sub>, Zn, MeOH, r.t., 15 min; (e) 4-nitroguaiacol, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C; (f) Boc<sub>2</sub>O, Et<sub>3</sub>N, DCM, r.t., overnight.</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/medium/jm-2017-00098k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the Aryl D-Region<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00098&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) bromoalkane derivatives or diethylcarbonate, <i>n</i>-BuLi, THF, −78 °C; (b) 4-nitroguaiacol, K<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C, 1 h or 4-nitroguaiacol, DEAD, Ph<sub>3</sub>P, DCM, r.t.; (c) Boc<sub>2</sub>O, <i>t</i>-BuOH, r.t., overnight; (d) TBAF, THF, r.t., 2 h; (e) LAH, THF, 0 °C, 1 h.</p></p></figure><div class="NLM_p">As described in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>, all of the synthesized 1-alkyloxy-2-methoxy-4-nitrobenzene fragments were reduced to corresponding amines, <b>103</b>–<b>145</b>, which were subsequently converted to isothiocyanate and coupled with 3-(5-methyl-1<i>H</i>-imidazol-1-yl)propan-1-amine to afford the final thiourea compounds <i>in situ</i>. Compounds <b>146</b>–<b>166</b> were further subjected to <i>N</i>-Boc deprotection, while compounds <b>167</b> and <b>168</b> were reacted with hydrazine to deprotect a phthalimide group, yielding primary amine final compounds (<b>172</b>–<b>174</b>, <b>191</b>–<b>193</b>, <b>197</b> and <b>198</b>, <b>203</b>–<b>205</b>, <b>210</b> and <b>211</b>, <b>214</b>–<b>216</b>, <b>219</b> and <b>220</b>) as well as amine intermediates (<b>169</b>–<b>171</b>, <b>199</b>, and <b>212</b>). The final modification of the primary amine group of these intermediates generated acetylated (<b>178</b>, <b>213</b>), guanidinylated (<b>179</b>), and methylated (<b>202</b>) analogues. The 2-chloropyrimidine derivatives (<b>180</b>–<b>184</b>) were synthesized via the nucleophilic substitution of the amine intermediates to afford the corresponding final compounds.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/medium/jm-2017-00098k_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0010.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Final QC Inhibitors<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00098&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd/C, H<sub>2</sub>, MeOH, r.t., overnight; (b) 3-(5-methyl-1<i>H</i>-imidazol-1-yl)propan-1-amine, TCDI, Et<sub>3</sub>N, DCM, r.t.–40 °C, overnight; (c) TFA, DCM, r.t., 2 h; (d) 2-chloropyrimidine derivatives, EtOH, Et<sub>3</sub>N, reflux, 2 days; (e) (HCHO)<sub>n</sub>, ZnCl<sub>2</sub>, DCM, r.t., 1 h; then NaBH<sub>4</sub>, reflux, overnight; (f) Ac<sub>2</sub>O, pyridine, MC, r.t., 4–5 h; (g) N<sub>2</sub>H<sub>4</sub>·H<sub>2</sub>O, EtOH, r.t., overnight; (h) 1<i>H</i>-pyrazole-1-carboxamidine-HCl, <i>i</i>Pr<sub>2</sub>EtN, MeOH, r.t.–50 °C, 2 h.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> <i>In Vitro</i> QC Inhibition</h3><div class="NLM_p">To evaluate the biological activity of the compound library, we determined the QC inhibition of each compound by using a fluorogenic substrate, Gln-AMC (<span class="smallcaps smallerCapital">l</span>-glutamine 7-amido-4-methylcoumarin), and pyroglutamyl peptidase (pGAP) as an auxiliary enzyme.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> In this assay, QC first converts Gln-AMC into pGlu-AMC, which is then hydrolyzed by pGAP to generate AMC. AMC can be detected by measuring the fluorescence at the excitation and emission wavelengths of 380 and 460 nm. These results are summarized in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, along with the IC<sub>50</sub> value of compound <b>1</b> (IC<sub>50</sub> = 29.2 nM) for comparison.</div><div class="NLM_p">First, we analyzed the structure–activity relationship of aliphatic amines in the D-region, as shown in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>. Group I (<b>169</b>–<b>184</b>) contains various terminal amine, amide, guanidine, and pyrimidylamine functional groups, while having an aliphatic linker that was varied in length. In general, compounds with a 2-carbon linker (<b>169</b>, <b>172</b>, <b>175</b>, <b>180</b>) showed an activity similar to that of <b>1</b>, whereas compounds with a 3-carbon (<b>170</b>, <b>173</b>, <b>176</b>, <b>181</b>, and <b>183</b>) or 4-carbon (<b>171</b>, <b>174</b>, <b>177</b>, <b>182</b>, and <b>184</b>) linker demonstrated more potent inhibition. In particular, <b>170</b>, <b>177</b>, and <b>182</b> were found to be 6–8-fold more potent than <b>1</b>, having IC<sub>50</sub> values of 5.3, 3.7, and 5.7 nM, respectively. Among the various terminal functional groups, amines and pyrimidylamines showed greater inhibition than amide or guanidine groups, suggesting that the electron density in this region might control the binding interactions rather than the size or number of hydrogens. Furthermore, compound <b>182</b> showed 3-fold more potent inhibition than compound <b>184</b>, which contained an extra fluorine atom in the pyrimidylamine ring, supporting our hypothesis.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. IC<sub>50</sub> Values for Inhibition of <i>h</i>QC by Benzocyclic Compounds (Group I)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/medium/jm-2017-00098k_0011.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/medium/jm-2017-00098k_0012.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">The values indicate the mean of at least three experiments.</p></div></div><div></div></div><div class="NLM_p">Next, we investigated the SAR of the cyclic amine-containing compounds, group II, as shown in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>. Interestingly, all of the compounds in this group proved to be highly potent inhibitors, with IC<sub>50</sub> values ranging from 0.7 to 24.7 nM, regardless of the type of cyclic amine and the length of the linker. In particular, 1-piperazinyl analogues (<b>191</b>–<b>193</b>) appeared to be the most potent in this group, with compound <b>191</b> demonstrating an IC<sub>50</sub> value of 0.7 nM, which was 42-fold more potent than <b>1</b>. Both nitrogen atoms in the piperazine appeared to be important in the binding interaction because removing any one of the nitrogens reduced inhibitory activity as observed in the 1-piperidinyl (<b>185</b>–<b>187</b>), 4-morpholinyl (<b>188</b>–<b>190</b>), 4-piperidinyl (<b>197</b> and <b>199</b>) except <b>198</b> (<i>n</i> = 3), and 4-(1-methylpiperadinyl) (<b>200</b>–<b>202</b>) analogues. In addition, the 4-NH hydrogen might play a crucial role in favorable binding interactions because the 1-piperidinyl (<b>185</b>–<b>187</b>) analogues were much less potent than the 4-piperidinyl analogues (<b>197</b>–<b>199</b>) as well as the 1-piperazinyl analogues (<b>191</b>–<b>193</b>). This apparent importance of the NH at the 4-position is not observed with <i>n</i> = 3 derivatives (<b>186</b>, <b>189</b>, <b>192</b>, <b>195</b>, <b>198</b>, and <b>201</b>), suggesting that the distance between the R-group and C-region also affects the hydrogen bond interaction of the 4-NH.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. IC<sub>50</sub> Values for the Inhibition of <i>h</i>QC by Benzocyclic Compounds (Group II)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/medium/jm-2017-00098k_0013.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">The values indicate the mean of at least three experiments.</p></div></div><div></div></div><div class="NLM_p">We examined the QC inhibition of compounds with aryl amines and nitrogen-containing heterocycles, group III, as demonstrated in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>. All three aniline analogues (<b>203</b>–<b>205</b>) appeared to be potent inhibitors, regardless of the length of the linker, with IC<sub>50</sub> values ranging from 7.7 to 9.0 nM. Within this group, the length of the alkyl linker does not significantly affect the inhibitory effects; rather, the position of nitrogen in the heterocycle seems to be crucial for favorable binding interactions, as was also observed for the compounds in group B. For example, the 3-pyridyl analogue (<b>209</b>, IC<sub>50</sub> = 19.8 nM) was less potent than the 4-pyridyl surrogate (<b>208</b>, IC<sub>50</sub> = 9.1 nM). Among the group C compounds, <b>212</b>, a 4-(2-aminopyridyl) analogue with a 4-carbon linker, was the most potent inhibitor, having an IC<sub>50</sub> value of 4.5 nM. In contrast, compound <b>216</b>, a positional isomer of <b>212</b>, exhibited much less potent inhibition (IC<sub>50</sub> = 19.3 nM), again supporting the fact that the binding direction or position of nitrogen atoms in the heterocycle is particularly important. In addition, to confirm the selectivity of compound <b>212</b>, we also determined the IC<sub>50</sub> value for isoQC, an isozyme of QC with a differential substrate specificity.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38, 39)</a> The IC<sub>50</sub> value of <b>212</b> for isoQC was 502 nM, which was more than 100-fold greater than the IC<sub>50</sub> value for QC, indicating that compound <b>212</b> is highly specific for QC. 5-Pyrimidinyl (<b>217</b>, <b>218</b>) and 5-(2-aminopyrimidinyl) (<b>219</b>, <b>220</b>) analogues were found to be slightly less potent than pyridine analogues.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. IC<sub>50</sub> Values for the Inhibition of <i>h</i>QC by Benzocyclic Compounds (Group III)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/medium/jm-2017-00098k_0014.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">The values indicate the mean of at least three experiments.</p></div></div><div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> <i>In Vivo</i> Activity</h3><div class="NLM_p">On the basis of the <i>in vitro</i> activity, we selected the eight most potent compounds, which demonstrated IC<sub>50</sub> values less than ca. 5 nM, along with compound <b>1</b> as a control for further animal studies. We first examined the cytotoxicity of each compound in an immortalized hippocampal neuronal cell line (HT-22) and found that all compounds were nontoxic at a 10 μM concentration. For the acute model studies, we injected human Aβ<sub>3–40</sub> (5 μg) and each compound (25 mg/kg) into the deep cortical/hippocampus of ICR mice (male, 6 weeks old). On the next day, the inhibitory activities were determined by measuring the levels of human Aβ<sub>N3pE−40</sub> in the brain extracts of the mice. As described in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>, compounds <b>170</b>, <b>191</b>, and <b>212</b> suppressed more than 60% of the formation of Aβ<sub>N3pE−40</sub> compared to the vehicle control, while compound <b>1</b> showed 41.6% inhibition. Specifically, compound <b>191</b>, which showed the most potent activity <i>in vitro</i>, also demonstrated the most potent Aβ<sub>N3pE−40</sub> lowering effects (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a> and <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>a).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. QC Inhibition in Acute Model Studies <i>in Vivo</i><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><i>in vitro</i> IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">cytotoxicity at 10 μM (% of control)</th><th class="colsep0 rowsep0" align="center">% inhibition of human Aβ<sub>N3pE−40</sub> formation (deep cortical/hippocampus injected)</th><th class="colsep0 rowsep0" align="center">% inhibition of human Aβ<sub>N3pE−40</sub> formation (i.p. injected)</th><th class="colsep0 rowsep0" align="center">PAMPA (−log<i>P</i><sub>e</sub>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">29.2 (21.5)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">∼100</td><td class="colsep0 rowsep0" align="left">41.6</td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left">6.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>170</b></td><td class="colsep0 rowsep0" align="left">5.3</td><td class="colsep0 rowsep0" align="left">∼100</td><td class="colsep0 rowsep0" align="left">64.6</td><td class="colsep0 rowsep0" align="left">NE</td><td class="colsep0 rowsep0" align="left">6.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>177</b></td><td class="colsep0 rowsep0" align="left">3.7</td><td class="colsep0 rowsep0" align="left">∼100</td><td class="colsep0 rowsep0" align="left">35.7</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>182</b></td><td class="colsep0 rowsep0" align="left">5.7</td><td class="colsep0 rowsep0" align="left">∼100</td><td class="colsep0 rowsep0" align="left">27.3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>191</b></td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">∼100</td><td class="colsep0 rowsep0" align="left">77.2</td><td class="colsep0 rowsep0" align="left">3.6</td><td class="colsep0 rowsep0" align="left">6.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>193</b></td><td class="colsep0 rowsep0" align="left">4.8</td><td class="colsep0 rowsep0" align="left">∼100</td><td class="colsep0 rowsep0" align="left">29.2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>200</b></td><td class="colsep0 rowsep0" align="left">4.6</td><td class="colsep0 rowsep0" align="left">∼100</td><td class="colsep0 rowsep0" align="left">18.7</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>210</b></td><td class="colsep0 rowsep0" align="left">5.5</td><td class="colsep0 rowsep0" align="left">∼100</td><td class="colsep0 rowsep0" align="left">38.0</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>212</b></td><td class="colsep0 rowsep0" align="left">4.5 (12.6)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">∼100</td><td class="colsep0 rowsep0" align="left">66.1</td><td class="colsep0 rowsep0" align="left">54.7</td><td class="colsep0 rowsep0" align="left">4.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">5 μL of human Aβ<sub>3–40</sub> in PBS (1 μg/μL) was injected into the deep cortical/hippocampus to 5 week old ICR mice (25 g, <i>n</i> = 4, male) using a stereotaxic frame to induce acute Aβ toxicity. Test compounds were administrated via i.c.v. or i.p. injection. Sandwich ELISA was performed for the quantification of the brain Aβ<sub>N3pE−40</sub>.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">IC<sub>50</sub> values were measured additionally by using mouse QC.</p></div></div></div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/medium/jm-2017-00098k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Inhibition of QC in acute AD model mice showing percent inhibition of the formation of human Aβ<sub>N3pE−40</sub> levels in the brain after (a) deep cortical/hippocampus injection (10 mM); (b) i.p. injection of each inhibitor (25 mg/kg). Data were analyzed by One-way ANOVA with a Bonferroni posthoc test in SPSS. (*, <i>p</i> < 0.05; **, <i>p</i> < 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00098&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Next, we performed another acute model study by intraperitoneally (i.p.) injecting the three most potent compounds (<b>170</b>, <b>191</b>, and <b>212</b>) to assess their <i>in vivo</i> efficacy, which can be translated to the ability to penetrate the blood–brain barrier (BBB). Again, human Aβ<sub>3–40</sub> was injected deep into cortical/hippocampus prior to the i.p. administration of each inhibitor into ICR mice. The inhibitory activities were estimated by measuring the levels of human Aβ<sub>N3pE−40</sub> in the brain extracts of the mice. As shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>b, among all the injected compounds, <b>212</b> exhibited significant Aβ<sub>N3pE−40</sub> lowering effects (54.7% inhibition), whereas compounds <b>1</b>, <b>170</b>, and <b>191</b> were found to be inactive via i.p. injection. A parallel artificial membrane permeability assay (PAMPA)<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> of these four compounds also correlated with the i.p. <i>in vivo</i> results, showing that <b>212</b> was the most permeable compound, while the other three compounds showed low permeabilities with similar −log<i>P</i><sub>e</sub> values (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Additionally, we determined the mouse liver microsomal stability of compound <b>212</b> and found that the percent remaining after 30 min was 50%, indicating that <b>212</b> is moderately stable for metabolism <i>in vivo</i>. These observations supported that a significant amount of <b>212</b> penetrated the BBB and successfully inhibited the brain QC.</div><div class="NLM_p">To validate the desired therapeutic effects of compound <b>212</b>, we next performed long-term studies in a transgenic model mice of AD. <b>212</b> was administered to the APP/PS1 mice via deep cortical/hippocampus brain infusion for 21 days. After the brain infusion, the brain concentrations of Aβ<sub>N3pE−42</sub> and Aβ<sub>1–42</sub> were measured. As described in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, compound <b>212</b> significantly reduced the brain concentrations of Aβ<sub>N3pE−42</sub> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>a), which corresponds to the observed percent inhibition in acute AD mice. Compound <b>212</b> also significantly reduced the total Aβ levels (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>b) without significant toxicity, indicating that the inhibition of QC not only reduced the amount of pGlu-Aβ but also contributed to the overall reduction of amyloid formation.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/medium/jm-2017-00098k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Inhibition of the formation of human Aβ<sub>N3pE−42</sub> and Aβ<sub>1–42</sub> in APP/PS1 mice. (a) Brain concentrations of Aβ<sub>N3pE−42</sub>; (b) brain concentrations of Aβ<sub>1–42</sub>. Data were analyzed by unpaired <i>t</i> test or one-way ANOVA. (ns, <i>p</i> > 0.05; *, <i>p</i> < 0.05; **, <i>p</i> < 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00098&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Next, we tested compound <b>212</b> in 5XFAD transgenic mice, a well-known AD mouse model suitable to study Aβ<sub>42</sub>-induced neurodegeneration and amyloid plaque formation.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> We specifically chose 5XFAD mice because this particular AD model generates severe AD related pathologies that resulted from the massive increase of Aβ and the pyroform of Aβ in the brains.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Aβ<sub>42</sub> accumulates in the 5XFAD brain starting at 2 months of age, and develops other typical AD pathologies such as reduced synaptic markers, neuronal loss, and memory impairments. We injected <b>212</b> into 5XFAD mice from 19 weeks to 34 weeks of age and performed the Morris Water Maze test to assess changes in the spatial memory impairment. The efficacy of <b>212</b> in 5XFAD mice was evaluated based on the subsequent improvement in cognitive functions, as shown in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>. The escape latency of <b>212</b>-treated mice became significantly shorter over repeated sessions compared with vehicle-treated mice (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>a), indicating that the treatment of <b>212</b> improved cognitive function. Additionally, the duration of time spent in the target quadrant was significantly longer with <b>212</b> treated mice (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>b), also supporting that the QC inhibitor <b>212</b> effectively recovered learning and memory function without fatal side effects.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/medium/jm-2017-00098k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of compound <b>212</b> on the cognitive function of 5XFAD mice. (a) Escape latency of each group in the hidden-platform training of the Morris water maze. Data were analyzed by two-way repeated-measures ANOVA. (b) Percentage of time spent in the target quadrant. Data were analyzed by independent samples <i>t</i> test in SPSS. (ns, <i>p</i> > 0.05; *, <i>p</i> < 0.05).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00098&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Molecular Modeling Studies</h3><div class="NLM_p">Among the compounds we designed based on the <i>N</i>-terminal tripeptide (Glu-Phe-Arg) of Aβ<sub>3E−42</sub>, compounds <b>191</b> and <b>212</b> exhibited excellent <i>in vitro</i> activity. Specifically, <b>191</b> demonstrated more than 40-fold higher potency compared with the reported dipeptide mimic compound <b>1</b>. Considering that the addition of the D-region pharmacophore improved the inhibitory effects to such a great extent, we decided to study the mode of binding of these compounds in the <i>h</i>QC active site. For our docking studies, we utilized the X-ray crystal structure of <i>h</i>QC complexed with a known QC inhibitor, PBD150 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBB">3PBB</a>).<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Since the ligand protonation states are important for an accurate docking study, we first performed the protonation state prediction of our ligands. At the physiological pH of 7.4, the D-region in <b>191</b> was monoprotonated in its major form and that of <b>212</b> was predicted to have neutral and protonated forms with the ratio of 2:1. Glide SP (Standard Precision) docking was also carried out, and both <b>191</b> and <b>212</b> docked very well into the active site of <i>h</i>QC. The 5-methyl imidazole in the A-region chelated with zinc and formed an H-bonding interaction with the indole NH of Trp329. Additionally, it displayed hydrophobic interactions with Leu249, Trp207, and Ile321. The thiourea group in the B-region acted as a linker, and the phenyl ring in the C-region exhibited a hydrophobic interaction with Tyr299. The piperazine or pyridine ring of the D-region also exhibited hydrophobic interactions with Pro326 and Pro324, but the NH in the Arg mimetic part of the compounds did not show any interactions. We further adopted Glide QM-polarized ligand docking (QPLD) in Maestro, which can improve the docking accuracy over pure molecular mechanics (MM) methods by calculating the partial charges of the ligand using quantum mechanics (QM).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The resulting docking modes showed that the Arg mimetic D-region considerably moved toward the Glu327 of the <i>h</i>QC active site, denoting promising interactions between them. These encouraging results prompted us to further optimize the protein–ligand complexes.</div><div class="NLM_p">The local optimization refinement made the side chain of Glu327 significantly move within the range of a salt bridge interaction with the D-region of our ligands. To estimate the global minimum, the protein–ligand complexes were further refined using Monte Carlo minimization by randomly sampling the discrete set of energy minima and accumulating the energy contributions.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Finally, scrupulous optimization of the protein–ligand complexes produced a remarkable change in the position of the Glu327 side chain, allowing it to interact with the D-region of the ligands (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00098/suppl_file/jm7b00098_si_001.pdf" class="ext-link">Supporting Information</a>).</div><div class="NLM_p">For the most potent compound, <b>191</b>, the D-region displayed a salt bridge interaction as well as H-bonding with the side chain carboxylate of Glu327 (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). In the case of <b>212</b>, the D-region showed H-bonding interaction in its neutral form and a salt bridge interaction in its protonated form (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). In addition, the D-region of both compounds showed hydrophobic interactions with Pro326 and Val328. The A-region maintained docking results such as zinc chelation, H-bonding, and hydrophobic interactions. The thiourea group in the B-region formed an additional H-bond with Gln304. The phenyl ring in the C-region presented π–π interactions with Phe325. Moreover, aside from the previous hydrophobic interaction with Tyr299, continuous refinements led to the formation of additional hydrophobic interactions with Pro324 and Phe325.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/medium/jm-2017-00098k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Docked and refined structure of <b>191</b> in <i>h</i>QC. (A) Binding interactions of <b>191</b> at the active site of <i>h</i>QC. <b>191</b> is displayed as sticks with magenta carbon atoms, and Zn<sup>2+</sup> is a purple ball. The interacting residues are depicted as light blue sticks. Hydrogen bonds are depicted as black dashed lines. (B) 2D representation of the interactions of <b>191</b> with the active site residues of the <i>h</i>QC. Hydrophobic interactions are marked in light brown. Hydrogen bonds are shown as red-dotted arrows with their directionality. The π–π stacking interaction is marked as a blue disc and arrow, and the salt bridge interaction is displayed as a blue wedged line.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00098&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/medium/jm-2017-00098k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0006.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Docked and refined structures of <b>212</b> in <i>h</i>QC. Binding interactions of <b>212</b> in (A) neutral form and (B) protonated form at the active site of the <i>h</i>QC. <b>212</b> is represented in sticks with cyan carbon atoms, and Zn<sup>2+</sup> is a purple ball. The interacting residues are depicted as light blue sticks. Hydrogen bonds are depicted as black dashed lines. 2D representation of <b>212</b> interactions in (C) neutral form and (D) protonated form with the active site of <i>h</i>QC. Hydrophobic interactions are marked in light brown. Hydrogen bonds are shown as red- and green-dotted arrows with their directionality. The π–π stacking interaction is marked as a blue disc and arrow, and the salt bridge interaction is displayed as a blue wedged line.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00098&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In summary, our docking and refinement results showed that the designed and synthesized inhibitors bind very well in the active site of the <i>h</i>QC via the aggregated interactions of the A-, B-, C-, and D-regions. Notably, the Arg mimetic D-regions of the inhibitors were able to form strong interactions with the carboxylate group of Glu327, providing a feasible explanation of how our Arg mimetic compounds enhanced the inhibitory activity against <i>h</i>QC.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03868" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03868" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We developed novel QC inhibitors that have the potential to serve as a novel therapeutic option for AD. In particular, we aimed to further expand our library of QC inhibitors and designed compounds with an extended scaffold based on the <i>N</i>-terminal tripeptide (Glu-Phe-Arg) of Aβ<sub>3E−42</sub>. In-depth SAR studies identified the eight most potent inhibitors, which demonstrated excellent QC inhibition, with 5- to 40-fold increases in potency compared to a known inhibitor, compound <b>1</b>. These inhibitors were further tested in acute model mice for Aβ-lowering effects <i>in vivo</i>, and compound <b>212</b> penetrated the BBB and effectively reduced the brain levels of Aβ<sub>1–42</sub> and Aβ<sub>N3pE−42</sub>. Moreover, we evaluated the <i>in vivo</i> efficacy of <b>212</b> in two different transgenic model mice of AD, APP/PS1, and 5XFAD, to verify the desired therapeutic effects. Compound <b>212</b> not only reduced the brain concentrations of pyroform Aβ and total Aβ in APP/PS1 mice but also restored cognitive functions in 5XFAD mice. This significant enhancement of the overall activity was achieved by adding the Arg mimetic D-region, which created an additional binding interaction. Stepwise computational studies utilizing quantum mechanics-based molecular docking and Monte Carlo algorithm-based refinement suggested that the Arg mimetic D-regions of <b>191</b> and <b>212</b> formed strong interactions with the carboxylate group of Glu327, and both compounds demonstrated favorable binding interactions with all four pharmacophoric regions. Taken together, compound <b>212</b> is an effective QC inhibitor for a possible therapeutic alternative in AD. We believe that this study provides useful insights in designing potent QC inhibitors in the future.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06551" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06551" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General</h3><div class="NLM_p last">All chemical reagents were commercially available. Melting points were determined on a melting point Buchi B-540 apparatus and are uncorrected. Silica gel column chromatography was performed on silica gel 60, 230–400 mesh, Merck. The PLC plates used PLC silica gel 60 F<sub>254</sub>, 1 mm, Merck. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on a JEOL JNM-LA 300 at 300 and 75 MHz, Bruker Analytik, DE/AVANCE Digital 400 at 400 and 100 MHz, Bruker Analytik, DE/AVANCE Digital 500 at 500 and 125 MHz, JEOL JNM-ECA-600 at 600 and 150 MHz, and Ultrashielded Bruker Avance III HD NMR spectrometer at 800 and 200 MHz. Chemical shifts are reported in ppm units with Me<sub>4</sub>Si as a reference standard. Mass spectra were recorded on a VG Trio-2 GC–MS instrument and a 6460 Triple Quad LC–MS instrument. All final compounds were purified to >95% purity, as determined by high-performance liquid chromatography (HPLC). HPLC was performed on an Agilent 1120 Compact LC (G4288A) instrument using an Agilent TC-C18 column (4.6 mm × 250 mm, 5 μm).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Procedure for the C-Alkylated Reaction (Procedure <b>1</b>)</h3><div class="NLM_p last">A solution of a picoline derivative (1 equiv) in anhydrous THF was added dropwise to a 2.5 M <i>n</i>-butyllithium solution in THF (1.5 equiv for compounds <b>85</b> and <b>86</b>; 2.5 equiv for compounds <b>87</b>–<b>89</b>, <b>92</b>; 3.5 equiv for <b>93</b>) at −78 °C under nitrogen. The reaction mixture was stirred at room temperature for 30 min before being cooled again to −78 °C. 1-Bromo-2-chloroethane (1.1 equiv, compounds <b>85</b> and <b>87</b>), 1-bromo-3-chloropropane (1.1 equiv, compound <b>86</b>), (3-bromopropoxy)-(<i>tert</i>-butyl)dimethylsilane (1.1 equiv, compounds <b>88</b> and <b>89</b>) or diethyl carbonate (1.5 equiv, compounds <b>92</b> and <b>93</b>) in anhydrous THF was added slowly to the reaction mixture. The reaction was monitored by TLC, and water was added when the reaction was finished. The mixture was extracted by EtOAc, washed by water, dried over MgSO<sub>4</sub>, and concentrated. The product was purified by silica gel chromatography with a gradient of 10 to 25% EtOAc in <i>n</i>-hexane as the eluting solvent.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Procedure for the Williamson Reaction (Procedure <b>2</b>)</h3><div class="NLM_p last">To a suspension of 4-nitroguaiacol <b>2</b> (1.0 equiv) and potassium carbonate (compounds <b>3</b>–<b>5</b>, <b>25</b>–<b>30</b>, and <b>96</b>–<b>98</b>) or cesium carbonate (compound <b>74</b>) (2.0 equiv) in anhydrous DMF, an alkyl halide was added. The reaction mixture was heated to 100 °C for 1 h and then cooled to room temperature and quenched by the addition of water. The precipitated was formed, filtered, and washed with water (3 times). The yellow solid product was collected, dried under vacuum, and carried on to the next step without further purification, or the crude was purified by column chromatography.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Procedure for N-Alkylation (Procedure <b>3</b>)</h3><div class="NLM_p last">To a solution of an amine (1.5 equiv) and the same amine participating in the reaction (2.0 equiv) as a base (compounds <b>6</b>–<b>17</b>) in anhydrous DMF, alkyl halide (1.0 equiv) was added. The reaction mixture was heated to 60 °C until the starting material was consumed, and then it was cooled to room temperature and quenched by the addition of water. The precipitate was formed, filtered, and washed with water (3 times), and the solid product was collected, dried under vacuum, and carried on to the next step without further purification; or the crude was purified by column chromatography.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Procedure for the Reduction of the Nitro Group to an Amine Group or Alkyne Derivatives to Alkyl Derivatives (Procedure <b>4</b>)</h3><div class="NLM_p last">The nitro compound or the alkyne compound was dissolved in MeOH (or a mixture of MeOH and THF), and then 10% Pd/C was added. The mixture was stirred at room temperature under hydrogen gas until the starting material was consumed. The crude mixture was filtered through Celite, washed with methanol, and then concentrated. The product was carried on to the next step without further purification or was purified by column chromatography.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Procedure for Thiourea Coupling (Procedure <b>5</b>)</h3><div class="NLM_p last">To a solution of 1,1′-thiocarbonyldiimidazole (TCDI) (1.02 equiv) in anhydrous DCM was added dropwise a solution of arylamine (1.0 equiv) in anhydrous DCM under nitrogen gas at room temperature. The reaction mixture was stirred at room temperature until the starting material was consumed, and then a solution of 3-(5-methyl-1<i>H</i>-imidazol-1-yl)propan-1-amine (1.1 equiv) in anhydrous DCM was added dropwise, followed by the addition of triethylamine (3.0 equiv) and stirring at room temperature until the reaction was complete (as monitored by TLC). The mixture was washed 2 times with water. The combined organic layer was dried over MgSO<sub>4</sub>, concentrated, and purified by column chromatography.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General Procedure for Boc-Protection (Procedure <b>6</b>)</h3><div class="NLM_p last">To a suspension of starting material amine (1.0 equiv) in DCM or <i>tert-</i>butyl alcohol (compounds <b>83</b> and <b>84</b>) were added triethylamine (1.2 equiv) and di-<i>tert</i>-butyl dicarbonate in DCM under ice cooling. The mixture was stirred at room temperature until the staring material was consumed. To this, was added water, and it was extracted with DCM. The organic layer was washed with 10% aqueous NaHCO<sub>3</sub> solution, water, and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The residue was purified by column chromatography.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> General Procedure for Boc-Deprotection (Procedure <b>7</b>)</h3><div class="NLM_p last">Trifluoroacetic acid (10.0 equiv) was added to the solution of <i>boc</i>-protected compound (1.0 equiv) in DCM (DCM/TFA = 1:1 (v/v)). The mixture was stirred at room temperature until the starting material was consumed, and then the solvent was evaporated. The residue was dissolved in MeOH and purified by an ion-exchange column, or water was added to the residue, and then it was basified by 1 N NaOH and extracted by DCM (2 times). The combined organic layer was washed with brine, dried over MgSO<sub>4</sub>, and purified by PLC or column chromatography to give the desired product.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> General Procedure for Mitsunobu Reaction (Procedure <b>8</b>)</h3><div class="NLM_p last">Triphenylphosphine (1.3 equiv) was added under nitrogen to a solution of 4-nitroguaiacol (<b>2</b>) (1.0 equiv) in DCM, followed by the addition of a primary alcohol (1.2 equiv) and a solution of diethyl azodicarboxylate (1.3 equiv) in DCM (2 mL). After the solution was stirred for 30 min at ambient temperature, the reaction mixture was poured onto a column of silica and was eluted with EtOAc/<i>n</i>-hexane to give the desired product.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> General Procedure for Sonogashira Coupling Reaction (Procedure <b>9</b>)</h3><div class="NLM_p">To a 3-necked round-bottomed flask of a solution of aryl halide (1.0 equiv) in anhydrous DCM was added copper iodide (5% mol), tetrakis(triphenylphosphine)palladium (0) (5% mol), triethylamine (3.0 equiv), and a terminal alkyne (2.0 equiv) under argon, and the reaction was stirred at 50 °C for 15 h. The reaction was diluted with EtOAc and washed with saturated aqueous NH<sub>4</sub>Cl solution (twice), and the combined aqueous layers were extracted with EtOAc (3 times). The combined organic layers were washed with brine, dried over MgSO<sub>4</sub>, and concentrated. Column chromatography (<i>n</i>-hexane/EtOAc) yielded the desired product.</div><div id="sec4_10_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 1-(4-(2-Aminoethoxy)-3-methoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>169</b>)</h4><div class="NLM_p last">From compound <b>146</b>, procedure <b>7</b>; yield 54%, white solid, mp 84–85 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.59 (d, <i>J</i> = 1.11 Hz, 1H), 6.98 (d, <i>J</i> = 8.61 Hz, 1H), 6.94 (d, <i>J</i> = 2.22 Hz, 1H), 6.78 (dd, <i>J</i> = 8.43, 2.40 Hz, 1H), 6.66 (s, 1H), 4.04 (t, <i>J</i> = 5.31 Hz, 2H), 3.99 (t, <i>J</i> = 7.32 Hz, 2H), 3.83 (s, 3H), 3.61 (t, <i>J</i> = 6.96 Hz, 2H), 3.00 (t, <i>J</i> = 5.31 Hz, 2H), 2.22 (d, <i>J</i> = 0.93 Hz, 3H), 2.07 (quintet, <i>J</i> = 7.14 Hz, 2H). <sup>13</sup>C NMR (200 MHz, CD<sub>3</sub>OD) δ 183.3, 152.0, 148.6, 138.8, 133.8, 129.8, 127.3, 119.9, 116.3, 112.0, 71.8, 57.3, 44.1, 43.8, 42.3, 32.0, 9.9. MS(FAB) <i>m</i>/<i>z</i> 364 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>17</sub>H<sub>25</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 364.1807, found 364.1805.</div></div><div id="sec4_10_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 1-(4-(3-Aminopropoxy)-3-methoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)-thiourea (<b>170</b>)</h4><div class="NLM_p last">Compound <b>167</b> (1.0 equiv) was dissolved in ethanol, and hydrazine monohydrate (5.0 equiv) was added dropwise. The mixture was stirred at room temperature until the starting material was consumed. The formed precipitate was filtered off and washed with ethanol. The filtrate was collected and concentrated by rotary evaporation to afford the desired product as an off white solid (48 mg, 42%), mp 78–79 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.59 (s, 1H), 6.97 (d, <i>J</i> = 8.61 Hz, 1H), 6.91 (d, <i>J</i> = 2.19 Hz, 1H), 6.77 (dd, <i>J</i> = 8.43, 2.37 Hz, 1H), 6.66 (s, 1H), 4.09 (t, <i>J</i> = 6.06 Hz, 2H), 4.00 (t, <i>J</i> = 6.96 Hz, 2H), 3.81 (s, 3H), 3.62 (t, <i>J</i> = 6.57 Hz, 2H), 2.86 (t, <i>J</i> = 6.78 Hz, 2H), 2.22 (d, <i>J</i> = 0.93 Hz, 3H), 2.08 (quintet, <i>J</i> = 7.14 Hz, 2H), 1.96 (quintet, <i>J</i> = 6.24 Hz, 2H). <sup>13</sup>C NMR (200 MHz, CD<sub>3</sub>OD) δ 183.4, 151.9, 148.6, 138.7, 133.4, 129.8, 127.3, 119.9, 116.4, 112.0, 70.1, 57.2, 44.1, 43.8, 42.0, 32.0, 27.5, 9.9. MS(FAB) <i>m</i>/<i>z</i> 378 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>18</sub>H<sub>27</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 378.1958, found 378.1965.</div></div><div id="sec4_10_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 1-(4-(4-Aminobutoxy)-3-methoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)-thiourea (<b>171</b>)</h4><div class="NLM_p last">Prepared from compound <b>168</b> by following the experiment procedure used for compound <b>170</b> to afford the desired product as a white solid (38 mg, 40%), the compound was decomposed at 199 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.59 (d, <i>J</i> = 0.93 Hz, 1H), 6.95–6.92 (m, 2H), 6.77 (dd, <i>J</i> = 8.40, 2.37 Hz, 1H), 6.66 (s, 1H), 4.03–3.95 (m, 4H), 3.81 (s, 3H), 3.61 (t, <i>J</i> = 5.67 Hz, 2H), 2.82 (t, <i>J</i> = 7.14 Hz, 2H), 2.22 (d, <i>J</i> = 0.93 Hz, 3H), 2.07 (quintet, <i>J</i> = 7.14 Hz, 2H), 1.88 (quintet, <i>J</i> = 6.24 Hz, 2H), 1.76 (quintet, <i>J</i> = 6.75 Hz, 2H). <sup>13</sup>C NMR (200 MHz, CD<sub>3</sub>OD) δ 183.5, 151.9, 148.7, 138.8, 133.6, 129.8, 127.3, 119.7, 115.5, 112.0, 70.7, 57.3, 44.2, 43.8, 41.6, 32.1, 28.0, 26.9, 9.9. MS(FAB) <i>m</i>/<i>z</i> 392 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>19</sub>H<sub>29</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 392.2120, found 392.2112.</div></div><div id="sec4_10_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 1-(3-Methoxy-4-(2-(methylamino)ethoxy)phenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>172</b>)</h4><div class="NLM_p last">From compound <b>149</b>, procedure <b>7</b>; yield 34%, white solid, mp 73–74 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.60 (s, 1H), 6.98 (d, <i>J</i> = 8.40 Hz, 1H), 6.97 (s, 1H), 6.77 (dd, <i>J</i> = 8.16, 2.37 Hz, 1H), 6.67 (s, 1H), 4.12 (t, <i>J</i> = 5.13 Hz, 2H), 3.98 (t, <i>J</i> = 7.32 Hz, 2H), 3.83 (s, 3H), 3.57 (t, <i>J</i> = 6.42 Hz, 2H), 3.00 (t, <i>J</i> = 5.31 Hz, 2H), 2.50 (s, 3H), 2.22 (d, <i>J</i> = 0.9 Hz, 3H), 2.04 (quintet, <i>J</i> = 6.75 Hz, 2H). <sup>13</sup>C NMR (200 MHz, CD<sub>3</sub>OD) δ 183.3, 152.0, 148.6, 138.8, 133.8, 129.7, 127.3, 119.8, 116.4, 112.1, 69.6, 57.3, 51.7, 44.1, 43.8, 36.3, 32.0, 9.9. MS(ESI) <i>m</i>/<i>z</i> 378 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>18</sub>H<sub>27</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 378.1963, found 378.1954.</div></div><div id="sec4_10_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 1-(3-Methoxy-4-(3-(methylamino)propoxy)phenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl) thiourea (<b>173</b>)</h4><div class="NLM_p last">From compound <b>150</b>, procedure <b>7</b>; yield 74%, white solid, mp 80–81 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.59 (d, <i>J</i> = 1.11 Hz, 1H), 6.95 (d, <i>J</i> = 8.61 Hz, 1H), 6.93 (d, <i>J</i> = 2.37 Hz, 1H), 6.75 (dd, <i>J</i> = 8.31, 2.37 Hz, 1H), 6.66 (s, 1H), 4.08 (t, <i>J</i> = 6.06 Hz, 2H), 3.97 (t, <i>J</i> = 7.32 Hz, 2H), 3.82 (s, 3H), 3.95 (t, <i>J</i> = 6.42 Hz, 2H), 2.84 (t, <i>J</i> = 6.75 Hz, 2H), 2.46 (s, 3H), 2.22 (d, <i>J</i> = 0.93 Hz, 3H), 2.08–1.97 (m, 4H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 181.3, 149.8, 146.9, 136.3, 129.9, 127.2, 125.9, 118.0, 113.4, 109.9, 67.7, 55.8, 48.5, 42.2, 41.8, 35.0, 29.9, 27.6, 9.2. MS (FAB) <i>m</i>/<i>z</i> 392 [M + H]<sup>+</sup>. HRMS (FAB) calcd for C<sub>19</sub>H<sub>29</sub>N<sub>5</sub>O<sub>2</sub>S (M + H<sup>+</sup>) 392.2115, found 392.2135.</div></div><div id="sec4_10_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 1-(3-Methoxy-4-(3-(methylamino)butoxy)phenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>174</b>)</h4><div class="NLM_p last">From compound <b>151</b>, procedure <b>7</b>; yield 31%, white solid, mp 60–61 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.59 (d, <i>J</i> = 1.08 Hz, 1H), 6.93 (d, <i>J</i> = 8.61 Hz, 1H), 6.92 (d, <i>J</i> = 2.73 Hz, 1H), 6.75 (dd, <i>J</i> = 8.61, 2.55 Hz, 1H), 6.66 (s, 1H), 4.02 (t, <i>J</i> = 5.67 Hz, 2H), 3.95 (t, <i>J</i> = 7.32 Hz, 2H), 3.81 (s, 3H), 3.59 (t, <i>J</i> = 6.78 Hz, 2H), 2.76 (t, <i>J</i> = 7.2 Hz, 2H), 2.47 (s, 3H), 2.22 (d, <i>J</i> = 0.93 Hz, 3H), 2.03 (quintet, <i>J</i> = 6.95 Hz, 2H), 1.87–1.73 (m, 4H). <sup>13</sup>C NMR (200 MHz, CD<sub>3</sub>OD) δ 183.3, 151.8, 148.9, 138.7, 133.2, 129.7, 127.3, 119.8, 115.5, 112.1, 70.8, 57.3, 52.1, 44.1, 43.8, 35.6, 32.1, 28.3, 26.5, 9.9. MS (ESI) <i>m</i>/<i>z</i> 406 [M + H]<sup>+</sup>. HRMS (FAB) calcd for C<sub>20</sub>H<sub>31</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 406.2276, found 406.2270.</div></div><div id="sec4_10_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 1-(4-(2-(Dimethylamino)ethoxy)-3-methoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>175</b>)</h4><div class="NLM_p last">From compound <b>103</b>, procedure <b>5</b>; yield 50%, off white solid, mp 153–154 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.62 (s, 1H), 6.99 (d, <i>J</i> = 8.61 Hz, 1H), 6.96 (d, <i>J</i> = 3.27 Hz, 1H), 6.78 (dd, <i>J</i> = 8.43, 2.40 Hz, 1H), 6.67 (s, 1H), 4.15 (t, <i>J</i> = 5.49 Hz, 2H), 4.00 (t, <i>J</i> = 7.14 Hz, 2H), 3.81 (s, 3H), 3.61 (t, <i>J</i> = 6.57 Hz, 2H), 2.92 (t, <i>J</i> = 5.49 Hz, 2H), 2.46 (s, 6H), 2.22 (d, <i>J</i> = 1.08 Hz, 3H), 2.08 (quintet, <i>J</i> = 7.32 Hz, 2H). <sup>13</sup>C NMR (200 MHz, CD<sub>3</sub>OD) δ 183.5, 152.5, 148.3, 138.8, 134.4, 129.9, 127.1, 119.5, 117.2, 112.0, 68.4, 59.5, 57.2, 46.1, 44.3, 43.7, 32.1, 9.9. MS (FAB) <i>m</i>/<i>z</i> 392 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>19</sub>H<sub>29</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 392.2120 found, 392.2128.</div></div><div id="sec4_10_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 1-(4-(3-(Dimethylamino)propoxy)-3-methoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>176</b>)</h4><div class="NLM_p last">From compound <b>104</b>, procedure <b>5</b>; yield 50%, off white solid, the compound was decomposed at 195 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.62 (s, 1H), 6.97 (s, 1H), 6.95 (s, 1H), 6.79 (dd, <i>J</i> = 8.61, 2.37 Hz, 1H), 6.68 (s, 1H), 4.11 (t, <i>J</i> = 5.88 Hz, 2H), 4.01 (t, <i>J</i> = 7.14 Hz, 2H), 3.83 (s, 3H), 3.60 (t, <i>J</i> = 6.96 Hz, 2H), 3.02 (t, <i>J</i> = 7.32 Hz, 2H), 2.65 (s, 6H), 2.23 (d, <i>J</i> = 0.90 Hz, 3H), 2.15–2.02 (m, 4H). <sup>13</sup>C NMR (125 MHz, CD<sub>3</sub>OD) δ 183.5, 152.0, 148.5, 138.7, 134.1, 129.9, 127.1, 119.6, 116.2, 112.0, 69.4, 58.4, 57.4, 45.1, 44.3, 43.7, 32.1, 27.2, 9.9. MS (FAB) <i>m</i>/<i>z</i> 406 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>20</sub>H<sub>31</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 406.2271, found 406.2277.</div></div><div id="sec4_10_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 1-(4-(4-(Dimethylamino)butoxy)-3-methoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>177</b>)</h4><div class="NLM_p last">From compound <b>105</b>, procedure <b>5</b>; yield 87%, white solid, mp 50–51 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.60 (s, 1H), 7.37 (s, 1H), 6.87 (d, <i>J</i> = 8.25 Hz, 1H), 6.75–6.70 (m, 3H), 5.95 (s, 1H), 4.05 (t, <i>J</i> = 6.42 Hz, 2H), 3.89 (t, <i>J</i> = 6.96 Hz, 2H), 3.83 (s, 3H), 3.66 (q, <i>J</i> = 7.32 Hz, 2H), 2.36 (t, <i>J</i> = 7.5 Hz, 2H), 2.25 (s, 6H), 2.17 (d, <i>J</i> = 0.93 Hz, 3H), 2.05 (t, <i>J</i> = 7.14 Hz, 2H), 1.89–1.86 (m, 2H), 1.67 (quintet, <i>J</i> = 6.78 Hz, 2H). <sup>13</sup>C NMR (75 MHz, CD<sub>3</sub>OD) δ 183.3, 152.2, 149.3, 138.8, 133.1, 129.7, 127.4, 119.8, 115.9, 112.2, 71.0, 61.1, 57.3, 46.0, 44.2, 43.8, 32.2, 29.0, 25.6, 9.9. MS (ESI) <i>m</i>/<i>z</i> 420 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>21</sub>H<sub>33</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 420.2428, found 420.2430.</div></div><div id="sec4_10_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> <i>N</i>-(3-(2-Methoxy-4-(3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thioureido)phenoxy)propyl)acetamide (<b>178</b>)</h4><div class="NLM_p last">Compound <b>170</b> (100 mg, 1.0 equiv) was dissolved in a solution of pyridine (3 equiv) in DCM (10 mL), then acetic anhydride (1.1 equiv) was added to the mixture. The reaction mixture was stirred at room temperature for 4 h and diluted with DCM, then washed with water, dried over MgSO<sub>4</sub>, and purified by silica gel chromatography to afford the desired product as a white solid (86 mg, 77%); mp 125–126 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.65 (s, 1H), 7.32 (s, 1H), 6.87 (d, <i>J</i> = 8.97 Hz, 1H), 6.76–6.71 (m, 4H), 5.96 (s, 1H), 4.14 (t, <i>J</i> = 5.67 Hz, 2H), 3.90 (t, <i>J</i> = 6.96 Hz, 2H), 3.86 (s, 3H), 3.62 (q, <i>J</i> = 6.96 Hz, 2H), 3.48 (q, <i>J</i> = 5.49 Hz, 2H), 2.19 (s, 3H), 2.11–1.97 (m, 4H), 1.99 (s, 3H). <sup>13</sup>C NMR (200 MHz, CDCl<sub>3</sub>) δ 181.8, 170.1, 149.8, 147.1, 136.5, 129.7, 127.1, 126.5, 118.2, 112.8, 109.9, 68.5, 55.9, 42.3, 42.1, 37.9, 30.1, 28.5, 23.2, 9.2. MS (FAB) <i>m</i>/<i>z</i> 420 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>20</sub>H<sub>29</sub>N<sub>5</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 420.2064, found 420.2060.</div></div><div id="sec4_10_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 1-(4-(3-Guanidinopropoxy)-3-methoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)-thiourea (<b>179</b>)</h4><div class="NLM_p last">To compound <b>170</b> (50 mg, 0.13 mmol) and 1<i>H</i>-pyrazole-1-carboxamidine hydrochloride (78 mg, 0.53 mmol) in anhydrous methanol (2 mL) was added diisopropylethylamine (0.23 mL, 1.3 mmol), and the reaction mixture was stirred at 50 °C for 12 h. The resulting mixture was purified by PLC (MeOH/DCM = 2/9) to afford the product as a white solid (25 mg, 46%), mp 256–257 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.51 (s, 1H), 6.92 (d, <i>J</i> = 2.19 Hz, 1H), 6.89–6.84 (m, 1H), 6.69 (dd, <i>J</i> = 6.57, 2.37 Hz, 1H), 6.57 (s, 1H), 4.01 (t, <i>J</i> = 5.85 Hz, 2H), 3. 92 (t, <i>J</i> = 7.14 Hz, 2H), 3.74 (s, 3H), 3.50 (t, <i>J</i> = 6.03 Hz, 2H), 3.33 (t, <i>J</i> = 6.60 Hz, 2H), 2.13 (d, <i>J</i> = 0.93 Hz, 3H), 2.00–1.93 (m, 4H). <sup>13</sup>C NMR (200 MHz, CD<sub>3</sub>OD) δ 183.4, 157.7, 152.0, 148.4, 138.7, 133.8, 129.6, 127.3, 119.5, 117.4, 112.1, 69.4, 57.5, 44.2, 43.5, 40.1, 32.2, 25.2, 9.9. MS (FAB) <i>m</i>/<i>z</i> 420 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>19</sub>H<sub>29</sub>N<sub>7</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 420.2176, found 420.2191.</div></div><div id="sec4_10_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 1-(3-Methoxy-4-(2-(pyrimidin-2-ylamino)ethoxy)phenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>180</b>)</h4><div class="NLM_p last">Compound <b>169</b> (98 mg, 0.27 mmol) was dissolved in ethanol. 2-Chloropyrimidine (78 mg, 0.54 mmol) and 0.7 mL of triethylamine were added. The mixture was refluxed for 2 days, then the solvent was removed by rotary evaporation and purified by PLC (MeOH/DCM = 1/9) to give a yellow solid product (85 mg, 72%); mp 83–84 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.27 (d, <i>J</i> = 4.95 Hz, 2H), 7.72 (s, 1H), 7.00 (d, <i>J</i> = 8.43 Hz, 1H), 6.92 (d, <i>J</i> = 2.19 Hz, 1H), 6.76–6.72 (m, 2H), 6.62 (t, <i>J</i> = 4.74 Hz, 1H), 4.15 (t, <i>J</i> = 5.49 Hz, 2H), 4.01 (t, <i>J</i> = 7.32 Hz, 2H), 3.81 (s, 3H), 3.77 (t, <i>J</i> = 5.49 Hz, 2H), 3.61 (t, <i>J</i> = 6.96 Hz, 2H), 2.22 (d, <i>J</i> = 0.9 Hz, 3H), 2.08 (quintet, <i>J</i> = 6.96 Hz, 2H). <sup>13</sup>C NMR (200 MHz, CD<sub>3</sub>OD) δ 183.4, 164.3, 160.1, 152.2, 148.9, 138.6, 133.6, 130.1, 126.5, 119.8, 116.4, 112.4, 112.2, 70.2, 57.4, 44.4, 43.7, 42.5, 32.1, 9.9. MS (FAB) <i>m</i>/<i>z</i> 442 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>21</sub>H<sub>27</sub>N<sub>7</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 442.2025, found 442.2036.</div></div><div id="sec4_10_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 1-(3-Methoxy-4-(3-(pyrimidin-2-ylamino)propoxy)phenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>181</b>)</h4><div class="NLM_p last">Prepared from compound <b>170</b> (230 mg, 0.61 mmol) and 2-chloropyrimidine (140 mg, 1.22 mmol) by following the experiment procedure used for compound <b>180</b> to afford a yellow solid product (90 mg, 64%); mp 86–87 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.25 (d, <i>J</i> = 4.77 Hz, 2H), 7.59 (s, 1H), 6.97 (d, <i>J</i> = 8.61 Hz, 1H), 6.91 (d, <i>J</i> = 2.19 Hz, 1H), 6.76 (dd, <i>J</i> = 8.43, 2.40 Hz, 1H), 6.66 (s, 1H), 6.59 (t, <i>J</i> = 4.95, 1H), 4.12 (t, <i>J</i> = 6.06 Hz, 2H), 3.99 (t, <i>J</i> = 7.14 Hz, 2H), 3.83 (s, 3H), 3,62–3.53 (m, 4H), 2.22 (d, <i>J</i> = 0.93 Hz, 3H), 2.11–2.01 (m, 4H). <sup>13</sup>C NMR (75 MHz, CD<sub>3</sub>OD) δ 183.3, 164.3, 160.1, 152.2, 149.1, 138.8, 133.2, 129.7, 127.3, 119.7, 116.0, 112.1, 112.0, 69.6, 57.3, 44.2, 43.8, 40.4, 32.2, 25.0, 9.9. MS (FAB) <i>m</i>/<i>z</i> 456 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>22</sub>H<sub>29</sub>N<sub>7</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 456.2176, found 456.2182.</div></div><div id="sec4_10_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 1-(3-Methoxy-4-(4-(pyrimidin-2-ylamino)butoxy)phenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>182</b>)</h4><div class="NLM_p last">Prepared from compound <b>171</b> (300 mg, 0.77 mmol) and 2-chloropyrimidine (176 mg, 1.53 mmol) by following the experiment procedure used for compound <b>180</b> to afford a white solid product (129 mg, 36%); mp 175–176 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.12 (d, <i>J</i> = 4.95 Hz, 2H), 7.48 (d, <i>J</i> = 2.52 Hz, 1H), 6.79 (d, <i>J</i> = 1.29 Hz, 1H), 6.78 (s, 1H), 6.66 (dd, <i>J</i> = 8.61, 2.37 Hz, 1H), 6.55 (s, 1H), 6.45 (t, <i>J</i> = 4.77 Hz, 1H), 3.91 (t, <i>J</i> = 5.85 Hz, 2H), 3.87 (t, <i>J</i> = 7.5 Hz, 2H), 3.67 (s, 3H), 3.48 (t, <i>J</i> = 6.95 Hz, 2H), 3.28 (t, <i>J</i> = 6.60 Hz, 2H), 2.09 (d, <i>J</i> = 0.90 Hz, 3H), 1.96 (quintet, <i>J</i> = 7.14 Hz, 2H), 1.75–1.60 (m, 4H). <sup>13</sup>C NMR (200 MHz, CD<sub>3</sub>OD) δ 183.3, 164.3, 160.0, 152.1, 149.3, 138.8, 130.1, 129.7, 127.3, 119.8, 115.7, 112.1, 111.8, 71.0, 57.3, 44.2, 43.8, 42.6, 32.2, 28.4, 27.9, 9.9. MS (FAB) <i>m</i>/<i>z</i> 470 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>23</sub>H<sub>31</sub>N<sub>7</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 470.2338, found 470.2338.</div></div><div id="sec4_10_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 1-(4-(3-(5-Fluoropyrimidin-2-ylamino)propoxy)-3-methoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>183</b>)</h4><div class="NLM_p last">Prepared from compound <b>170</b> (150 mg, 0.40 mmol) and 2-chloro-5-fluoropyrimidine (0.098 mL, 0.80 mmol) by following the experiment procedure used for compound <b>180</b> to afford an off white solid product (65 mg, 65%); mp 75–76 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.20 (d, <i>J</i> = 0.75 Hz, 2H), 7.59 (s, 1H), 6.96 (d, <i>J</i> = 8.43 Hz, 1H), 6.90 (d, <i>J</i> = 2.19 Hz, 1H), 6.75 (dd, <i>J</i> = 8.61, 2.37 Hz, 1H), 6.66 (s, 1H), 4.11 (t, <i>J</i> = 6.06 Hz, 2H), 3.97 (t, <i>J</i> = 7.14 Hz, 2H), 3.70 (s, 3H), 3.61 (t, <i>J</i> = 7.35 Hz, 2H), 3.54 (t, <i>J</i> = 6.42 Hz, 2H), 2.21 (d, <i>J</i> = 0.72 Hz, 3H), 2.09–2.00 (m, 4H). <sup>13</sup>C NMR (75 MHz, CD<sub>3</sub>OD) δ 183.2, 161.8, 154.0 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 243 Hz), 152.1, 149.1, 147.3 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 22 Hz), 138.7, 133.1, 129.7, 127.3, 119.7, 115.8, 112.0, 69.6, 57.3, 44.2, 43.8, 41.0, 32.2, 30.8, 9.9. MS (FAB) <i>m</i>/<i>z</i> 474 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>22</sub>H<sub>28</sub>FN<sub>7</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 474.2087, found 474.2086.</div></div><div id="sec4_10_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 1-(4-(4-(5-Fluoropyrimidin-2-ylamino)butoxy)-3-methoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>184</b>)</h4><div class="NLM_p last">Prepared from compound <b>171</b> (100 mg, 0.26 mmol) and 2-chloro-5-fluoropyrimidine (0.063 mL, 0.51 mmol) by following the procedure described for compound <b>180</b> to afford a yellow solid product (53 mg, 42%); mp 70–71 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.09 (d, <i>J</i> = 1.08 Hz, 2H), 7.49 (d, <i>J</i> = 0.93 Hz, 1H), 6.84 (d, <i>J</i> = 8.61 Hz, 1H), 6.80 (s, 1H), 6.66 (dd, <i>J</i> = 8.43, 2.37 Hz, 1H), 6.56 (s, 1H), 3.93 (t, <i>J</i> = 5.85 Hz, 2H), 3.86 (t, <i>J</i> = 7.14 Hz, 2H), 3.70 (s, 3H), 3.51 (t, <i>J</i> = 6.78 Hz, 2H), 3.31 (t, <i>J</i> = 6.75 Hz, 2H), 2.11 (d, <i>J</i> = 0.90 Hz, 3H), 1.97 (quintet, <i>J</i> = 7.14 Hz, 2H), 1.74–1.61 (m, 4H). <sup>13</sup>C NMR (200 MHz, CD<sub>3</sub>OD) δ 183.3, 161.9, 153.9 (d, <sup>2</sup><i>J</i><sub>C–F</sub> = 243 Hz), 152.1, 149.3, 147.3 (d, <sup>3</sup><i>J</i><sub>C–F</sub> = 20 Hz) 138.8, 130.0, 129.7, 127.3, 119.8, 115.7, 112.1, 71.0, 57.3, 44.2, 43.8, 43.1, 32.2, 28.5, 27.9, 9.9. MS (FAB) <i>m</i>/<i>z</i> 488 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>23</sub>H<sub>30</sub>FN<sub>7</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 488.2244, found 488.2244.</div></div><div id="sec4_10_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 1-(3-Methoxy-4-(2-(piperidin-1-yl)ethoxy)phenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>185</b>)</h4><div class="NLM_p last">From compound <b>106</b>, procedure <b>5</b>; yield 59%, white solid, mp 100–101 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.50 (d, <i>J</i> = 0.75 Hz, 1H), 6.87 (d, <i>J</i> = 5.85 Hz, 1H), 6.84 (s, 1H), 6.68 (dd, <i>J</i> = 8.49, 2.19 Hz, 1H), 6.56 (s, 1H), 4.05 (t, <i>J</i> = 5.70 Hz, 2H), 3.90 (t, <i>J</i> = 6.96 Hz, 2H), 3.70 (s, 3H), 3.51 (t, <i>J</i> = 6.75 Hz, 2H), 2.69 (t, <i>J</i> = 5.67 Hz, 2H), 2.46 (br, 4H), 2.12 (d, <i>J</i> = 0.75 Hz, 3H), 1.98 (quintet, <i>J</i> = 7.14 Hz, 2H), 1.55–1.48 (m, 4H), 1.39–1.37 (m, 2H). <sup>13</sup>C NMR (200 MHz, CD<sub>3</sub>OD) δ 183.4, 152.3, 148.7, 138.8, 133.9, 129.7, 127.3, 119.6, 116.5, 112.1, 68.6, 59.4, 57.3, 56.6, 44.2, 43.8, 32.1, 27.0, 25.5, 9.9. MS (FAB) <i>m</i>/<i>z</i> 432 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>22</sub>H<sub>33</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 432.2433, found 432.2441.</div></div><div id="sec4_10_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 1-(3-Methoxy-4-(3-(piperidin-1-yl)propoxy)phenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>186</b>)</h4><div class="NLM_p last">From compound <b>107</b>, procedure <b>5</b>; yield 30%, white solid, mp 145–146 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.52 (s, 1H), 6.88 (d, <i>J</i> = 2.73, 1H), 6.86 (d, <i>J</i> = 8.79 Hz, 1H), 6.68 (dd, <i>J</i> = 8.58, 2.37 Hz, 1H), 6.58 (s, 1H), 4.01 (t, <i>J</i> = 5.88 Hz, 2H), 3.89 (t, <i>J</i> = 6.96 Hz, 2H), 3.74 (s, 3H), 3.50 (m, 2H), 2.99–2.96 (m, 6H), 2.13 (d, <i>J</i> = 0.9 Hz, 3H), 2.09–2.06 (m, 2H), 1.95 (quintet, <i>J</i> = 6.93 Hz, 2H), 1.73–1.69 (m, 4H), 1.54 (m, 2H). <sup>13</sup>C NMR (125 MHz, CD<sub>3</sub>OD) δ 183.5, 152.0, 148.5, 138.8, 133.9, 129.8, 127.2, 119.6, 116.1, 112.0, 69.3, 57.6, 57.3, 55.7, 44.2, 43.7, 32.5, 26.6, 25.7, 24.2, 9.9. MS (FAB) <i>m</i>/<i>z</i> 446 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>23</sub>H<sub>35</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 446.2591, found 446.2600.</div></div><div id="sec4_10_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 1-(3-Methoxy-4-(4-(piperidin-1-yl)butoxy)phenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>187</b>)</h4><div class="NLM_p last">From compound <b>108</b>, procedure <b>5</b>; yield 54%, white solid, mp 86–87 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.73 (s, 1H), 6.99 (d, <i>J</i> = 2.37 Hz, 1H), 6.93 (d, <i>J</i> = 8.61 Hz, 1H), 6.78 (dd, <i>J</i> = 8.43, 2.37 Hz, 1H), 6.72 (s, 1H), 4.05–3.98 (m, 4H), 3.81 (s, 3H), 3.59 (t, <i>J</i> = 6.6 Hz, 2H), 3.18–3.09 (m, 6H), 2.23 (d, <i>J</i> = 1.11 Hz, 3H), 2.05 (quintet, <i>J</i> = 6.96 Hz, 2H), 1.97–1.90 (m, 2H), 1.85 (quintet, <i>J</i> = 5.67 Hz, 6H), 1.64 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 181.3, 149.1, 145.8, 136.3, 131.7, 127.6, 124.2, 116.9, 113.1, 109.5, 68.3, 56.8, 55.7, 52.9, 42.5, 41.2, 29.6, 26.2, 22.7, 22.0, 20.9, 9.2. MS (FAB) <i>m</i>/<i>z</i> 460 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>24</sub>H<sub>37</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 460.2741, found 460.2754.</div></div><div id="sec4_10_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 1-(3-Methoxy-4-(2-morpholinoethoxy)phenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>188</b>)</h4><div class="NLM_p last">From compound <b>109</b>, procedure <b>5</b>; yield 53%, white solid, mp 104–105 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.59 (s, 1H), 6.98 (d, <i>J</i> = 8.61 Hz, 1H), 6.92 (d, <i>J</i> = 2.19 Hz, 1H), 6.76 (dd, <i>J</i> = 8.43, 2.4 Hz, 1H), 6.66 (s, 1H), 4.16 (t, <i>J</i> = 5.49 Hz, 2H), 3.99 (t, <i>J</i> = 7.14 Hz, 2H), 3.80 (s, 3H), 3.71 (t, <i>J</i> = 4.56 Hz, 4H), 3.61 (t, <i>J</i> = 6.60 Hz, 2H), 2.82 (t, <i>J</i> = 5.49 Hz, 2H), 2.63 (t, <i>J</i> = 4.59 Hz, 4H), 2.22 (d, <i>J</i> = 0.9 Hz, 3H), 2.07 (quintet, <i>J</i> = 7.35 Hz, 2H). <sup>13</sup>C NMR (200 MHz, CD<sub>3</sub>OD) δ 183.4, 152.4, 148.9, 138.8, 133.6, 129.7, 127.4, 119.6, 116.5, 112.1, 69.2, 68.5, 59.5, 57.3, 56.0, 44.2, 43.8, 32.2, 9.9. MS (FAB) <i>m</i>/<i>z</i>: 434 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>21</sub>H<sub>31</sub>N<sub>5</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 434.2226, found 434.2231.</div></div><div id="sec4_10_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 1-(3-Methoxy-4-(3-morpholinopropoxy)phenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>189</b>)</h4><div class="NLM_p last">From compound <b>110</b>, procedure <b>5</b>; yield 18%, white solid, mp 84–85 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.59 (s, 1H), 6.95 (d, <i>J</i> = 8.61 Hz, 1H), 6.91 (d, <i>J</i> = 2.37 Hz, 1H), 6.75 (dd, <i>J</i> = 8.61, 2.37 Hz, 1H), 6.67 (s, 1H), 4.05 (t, <i>J</i> = 6.03 Hz, 2H), 3.98 (t, <i>J</i> = 7.14 Hz, 2H), 3.81 (s, 3H), 3.69 (t, <i>J</i> = 4.77 Hz, 4H), 3.60 (t, <i>J</i> = 6.75 Hz, 2H), 2.56 (t, <i>J</i> = 7.32 Hz, 2H), 2.51 (br, 4H), 2.22 (d, <i>J</i> = 0.93 Hz, 3H), 2.03 (m, 4H). <sup>13</sup>C NMR (125 MHz, CD<sub>3</sub>OD) δ 183.2, 151.9, 148.9, 138.5, 132.9, 129.4, 127.3, 119.6, 115.6, 111.9, 69.3, 68.3, 57.3, 57.2, 55.4, 44.0, 43.6, 32.0, 27.8, 9.9. MS (FAB) <i>m</i>/<i>z</i> 448 [M + H]<sup>+</sup>. MS (HR-FAB-MS) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calc. for C<sub>22</sub>H<sub>33</sub>N<sub>5</sub>O<sub>3</sub>S 448.2377, found 448.2372.</div></div><div id="sec4_10_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 1-(3-Methoxy-4-(4-morpholinobutoxy)phenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>190</b>)</h4><div class="NLM_p last">From compound <b>111</b>, procedure <b>5</b>.; yield 41%, white solid (75 mg, 41%), mp 83–84 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.59 (d, <i>J</i> = 1.11 Hz, 1H), 6.94 (d, <i>J</i> = 8.58 Hz, 1H), 6.90 (d, <i>J</i> = 2.4 Hz, 1H), 6.75 (dd, <i>J</i> = 8.43, 2.37 Hz, 1H), 6.66 (s, 1H), 4.02 (t, <i>J</i> = 5.88 Hz, 2H), 3.97 (t, <i>J</i> = 7.32 Hz, 2H), 3.81 (s, 3H), 3.68 (t, <i>J</i> = 4.74 Hz, 4H), 3.59 (t, <i>J</i> = 6.75 Hz, 2H), 2.49–2.41 (m, 4H), 2.22 (d, <i>J</i> = 0.93 Hz, 3H), 2.03 (quintet, <i>J</i> = 6.96 Hz, 2H), 1.83–1.67 (m, 4H). <sup>13</sup>C NMR (75 MHz, CD<sub>3</sub>OD) δ 183.2, 152.1, 149.3, 138.7, 132.9, 129.7, 127.3, 119.7, 115.7, 112.1, 70.9, 68.4, 60.5, 57.3, 55.5, 44.2, 43.8, 32.2, 29.1, 24.6, 9.9. MS (FAB) <i>m</i>/<i>z</i> 462 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>23</sub>H<sub>35</sub>N<sub>5</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 462.2533, found 462.2547.</div></div><div id="sec4_10_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 1-(3-Methoxy-4-(2-(piperazin-1-yl)ethoxy)phenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>191</b>)</h4><div class="NLM_p last">From compound <b>152</b>, procedure <b>7</b>; yield 70%, white solid, mp 81–82 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.72 (br, 1H), 7.40 (s, 1H), 6.91 (d, <i>J</i> = 8.97 Hz, 1H), 6.75–6.72 (m, 3H), 6.04 (br, 1H), 4.17 (t, <i>J</i> = 6.06 Hz, 2H), 3.92 (t, <i>J</i> = 6.96 Hz, 2H), 3.83 (s, 3H), 3.69 (q, <i>J</i> = 6.24 Hz, 2H), 2.95 (t, <i>J</i> = 4.77 Hz, 4H), 2.87 (t, <i>J</i> = 6.06 Hz, 2H), 2.59 (br, 4H), 2.18 (d, <i>J</i> = 0.93 Hz, 3H), 2.10 (quintet, <i>J</i> = 6.96 Hz, 2H). <sup>13</sup>C NMR (125 MHz, CD<sub>3</sub>OD) δ 183.4, 152.4, 149.0, 138.8, 133.5, 129.7, 127.4, 119.7, 116.5, 112.2, 69.2, 59.6, 57.3, 55.9, 46.8, 44.2, 43.8, 32.2, 9.9. MS (FAB) <i>m</i>/<i>z</i> 433 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>21</sub>H<sub>32</sub>N<sub>6</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 433.2386, found 433.2386.</div></div><div id="sec4_10_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 1-(3-Methoxy-4-(3-(piperazin-1-yl)propoxy)phenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>192</b>)</h4><div class="NLM_p last">From compound <b>153</b>, procedure <b>7</b>; yield 28%, white solid, mp 73–74 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.61 (s, 1H), 6.95 (d, <i>J</i> = 9.51 Hz, 1H), 6.93 (s, 1H), 6.76 (d, <i>J</i> = 8.79 Hz, 1H), 6.68 (s, 1H), 4.06 (t, <i>J</i> = 6.06 Hz, 2H), 3.98 (t, <i>J</i> = 7.5 Hz, 2H), 3.81 (s, 3H), 3.60 (m, 2H), 3.08 (t, <i>J</i> = 5.31 Hz, 4H), 2.63 (br, 6H), 2.23 (s, 3H), 2.06–1.99 (m, 4H). <sup>13</sup>C NMR (150 MHz, CD<sub>3</sub>OD) δ 183.5, 152.1, 149.1, 138.7, 133.1 129.8, 127.2, 119.7, 115.9, 112.2, 69.3, 57.3, 56.8, 52.7, 45.9, 44.2, 43.7, 32.1, 28.2, 9.9. MS (FAB) <i>m</i>/<i>z</i> 447 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>22</sub>H<sub>34</sub>N<sub>6</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 447.2537, found 447.2524.</div></div><div id="sec4_10_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 1-(3-Methoxy-4-(4-(piperazin-1-yl)butoxy)phenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>193</b>)</h4><div class="NLM_p last">From compound <b>154</b>, procedure <b>7</b>; yield 54%, white solid, mp 80–81 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.62 (s, 1H), 6.94 (d, <i>J</i> = 8.04 Hz, 1H), 6.92 (s, 1H), 6.75 (d, <i>J</i> = 8.61 Hz, 1H), 6.68 (s, 1H), 4.04–3.96 (m, 4H), 3.81 (s, 3H), 3.59 (t, <i>J</i> = 6.39 Hz, 2H), 3.09 (br, 4H), 2.64 (br, 4H), 2.51 (t, <i>J</i> = 7.14 Hz, 2H), 2.22 (s, 3H), 2.04 (quintet, <i>J</i> = 6.78 Hz, 2H), 1.81–1.71 (m, 4H). <sup>13</sup>C NMR (200 MHz, CD<sub>3</sub>OD) δ 183.4, 152.0, 149.1, 138.7, 133.1, 129.8, 127.1, 119.6, 115.7, 112.1, 70.9, 59.7, 57.3, 52.4, 45.6, 44.2, 43.7, 32.1, 28.8, 24.7, 9.9. MS(FAB) <i>m</i>/<i>z</i> 461 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>23</sub>H<sub>36</sub>N<sub>6</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 461.2693, found 461.2695.</div></div><div id="sec4_10_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 1-(3-Methoxy-4-(2-(4-methylpiperazin-1-yl)ethoxy)phenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>194</b>)</h4><div class="NLM_p last">From compound <b>112</b>, procedure <b>5</b>; yield 60%, white solid, mp 94–95 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.59 (d, <i>J</i> = 1.11 Hz, 1H), 6.97 (d, <i>J</i> = 8.61 Hz, 1H), 6.91 (d, <i>J</i> = 2.37 Hz, 1H), 6.76 (dd, <i>J</i> = 8.4, 2.37 Hz, 1H), 6.66 (s, 1H), 4.15 (t, <i>J</i> = 5.49 Hz, 2H), 3.99 (t, <i>J</i> = 7.32 Hz, 2H), 3.80 (s, 3H), 3.59 (t, <i>J</i> = 6.78 Hz, 2H), 2.83 (t, <i>J</i> = 5.31 Hz, 2H), 2.50 (br, 8H), 2.28 (s, 3H), 2.22 (d, <i>J</i> = 0.93 Hz, 3H), 2.05 (quintet, <i>J</i> = 6.78 Hz, 2H). <sup>13</sup>C NMR (200 MHz, CD<sub>3</sub>OD) δ 183.4, 153.3, 149.0, 138.8, 133.7, 129.7, 127.4, 119.7, 116.5, 112.2, 70.5, 59.2, 57.3, 56.4, 54.9, 46.8, 44.2, 43.8, 32.2, 9.9. MS(FAB) <i>m</i>/<i>z</i> 447 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>22</sub>H<sub>34</sub>N<sub>6</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 447.2542, found 447.2539.</div></div><div id="sec4_10_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 1-(3-Methoxy-4-(3-(4-methylpiperazin-1-yl)phenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>195</b>)</h4><div class="NLM_p last">From compound <b>113</b>, procedure <b>5</b>; yield 19%, white solid, mp 65–66 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.59 (d, <i>J</i> = 1.08 Hz, 1H), 6.95 (d, <i>J</i> = 8.61 Hz, 1H), 6.90 (d, <i>J</i> = 2.19 Hz, 1H), 6.75 (dd, <i>J</i> = 8.4, 2.37 Hz, 1H), 6.67 (s, 1H), 4.02 (t, <i>J</i> = 6.24 Hz, 2H), 3.98 (t, <i>J</i> = 7.14 Hz, 2H), 3.81 (s, 3H), 3.60 (t, <i>J</i> = 7.14 Hz, 2H), 2.58 (br, 10H), 2.29 (s, 3H), 2.22 (d, <i>J</i> = 1.11 Hz, 3H), 2.01 (m, 4H). <sup>13</sup>C NMR (125 MHz, CD<sub>3</sub>OD) δ 183.3, 153.2, 149.2, 138.7, 133.1, 129.6, 127.3, 119.7, 115.9, 112.2, 69.4, 57.3, 56.9, 56.4, 54.4, 46.8, 44.1, 43.8, 32.1, 28.3, 9.9. MS(FAB) <i>m</i>/<i>z</i> 461 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>23</sub>H<sub>36</sub>N<sub>6</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 461.2693, found 461.2695.</div></div><div id="sec4_10_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 1-(3-Methoxy-4-(4-(4-methylpiperazin-1-yl)butoxy)phenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>196</b>)</h4><div class="NLM_p last">From compound <b>114</b>, procedure <b>5</b>; yield 64%, white solid, mp 83–84 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.27 (s, 1H), 6.98–6.91 (m, 3H), 6.79 (m, <i>J</i> = 8.43 Hz, 1H), 4.10 (t, <i>J</i> = 7.14 Hz, 2H), 4.03 (m, 2H), 3.81 (s, 3H), 3.61 (m, 2H), 2.98 (m, 8H), 2.73 (m, 2H), 2.63 (s, 3H), 2.29 (s, 3H), 2.10 (quintet, <i>J</i> = 6.78 Hz, 2H), 1.81 (m, 4H). <sup>13</sup>C NMR (150 MHz, CD<sub>3</sub>OD) δ 183.5, 151.8, 148.7, 137.9, 133.9, 131.4, 123.3, 119.4, 115.7, 112.1, 70.8, 58.9, 57.4, 54.9, 52.6, 45.3, 43.2, 43.3, 31.5, 28.6, 24.3, 9.9. MS(FAB) <i>m</i>/<i>z</i> 475 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>24</sub>H<sub>38</sub>N<sub>6</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 475.2850, found 475.2862.</div></div><div id="sec4_10_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 1-(3-Methoxy-4-(2-(piperidin-4-yl)ethoxy)phenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>197</b>)</h4><div class="NLM_p last">From compound <b>155</b>, procedure <b>7</b>; yield 82%, white solid, the compound was decomposed at 199 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.50 (d, <i>J</i> = 1.11 Hz, 1H), 6.86 (d, <i>J</i> = 8.43 Hz, 1H), 6.81 (d, <i>J</i> = 2.37 Hz, 1H), 6.67 (dd, <i>J</i> = 8.43, 2.37 Hz, 1H), 6.57 (s, 1H), 3.97 (t, <i>J</i> = 6.06 Hz, 2H), 3.90 (t, <i>J</i> = 7.14 Hz, 2H), 3.72 (s, 3H), 3.50 (t, <i>J</i> = 7.14 Hz, 2H), 3.02–2.97 (m, 2H), 2.60 (td, <i>J</i> = 10.44, 2.01 Hz, 2H), 2.13 (d, <i>J</i> = 1.11 Hz, 3H), 1.96 (quintet, <i>J</i> = 6.78 Hz, 4H), 1.79–1.74 (m, 3H), 1.69–1.64 (m, 2H). <sup>13</sup>C NMR (200 MHz, CD<sub>3</sub>OD) δ 183.5, 152.2, 149.1, 138.8, 133.2, 129.7, 127.4, 119.7, 115.9, 112.1, 68.7, 57.3, 46.5, 44.2, 43.8, 37.3, 32.1, 31.7, 31.6, 9.9. MS(FAB) <i>m</i>/<i>z</i> 432 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>22</sub>H<sub>33</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 432.2428, found 432.243.</div></div><div id="sec4_10_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 1-(3-Methoxy-4-(3-(piperidin-4-yl)propoxy)phenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>198</b>)</h4><div class="NLM_p last">From compound <b>156</b>, procedure <b>7</b>; yield 64%, white solid, mp 153–154 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.59 (s, 1H), 6.95 (d, <i>J</i> = 4.23 Hz, 1H), 6.92 (d, <i>J</i> = 1.83 Hz, 1H), 6.77 (dd, <i>J</i> = 8.58, 2.37 Hz, 1H), 6.67 (s, 1H), 4.02 (q, <i>J</i> = 6.03 Hz, 4H), 3.81 (s, 3H), 3.59 (t, <i>J</i> = 7.14 Hz, 2H), 3.38 (t, <i>J</i> = 7.14 Hz, 2H), 2.97–2.90 (m, 2H), 2.22 (d, <i>J</i> = 1.08 Hz, 3H), 2.06–1.95 (m, 4H), 1.89–1.80 (m, 2H), 1.65 (br, 1H), 1.53–1.48 (m, 2H), 1.38–1.28 (m, 2H). <sup>13</sup>C NMR (150 MHz, CD<sub>3</sub>OD) δ 183.4, 152.1, 149.2, 138.8, 133.2, 129.8, 127.2, 119.8, 115.7, 112.2, 71.2, 57.3, 46.1, 44.2, 43.8, 35.5, 34.5, 32.1, 30.9, 28.0, 9.9. MS(FAB) <i>m</i>/<i>z</i> 446 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>23</sub>H<sub>35</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 446.2584, found 446.2590.</div></div><div id="sec4_10_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 1-(3-Methoxy-4-(4-(piperidin-4-yl)butoxy)phenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>199</b>)</h4><div class="NLM_p last">From compound <b>147</b>, procedure <b>7</b>; yield 64%, white solid, mp 95–96 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.59 (d, <i>J</i> = 1.11 Hz, 1H), 6.95 (d, <i>J</i> = 8.61 Hz, 1H), 6.90 (d, <i>J</i> = 2.40 Hz, 1H), 6.76 (dd, <i>J</i> = 8.61, 2.37 Hz, 1H), 6.66 (s, 1H), 4.01 (q, <i>J</i> = 6.39 Hz, 4H), 3.81 (s, 3H), 3.62 (t, <i>J</i> = 6.96, 2H), 3.10–3.05 (m, 2H), 2.67–2.59 (m, 2H), 2.22 (d, <i>J</i> = 0.93 Hz, 3H), 2.08 (quintet, <i>J</i> = 6.78 Hz, 2H), 1.77–1.74 (m, 4H), 1.51–1.46 (m, 3H), 1.35–1.30 (m, 2H), 1.23–1.14 (m, 2H). <sup>13</sup>C NMR (200 MHz, CD<sub>3</sub>OD) δ 183.4, 152.1, 149.3, 138.8, 133.1, 129.7, 127.3, 119.7, 115.7, 112.2, 71.1, 57.4, 47.2, 44.2, 43.8, 38.3, 37.0, 33.2, 32.2, 31.2, 24.8, 9.9. MS(FAB) <i>m</i>/<i>z</i> 460 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>24</sub>H<sub>37</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 460.2741, found 460.2746.</div></div><div id="sec4_10_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 1-(3-Methoxy-4-(2-(1-methylpiperidin-4-yl)ethoxy)phenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>200</b>)</h4><div class="NLM_p last">From compound <b>115</b>, procedure <b>5</b>; yield 34%, white solid, mp 111–112 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.50 (d, <i>J</i> = 1.11 Hz, 1H), 6.86 (d, <i>J</i> = 8.61 Hz, 1H), 6.80 (d, <i>J</i> = 2.40 Hz, 1H), 6.67 (dd, <i>J</i> = 8.61, 2.40 Hz, 1H), 6.57 (br, 1H), 3.96 (t, <i>J</i> = 6.39 Hz, 2H), 3.90 (t, <i>J</i> = 7.32 Hz, 2H), 3.71 (s, 3H), 3.52 (q, <i>J</i> = 7.14 Hz, 2H), 2.79–2.75 (m, 2H), 2.15 (s, 3H), 2.13 (d, <i>J</i> = 0.93 Hz, 3H), 1.96–1.88 (m, 4H), 1.71–1.60 (m, 4H), 1.48 (br, 1H), 1.26–1.18 (m, 2H). <sup>13</sup>C NMR (125 MHz, CD<sub>3</sub>OD) δ 183.3, 152.2, 149.3, 138.8, 133.1, 129.7, 127.4, 119.8, 115.9, 112.2, 68.9, 57.3, 46.9, 44.2, 43.8, 37.5, 33.8, 33.5, 32.2, 9.9. MS(FAB) <i>m</i>/<i>z</i> 446 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>23</sub>H<sub>35</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 446.2590, found 446.2590.</div></div><div id="sec4_10_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 1-(3-Methoxy-4-(3-(1-methylpiperidin-4-yl)propoxy)phenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>201</b>)</h4><div class="NLM_p last">From compound <b>116</b>, procedure <b>5</b>; yield 40%, light yellow solid, mp 168–169 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.65 (s, 1H), 6.85–6.82 (m, 2H), 6.67–6.64 (m, 2H), 3.92 (t, <i>J</i> = 6.03 Hz, 4H), 3.72 (s, 3H), 3.50 (t, <i>J</i> = 6.96 Hz, 2H), 3.36 (br, 1H), 3.32 (br, 1H), 2.86 (t, <i>J</i> = 11.34 Hz, 2H), 2.71 (s, 3H), 2.14 (d, <i>J</i> = 0.93 Hz, 3H), 1.97–1.89 (m, 4H), 1.71 (m, 2H), 1.52–1.31 (m, 5H). <sup>13</sup>C NMR (75 MHz, CD<sub>3</sub>OD) δ 183.4, 152.1, 149.2, 139.2, 133.2, 130.1, 126.6, 119.7, 115.7, 112.2, 71.2, 57.3, 56.5, 44.8, 44.4, 43.7, 34.9, 34.0, 32.0, 31.6, 28.2, 9.9. MS(FAB) <i>m</i>/<i>z</i> 460 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>24</sub>H<sub>37</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 460.2746, found 460.2746.</div></div><div id="sec4_10_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 1-(3-Methoxy-4-(4-(1-methylpiperidin-4-yl)butoxy)phenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>202</b>)</h4><div class="NLM_p last">Prepared from compound <b>199</b> by following the experimental procedure used for compound <b>22</b> to afford the desired product as a white solid (36 mg, 38%); mp 113–114 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.49 (d, <i>J</i> = 1.11 Hz, 1H), 6.84–6.80 (m, 2H), 6.67 (dd, <i>J</i> = 8.40, 2.37 Hz, 1H), 6.56 (s, 1H), 3.91–3.85 (m, 4H), 3.71 (s, 3H), 3.52 (quintet, <i>J</i> = 6.96 Hz, 2H), 2.76 (br, 1H), 2.72 (br, 1H), 2.13 (s, 3H), 2.12 (d, <i>J</i> = 0.90 Hz, 3H), 1.98–1.88 (m, 4H), 1.71–1.62 (m, 5H), 1.36–1.33 (m, 2H), 1.23–1.10 (m, 4H). <sup>13</sup>C NMR (200 MHz, CD<sub>3</sub>OD) δ 183.4, 152.1, 149.4, 138.8, 133.1, 129.7, 127.3, 119.7, 115.7, 112.2, 71.1, 57.4, 57.2, 46.3, 44.2, 43.8, 37.7, 36.2, 33.0, 32.2, 31.2, 25.0, 9.9. MS(FAB) <i>m</i>/<i>z</i> 474 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>25</sub>H<sub>39</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 474.2902, found 474.2903.</div></div><div id="sec4_10_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 1-(4-(4-Aminophenethoxy)-3-methoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>203</b>)</h4><div class="NLM_p last">From compound <b>157</b>, procedure <b>7</b>; yield 68%, white solid, mp 74–75 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.58 (d, <i>J</i> = 1.11 Hz, 1H), 7.05–7.02 (m, 2H), 6.92 (d, <i>J</i> = 8.40 Hz, 1H), 6.89 (d, <i>J</i> = 2.37 Hz, 1H), 6.74 (dd, <i>J</i> = 8.43, 2.40 Hz, 1H), 6.68–6.65 (m, 3H), 4.10 (t, <i>J</i> = 7.14 Hz, 2H), 3.98 (t, <i>J</i> = 7.32 Hz, 2H), 3.80 (s, 3H), 3.60 (q, <i>J</i> = 6.96 Hz, 2H), 2.95 (t, <i>J</i> = 7.14 Hz, 2H), 2.21 (d, <i>J</i> = 1.08 Hz, 3H), 2.06 (quintet, <i>J</i> = 7.14 Hz, 2H). <sup>13</sup>C (150 MHz, CDCl<sub>3</sub>) δ 181.7, 150.4, 148.0, 145.0, 136.5, 129.8, 128.7, 127.4, 126.9, 126.8, 118.5, 115.2, 113.4, 110.3, 70.4, 56.2, 42.3, 42.2, 34.8, 30.3, 9.2. MS(ESI) <i>m</i>/<i>z</i> 440 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>23</sub>H<sub>29</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 440.2120, found 440.2118.</div></div><div id="sec4_10_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 1-(4-(3-(4-Aminophenyl)propoxy)-3-methoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>204</b>)</h4><div class="NLM_p last">From compound <b>158</b>, procedure <b>7</b>; yield 62%, white solid, mp 58–59 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.52 (s, 1H), 7.37 (s, 1H), 7.00 (d, <i>J</i> = 8.43 Hz, 2H), 6.83 (d, <i>J</i> = 8.97 Hz, 1H), 6.73–6.68 (m, 3H), 6.63 (d, <i>J</i> = 8.22 Hz, 2H), 5.90 (br, 1H), 4.02 (t, <i>J</i> = 6.57 Hz, 2H), 3.90 (t, <i>J</i> = 7.14 Hz, 2H), 3.84 (s, 3H), 3.69 (q, <i>J</i> = 6.42 Hz, 2H), 2.72 (t, <i>J</i> = 7.14 Hz, 2H), 2.21 (d, <i>J</i> = 0.93 Hz, 3H), 2.17–1.99 (m, 4H). <sup>13</sup>C NMR (75 MHz, CD<sub>3</sub>OD) δ 183.2, 152.1, 149.3, 147.0, 138.7, 133.4, 132.8, 130.1, 129.7, 119.8, 117.7, 115.7, 115.7, 112.1, 70.2, 57.4, 44.2, 43.8, 33.1, 32.9, 32.2, 9.9. MS(FAB) <i>m</i>/<i>z</i> 454 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>24</sub>H<sub>31</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 454.2277, found 454.2274.</div></div><div id="sec4_10_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 1-(4-(4-(4-Aminophenyl)butoxy)-3-methoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>205</b>)</h4><div class="NLM_p last">From compound <b>159</b>, procedure <b>7</b>; yield 62%, white solid, mp 59–60 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.57 (s, 1H), 7.37 (s, 1H), 6.99 (d, <i>J</i> = 8.40 Hz, 2H), 6.85 (d, <i>J</i> = 8.43 Hz, 1H), 6.72–6.67 (m, 3H), 6.64–6.59 (m, 2H), 5.92 (br, NH), 4.03 (t, <i>J</i> = 6.42 Hz, 2H), 3.90 (t, <i>J</i> = 7.14 Hz, 2H), 3.82 (s, 3H), 3.69 (q, <i>J</i> = 6.24 Hz, 2H), 2.60 (t, <i>J</i> = 7.53 Hz, 2H), 2.17 (d, <i>J</i> = 0.93 Hz, 3H), 2.08 (quintet, <i>J</i> = 6.93 Hz, 2H), 1.94–1.69 (m, 4H). <sup>13</sup>C NMR (150 MHz, CD<sub>3</sub>OD) δ 183.2, 152.1, 149.4, 146.9, 138.7, 134.2, 132.8, 130.8, 129.7, 127.3, 119.8, 117.7, 115.8, 112.2, 71.2, 57.4, 44.2, 43.8, 36.5, 32.1, 30.6, 30.1, 9.9. MS(FAB) <i>m</i>/<i>z</i> 468 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>25</sub>H<sub>33</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 468.2433, found 468.2425.</div></div><div id="sec4_10_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 1-(3-Methoxy-4-(2-(pyridin-4-yl)ethoxy)phenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>206</b>)</h4><div class="NLM_p last">From compound <b>117</b>, procedure <b>5</b>; yield 63%, white solid, mp 114–115 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.42 (dd, <i>J</i> = 4.38, 1.47 Hz, 2H), 7.61 (d, <i>J</i> = 1.11 Hz, 1H), 7.43 (dd, <i>J</i> = 4.59, 1.65 Hz, 2H), 6.94 (d, <i>J</i> = 8.61 Hz, 1H), 6.90 (d, <i>J</i> = 2.19 Hz, 1H), 6.73 (dd, <i>J</i> = 8.43, 2.37 Hz, 1H), 6.67 (s, 1H), 4.26 (t, <i>J</i> = 6.21 Hz, 2H), 3.97 (t, <i>J</i> = 7.14 Hz, 2H), 3.78 (s, 3H), 3.58 (t, <i>J</i> = 5.85 Hz, 2H), 3.13 (t, <i>J</i> = 6.21 Hz, 2H), 2.21 (d, <i>J</i> = 1.11 Hz, 3H), 2.02 (quintet, <i>J</i> = 6.96 Hz, 2H). <sup>13</sup>C NMR (200 MHz, CDCl<sub>3</sub>) δ 181.2, 150.0, 148.9, 147.9, 146.7, 136.2, 130.1, 127.1, 125.8, 124.5, 117.7, 113.8, 110.0, 68.5, 55.8, 42.1, 41.7, 34.7, 30.0, 9.2. MS(FAB) <i>m</i>/<i>z</i> 426 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>22</sub>H<sub>27</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 426.1958, found 426.1962.</div></div><div id="sec4_10_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 1-(3-Methoxy-4-(4-(pyridin-4-yl)propoxy)phenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>207</b>)</h4><div class="NLM_p last">From compound <b>118</b>, procedure <b>5</b>; yield 26%, white solid, mp 81–82 °C. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 8.39 (dd, <i>J</i> = 4.56, 1.32 Hz, 2H), 7.59 (s, 1H), 7.32 (d, <i>J</i> = 6.42 Hz, 2H), 6.93 (br, 2H), 6.75 (dd, <i>J</i> = 8.28, 2.28 Hz, 1H), 6.66 (s, 1H), 4.00 (t, <i>J</i> = 6.42 Hz, 2H), 3.97 (t, <i>J</i> = 7.32 Hz, 2H), 3.83 (s, 3H), 3.60 (t, <i>J</i> = 6.42 Hz, 2H), 2.88 (t, <i>J</i> = 7.32 Hz, 2H), 2.22 (s, 3H), 2.15–2.10 (m, 2H), 2.03 (quintet, <i>J</i> = 7.32 Hz, 2H). <sup>13</sup>C NMR (125 MHz, CD<sub>3</sub>OD) δ 183.4, 154.6, 152.2, 150.7, 149.0, 138.8, 133.4, 129.7, 127.4, 126.6, 119.7, 116.0, 112.1, 70.1, 57.3, 44.2, 43.8, 33.3, 32.2, 31.7, 9.9. MS(FAB) <i>m</i>/<i>z</i> 440 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>23</sub>H<sub>29</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 440.2115, found 440.2121.</div></div><div id="sec4_10_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 1-(3-(1<i>H</i>-Imidazol-1-yl)propyl)-3-(3-methoxy-4-(4-(pyridin-4-yl)butoxy)phenyl)thiourea (<b>208</b>)</h4><div class="NLM_p last">From compound <b>119</b>, procedure <b>5</b>; yield 45%, white solid, mp 58–59 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.43 (d, <i>J</i> = 6.06 Hz, 2H), 7.51 (s, 1H), 7.36 (s, 1H), 7.12 (d, <i>J</i> = 5.85 Hz, 2H), 6.79 (d, <i>J</i> = 8.97 Hz, 1H), 6.73 (s, 1H), 6.71–6.68 (m, 2H), 6.04 (s, 1H), 4.01 (m, 2H), 3.89 (t, <i>J</i> = 7.14 Hz, 2H), 3.84 (s, 3H), 3.67 (q, <i>J</i> = 7.53 Hz, 2H), 2.70 (m, 2H), 2.17 (d, <i>J</i> = 0.9 Hz, 3H), 2.06 (quintet, <i>J</i> = 7.14 Hz, 2H), 1.88–1.86 (m, 4H). <sup>13</sup>C NMR (75 MHz, CD<sub>3</sub>OD) δ 183.3, 155.2, 152.1, 150.6, 149.3, 138.8, 133.0, 129.7, 127.3, 126.5, 119.8, 115.7, 112.2, 70.9, 57.3, 44.2, 43.8, 36.5, 32.2, 30.6, 28.8, 9.9. MS(ESI) <i>m</i>/<i>z</i> 454 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>24</sub>H<sub>31</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 454.2276, found 454.2273.</div></div><div id="sec4_10_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 1-(3-Methoxy-4-(4-(pyridin-3-yl)butoxy)phenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>209</b>)</h4><div class="NLM_p last">From compound <b>122</b>, procedure <b>5</b>; yield 52%, white solid, mp 70–71 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.42 (d, <i>J</i> = 1.44 Hz, 1H), 8.40 (d, <i>J</i> = 1.65 Hz, 1H), 7.62 (s, 1H), 7.52 (d, <i>J</i> = 7.68 Hz, 1H), 7.41 (s, 1H), 7.23 (dd, <i>J</i> = 7.68, 4.95 Hz, 1H), 6.84 (d, <i>J</i> = 8.97 Hz, 1H), 6.73–6.71 (m, 3H), 6.13 (br, 1H), 4.06 (t, <i>J</i> = 5.57 Hz, 2H), 3.92 (t, <i>J</i> = 7.14 Hz, 2H), 3.82 (s, 3H), 3.70 (q, <i>J</i> = 6.39 Hz, 2H), 2.72 (t, <i>J</i> = 7.14 Hz, 2H), 2.17 (s, 3H), 2.10 (quintet, <i>J</i> = 6.93 Hz, 2H), 1.88–1.81 (m, 4H). <sup>13</sup>C NMR (200 MHz, CDCl<sub>3</sub>) δ 181.2, 149.8, 148.9, 147.3, 146.5, 137.6, 136.4, 136.1, 129.4, 127.2, 125.6, 123.4, 117.9, 113.1, 109.8, 68.7, 55.8, 42.2, 41.7, 32.3, 29.9, 28.2, 27.2, 9.2. MS (FAB) <i>m</i>/<i>z</i> 454 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>24</sub>H<sub>31</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 454.2277, found 454.2277.</div></div><div id="sec4_10_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 1-(4-(2-(2-Aminopyridin-4-yl)ethoxy)-3-methoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl) thiourea (<b>210</b>)</h4><div class="NLM_p last">From compound <b>160</b>, procedure <b>7</b>; yield 41%, white solid, mp 60–61 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.77 (d, <i>J</i> = 5.49 Hz, 1H), 7.59 (d, <i>J</i> = 2.40 Hz, 1H), 6.94 (d, <i>J</i> = 8.43 Hz, 1H), 6.90 (d, <i>J</i> = 2.40 Hz, 1H), 6.73 (dd, <i>J</i> = 8.40, 2.37 Hz, 1H), 6.66 (s, 1H), 6.59 (dd, <i>J</i> = 5.52, 1.26 Hz, 1H), 6.54 (s, 1H), 4.20 (t, <i>J</i> = 6.60 Hz, 2H), 3.97 (t, <i>J</i> = 6.96 Hz, 2H), 3.79 (s, 3H), 3.59 (t, <i>J</i> = 6.78 Hz, 2H), 2.96 (t, <i>J</i> = 6.39 Hz, 2H), 2.21 (d, <i>J</i> = 1.11 Hz, 3H), 2.02 (quintet, <i>J</i> = 6.42 Hz, 2H). <sup>13</sup>C NMR (150 MHz, CD<sub>3</sub>OD) δ 183.9, 161.7, 154.8, 152.4, 149.1, 148.3, 138.8, 133.2, 129.7, 127.3, 119.8, 116.5, 115.9, 111.3, 110.3, 71.0, 57.5, 44.2, 43.8, 36.9, 32.2, 9.9. MS (FAB) <i>m</i>/<i>z</i> 441 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>22</sub>H<sub>28</sub>N<sub>6</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 441.2067, found 441.2080.</div></div><div id="sec4_10_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 1-(4-(3-(2-Aminopyridin-4-yl)propoxy)-3-methoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl) thiourea (<b>211</b>)</h4><div class="NLM_p last">From compound <b>161</b>, procedure <b>7</b>; yield 22%, white solid, mp 148–149 °C. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.75 (d, <i>J</i> = 5.40 Hz, 1H), 7.58 (s, 1H), 6.93–6.91 (m, 2H), 6.74 (dd, <i>J</i> = 8.40, 2.10 Hz, 1H), 6.66 (s, 1H), 6.50 (d, <i>J</i> = 5.35 Hz, 1H), 6.45 (s, 1H), 4.00–3.96 (m, 4H), 3.83 (s, 3H), 3.59 (t, <i>J</i> = 6.35 Hz, 2H), 2.70 (t, <i>J</i> = 7.45 Hz, 2H), 2.22 (s, 3H), 2.09–2.00 (m, 4H). <sup>13</sup>C NMR (125 MHz, CD<sub>3</sub>OD) δ 183.4, 161.8, 155.3, 152.3, 149.3, 148.4, 138.8, 133.6, 129.7, 127.4, 119.8, 116.2, 115.7, 112.3, 110.7, 70.3, 57.4, 44.2, 43.8, 33.3, 32.2, 31.6, 9.9. MS (FAB) <i>m</i>/<i>z</i> 455 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>23</sub>H<sub>30</sub>N<sub>6</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 455.2224, found 455.2235.</div></div><div id="sec4_10_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 1-(4-(4-(2-Aminopyridin-4-yl)butoxy)-3-methoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl) thiourea (<b>212</b>)</h4><div class="NLM_p last">From compound <b>148</b>, procedure <b>7</b>; yield 84%, white solid, mp 102–103 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.75 (d, <i>J</i> = 5.49 Hz, 1H), 7.59 (s, 1H), 6.94–6.90 (m, 2H), 6.74 (dd, <i>J</i> = 8.43, 2.37 Hz, 1H), 6.66 (s, 1H), 6.49 (dd, <i>J</i> = 5.49, 1.47 Hz, 1H), 6.44 (s, 1H), 4.01–3.94 (m, 4H), 3.81 (s, 3H), 3.59 (t, <i>J</i> = 7.14 Hz, 2H), 2.57 (m, 2H), 2.21 (d, <i>J</i> = 0.90 Hz, 3H), 2.05 (quintet, <i>J</i> = 6.96 Hz, 2H), 1.79 (m, 4H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 181.1, 158.5, 153.3, 149.8, 147.2, 146.4, 136.1, 129.5, 127.1, 125.7, 117.8, 114.2, 113.1, 109.9, 108.5, 68.7, 55.7, 42.1, 41.7, 34.5, 30.0, 28.3, 26.1, 9.2. MS (FAB) <i>m</i>/<i>z</i> 469 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>24</sub>H<sub>32</sub>N<sub>6</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 469.2380, found 469.2377.</div></div><div id="sec4_10_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> <i>N</i>-(4-(4-(2-Methoxy-4-(3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thioureido)phenoxy)butyl)pyridin-2-yl)acetamide (<b>213</b>)</h4><div class="NLM_p last">Prepared from compound <b>212</b> (1.0 equiv) by following the experimental procedure used for compound <b>178</b> to afford the desired product as a white solid (44%); the compound was decomposed at 211 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.69 (s, 1H), 8.08 (s, 1H), 8.06 (d, <i>J</i> = 2.94 Hz, 1H), 8.00 (s, 1H), 7.46 (s, 1H), 6.88 (d, <i>J</i> = 5.13 Hz, 1H), 6.84 (d, <i>J</i> = 8.25 Hz, 1H), 6.74–6.71 (m, 3H), 6.04 (s, 1H), 4.03 (t, <i>J</i> = 5.67 Hz, 2H), 3.91 (t, <i>J</i> = 6.96 Hz, 2H), 3.83 (s, 3H), 3.67 (q, <i>J</i> = 6.39 Hz, 2H), 2.71 (t, <i>J</i> = 7.14 Hz, 2H), 2.21 (s, 3H), 2.18 (s, 3H), 2.06 (quintet, <i>J</i> = 6.96 Hz, 2H), 1.87 (m, 4H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 181.8, 168.8, 153.9, 151.5, 150.5, 148.3, 147.4, 136.6, 129.8, 128.3, 127.0, 120.1, 118.7, 113.7, 113.3, 110.2, 68.8, 56.1, 42.4, 42.3, 35.1, 30.4, 28.5, 26.7, 24.8, 9.2. MS (ESI) <i>m</i>/<i>z</i> 511 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>26</sub>H<sub>34</sub>N<sub>6</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 511.2492, found 511.2500.</div></div><div id="sec4_10_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 1-(4-(3-(2,6-Diaminopyridin-4-yl)propoxy)-3-methoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl) propyl)thiourea (<b>214</b>)</h4><div class="NLM_p last">From compound <b>162</b>, procedure <b>7</b>; yield 11%, white solid; the compound was decomposed at 151 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub> + 5% CD<sub>3</sub>OD) δ 7.42 (s, 1H), 6.84 (d, <i>J</i> = 8.43 Hz, 1H), 6.79 (d, <i>J</i> = 2.37 Hz, 1H), 6.73 (dd, <i>J</i> = 8.22, 2.37 Hz, 1H), 6.70 (s, 1H), 5.77 (s, 2H), 4.00 (t, <i>J</i> = 6.24 Hz, 2H), 3.91 (t, <i>J</i> = 7.32 Hz, 2H), 3.86 (s, 3H), 3.64 (t, <i>J</i> = 7.14 Hz, 2H), 2.59 (t, <i>J</i> = 7.86 Hz, 2H), 2.20 (s, 3H), 2.12–2.03 (m, 4H). <sup>13</sup>C NMR (150 MHz, CD<sub>3</sub>OD) δ 183.7, 160.6, 156.7, 152.3, 149.4, 138.8, 133.2, 129.7, 127.4, 119.9, 116.1, 112.3, 99.2, 70.4, 57.4, 44.2, 43.8, 33.4, 32.2, 31.6, 9.9. MS (ESI) <i>m</i>/<i>z</i> 470 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>23</sub>H<sub>31</sub>N<sub>7</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 470.2338, found 470.2331.</div></div><div id="sec4_10_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 1-(4-(3-(2,6-Diaminopyridin-4-yl)butoxy)-3-methoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl) propyl)thiourea (<b>215</b>)</h4><div class="NLM_p last">From compound <b>163</b>, procedure <b>7</b>; yield 31%, white solid; the compound was decomposed at 145 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.58 (s, 1H), 7.37 (s, 1H), 6.84 (d, <i>J</i> = 8.22 Hz, 1H), 6.73–6.68 (m, 3H), 5.96 (s, 1H), 5.75 (s, 2H), 4.13 (br, 4H), 4.01 (t, <i>J</i> = 6.24 Hz, 2H), 3.89 (t, <i>J</i> = 7.14 Hz, 2H), 3.84 (s, 3H), 3.66 (q, <i>J</i> = 7.71 Hz, 2H), 2.46 (t, <i>J</i> = 7.32 Hz, 2H), 2.17 (d, <i>J</i> = 0.93 Hz, 2H), 2.05 (quintet, <i>J</i> = 7.14 Hz, 2H), 1.88–1.72 (m, 4H). <sup>13</sup>C NMR (150 MHz, CD<sub>3</sub>OD) δ 183.4, 160.5, 157.3, 152.2, 149.3, 138.8, 133.2, 129.7, 127.4, 119.8, 115.9, 112.3, 99.3, 71.1, 57.4, 44.2, 43.8, 36.8, 32.2, 30.7, 28.5, 9.9. MS (ESI) <i>m</i>/<i>z</i> 484 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>24</sub>H<sub>33</sub>N<sub>7</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 484.2495, found 484.2502.</div></div><div id="sec4_10_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 1-(4-(4-(6-Aminopyridin-2-yl)butoxy)-3-methoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>216</b>)</h4><div class="NLM_p last">From compound <b>166</b>, procedure <b>7</b>; yield 55%, white solid, mp 95–96 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 7.58 (d, <i>J</i> = 0.93 Hz, 1H), 7.38 (dd, <i>J</i> = 8.25, 7.32 Hz, 1H), 6.93 (d, <i>J</i> = 8.43 Hz, 1H), 6.88 (d, <i>J</i> = 2.37 Hz, 1H), 6.75 (dd, <i>J</i> = 8.40, 2.40 Hz, 1H), 6.65 (s, 1H), 6.50 (d, <i>J</i> = 7.32 Hz, 1H), 6.39 (d, <i>J</i> = 8.25 Hz, 1H), 4.02–3.94 (m, 4H), 3.80 (s, 3H), 3.61 (t, <i>J</i> = 7.14 Hz, 2H), 2.64 (t, <i>J</i> = 6.96 Hz, 2H), 2.21 (d, <i>J</i> = 0.93 Hz, 3H), 2.07 (quintet, <i>J</i> = 6.96 Hz, 2H), 1.82–1.79 (m, 4H). <sup>13</sup>C (100 MHz, CD<sub>3</sub>OD) δ 183.3, 161.5, 161.3, 152.2, 149.4, 140.4, 138.8, 133.0, 129.7, 127.4, 119.8, 115.8, 113.6, 112.2, 108.3, 71.0, 57.3, 44.2, 43.8, 39.0, 32.2, 30.7, 28.3, 9.9. MS (ESI) <i>m</i>/<i>z</i> 469 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>24</sub>H<sub>32</sub>N<sub>6</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 469.2385, found 469.2378.</div></div><div id="sec4_10_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 1-(3-Methoxy-4-(3-(pyrimidin-5-yl)propoxy)phenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>217</b>)</h4><div class="NLM_p last">From compound <b>120</b>, procedure <b>5</b>; yield 66%, white solid, mp 298–299 °C. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.97 (s, 1H), 8.69 (s, 2H), 7.58 (d, <i>J</i> = 0.68 Hz, 1H), 6.93–6.91 (m, 2H), 6.76 (dd, <i>J</i> = 8.52, 2.40 Hz, 1H), 6.66 (br, 1H), 4.03 (t, <i>J</i> = 3.84 Hz, 2H), 3.99 (t, <i>J</i> = 7.28 Hz, 2H), 3.81 (s, 3H), 3.61 (t, <i>J</i> = 6.92 Hz, 2H), 2.91 (t, <i>J</i> = 7.36 Hz, 2H), 2.21 (d, <i>J</i> = 0.72 Hz, 3H), 2.17 (quintet, <i>J</i> = 6.08 Hz, 2H), 2.07 (quintet, <i>J</i> = 7.16 Hz, 2H). <sup>13</sup>C NMR (75 MHz, CD<sub>3</sub>OD) δ 183.3, 158.9, 157.7, 152.0, 148.7, 138.6, 137.7, 133.3, 129.5, 127.3, 119.6, 115.8, 111.9, 69.8, 57.2, 44.1, 43.7, 32.1, 31.7, 28.5, 9.9. MS (FAB) <i>m</i>/<i>z</i> 441 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>22</sub>H<sub>28</sub>N<sub>6</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 441.2072, found 441.2067.</div></div><div id="sec4_10_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 1-(3-Methoxy-4-(4-(pyrimidin-5-yl)butoxy)phenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>218</b>)</h4><div class="NLM_p last">From compound <b>121</b>, procedure <b>5</b>; yield 48%, white solid, mp 104–105 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.97 (s, 1H), 8.70 (s, 2H), 7.59 (s, 1H), 6.94 (d, <i>J</i> = 8.58 Hz, 1H), 6.90 (d, <i>J</i> = 2.22 Hz, 1H), 6.75 (dd, <i>J</i> = 8.43, 2.37 Hz, 1H), 6.66 (br, 1H), 4.05 (t, <i>J</i> = 5.67 Hz, 2H), 3.99 (t, <i>J</i> = 7.32 Hz, 2H), 3.81 (s, 3H), 3.61 (t, <i>J</i> = 6.78 Hz, 2H), 2.79 (t, <i>J</i> = 6.93 Hz, 2H), 2.21 (d, <i>J</i> = 0.72 Hz, 3H), 2.07 (quintet, <i>J</i> = 7.14 Hz, 2H), 1.85–1.83 (m, 4H). <sup>13</sup>C NMR (75 MHz, CD<sub>3</sub>OD) δ 183.3, 158.9, 157.7, 152.1, 149.2, 138.8, 138.4, 133.2, 129.7, 127.4, 119.8, 115.7, 112.1, 70.8, 57.3, 44.2, 43.9, 32.2, 31.5, 30.3, 29.3, 9.9. MS (FAB) <i>m</i>/<i>z</i> 455 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>23</sub>H<sub>30</sub>N<sub>6</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 455.2229, found 455.2229.</div></div><div id="sec4_10_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 1-(4-(3-(2-Aminopyrimidin-5-yl)propoxy)-3-methoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>219</b>)</h4><div class="NLM_p last">From compound <b>164</b>, procedure <b>7</b>; yield 45%, white solid, mp 88–89 °C. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.15 (s, 2H), 7.58 (s, 1H), 6.94–6.91 (m, 2H), 6.75 (d, <i>J</i> = 8.43, 2.37 Hz, 1H), 6.66 (br, 1H), 4.00–3.94 (m, 4H), 3.82 (s, 3H), 3.62 (t, <i>J</i> = 7.14 Hz, 2H), 2.69 (t, <i>J</i> = 7.14 Hz, 2H), 2.21 (d, <i>J</i> = 0.90 Hz, 3H), 2.05–2.01 (m, 4H). <sup>13</sup>C NMR (125 MHz, CD<sub>3</sub>OD) δ 183.3, 164.0, 160.1, 152.2, 149.1, 138.8, 133.2, 129.7, 127.4, 125.5, 119.8, 115.9, 112.1, 69.8, 57.3, 44.2, 43.8, 32.3, 32.2, 27.5, 9.9. MS (FAB) <i>m</i>/<i>z</i> 456 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>22</sub>H<sub>29</sub>N<sub>7</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 456.2181, found 456.2187.</div></div><div id="sec4_10_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 1-(4-(4-(2-Aminopyrimidin-5-yl)butoxy)-3-methoxyphenyl)-3-(3-(5-methyl-1<i>H</i>-imidazol-1-yl)propyl)thiourea (<b>220</b>)</h4><div class="NLM_p last">From compound <b>165</b>, procedure <b>7</b>; yield 77%, white solid, mp 74–75 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.13 (s, 2H), 7.87 (s, 1H), 7.55 (s, 1H), 6.84 (d, <i>J</i> = 8.25 Hz, 1H), 6.75–6.71 (m, 3H), 6.24 (br, 1H), 4.98 (br, 2H), 4.04 (t, <i>J</i> = 6.03 Hz, 2H), 3.94 (t, <i>J</i> = 7.14 Hz, 2H), 3.82 (s, 3H), 3.67 (q, <i>J</i> = 6.60 Hz, 2H), 2.55 (t, <i>J</i> = 7.53 Hz, 2H), 2.18 (d, <i>J</i> = 0.93 Hz, 3H), 2.09–2.01 (m, 2H), 1.88–1.71 (m, 4H). <sup>13</sup>C NMR (75 MHz, CD<sub>3</sub>OD) δ 183.2, 163.8, 159.9, 151.9, 149.0, 138.7, 133.0, 129.8, 127.0, 126.2, 119.6, 115.6, 112.0, 70.9, 57.3, 44.3, 43.7, 32.0, 31.2, 30.7, 29.7, 9.9. MS (FAB) 470 [M + H]<sup>+</sup>. HRMS (FAB) calc. for C<sub>23</sub>H<sub>31</sub>N<sub>7</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 470.2338, found 470.2331.</div></div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> Computational Study</h3><div id="sec4_11_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> Protein Structure Preparation</h4><div class="NLM_p last">The X-ray crystal structure of the human glutaminyl cyclase (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBB">3PBB</a>)<sup>M-1</sup> was selected and prepared using the Protein Preparation Wizard in Maestro v.9.2 (Schrödinger, LLC, NY, USA). During the preparation process, the bond orders were assigned, zero-order bonds to Zn<sup>2+</sup> were created, and hydrogen atoms were added. All of the hydrogen atoms were energy-minimized with the optimized potential for liquid simulation (OPLS) 2005 force field until the average root-mean-square deviation for hydrogen atoms reached 0.30 Å.</div></div><div id="sec4_11_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> Ligand Preparation</h4><div class="NLM_p last">The protonation states of the ligand molecules were predicted using the p<i>K</i><sub>a</sub> prediction module in the ACD/I-Lab web server (ACD/Laboratories, Toronto, Ontario, Canada). At pH 7.4, the major form of <b>B7</b> was protonated at the D-region, and that of <b>C10</b> is predicted to have neutral and protonated forms with a ratio of 2:1. The three-dimensional structures of the ligand molecules were generated by LigPrep v.2.8 in Maestro. The resulting structures were energy-minimized in implicit solvent with the OPLS 2005 force field in Maestro.</div></div><div id="sec4_11_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> Glide Standard Precision (SP) Docking</h4><div class="NLM_p last">The prepared ligand molecules were docked to <i>h</i>QC using Glide v.6.1 in Maestro. The grid for the active site was generated using the centroid of the cocrystallized ligand, PBD150, and the grid box size was set as the default value. The metal coordination constraint was set as tetrahedral geometry for the Zn<sup>2+</sup>. For the initial docking stage, Glide SP docking was performed with the maximum number of 30 poses per ligand.</div></div><div id="sec4_11_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> Glide Quantum Mechanics Polarized Ligand Docking (QPLD)</h4><div class="NLM_p last">The top 5 poses for each ligand from the previous Glide SP docking were selected and used for the following QPLD process. The partial charges of the docked ligands were calculated using Jaguar with the option of an accurate QM level. Then, the ligands with the updated charges were redocked using Glide extra precision (XP).</div></div><div id="sec4_11_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> Refinement of the Protein–Ligand Complex Structure</h4><div class="NLM_p last">The protein–ligand complexes obtained from the QPLD were taken for further optimization by the Refine Protein–Ligand Complex module in Prime v.3.4 in Maestro (Schrödinger, LLC, NY, USA). Local optimization refinement within 5 Å of the docked ligand was performed. During this process, the side chain conformations of the selected protein residues were predicted and minimized and subsequently minimized along with the docked ligand. The results were further energy-minimized using a Monte Carlo sampling algorithm in 6000 steps. All of the molecular graphic figures were generated by PyMOL software (<a href="http://www.pymol.org" class="extLink">http://www.pymol.org</a>). All computational studies were undertaken on an Intel Xeon Octa-Core 2.5 GHz workstation with Linux CentOS release 5.8.</div></div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> Biological Study</h3><div id="sec4_12_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> <i>In Vitro</i> QC Activity Assay</h4><div class="NLM_p last">For testing the inhibition activities of test compounds, QC activity was fluorometrically evaluated. The used buffer consisted of 25 mM HEPES (Sigma), with pH 7.0, adjusted with HCl. The substrate H-Gln-AMC hydrobromide (<span class="smallcaps smallerCapital">l</span>-glutamine 7-amido-4-methylcoumarin, BACHEM, Switzerland) was used at a concentration of 0.4 mM. The auxiliary enzyme pGAPase (50 units, Qiagen, Germany) was prediluted 1:250 in HEPES. The human QC (10 μg/mL, rhQPCT, R&D systems) was prediluted 1:250 in HEPES. A typical reaction mixture consisted of 25 μL of substrate, 50 μL of the test compounds, and 25 μL of pGAPase. After incubation in 96-well black plates (Greiner, Austria) for 10 min at 37 °C, the reaction was started by adding 50 μL of the <i>h</i>QC solution.</div></div><div id="sec4_12_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> Cytotoxicity Assays</h4><div class="NLM_p last">HT-22 (mouse hippocampal cells) cells were grown in Dulbecco’s modified Eagle’s medium (DMEM, GIBCO) supplemented with 10% (v/v) fetal bovine serum and antibiotics (100 mg/mL penicillin/streptomycin mix) in a humidified atmosphere at 37 °C with 5% CO<sub>2</sub>. 5000 HT-22 cells per well were seeded into a clear 96-well plate 1 day prior to assay. Medium was removed from the plate, and cells were treated with 25 μL solution of each compound at 10 μM and incubated at 37 °C for 18 h. Fifteen microliters of 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) solution (5 mg/mL) was added to each well and incubated for 3 h. The formazan formed was dissolved in dimethyl sulfoxide (DMSO), and absorbance at 570 nm was measured using a microplate reader (Sunrise, TECAN). OD values from each well were subtracted with vehicle control, and cell viability was calculated by using the signals from the vehicle control as 100%.</div></div><div id="sec4_12_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> Permeability Assay</h4><div class="NLM_p last">Parallel artificial membrane permeability assay (PAMPA)-BBB studies were conducted using the PAMPA Explorer kit (<i>p</i>ION Inc.). Stock solutions of all compounds were prepared in dimethyl sulfoxide (DMSO) (10 mM). Each stock solution was diluted to 50 μL (Final DMSO concentration 1%) in pH 7.4 Prisma HT buffer (<i>p</i>ION), and 200 μL was added to each well of the donor plate (<i>n</i> = 3). The polyvinylidene fluoride (PVDF, 0.45 μm) filter membrane on the acceptor plate was coated with 5 μL of BBB-1 lipid (<i>p</i>ION) formulation, and to each well of the acceptor plate, 200 μL of brain sink buffer (BSB, <i>p</i>ION) was added. The acceptor filter plate was carefully placed on top of the donor plate to form a “sandwich”. The sandwich was incubated at 25 °C for 4 h, without stirring. UV–vis spectra of the solutions in the reference, acceptor, and donor plates were measured using a microplate reader, Safire (Tecan, Switzerland). For each compound, −log<i>P</i><sub>e</sub> was calculated using the PAMPA Explorer software v.3.5 (<i>p</i>ION).</div></div><div id="sec4_12_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> Animals and Treatment</h4><div class="NLM_p">For acute model study, ICR mice were utilized. ICR mice were obtained from SAMTACO (Korea). Five micrograms in five microliters of human Aβ<sub>3–40</sub> (62–0–99, American peptide) in PBS was injected into the deep cortical/hippocampus to 5 week old ICR mice (25 g, <i>n</i> = 4, male) using a stereotaxic frame (myNeuroLab, USA). Test compounds were administrated via deep cortical/hippocampus or i.p. injection. After mice were anaesthetized with Zoletil50 and 2% Rumpun (1:2 ratio, 0.4 mL/kg) i.m., the animal was placed into a stereotaxic frame. A small incision (1 cm) was made over the midline of the skull and the landmarks of the cranium (bregma and lambda) exposed. A small hole was drilled through the skull. Human Aβ<sub>3–40</sub> was injected into the deep cortical/hippocampus by using the following coordinates: AP −2.0 mm, ML 1.2 mm, and DV 1.0 mm from the bregma. Using a Hamilton 25 μL syringe with 27-gauge guide needle, a 5 μL volume containing human Aβ<sub>3–40</sub> was delivered.</div><div class="NLM_p">For the brain infusion study, APP/PS1 AD model Tg mice were obtained from Jackson Lab (USA). For continuous delivering of our compound, we implanted miniosmotic pumps (ALZET) for <i>in vivo</i> delivery. Briefly, mice were anesthetized with and placed in a stereotactic frame. A brain-infusion cannula (Brain Infusion Kit 3; ALZET, Cupertino, CA, USA) coupled via vinyl tubing to the osmotic pump was implanted into the deep cortical/hippocampus (AP −2.0 mm, ML 1.2 mm, and DV 1.0 mm from the bregma.). The test compounds were infused into the brain of APP/PS1 mice for 3 weeks.</div><div class="NLM_p last">For the transgenic mice model study, a total of 12 (<i>n</i> = 6 for vehicle; <i>n</i> = 6 for compound treatment) 5XFAD mice (Jackson Lab, ME) were utilized. 5XFAD mice coexpress a total of five FAD mutations, including APP with three FAD mutations [K670N/M671L (Swedish), I716 V (Florida) and V717I (London)] and PS1 with two mutations (M146L and L286 V) under the control of a neuronal specific Thy1 promoter. In this study, we followed the national guidelines in conducting animal experiments. All procedures for animal tests were approved by the Medifron Animal Care and Use Committee (approval number, Medifron 2013-2, IACUC). All surgical procedures were performed with care to minimize pain and discomfort. To evaluate the test compounds on AD model mice, the test compounds were administrated via intraperitoneal injection to mice to 19 week old male 5XFAD mice for 3 months. Mice were housed individually with a 12:12 h light/dark cycle (07:00–19:00 h). The cognitive function of each mouse was measured after 3 months of administration.</div></div><div id="sec4_12_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> Morris Water Maze (MWM) Test</h4><div class="NLM_p last">The MWM was conducted during the last 6 days of the treatment period. The mouse had to find the hidden platform (10 cm in diameter) during 60 s trials in a circular pool with a diameter of 120 cm filled with opaque water at temperature of 22 ± 1 °C. After each trial, mice were allowed to rest on the platform for 10 s. All mice were given four training trials per day for 5 consecutive days. Escape latency, pathway, and presence of the mice in the platform quadrant were quantified. Twenty-four hours after the hidden-platform trial, mice were subjected to a probe trial in which the platform was removed, and their swimming paths were recorded for 60 s. All mouse behaviors (time/distance for reaching the platform, swimming speed, path length, and time spent in each quadrant) were quantified with EthoVision XT 7.0 software (Noldus Information Technology, Germany)</div></div><div id="sec4_12_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> Aβ Sandwich ELISAs</h4><div class="NLM_p last">Sandwich ELISA was performed for the quantification of N3pE−40 (for acute model mouse brain), Aβ<sub>42</sub> (for TG mouse brain), and N3pE−42 (for TG mouse brain). The mouse brains were completely lysed with RIPA buffer using a sonicator (SONICS, USA) and ultracentrifuged at 100,000<i>g</i>, 4 °C for 1 h. The supernatant obtained here was a RIPA-soluble fraction. The pellet was resuspended in 70% formic acid and ultracentrifuged under the same condition. The supernatant was collected as formic acid-soluble fraction. Protein concentrations were determined using a BCA kit (Thermo scientific). Sample duplicates were then run on Aβ<sub>42</sub> and N3pE−42 Aβ specific sandwich ELISAs following the protocol of the manufacturer (#27418 for N3pE−40, #27711 for Aβ<sub>42</sub>, and #27716 for N3pE−42, IBL Japan). Optical densities at 450 nm of each well were read on a plate reader, Safire (Tecan, Switzerland). The concentration of the sample Aβ<sub>42</sub> and N3pE−42 Aβ were determined by their standard curves. All readings were in the linear range of the assay. The concentration values were normalized to total brain weight and expressed in pg or ng of Aβ per mg of total protein. After the average of the duplicates was determined, the mean and SEM for each group were calculated.</div></div><div id="sec4_12_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> Statistical Analyses</h4><div class="NLM_p last">Data was expressed as the mean ± SEM. All experiments were repeated at least 3 times. Statistical analyses between groups were performed using SPSS software (SPSS, Chicago, IL). For group comparisons of variables, we analyzed data with either One-way ANOVA with Bonferroni posthoc test or independent samples <i>t</i> test in SPSS. (ns, <i>p</i> > 0.05; *, <i>p</i> < 0.05; **, <i>p</i> < 0.01; ***, <i>p</i> < 0.001).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i93"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00098">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24048" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24048" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00098" class="ext-link">10.1021/acs.jmedchem.7b00098</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular modeling and the HPLC purities of all final compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00098/suppl_file/jm7b00098_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">SMILES data (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00098/suppl_file/jm7b00098_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00098/suppl_file/jm7b00098_si_001.pdf">jm7b00098_si_001.pdf (1.32 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00098/suppl_file/jm7b00098_si_002.csv">jm7b00098_si_002.csv (3.15 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00098" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76347" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76347" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeewoo Lee</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry, Research Institute of Pharmaceutical Sciences,
College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7832-6719" title="Orcid link">http://orcid.org/0000-0002-7832-6719</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#caa0afafbda5a58ab9a4bfe4aba9e4a1b8"><span class="__cf_email__" data-cfemail="a6ccc3c3d1c9c9e6d5c8d388c7c588cdd4">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Van-Hai Hoang</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry, Research Institute of Pharmaceutical Sciences,
College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Phuong-Thao Tran</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry, Research Institute of Pharmaceutical Sciences,
College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Chemistry, Hanoi University
of Pharmacy, Hanoi, Vietnam</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Minghua Cui</span> - <span class="hlFld-Affiliation affiliation">National
Leading Research Laboratory of Molecular Modeling & Drug Design,
College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic
of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Van T. H. Ngo</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry, Research Institute of Pharmaceutical Sciences,
College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jihyae Ann</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry, Research Institute of Pharmaceutical Sciences,
College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jongmi Park</span> - <span class="hlFld-Affiliation affiliation">National
Leading Research Laboratory of Molecular Modeling & Drug Design,
College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic
of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiyoun Lee</span> - <span class="hlFld-Affiliation affiliation">Department
of Global Medical Science, Sungshin University, Seoul 01133, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kwanghyun Choi</span> - <span class="hlFld-Affiliation affiliation">Medifron
DBT, Sandanro 349, Danwon-Gu, Ansan-City, Gyeonggi-Do 15426, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hanyang Cho</span> - <span class="hlFld-Affiliation affiliation">Medifron
DBT, Sandanro 349, Danwon-Gu, Ansan-City, Gyeonggi-Do 15426, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hee Kim</span> - <span class="hlFld-Affiliation affiliation">Medifron
DBT, Sandanro 349, Danwon-Gu, Ansan-City, Gyeonggi-Do 15426, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hee-Jin Ha</span> - <span class="hlFld-Affiliation affiliation">Medifron
DBT, Sandanro 349, Danwon-Gu, Ansan-City, Gyeonggi-Do 15426, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hyun-Seok Hong</span> - <span class="hlFld-Affiliation affiliation">Medifron
DBT, Sandanro 349, Danwon-Gu, Ansan-City, Gyeonggi-Do 15426, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sun Choi</span> - <span class="hlFld-Affiliation affiliation">National
Leading Research Laboratory of Molecular Modeling & Drug Design,
College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic
of Korea</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7669-7954" title="Orcid link">http://orcid.org/0000-0002-7669-7954</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Young-Ho Kim</span> - <span class="hlFld-Affiliation affiliation">Medifron
DBT, Sandanro 349, Danwon-Gu, Ansan-City, Gyeonggi-Do 15426, Republic of Korea</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d65e6774-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i94">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24530" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24530" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the Korea Science and Engineering Foundation (KOSEF) grants from the Korea government (MOST) (NRF-2014M3A9D9069725) and National Leading Research Lab (NLRL) program (2011-0028885).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i95" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i95"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i96" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i96"> Abbreviations Used</h2><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">β-amyloid</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">AchEI</td><td class="NLM_def"><p class="first last">acetylcholinesterase inhibitors</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid precursor protein</p></td></tr><tr><td class="NLM_term">NMDA</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate</p></td></tr><tr><td class="NLM_term">pGlu</td><td class="NLM_def"><p class="first last">pyroglutamate</p></td></tr><tr><td class="NLM_term">QC</td><td class="NLM_def"><p class="first last">glutamyl cyclase</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i97">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61825" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61825" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 44 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span><span class="refDoi"> DOI: 10.1126/science.1072994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+progress+and+problems+on+the+road+to+therapeutics&doi=10.1126%2Fscience.1072994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0lg4rOGWP3DtpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520progress%2520and%2520problems%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356%26doi%3D10.1126%2Fscience.1072994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Bishop, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, S. R.</span><span> </span><span class="NLM_article-title">Physiological roles of amyloid-beta and implications for its removal in Alzheimer’s disease</span> <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">630</span><span class="refDoi"> DOI: 10.2165/00002512-200421100-00001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.2165%2F00002512-200421100-00001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=15287821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvFOlu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2004&pages=621-630&author=G.+M.+Bishopauthor=S.+R.+Robinson&title=Physiological+roles+of+amyloid-beta+and+implications+for+its+removal+in+Alzheimer%E2%80%99s+disease&doi=10.2165%2F00002512-200421100-00001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Physiological roles of amyloid-β and implications for its removal in Alzheimer's disease</span></div><div class="casAuthors">Bishop, Glenda M.; Robinson, Stephen R.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & Aging</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">621-630</span>CODEN:
                <span class="NLM_cas:coden">DRAGE6</span>;
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review.  The underlying pathol. cause of Alzheimer's disease has been postulated to be an excess of amyloid-β (Aβ) which aggregates into toxic fibrillar deposits within the extracellular space of the brain, thereby disrupting neuronal and synaptic function and eventually leading to neuronal degeneration and dementia.  As a result, therapeutic strategies have been developed that are designed to remove Aβ from the brain.  Caution needs to be exercised concerning such strategies because, in addn. to its presence in neuritic plaques, Aβ has a widespread distribution through the brain and body, even in cognitively normal individuals.  Evidence indicates that instead of being a toxic peptide, sol. Aβ serves a variety of physiol. functions, including modulation of synaptic function, facilitation of neuronal growth and survival, protection against oxidative stress, and surveillance against neuroactive compds., toxins and pathogens.  These physiol. functions must be taken into account when strategies are developed to reduce Aβ load in Alzheimer's disease.  Ideally, such strategies should target forms of Aβ that are not bioavailable, such as fibrillar Aβ, or forms that are regarded to be overexpressed in Alzheimer's disease (such as oligomers) while leaving normal sol. Aβ1-40 and Aβ1-42 intact.  At present none of the available therapeutic strategies appears to have such selectivity.  Until these tech. limitations and the uncertainties regarding the effect of depletion of Aβ from the brain are resolved, it would not be prudent to begin further clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfnaDxhoWFObVg90H21EOLACvtfcHk0ljKb4X6k5FJKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvFOlu7w%253D&md5=d00dcf814a383fecc05e767a6e54af1f</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2165%2F00002512-200421100-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002512-200421100-00001%26sid%3Dliteratum%253Aachs%26aulast%3DBishop%26aufirst%3DG.%2BM.%26aulast%3DRobinson%26aufirst%3DS.%2BR.%26atitle%3DPhysiological%2520roles%2520of%2520amyloid-beta%2520and%2520implications%2520for%2520its%2520removal%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DDrugs%2520Aging%26date%3D2004%26volume%3D21%26spage%3D621%26epage%3D630%26doi%3D10.2165%2F00002512-200421100-00001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Puzzo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span> </span><span class="NLM_article-title">Amyloid-beta peptide: Dr. Jekyll or Mr. Hyde?</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S111</span><span class="NLM_x">–</span> <span class="NLM_lpage">120</span><span class="refDoi"> DOI: 10.3233/JAD-2012-129033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.3233%2FJAD-2012-129033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=S111-120&issue=Suppl+1&author=D.+Puzzoauthor=O.+Arancio&title=Amyloid-beta+peptide%3A+Dr.+Jekyll+or+Mr.+Hyde%3F&doi=10.3233%2FJAD-2012-129033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3233%2FJAD-2012-129033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2012-129033%26sid%3Dliteratum%253Aachs%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DAmyloid-beta%2520peptide%253A%2520Dr.%2520Jekyll%2520or%2520Mr.%2520Hyde%253F%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2013%26volume%3D33%26issue%3DSuppl%25201%26spage%3DS111%26epage%3D120%26doi%3D10.3233%2FJAD-2012-129033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Lopez-Toledano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelanski, M. L.</span><span> </span><span class="NLM_article-title">Neurogenic effect of beta-amyloid peptide in the development of neural stem cells</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">5439</span><span class="NLM_x">–</span> <span class="NLM_lpage">5444</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.0974-04.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1523%2FJNEUROSCI.0974-04.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=15190117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltFCgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=5439-5444&author=M.+A.+Lopez-Toledanoauthor=M.+L.+Shelanski&title=Neurogenic+effect+of+beta-amyloid+peptide+in+the+development+of+neural+stem+cells&doi=10.1523%2FJNEUROSCI.0974-04.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Neurogenic effect of β-amyloid peptide in the development of neural stem cells</span></div><div class="casAuthors">Lopez-Toledano, Miguel A.; Shelanski, Michael L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5439-5444</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The adult mammalian brain contains neural stem cells (NSCs) with self-renewal and multilineage potential in the hippocampus and subventricular zone.  However, neurogenesis from these areas does not compensate for neuronal loss in age-related neurodegenerative disorders such as Alzheimer's disease (AD).  To test whether an impairment of neurogenesis could contribute to the pathogenesis of AD, we examd. the effects of amyloid-β peptide (Aβ) on the survival and neuronal differentiation of cultured NSCs from striatum and hippocampus.  We show that Aβ peptide does not impair the neurogenic rate in NSC progeny, but that it increases the total no. of neurons in vitro in a dose-dependent manner.  The neurogenic effect of Aβ peptide is not dependent on sol. factors released from the NSC progeny.  Neurogenesis is induced by Aβ42 and not Aβ40 or Aβ 25-35, and the activity appears to be a property of Aβ oligomers and not fibrils.  These results suggest that Aβ may have pos. as well as deleterious actions, and that a knowledge of the mechanisms involved in the former could be valuable in exploiting the regenerative and plastic potential of the brain in preventing and treating Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4XsvDahB767Vg90H21EOLACvtfcHk0ljKb4X6k5FJKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltFCgu78%253D&md5=904d3e58af4a01cb63667474f308f20b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0974-04.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0974-04.2004%26sid%3Dliteratum%253Aachs%26aulast%3DLopez-Toledano%26aufirst%3DM.%2BA.%26aulast%3DShelanski%26aufirst%3DM.%2BL.%26atitle%3DNeurogenic%2520effect%2520of%2520beta-amyloid%2520peptide%2520in%2520the%2520development%2520of%2520neural%2520stem%2520cells%26jtitle%3DJ.%2520Neurosci.%26date%3D2004%26volume%3D24%26spage%3D5439%26epage%3D5444%26doi%3D10.1523%2FJNEUROSCI.0974-04.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Yankner, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffy, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirschner, D. A.</span><span> </span><span class="NLM_article-title">Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">250</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span><span class="refDoi"> DOI: 10.1126/science.2218531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1126%2Fscience.2218531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=2218531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADyaK3MXlslansg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=250&publication_year=1990&pages=279-282&author=B.+A.+Yanknerauthor=L.+K.+Duffyauthor=D.+A.+Kirschner&title=Neurotrophic+and+neurotoxic+effects+of+amyloid+beta+protein%3A+reversal+by+tachykinin+neuropeptides&doi=10.1126%2Fscience.2218531"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotrophic and neurotoxic effects of amyloid β protein:  reversal by tachykinin neuropeptides</span></div><div class="casAuthors">Yankner, Bruce A.; Duffy, Lawrence K.; Kirschner, Daniel A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">250</span>
        (<span class="NLM_cas:issue">4978</span>),
    <span class="NLM_cas:pages">279-82</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">In culture, the amyloid β protein was neurotrophic to undifferentiated hippocampal neurons at low concns. and neurotoxic to mature neurons at higher concns.  In differentiated neurons, amyloid β protein caused dendritic and axonal retraction followed by neuronal death.  A portion of the amyloid β protein (amino acids 25 to 35) mediated both the trophic and toxic effects and was homologous to the tachykinin neuropeptide family.  The effects of the amyloid β protein were mimicked by tachykinin neuropeptide family.  The effects of the amyloid β protein were mimicked by tachykinin antagonists and completely reversed by specific tachykinin agonists.  Thus, the amyloid β protein could function as a neurotrophic factor for differentiating neurons, but at high concns. in mature neurons, as in Alzheimer's disease, could cause neuronal degeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJRCaiy24wQ7Vg90H21EOLACvtfcHk0ljKb4X6k5FJKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlslansg%253D%253D&md5=fbfae857924c6783ceeee51926a077a3</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.2218531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.2218531%26sid%3Dliteratum%253Aachs%26aulast%3DYankner%26aufirst%3DB.%2BA.%26aulast%3DDuffy%26aufirst%3DL.%2BK.%26aulast%3DKirschner%26aufirst%3DD.%2BA.%26atitle%3DNeurotrophic%2520and%2520neurotoxic%2520effects%2520of%2520amyloid%2520beta%2520protein%253A%2520reversal%2520by%2520tachykinin%2520neuropeptides%26jtitle%3DScience%26date%3D1990%26volume%3D250%26spage%3D279%26epage%3D282%26doi%3D10.1126%2Fscience.2218531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Giuffrida, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caraci, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pignataro, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cataldo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Bona, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molinaro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pappalardo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmigiano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garozzo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoletti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzarelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copani, A.</span><span> </span><span class="NLM_article-title">Beta-amyloid monomers are neuroprotective</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">10582</span><span class="NLM_x">–</span> <span class="NLM_lpage">10587</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.1736-09.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1523%2FJNEUROSCI.1736-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=19710311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVyntr3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=10582-10587&author=M.+L.+Giuffridaauthor=F.+Caraciauthor=B.+Pignataroauthor=S.+Cataldoauthor=P.+De+Bonaauthor=V.+Brunoauthor=G.+Molinaroauthor=G.+Pappalardoauthor=A.+Messinaauthor=A.+Palmigianoauthor=D.+Garozzoauthor=F.+Nicolettiauthor=E.+Rizzarelliauthor=A.+Copani&title=Beta-amyloid+monomers+are+neuroprotective&doi=10.1523%2FJNEUROSCI.1736-09.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">β-Amyloid monomers are neuroprotective</span></div><div class="casAuthors">Giuffrida, Maria Laura; Caraci, Filippo; Pignataro, Bruno; Cataldo, Sebastiano; De Bona, Paolo; Bruno, Valeria; Molinaro, Gemma; Pappalardo, Giuseppe; Messina, Angela; Palmigiano, Angelo; Garozzo, Domenico; Nicoletti, Ferdinando; Rizzarelli, Enrico; Copani, Agata</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">10582-10587</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The 42-aa-long β-amyloid protein-Aβ1-42-is thought to play a central role in the pathogenesis of Alzheimer's disease (AD).  Data from AD brain, transgenic APP (amyloid precursor protein)-overexpressing mice, and neuronal cultures treated with synthetic Aβ peptides indicate that self-assocn. of Aβ1-42 monomers into sol. oligomers is required for neurotoxicity.  The function of monomeric Aβ1-42 is unknown.  The evidence that Aβ1-42 is present in the brain and CSF of normal individuals suggests that the peptide is physiol. active.  Here we show that synthetic Aβ1-42 monomers support the survival of developing neurons under conditions of trophic deprivation and protect mature neurons against excitotoxic death, a process that contributes to the overall neurodegeneration assocd. with AD.  The neuroprotective action of Aβ1-42 monomers was mediated by the activation of the PI-3-K (phosphatidylinositol-3-kinase) pathway, and involved the stimulation of IGF-1 (insulin-like growth factor-1) receptors and/or other receptors of the insulin superfamily.  Interestingly, monomers of Aβ1-42 carrying the Arctic mutation (E22G) assocd. with familiar AD were not neuroprotective.  We suggest that pathol. aggregation of Aβ1-42 may also cause neurodegeneration by depriving neurons of the protective activity of Aβ1-42 monomers.  This "loss-of-function" hypothesis of neuronal death should be taken into consideration when designing therapies aimed at reducing Aβ burden.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSmQtdvzLazLVg90H21EOLACvtfcHk0lgm_o-yof0L5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVyntr3I&md5=bd2dd3dbe1b024d9457a5a9cdac6376f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1736-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1736-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DGiuffrida%26aufirst%3DM.%2BL.%26aulast%3DCaraci%26aufirst%3DF.%26aulast%3DPignataro%26aufirst%3DB.%26aulast%3DCataldo%26aufirst%3DS.%26aulast%3DDe%2BBona%26aufirst%3DP.%26aulast%3DBruno%26aufirst%3DV.%26aulast%3DMolinaro%26aufirst%3DG.%26aulast%3DPappalardo%26aufirst%3DG.%26aulast%3DMessina%26aufirst%3DA.%26aulast%3DPalmigiano%26aufirst%3DA.%26aulast%3DGarozzo%26aufirst%3DD.%26aulast%3DNicoletti%26aufirst%3DF.%26aulast%3DRizzarelli%26aufirst%3DE.%26aulast%3DCopani%26aufirst%3DA.%26atitle%3DBeta-amyloid%2520monomers%2520are%2520neuroprotective%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D10582%26epage%3D10587%26doi%3D10.1523%2FJNEUROSCI.1736-09.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Giuffrida, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caraci, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Bona, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pappalardo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoletti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzarelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copani, A.</span><span> </span><span class="NLM_article-title">The monomer state of beta-amyloid: where the Alzheimer’s disease protein meets physiology</span> <span class="citation_source-journal">Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span><span class="refDoi"> DOI: 10.1515/REVNEURO.2010.21.2.83</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1515%2FREVNEURO.2010.21.2.83" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=20614800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosVSmsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=83-93&author=M.+L.+Giuffridaauthor=F.+Caraciauthor=P.+De+Bonaauthor=G.+Pappalardoauthor=F.+Nicolettiauthor=E.+Rizzarelliauthor=A.+Copani&title=The+monomer+state+of+beta-amyloid%3A+where+the+Alzheimer%E2%80%99s+disease+protein+meets+physiology&doi=10.1515%2FREVNEURO.2010.21.2.83"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The monomer state of beta-amyloid: where the Alzheimer's disease protein meets physiology</span></div><div class="casAuthors">Giuffrida, M. L.; Caraci, F.; de Bona, P.; Pappalardo, G.; Nicoletti, F.; Rizzarelli, E.; Copani, A.</div><div class="citationInfo"><span class="NLM_cas:title">Reviews in the Neurosciences (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">83-93</span>CODEN:
                <span class="NLM_cas:coden">RNEUEO</span>;
        ISSN:<span class="NLM_cas:issn">0334-1763</span>.
    
            (<span class="NLM_cas:orgname">Freund & Pettman</span>)
        </div><div class="casAbstract">A review.  One hundred years of study have identified beta-Amyloid (Aβ) as the most interesting feature of Alzheimer's disease (AD).  Since the discovery of Aβ as the principal component of amyloid plaques, the central challenge in AD research has been the understanding of Aβ involvement in the neurodegenerative process of the disease.  The ability of Aβ to undergo conformational changes and subsequent aggregation has always been a limiting factor in finding out the activities of the peptide.  Extensive research has been carried out to study the mol. mechanisms of amyloid self-assembly.  The finding that sol. Aβ concns. in the brain are correlated with the severity of AD, whereas fibrillar d. is not /40,42/, has pointed attention toward the oligomeric forms of Aβ, which are generally considered the most toxic and, therefore, the most important species to be addressed.  Despite great efforts in basic AD research, none of the currently available treatments is able to treat the devastating effects of the disease, leading to the consideration that there is more to reason than just Aβ prodn. and aggregation.  Here we summarize the emerging evidence for the physiol. functions of Aβ, including our recent demonstration that Aβ monomers are endowed with neuroprotective activity, and propose that Aβ aggregation might contribute to AD pathol. through a "loss-of-function" process.  Finally, we discuss the current therapeutics targeting the cerebral load of Aβ and possible new ones aimed at preserving the biol. functions of Aβ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD_O2Wutn2VLVg90H21EOLACvtfcHk0lgm_o-yof0L5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosVSmsb0%253D&md5=067db06db21cc4a0e987267b99e6ca0e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1515%2FREVNEURO.2010.21.2.83&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FREVNEURO.2010.21.2.83%26sid%3Dliteratum%253Aachs%26aulast%3DGiuffrida%26aufirst%3DM.%2BL.%26aulast%3DCaraci%26aufirst%3DF.%26aulast%3DDe%2BBona%26aufirst%3DP.%26aulast%3DPappalardo%26aufirst%3DG.%26aulast%3DNicoletti%26aufirst%3DF.%26aulast%3DRizzarelli%26aufirst%3DE.%26aulast%3DCopani%26aufirst%3DA.%26atitle%3DThe%2520monomer%2520state%2520of%2520beta-amyloid%253A%2520where%2520the%2520Alzheimer%25E2%2580%2599s%2520disease%2520protein%2520meets%2520physiology%26jtitle%3DRev.%2520Neurosci.%26date%3D2010%26volume%3D21%26spage%3D83%26epage%3D93%26doi%3D10.1515%2FREVNEURO.2010.21.2.83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Butterfield, D. A.</span><span> </span><span class="NLM_article-title">Amyloid beta-peptide (1–42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer’s disease brain. A review</span> <span class="citation_source-journal">Free Radical Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1307</span><span class="NLM_x">–</span> <span class="NLM_lpage">1313</span><span class="refDoi"> DOI: 10.1080/1071576021000049890</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1080%2F1071576021000049890" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=12607822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslamtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2002&pages=1307-1313&author=D.+A.+Butterfield&title=Amyloid+beta-peptide+%281%E2%80%9342%29-induced+oxidative+stress+and+neurotoxicity%3A+implications+for+neurodegeneration+in+Alzheimer%E2%80%99s+disease+brain.+A+review&doi=10.1080%2F1071576021000049890"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid β-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review</span></div><div class="casAuthors">Butterfield, D. Allan</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1307-1313</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1071-5762</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Oxidative stress, manifested by protein oxidn., lipid peroxidn., DNA oxidn. and 3-nitrotyrosine formation, among other indexes, is obsd. in Alzheimer's disease (AD) brain.  Amyloid β-peptide (1-42) [Aβ(1-42)] may be central to the pathogenesis of AD.  Our lab. and others have implicated Aβ(1-42)-induced free radical oxidative stress in the neurodegeneration obsd. in AD brain.  This paper reviews some of these studies from our lab.  Recently, we showed both in-vitro and in-vivo that methionine residue 35 (Met-35) of Aβ(1-42) was crit. to its oxidative stress and neurotoxic properties.  Because the C-terminal region of Aβ(1-42) is helical, and invoking the i + 4 rule of helixes, we hypothesized that the carboxyl oxygen of lle-31, known to be within a van der Waals distance of the S atom of Met-35, would interact with the latter.  This interaction could alter the susceptibility for oxidn. of Met-35, i.e. free radical formation.  Consistent with this hypothesis, substitution of lle-31 by the helix-breaking amino acid, proline, completely abrogated the oxidative stress and neurotoxic properties of Aβ(1-42).  Removal of the Met-35 residue from the lipid bilayer by substitution of the neg. charged Asp for Gly-37 abrogated oxidative stress and neurotoxic properties of Aβ(1-42).  The free radical scavenger vitamin E prevented Aβ (1-42)-induced ROS formation, protein oxidn., lipid peroxidn., and neurotoxicity in hippocampal neurons, consistent with our model for Aβ-assocd. free radical oxidative stress induced neurodegeneration in AD.  ApoE, allele 4, is a risk factor for AD.  Synaptosomes from apoE knock-out mice are more vulnerable to Aβ-induced oxidative stress (protein oxidn., lipid peroxidn., and ROS generation) than are those from wild-type mice.  We also studied synaptosomes from allele-specific human apoE knock-in mice.  Brain membranes from human apoE4 mice have greater vulnerability to Aβ(1-42)-induced oxidative stress than brain membranes from apoE2 or E3, assessed by the same indexes, consistent with the notion of a coupling of the oxidative environment in AD brain and increased risk of developing this disorder.  Using immunopptn. of proteins from AD and control brain obtained no longer than 4 h PMI, selective oxidized proteins were identified in the AD brain.  Creatine kinase (CK) and β-actin have increased carbonyl groups, an index of protein oxidn., and Glt-1, the principal glutamate transporter, has increased binding of the lipid peroxidn. product, 4-hydroxy-2-nonenal (HNE).  Aβ inhibits CK and causes lipid peroxidn., leading to HNE formation.  Implications of these findings relate to decreased energy utilization, altered assembly of cytoskeletal proteins, and increased excitotoxicity to neurons by glutamate, all reported for AD.  Other oxidatively modified proteins have been identified in AD brain by proteomics anal., and these oxidatively-modified proteins may be related to increased excitotoxicity (glutamine synthetase), aberrant proteasomal degrdn. of damaged or aggregated proteins (ubiquitin C-terminal hydrolase L-1), altered energy prodn. (α-enolase), and diminished growth cone elongation and directionality (dihydropyrimindase-related protein 2).  Taken together, these studies outlined above suggest that Met-35 is key to the oxidative stress and neurotoxic properties of Aβ(1-42) and may help explain the apoE allele dependence on risk for AD, some of the functional and structural alterations in AD brain, and strongly support a causative role of Aβ(1-42)-induced oxidative stress and neurodegeneration in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovbtGvhIQlIrVg90H21EOLACvtfcHk0lgm_o-yof0L5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslamtA%253D%253D&md5=ad37b360cb8245ded7a9acad99e15b5e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1080%2F1071576021000049890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F1071576021000049890%26sid%3Dliteratum%253Aachs%26aulast%3DButterfield%26aufirst%3DD.%2BA.%26atitle%3DAmyloid%2520beta-peptide%2520%25281%25E2%2580%259342%2529-induced%2520oxidative%2520stress%2520and%2520neurotoxicity%253A%2520implications%2520for%2520neurodegeneration%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520brain.%2520A%2520review%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2002%26volume%3D36%26spage%3D1307%26epage%3D1313%26doi%3D10.1080%2F1071576021000049890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Baruch-Suchodolsky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, B.</span><span> </span><span class="NLM_article-title">Abeta40, either soluble or aggregated, is a remarkably potent antioxidant in cell-free oxidative systems</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4354</span><span class="NLM_x">–</span> <span class="NLM_lpage">4370</span><span class="refDoi"> DOI: 10.1021/bi802361k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi802361k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=4354-4370&author=R.+Baruch-Suchodolskyauthor=B.+Fischer&title=Abeta40%2C+either+soluble+or+aggregated%2C+is+a+remarkably+potent+antioxidant+in+cell-free+oxidative+systems&doi=10.1021%2Fbi802361k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fbi802361k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi802361k%26sid%3Dliteratum%253Aachs%26aulast%3DBaruch-Suchodolsky%26aufirst%3DR.%26aulast%3DFischer%26aufirst%3DB.%26atitle%3DAbeta40%252C%2520either%2520soluble%2520or%2520aggregated%252C%2520is%2520a%2520remarkably%2520potent%2520antioxidant%2520in%2520cell-free%2520oxidative%2520systems%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D4354%26epage%3D4370%26doi%3D10.1021%2Fbi802361k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Soscia, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washicosky, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingelsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, R. D.</span><span> </span><span class="NLM_article-title">The Alzheimer’s disease-associated amyloid beta-protein is an antimicrobial peptide</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e9505</span><span class="refDoi"> DOI: 10.1371/journal.pone.0009505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1371%2Fjournal.pone.0009505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=20209079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A280%3ADC%252BC3c7mtlCmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e9505&author=S.+J.+Sosciaauthor=J.+E.+Kirbyauthor=K.+J.+Washicoskyauthor=S.+M.+Tuckerauthor=M.+Ingelssonauthor=B.+Hymanauthor=M.+A.+Burtonauthor=L.+E.+Goldsteinauthor=S.+Duongauthor=R.+E.+Tanziauthor=R.+D.+Moir&title=The+Alzheimer%E2%80%99s+disease-associated+amyloid+beta-protein+is+an+antimicrobial+peptide&doi=10.1371%2Fjournal.pone.0009505"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide</span></div><div class="casAuthors">Soscia Stephanie J; Kirby James E; Washicosky Kevin J; Tucker Stephanie M; Ingelsson Martin; Hyman Bradley; Burton Mark A; Goldstein Lee E; Duong Scott; Tanzi Rudolph E; Moir Robert D</div><div class="citationInfo"><span class="NLM_cas:title">PloS one</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e9505</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The amyloid beta-protein (Abeta) is believed to be the key mediator of Alzheimer's disease (AD) pathology.  Abeta is most often characterized as an incidental catabolic byproduct that lacks a normal physiological role.  However, Abeta has been shown to be a specific ligand for a number of different receptors and other molecules, transported by complex trafficking pathways, modulated in response to a variety of environmental stressors, and able to induce pro-inflammatory activities.  METHODOLOGY/PRINCIPAL FINDINGS:  Here, we provide data supporting an in vivo function for Abeta as an antimicrobial peptide (AMP).  Experiments used established in vitro assays to compare antimicrobial activities of Abeta and LL-37, an archetypical human AMP.  Findings reveal that Abeta exerts antimicrobial activity against eight common and clinically relevant microorganisms with a potency equivalent to, and in some cases greater than, LL-37.  Furthermore, we show that AD whole brain homogenates have significantly higher antimicrobial activity than aged matched non-AD samples and that AMP action correlates with tissue Abeta levels.  Consistent with Abeta-mediated activity, the increased antimicrobial action was ablated by immunodepletion of AD brain homogenates with anti-Abeta antibodies.  CONCLUSIONS/SIGNIFICANCE:  Our findings suggest Abeta is a hitherto unrecognized AMP that may normally function in the innate immune system.  This finding stands in stark contrast to current models of Abeta-mediated pathology and has important implications for ongoing and future AD treatment strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRXGndyYusJ4Y2y4bB4mnvYfW6udTcc2eaEixSdJjsw07ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7mtlCmsA%253D%253D&md5=74845535cf4f072df2baa4bb7ab08bf8</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0009505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0009505%26sid%3Dliteratum%253Aachs%26aulast%3DSoscia%26aufirst%3DS.%2BJ.%26aulast%3DKirby%26aufirst%3DJ.%2BE.%26aulast%3DWashicosky%26aufirst%3DK.%2BJ.%26aulast%3DTucker%26aufirst%3DS.%2BM.%26aulast%3DIngelsson%26aufirst%3DM.%26aulast%3DHyman%26aufirst%3DB.%26aulast%3DBurton%26aufirst%3DM.%2BA.%26aulast%3DGoldstein%26aufirst%3DL.%2BE.%26aulast%3DDuong%26aufirst%3DS.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DMoir%26aufirst%3DR.%2BD.%26atitle%3DThe%2520Alzheimer%25E2%2580%2599s%2520disease-associated%2520amyloid%2520beta-protein%2520is%2520an%2520antimicrobial%2520peptide%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26spage%3De9505%26doi%3D10.1371%2Fjournal.pone.0009505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Larner, A. J.</span><span> </span><span class="NLM_article-title">Hypothesis: amyloid beta-peptides truncated at the N-terminus contribute to the pathogenesis of Alzheimer’s disease</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span><span class="refDoi"> DOI: 10.1016/S0197-4580(99)00014-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1016%2FS0197-4580%2899%2900014-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10466895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADyaK1MXlvVKnurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=65-69&author=A.+J.+Larner&title=Hypothesis%3A+amyloid+beta-peptides+truncated+at+the+N-terminus+contribute+to+the+pathogenesis+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0197-4580%2899%2900014-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Hypothesis: amyloid β-peptides truncated at the N-terminus contribute to the pathogenesis of Alzheimer's disease</span></div><div class="casAuthors">Larner, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-69</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Fragments of amyloid β-peptide truncated at the N-terminus are present in AD brain early in the course of Alzheimer's disease.  It is proposed that these species contribute to the pathogenesis of AD, possibly through destabilization of elements of the neuronal cytoskeleton by small fibrillar deposits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVBDWqVDUChLVg90H21EOLACvtfcHk0liKBgaRhhzXgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvVKnurw%253D&md5=c6fc637848837e8d6b797073966df531</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0197-4580%2899%2900014-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0197-4580%252899%252900014-7%26sid%3Dliteratum%253Aachs%26aulast%3DLarner%26aufirst%3DA.%2BJ.%26atitle%3DHypothesis%253A%2520amyloid%2520beta-peptides%2520truncated%2520at%2520the%2520N-terminus%2520contribute%2520to%2520the%2520pathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D1999%26volume%3D20%26spage%3D65%26epage%3D69%26doi%3D10.1016%2FS0197-4580%2899%2900014-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Kumar-Singh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Jonghe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruts, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderstichele, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lofgren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderhoeven, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backhovens, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanmechelen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroisel, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Broeckhoven, C.</span><span> </span><span class="NLM_article-title">Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase site mutation points to an essential role for N-truncated A beta(42) in Alzheimer’s disease</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2589</span><span class="NLM_x">–</span> <span class="NLM_lpage">2598</span><span class="refDoi"> DOI: 10.1093/hmg/9.18.2589</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1093%2Fhmg%2F9.18.2589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=11063718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVKktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2000&pages=2589-2598&author=S.+Kumar-Singhauthor=C.+De+Jongheauthor=M.+Crutsauthor=R.+Kleinertauthor=R.+Wangauthor=M.+Merckenauthor=B.+De+Strooperauthor=H.+Vandersticheleauthor=A.+Lofgrenauthor=I.+Vanderhoevenauthor=H.+Backhovensauthor=E.+Vanmechelenauthor=P.+M.+Kroiselauthor=C.+Van+Broeckhoven&title=Nonfibrillar+diffuse+amyloid+deposition+due+to+a+gamma%2842%29-secretase+site+mutation+points+to+an+essential+role+for+N-truncated+A+beta%2842%29+in+Alzheimer%E2%80%99s+disease&doi=10.1093%2Fhmg%2F9.18.2589"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Nonfibrillar diffuse amyloid deposition due to a γ42-secretase site mutation points to an essential role for N-truncated Aβ42 in Alzheimer's disease</span></div><div class="casAuthors">Kumar-Singh, Samir; De Jonghe, Chris; Cruts, Marc; Kleinert, Reinhold; Wang, Rong; Mercken, Marc; De Strooper, Bart; Vanderstichele, Hugo; Lofgren, Ann; Vanderhoeven, Inge; Backhovens, Hubert; Vanmechelen, Eugeen; Kroisel, Peter M.; Van Broeckhoven, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2589-2598</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Amyloidogenic processing of the amyloid precursor protein (APP) with deposition in brain of the 42-amino acid long amyloid β-peptide (Aβ42) is considered central to Alzheimer's disease (AD) pathol.  However, it is generally believed that nonfibrillar pre-amyloid Aβ42 deposits have to mature in the presence of Aβ40 into fibrillar amyloid plaques to cause neurodegeneration.  Here, an aggressive form of AD is shown to be caused by a novel missense mutation in APP (T714I) directly involving γ-secretase cleavages of APP.  The mutation had the most drastic effect on Aβ42/Aβ40 ratio in vitro of ∼11-fold, simultaneously increasing Aβ42 and decreasing Aβ40 secretion, as measured by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.  This coincided in brain with deposition of abundant and predominant nonfibrillar pre-amyloid plaques composed primarily of N-truncated Aβ42 in complete absence of Aβ40.  These data indicate that N-truncated Aβ42 as diffuse nonfibrillar plaques has an essential but undermined role in AD pathol.  Importantly, inhibiting secretion of full-length Aβ42 by therapeutic targeting of APP processing should not result in secretion of an equally toxic N-truncated Aβ42.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbZLr8Yf4DdbVg90H21EOLACvtfcHk0ljBcTgtlaLFmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVKktL0%253D&md5=49e857dfb99cefd1e71df74cfd407fd1</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F9.18.2589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F9.18.2589%26sid%3Dliteratum%253Aachs%26aulast%3DKumar-Singh%26aufirst%3DS.%26aulast%3DDe%2BJonghe%26aufirst%3DC.%26aulast%3DCruts%26aufirst%3DM.%26aulast%3DKleinert%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DVanderstichele%26aufirst%3DH.%26aulast%3DLofgren%26aufirst%3DA.%26aulast%3DVanderhoeven%26aufirst%3DI.%26aulast%3DBackhovens%26aufirst%3DH.%26aulast%3DVanmechelen%26aufirst%3DE.%26aulast%3DKroisel%26aufirst%3DP.%2BM.%26aulast%3DVan%2BBroeckhoven%26aufirst%3DC.%26atitle%3DNonfibrillar%2520diffuse%2520amyloid%2520deposition%2520due%2520to%2520a%2520gamma%252842%2529-secretase%2520site%2520mutation%2520points%2520to%2520an%2520essential%2520role%2520for%2520N-truncated%2520A%2520beta%252842%2529%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2000%26volume%3D9%26spage%3D2589%26epage%3D2598%26doi%3D10.1093%2Fhmg%2F9.18.2589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Miravalle, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calero, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roher, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghetti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, R.</span><span> </span><span class="NLM_article-title">Amino-terminally truncated Abeta peptide species are the main component of cotton wool plaques</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">10810</span><span class="NLM_x">–</span> <span class="NLM_lpage">10821</span><span class="refDoi"> DOI: 10.1021/bi0508237</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0508237" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsVynsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=10810-10821&author=L.+Miravalleauthor=M.+Caleroauthor=M.+Takaoauthor=A.+E.+Roherauthor=B.+Ghettiauthor=R.+Vidal&title=Amino-terminally+truncated+Abeta+peptide+species+are+the+main+component+of+cotton+wool+plaques&doi=10.1021%2Fbi0508237"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Amino-Terminally Truncated Aβ Peptide Species Are the Main Component of Cotton Wool Plaques</span></div><div class="casAuthors">Miravalle, Leticia; Calero, Miguel; Takao, Masaki; Roher, Alex E.; Ghetti, Bernardino; Vidal, Ruben</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">10810-10821</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cotton wool plaques (CWPs) are round lesions that lack a central amyloid core.  CWPs have been obsd. in individuals affected by early-onset familial Alzheimer disease (FAD) assocd. with mutations in the presenilin 1 (PSEN1) gene.  Here we present the characterization of the amyloid-β (Aβ) peptides deposited in the brain of an individual affected by FAD carrying the novel missense (V261I) mutation in the PSEN1 gene.  Matrix-assisted laser desorption ionization time-of-flight mass spectrometry was used to det. the Aβ peptide species present in the cerebral and cerebellar cortexes, in leptomeningeal vessels, and in CWPs isolated by laser microdissection (LMD).  Our results indicate that amino-terminally truncated Aβ peptide species ending at residues 42 and 43 are the main Aβ peptides deposited in brain parenchyma and LMD-CWPs in assocn. with the PSEN1 V261I mutation.  Full-length Aβ1-42 and Aβ1-43 peptide species were underrepresented.  CWPs were not found to be assocd. with vessels and did not contain Aβ1-40 peptides, the main component of the vascular deposits.  Although Aβ deposits were present mostly in the form of CWPs in the cerebral cortex and as diffuse deposits in the cerebellar cortex, a similar array of amino-terminally truncated Aβ peptide species was seen in both cases.  The biochem. data support the concept that parenchymal and vascular amyloid deposits are assocd. with a different array of Aβ peptide species.  The generation and parenchymal deposition of highly insol. amino-terminally truncated Aβ peptides may play an important role in the pathogenesis of AD and must be taken into consideration in developing new diagnostic and therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAq_XS9LmMPrVg90H21EOLACvtfcHk0ljBcTgtlaLFmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsVynsrY%253D&md5=15b5a7a7cc10e2f4013b40f344988c81</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fbi0508237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0508237%26sid%3Dliteratum%253Aachs%26aulast%3DMiravalle%26aufirst%3DL.%26aulast%3DCalero%26aufirst%3DM.%26aulast%3DTakao%26aufirst%3DM.%26aulast%3DRoher%26aufirst%3DA.%2BE.%26aulast%3DGhetti%26aufirst%3DB.%26aulast%3DVidal%26aufirst%3DR.%26atitle%3DAmino-terminally%2520truncated%2520Abeta%2520peptide%2520species%2520are%2520the%2520main%2520component%2520of%2520cotton%2520wool%2520plaques%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D10810%26epage%3D10821%26doi%3D10.1021%2Fbi0508237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Jawhar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirths, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayer, T. A.</span><span> </span><span class="NLM_article-title">Pyroglutamate amyloid-beta (Abeta): a hatchet man in Alzheimer disease</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">38825</span><span class="NLM_x">–</span> <span class="NLM_lpage">38832</span><span class="refDoi"> DOI: 10.1074/jbc.R111.288308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1074%2Fjbc.R111.288308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=21965666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSqt7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=38825-38832&author=S.+Jawharauthor=O.+Wirthsauthor=T.+A.+Bayer&title=Pyroglutamate+amyloid-beta+%28Abeta%29%3A+a+hatchet+man+in+Alzheimer+disease&doi=10.1074%2Fjbc.R111.288308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamate amyloid-β (Aβ): a hatchet man in Alzheimer disease</span></div><div class="casAuthors">Jawhar, Sadim; Wirths, Oliver; Bayer, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">38825-38832</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  Pyroglutamate-modified amyloid-β (AβpE3) peptides are gaining considerable attention as potential key participants in the pathol. of Alzheimer disease (AD) due to their abundance in AD brain, high aggregation propensity, stability, and cellular toxicity.  Transgenic mice that produce high levels of AβpE3-42 show severe neuron loss.  Recent in vitro and in vivo expts. have proven that the enzyme glutaminyl cyclase catalyzes the formation of AβpE3.  In this minireview, we summarize the current knowledge on AβpE3, discussing its discovery, biochem. properties, mol. events detg. formation, prevalence in the brains of AD patients, Alzheimer mouse models, and potential as a target for therapy and as a diagnostic marker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9SRHPGwO6ErVg90H21EOLACvtfcHk0ljBcTgtlaLFmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSqt7vE&md5=e7b0363724dd2e7cbbfc2071abdc8241</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R111.288308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R111.288308%26sid%3Dliteratum%253Aachs%26aulast%3DJawhar%26aufirst%3DS.%26aulast%3DWirths%26aufirst%3DO.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26atitle%3DPyroglutamate%2520amyloid-beta%2520%2528Abeta%2529%253A%2520a%2520hatchet%2520man%2520in%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D38825%26epage%3D38832%26doi%3D10.1074%2Fjbc.R111.288308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Saido, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawashima, S.</span><span> </span><span class="NLM_article-title">Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">466</span><span class="refDoi"> DOI: 10.1016/0896-6273(95)90301-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1016%2F0896-6273%2895%2990301-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=7857653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADyaK2MXjvFejsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1995&pages=457-466&author=T.+C.+Saidoauthor=T.+Iwatsuboauthor=D.+M.+Mannauthor=H.+Shimadaauthor=Y.+Iharaauthor=S.+Kawashima&title=Dominant+and+differential+deposition+of+distinct+beta-amyloid+peptide+species%2C+A+beta+N3%28pE%29%2C+in+senile+plaques&doi=10.1016%2F0896-6273%2895%2990301-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Dominant and differential deposition of distinct β-amyloid peptide species, AβN3(pE), in senile plaques</span></div><div class="casAuthors">Saido, Takaomi C.; Iwatsubo, Takeshi; Mann, David M. A.; Shimada, Hiroyuki; Ihara, Yasuo; Kawashima, Selichi</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">457-66</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We analyzed an amino-terminal modification of β-amyloid (Aβ) peptide in brain, using anti-Aβ antibodies that distinguish distinct mol. species.  Examn. of cortical sections from 28 aged individuals with a wide range in senile plaque d. revealed that a mol. species distinct from the std. Aβ is deposited in the brain in a dominant and differential manner.  This modified Aβ peptide (AβN3(pE)) starts at the 3rd amino-terminal residue of the std. αβ, glutamate, converted to pyroglutamate through intramol. dehydration.  Because plaques composed of αβN3(pE) are present in equiv. or greater densities than those composed of std. Aβ bearing the first amino-terminal residue (AβN1) and because deposition of the former species appears to precede deposition of the latter, as confirmed with specimens from Down's syndrome patients, the processes involved in AβNe(pE) prodn. and retention may play an early and crit. role in senile plaque formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEs7XnR_KCcbVg90H21EOLACvtfcHk0ljBcTgtlaLFmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjvFejsLk%253D&md5=8405ddfabcebe721ccd5b1dc1e222069</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2F0896-6273%2895%2990301-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0896-6273%252895%252990301-1%26sid%3Dliteratum%253Aachs%26aulast%3DSaido%26aufirst%3DT.%2BC.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DMann%26aufirst%3DD.%2BM.%26aulast%3DShimada%26aufirst%3DH.%26aulast%3DIhara%26aufirst%3DY.%26aulast%3DKawashima%26aufirst%3DS.%26atitle%3DDominant%2520and%2520differential%2520deposition%2520of%2520distinct%2520beta-amyloid%2520peptide%2520species%252C%2520A%2520beta%2520N3%2528pE%2529%252C%2520in%2520senile%2520plaques%26jtitle%3DNeuron%26date%3D1995%26volume%3D14%26spage%3D457%26epage%3D466%26doi%3D10.1016%2F0896-6273%2895%2990301-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Schlenzig, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manhart, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cinar, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinschmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hause, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willbold, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funke, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span> </span><span class="NLM_article-title">Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7072</span><span class="NLM_x">–</span> <span class="NLM_lpage">7078</span><span class="refDoi"> DOI: 10.1021/bi900818a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi900818a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnvFWkurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=7072-7078&author=D.+Schlenzigauthor=S.+Manhartauthor=Y.+Cinarauthor=M.+Kleinschmidtauthor=G.+Hauseauthor=D.+Willboldauthor=S.+A.+Funkeauthor=S.+Schillingauthor=H.+U.+Demuth&title=Pyroglutamate+formation+influences+solubility+and+amyloidogenicity+of+amyloid+peptides&doi=10.1021%2Fbi900818a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamate Formation Influences Solubility and Amyloidogenicity of Amyloid Peptides</span></div><div class="casAuthors">Schlenzig, Dagmar; Manhart, Susanne; Cinar, Yeliz; Kleinschmidt, Martin; Hause, Gerd; Willbold, Dieter; Funke, Susanne Aileen; Schilling, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">7072-7078</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Terminally truncated and pyroglutamate (pGlu) modified amyloid β (Aβ) peptides are major constituents of amyloid deposits in sporadic and inherited Alzheimer's disease (AD).  Formation of pGlu at the N-terminus confers resistance against cleavage by most aminopeptidases, increases toxicity of the peptides, and may seed Aβ aggregate formation.  Similarly, the deposited amyloid peptides ABri and ADan, which cause a very similar histopathol. in familial British dementia (FBD) and familial Danish dementia (FDD), are N-terminally blocked by pGlu.  Triggered by the coincidence of pGlu-modified amyloid peptides and similar pathol. in AD, FBD, and FDD, we investigated the impact of N-terminal pGlu on biochem. and biophys. properties of Aβ, ABri, and ADan.  N-Terminal pGlu increases the hydrophobicity and changes the pH-dependent soly. profile, rendering the pGlu-modified peptides less sol. in the basic pH range.  The pGlu residue increases the aggregation propensity of all amyloid peptides as evidenced by ThT fluorescence assays and dynamic light scattering.  The far-UV CD spectroscopic anal. points toward an enhanced β-sheet structure of the pGlu-Aβ.  Importantly, changes in fibril morphol. are clearly caused by the N-terminal pGlu, resulting in the formation of short fibers, which are frequently arranged in bundles.  The effect of pGlu on the morphol. is virtually indistinguishable between ABri, ADan, and Aβ.  The data provide evidence for a comparable influence of the pGlu modification on the aggregation process of structurally different amyloid peptides, thus likely contributing to the molecularly distinct neurodegenerative diseases AD, FBD, and FDD.  The main driving force for the aggregation is apparently an increase in the hydrophobicity and thus an accelerated seed formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo01m64gYKSRLVg90H21EOLACvtfcHk0lhcib30P4eePw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnvFWkurk%253D&md5=f32a500d5c6e5f44fa2809256c8a90ca</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fbi900818a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi900818a%26sid%3Dliteratum%253Aachs%26aulast%3DSchlenzig%26aufirst%3DD.%26aulast%3DManhart%26aufirst%3DS.%26aulast%3DCinar%26aufirst%3DY.%26aulast%3DKleinschmidt%26aufirst%3DM.%26aulast%3DHause%26aufirst%3DG.%26aulast%3DWillbold%26aufirst%3DD.%26aulast%3DFunke%26aufirst%3DS.%2BA.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DPyroglutamate%2520formation%2520influences%2520solubility%2520and%2520amyloidogenicity%2520of%2520amyloid%2520peptides%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D7072%26epage%3D7078%26doi%3D10.1021%2Fbi900818a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Russo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Violani, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venezia, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolcini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damonte, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benatti, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arrigo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrone, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schettini, G.</span><span> </span><span class="NLM_article-title">Pyroglutamate-modified amyloid beta-peptides--AbetaN3(pE)--strongly affect cultured neuron and astrocyte survival</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">1480</span><span class="NLM_x">–</span> <span class="NLM_lpage">1489</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.2002.01107.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1046%2Fj.1471-4159.2002.01107.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=12354296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsV2hs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2002&pages=1480-1489&author=C.+Russoauthor=E.+Violaniauthor=S.+Salisauthor=V.+Veneziaauthor=V.+Dolciniauthor=G.+Damonteauthor=U.+Benattiauthor=C.+D%E2%80%99Arrigoauthor=E.+Patroneauthor=P.+Carloauthor=G.+Schettini&title=Pyroglutamate-modified+amyloid+beta-peptides%2D%2DAbetaN3%28pE%29%2D%2Dstrongly+affect+cultured+neuron+and+astrocyte+survival&doi=10.1046%2Fj.1471-4159.2002.01107.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamate-modified amyloid β-peptides - AβN3(pE) -strongly affect cultured neuron and astrocyte survival</span></div><div class="casAuthors">Russo, Claudio; Violani, Elisabetta; Salis, Serena; Venezia, Valentina; Dolcini, Virginia; Damonte, Gianluca; Benatti, Umberto; D'Arrigo, Cristina; Patrone, Eligio; Carlo, Pia; Schettini, Gennaro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1480-1489</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">N-terminally truncated amyloid-β (Aβ) peptides are present in early and diffuse plaques of individuals with Alzheimer's disease (AD), are overproduced in early onset familial AD and their amt. seems to be directly correlated to the severity and the progression of the disease in AD and Down's syndrome (DS).  The pyroglutamate-contg. isoforms at position 3 [AβN3(pE)-40/42] represent the prominent form among the N-truncated species, and may account for more than 50% of Aβ accumulated in plaques.  In this study, the authors compared the toxic properties, fibrillogenic capabilities, and in vitro degrdn. profile of Aβ1-40, Aβ1-42, AβN3(pE)-40 and AβN3(pE)-42.  The authors' data show that fiber morphol. of Aβ peptides is greatly influenced by the C-terminus while toxicity, interaction with cell membranes and degrdn. are influenced by the N-terminus.  AβN3(pE)-40 induced significantly more cell loss than the other species both in neuronal and glial cell cultures.  Aggregated AβN3(pE) peptides were heavily distributed on plasma membrane and within the cytoplasm of treated cells.  AβN3(pE)-40/42 peptides showed a significant resistance to degrdn. by cultured astrocytes, while full-length peptides resulted partially degraded.  These findings suggest that formation of N-terminally modified peptides may enhance β-amyloid aggregation and toxicity, likely worsening the onset and progression of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR0uvn5GQRVLVg90H21EOLACvtfcHk0lhcib30P4eePw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsV2hs7g%253D&md5=41ad79cbdbb8f5debcec7c93035a709d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2002.01107.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2002.01107.x%26sid%3Dliteratum%253Aachs%26aulast%3DRusso%26aufirst%3DC.%26aulast%3DViolani%26aufirst%3DE.%26aulast%3DSalis%26aufirst%3DS.%26aulast%3DVenezia%26aufirst%3DV.%26aulast%3DDolcini%26aufirst%3DV.%26aulast%3DDamonte%26aufirst%3DG.%26aulast%3DBenatti%26aufirst%3DU.%26aulast%3DD%25E2%2580%2599Arrigo%26aufirst%3DC.%26aulast%3DPatrone%26aufirst%3DE.%26aulast%3DCarlo%26aufirst%3DP.%26aulast%3DSchettini%26aufirst%3DG.%26atitle%3DPyroglutamate-modified%2520amyloid%2520beta-peptides--AbetaN3%2528pE%2529--strongly%2520affect%2520cultured%2520neuron%2520and%2520astrocyte%2520survival%26jtitle%3DJ.%2520Neurochem.%26date%3D2002%26volume%3D82%26spage%3D1480%26epage%3D1489%26doi%3D10.1046%2Fj.1471-4159.2002.01107.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">He, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrow, C. J.</span><span> </span><span class="NLM_article-title">The A beta 3-pyroglutamyl and 11-pyroglutamyl peptides found in senile plaque have greater beta-sheet forming and aggregation propensities in vitro than full-length A beta</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">10871</span><span class="NLM_x">–</span> <span class="NLM_lpage">10877</span><span class="refDoi"> DOI: 10.1021/bi990563r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi990563r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADyaK1MXltFSltbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=10871-10877&author=W.+Heauthor=C.+J.+Barrow&title=The+A+beta+3-pyroglutamyl+and+11-pyroglutamyl+peptides+found+in+senile+plaque+have+greater+beta-sheet+forming+and+aggregation+propensities+in+vitro+than+full-length+A+beta&doi=10.1021%2Fbi990563r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The Aβ 3-Pyroglutamyl and 11-Pyroglutamyl Peptides Found in Senile Plaque Have Greater β-Sheet Forming and Aggregation Propensities in Vitro than Full-Length Aβ</span></div><div class="casAuthors">He, Weilan; Barrow, Colin J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">10871-10877</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aβ isolated from neuritic plaque and vascular walls of the brains of patients with Alzheimer's disease has been shown to contain significant quantities of Aβ peptides which begin at residue 3Glu or 11Glu in the form of pyroglutamyl residues (Aβ3pE and Aβ11pE).  To investigate the effects of these N-terminal modifications on the biophys. properties of Aβ, peptides Aβ1-40, Aβ3pE-40, Aβ11pE-40, Aβ1-28, Aβ3pE-28, and Aβ11pE-28 were synthesized.  Using CD spectroscopy, we detd. that the pyroglutamyl-contg. peptides form β-sheet structure more readily than the corresponding full-length Aβ peptides, both in aq. solns. and in 10% SDS micelles.  Trifluoroethanol spectra indicated that the relative β-sheet to α-helical stability is higher for the pyroglutamyl-contg. peptides.  Sedimentation expts. show that the pyroglutamyl-contg. peptides have greater aggregation propensities than the corresponding full-length peptides.  Comparison between the Aβ40 and the Aβ28 series indicated that the greater β-sheet forming and aggregation propensities of the pyroglutamyl peptides are not simply due to an increase in hydrophobicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5xcOsA5djELVg90H21EOLACvtfcHk0liX9KTj1pXLUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltFSltbk%253D&md5=edb7b92c11ef110e8d87d397b7531a8d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fbi990563r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi990563r%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DW.%26aulast%3DBarrow%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520A%2520beta%25203-pyroglutamyl%2520and%252011-pyroglutamyl%2520peptides%2520found%2520in%2520senile%2520plaque%2520have%2520greater%2520beta-sheet%2520forming%2520and%2520aggregation%2520propensities%2520in%2520vitro%2520than%2520full-length%2520A%2520beta%26jtitle%3DBiochemistry%26date%3D1999%26volume%3D38%26spage%3D10871%26epage%3D10877%26doi%3D10.1021%2Fbi990563r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Nussbaum, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cynis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wangsanut, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tayler, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiltgen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronicke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reymann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutter-Paier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexandru, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagla, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graubner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glabe, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloom, G. S.</span><span> </span><span class="NLM_article-title">Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-beta</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">485</span><span class="NLM_x">, </span> <span class="NLM_fpage">651</span><span class="NLM_x">–</span> <span class="NLM_lpage">655</span><span class="refDoi"> DOI: 10.1038/nature11060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1038%2Fnature11060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=22660329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVymsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=485&publication_year=2012&pages=651-655&author=J.+M.+Nussbaumauthor=S.+Schillingauthor=H.+Cynisauthor=A.+Silvaauthor=E.+Swansonauthor=T.+Wangsanutauthor=K.+Taylerauthor=B.+Wiltgenauthor=A.+Hatamiauthor=R.+Ronickeauthor=K.+Reymannauthor=B.+Hutter-Paierauthor=A.+Alexandruauthor=W.+Jaglaauthor=S.+Graubnerauthor=C.+G.+Glabeauthor=H.+U.+Demuthauthor=G.+S.+Bloom&title=Prion-like+behaviour+and+tau-dependent+cytotoxicity+of+pyroglutamylated+amyloid-beta&doi=10.1038%2Fnature11060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Prion-like behavior and tau-dependent cytotoxicity of pyroglutamylated amyloid-β</span></div><div class="casAuthors">Nussbaum, Justin M.; Schilling, Stephan; Cynis, Holger; Silva, Antonia; Swanson, Eric; Wangsanut, Tanaporn; Tayler, Kaycie; Wiltgen, Brian; Hatami, Asa; Roenicke, Raik; Reymann, Klaus; Hutter-Paier, Birgit; Alexandru, Anca; Jagla, Wolfgang; Graubner, Sigrid; Glabe, Charles G.; Demuth, Hans-Ulrich; Bloom, George S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">485</span>
        (<span class="NLM_cas:issue">7400</span>),
    <span class="NLM_cas:pages">651-655</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Extracellular plaques of amyloid-β and intraneuronal neurofibrillary tangles made from tau are the histopathol. signatures of Alzheimer's disease.  Plaques comprise amyloid-β fibrils that assemble from monomeric and oligomeric intermediates, and are prognostic indicators of Alzheimer's disease.  Despite the importance of plaques to Alzheimer's disease, oligomers are considered to be the principal toxic forms of amyloid-β.  Interestingly, many adverse responses to amyloid-β, such as cytotoxicity, microtubule loss, impaired memory and learning, and neuritic degeneration, are greatly amplified by tau expression.  Amino-terminally truncated, pyroglutamylated (pE) forms of amyloid-β are strongly assocd. with Alzheimer's disease, are more toxic than amyloid-β, residues 1-42 (Aβ1-42) and Aβ1-40, and have been proposed as initiators of Alzheimer's disease pathogenesis.  Here we report a mechanism by which pE-Aβ may trigger Alzheimer's disease.  Aβ3(pE)-42 co-oligomerizes with excess Aβ1-42 to form metastable low-n oligomers (LNOs) that are structurally distinct and far more cytotoxic to cultured neurons than comparable LNOs made from Aβ1-42 alone.  Tau is required for cytotoxicity, and LNOs comprising 5% Aβ3(pE)-42 plus 95% Aβ1-42 (5% pE-Aβ) seed new cytotoxic LNOs through multiple serial dilns. into Aβ1-42 monomers in the absence of addnl. Aβ3(pE)-42.  LNOs isolated from human Alzheimer's disease brain contained Aβ3(pE)-42, and enhanced Aβ3(pE)-42 formation in mice triggered neuron loss and gliosis at 3 mo, but not in a tau-null background.  We conclude that Aβ3(pE)-42 confers tau-dependent neuronal death and causes template-induced misfolding of Aβ1-42 into structurally distinct LNOs that propagate by a prion-like mechanism.  Our results raise the possibility that Aβ3(pE)-42 acts similarly at a primary step in Alzheimer's disease pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotg6vra9ty9rVg90H21EOLACvtfcHk0liX9KTj1pXLUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVymsbc%253D&md5=67ba093a16fe5db1bea9f3873bd92ee5</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnature11060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11060%26sid%3Dliteratum%253Aachs%26aulast%3DNussbaum%26aufirst%3DJ.%2BM.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DSilva%26aufirst%3DA.%26aulast%3DSwanson%26aufirst%3DE.%26aulast%3DWangsanut%26aufirst%3DT.%26aulast%3DTayler%26aufirst%3DK.%26aulast%3DWiltgen%26aufirst%3DB.%26aulast%3DHatami%26aufirst%3DA.%26aulast%3DRonicke%26aufirst%3DR.%26aulast%3DReymann%26aufirst%3DK.%26aulast%3DHutter-Paier%26aufirst%3DB.%26aulast%3DAlexandru%26aufirst%3DA.%26aulast%3DJagla%26aufirst%3DW.%26aulast%3DGraubner%26aufirst%3DS.%26aulast%3DGlabe%26aufirst%3DC.%2BG.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DBloom%26aufirst%3DG.%2BS.%26atitle%3DPrion-like%2520behaviour%2520and%2520tau-dependent%2520cytotoxicity%2520of%2520pyroglutamylated%2520amyloid-beta%26jtitle%3DNature%26date%3D2012%26volume%3D485%26spage%3D651%26epage%3D655%26doi%3D10.1038%2Fnature11060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Busby, W. H.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humm, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youngblood, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kizer, J. S.</span><span> </span><span class="NLM_article-title">An enzyme(s) that converts glutaminyl-peptides into pyroglutamyl-peptides. Presence in pituitary, brain, adrenal medulla, and lymphocytes</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">262</span><span class="NLM_x">, </span> <span class="NLM_fpage">8532</span><span class="NLM_x">–</span> <span class="NLM_lpage">8536</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=3597387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADyaL2sXlt12lsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=262&publication_year=1987&pages=8532-8536&author=W.+H.+Busbyauthor=G.+E.+Quackenbushauthor=J.+Hummauthor=W.+W.+Youngbloodauthor=J.+S.+Kizer&title=An+enzyme%28s%29+that+converts+glutaminyl-peptides+into+pyroglutamyl-peptides.+Presence+in+pituitary%2C+brain%2C+adrenal+medulla%2C+and+lymphocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">An enzyme(s) that converts glutaminyl-peptides into pyroglutamyl-peptides.  Presence in pituitary, brain, adrenal medulla, and lymphocytes</span></div><div class="casAuthors">Busby, Walker H., Jr.; Quackenbush, Gail E.; Humm, Jane; Youngblood, William W.; Kizer, John S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">262</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8532-6</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The mechanism for the post-translational conversion of glutamine to pyroglutamic acid on the N-terminus of newly synthesized peptides and proteins is unknown.  An assay is reported here that permits measurement of the rate of conversion of Gln-His-Pro-NH2 to <Glu-His-Pro-NH2 (TRH), where <Glu is pyroglutamate.  Using this assay, it was demonstrated that the spontaneous cyclization of the N-terminal glutamine of this peptide occurs only slowly under physiol. conditions.  Furthermore, the presence in rat brain, porcine pituitary, and human B lymphocytes of a glutaminyl-peptide cyclase which converts Gln-His-Pro-NH2 into <Glu-His-Pro-NH2, is described.  The enzyme(s) appears to be a glycoprotein, is maximally active at neutral pH, has a mol. wt. of 55,000, and contains catalytically significant SH groups.  The product of the enzymic reaction was confirmed by high-resoln. fast atom bombardment-mass spectrometry.  In preliminary studies, it was found that >90% of the enzyme in bovine adrenal medulla is contained in the sol. chromaffin vesicle fraction.  These findings indicate that in vivo the post-translational conversion of a glutaminyl-peptide into a pyroglutamyl-peptide is neither spontaneous nor abiotic as has been previously proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRgXDyJEuhjrVg90H21EOLACvtfcHk0lgRVGUrx--MrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXlt12lsLs%253D&md5=8a8b35c61b2c94f4437fd06fc400656e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBusby%26aufirst%3DW.%2BH.%26aulast%3DQuackenbush%26aufirst%3DG.%2BE.%26aulast%3DHumm%26aufirst%3DJ.%26aulast%3DYoungblood%26aufirst%3DW.%2BW.%26aulast%3DKizer%26aufirst%3DJ.%2BS.%26atitle%3DAn%2520enzyme%2528s%2529%2520that%2520converts%2520glutaminyl-peptides%2520into%2520pyroglutamyl-peptides.%2520Presence%2520in%2520pituitary%252C%2520brain%252C%2520adrenal%2520medulla%252C%2520and%2520lymphocytes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1987%26volume%3D262%26spage%3D8532%26epage%3D8536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Bockers, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreutz, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pohl, T.</span><span> </span><span class="NLM_article-title">Glutaminyl-cyclase expression in the bovine/porcine hypothalamus and pituitary</span> <span class="citation_source-journal">J. Neuroendocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">–</span> <span class="NLM_lpage">453</span><span class="refDoi"> DOI: 10.1111/j.1365-2826.1995.tb00780.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1111%2Fj.1365-2826.1995.tb00780.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=7550291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A280%3ADyaK28%252FgvVSkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1995&pages=445-453&author=T.+M.+Bockersauthor=M.+R.+Kreutzauthor=T.+Pohl&title=Glutaminyl-cyclase+expression+in+the+bovine%2Fporcine+hypothalamus+and+pituitary&doi=10.1111%2Fj.1365-2826.1995.tb00780.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl-cyclase expression in the bovine/porcine hypothalamus and pituitary</span></div><div class="casAuthors">Bockers T M; Kreutz M R; Pohl T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroendocrinology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">445-53</span>
        ISSN:<span class="NLM_cas:issn">0953-8194</span>.
    </div><div class="casAbstract">The expression of the glutaminyl cyclase (QC), an enzyme responsible for the post-translational modification of N-terminal pyroglutamyl residues of neuropeptide precursors, was examined in bovine/porcine hypothalamic and pituitary tissue by means of immunocytochemistry and in situ hybridization.  In the anterior pituitary a distinct pattern of QC immunoreactivity and mRNA expression was found associated exclusively with somatotrophs.  In corticotrophs of the pars intermedia QC expression was undetectable, whereas a small portion of putative pars tuberalis cells in the rostral part of the pars distalis were heavily labelled.  The neurointermediate lobe was devoid of signals for QC mRNA, but showed significant QC-immunoreactivity on secretory granules of axonal nerve endings.  Also nuclei of the hypothalamus were found to be positive for QC-immunoreactivity.  Intense labelling was observed in the nucleus supraopticus and nucleus paraventricularis.  Staining of the nucleus periventricularis was found to be moderate, whereas no labelling of perikarya in the nucleus arcuatus, the preoptic area and the nucleus suprachiasmaticus was detectable.  Moreover, varicose fibers stained positive for QC-immunoreactivity and could be identified in the main transport route from the hypothalamus to the pars neuronalis (tractus hypothalamo hypophysialis).  These results suggest that the enzyme is transported via the same routes as its substrate/product to the median eminence or the neural lobe.  Furthermore, the mapping of the cellular QC distribution reveals a strikingly distinctive expression pattern, that should be useful for the identification of yet undiscovered places of peptide synthesis and processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTvTdinpe-TVvEeosoOnpOLfW6udTcc2eazRqz21H8BeLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28%252FgvVSkuw%253D%253D&md5=623044c0c3d4e838cf9b833b04722f41</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2826.1995.tb00780.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2826.1995.tb00780.x%26sid%3Dliteratum%253Aachs%26aulast%3DBockers%26aufirst%3DT.%2BM.%26aulast%3DKreutz%26aufirst%3DM.%2BR.%26aulast%3DPohl%26aufirst%3DT.%26atitle%3DGlutaminyl-cyclase%2520expression%2520in%2520the%2520bovine%252Fporcine%2520hypothalamus%2520and%2520pituitary%26jtitle%3DJ.%2520Neuroendocrinol.%26date%3D1995%26volume%3D7%26spage%3D445%26epage%3D453%26doi%3D10.1111%2Fj.1365-2826.1995.tb00780.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Pohl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mugele, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiess, J.</span><span> </span><span class="NLM_article-title">Primary structure and functional expression of a glutaminyl cyclase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">10059</span><span class="NLM_x">–</span> <span class="NLM_lpage">10063</span><span class="refDoi"> DOI: 10.1073/pnas.88.22.10059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1073%2Fpnas.88.22.10059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1946423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADyaK3sXhvVCnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1991&pages=10059-10063&author=T.+Pohlauthor=M.+Zimmerauthor=K.+Mugeleauthor=J.+Spiess&title=Primary+structure+and+functional+expression+of+a+glutaminyl+cyclase&doi=10.1073%2Fpnas.88.22.10059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Primary structure and functional expression of a glutaminyl cyclase</span></div><div class="casAuthors">Pohl, Thomas; Zimmer, Michael; Mugele, Katrin; Spiess, Joachim</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10059-63</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">A glutaminyl cyclase (QC) that is probably involved in the biosynthesis of pyroglutamyl peptides such as gonadotropin-releasing hormone and TSH-releasing hormone has been purified to homogeneity from bovine anterior pituitary.  On the basis of N-terminal sequence anal., a 2088-base-pair cDNA clone was isolated from a bovine anterior pituitary library.  From the nucleotide sequence of this clone, the primary structure of a 330-residue protein and a preceding 31-residue prepropeptide sequence was deduced.  By transfection of COS-7 monkey cells with a QC cDNA/pCDM8 vector construct, QC activity was expressed.  Hybridization with mRNAs of various bovine tissues revealed expression of QC mainly in brain tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdQGThtNPlPLVg90H21EOLACvtfcHk0lgRVGUrx--MrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhvVCnsQ%253D%253D&md5=3d0e422d9b00b1184d8646c5a12bf353</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1073%2Fpnas.88.22.10059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.88.22.10059%26sid%3Dliteratum%253Aachs%26aulast%3DPohl%26aufirst%3DT.%26aulast%3DZimmer%26aufirst%3DM.%26aulast%3DMugele%26aufirst%3DK.%26aulast%3DSpiess%26aufirst%3DJ.%26atitle%3DPrimary%2520structure%2520and%2520functional%2520expression%2520of%2520a%2520glutaminyl%2520cyclase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1991%26volume%3D88%26spage%3D10059%26epage%3D10063%26doi%3D10.1073%2Fpnas.88.22.10059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Morawski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreuzberger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waniek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jager, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cynis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehlen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arendt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartlage-Rubsamen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossner, S.</span><span> </span><span class="NLM_article-title">Glutaminyl cyclase in human cortex: correlation with (pGlu)-amyloid-beta load and cognitive decline in Alzheimer’s disease</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.3233%2FJAD-131535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=24164736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFKls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=385-400&author=M.+Morawskiauthor=S.+Schillingauthor=M.+Kreuzbergerauthor=A.+Waniekauthor=C.+Jagerauthor=B.+Kochauthor=H.+Cynisauthor=A.+Kehlenauthor=T.+Arendtauthor=M.+Hartlage-Rubsamenauthor=H.+U.+Demuthauthor=S.+Rossner&title=Glutaminyl+cyclase+in+human+cortex%3A+correlation+with+%28pGlu%29-amyloid-beta+load+and+cognitive+decline+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl Cyclase in Human Cortex: Correlation with (pGlu)-Amyloid-β Load and Cognitive Decline in Alzheimer's Disease</span></div><div class="casAuthors">Morawski, Markus; Schilling, Stephan; Kreuzberger, Moritz; Waniek, Alexander; Jaeger, Carsten; Koch, Birgit; Cynis, Holger; Kehlen, Astrid; Arendt, Thomas; Hartlage-Ruebsamen, Maike; Demuth, Hans-Ulrich; Rossner, Steffen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">385-400</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Brains of Alzheimer's disease (AD) patients are characterized in part by the formation of high mol. wt. aggregates of amyloid-β (Aβ) peptides, which interfere with neuronal function and provoke neuronal cell death.  The pyroglutamate (pGlu) modification of Aβ was demonstrated to be catalyzed by the enzyme glutaminyl cyclase (QC) and to enhance pathogenicity and neurotoxicity.  Here, we addressed the role of QC in AD pathogenesis in human cortex.  Two sets of human postmortem brain tissue from a total of 13 non-demented controls and 11 AD cases were analyzed by immunohistochem. and unbiased stereol., quant. RT-PCR, and enzymic activity assays for the expression level of QC in temporal and entorhinal cortex.  Addnl., cortical Aβ and pGlu-Aβ concns. were quantified by ELISA.  Data on QC expression and Aβ peptide concns. were correlated with each other and with the Mini-Mental State Examn. (MMSE) of individual cases.  In control cases, QC expression was higher in the more vulnerable entorhinal cortex than in temporal cortex.  In AD brains, QC mRNA expression and the immunoreactivity of QC were increased in both cortical regions and frequently assocd. with pGlu-Aβ deposits.  The analyses of individual cases revealed significant correlations between QC mRNA levels and the concn. of insol. pGlu-Aβ aggregates, but not of unmodified Aβ peptides.  Elevated pGlu-Aβ load showed a better correlation with the decline in MMSE than elevated concn. of unmodified Aβ.  Our observations provide evidence for an involvement of QC in AD pathogenesis and cognitive decline by QC-catalyzed pGlu-Aβ formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS8tVHNEV2BbVg90H21EOLACvtfcHk0ljNm7eZS8Bflw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFKls7k%253D&md5=6500fe542f7ccbc6b61c9a4c862cde6d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.3233%2FJAD-131535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-131535%26sid%3Dliteratum%253Aachs%26aulast%3DMorawski%26aufirst%3DM.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DKreuzberger%26aufirst%3DM.%26aulast%3DWaniek%26aufirst%3DA.%26aulast%3DJager%26aufirst%3DC.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DArendt%26aufirst%3DT.%26aulast%3DHartlage-Rubsamen%26aufirst%3DM.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DRossner%26aufirst%3DS.%26atitle%3DGlutaminyl%2520cyclase%2520in%2520human%2520cortex%253A%2520correlation%2520with%2520%2528pGlu%2529-amyloid-beta%2520load%2520and%2520cognitive%2520decline%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2014%26volume%3D39%26spage%3D385%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeitschel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehlen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutter-Paier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokesch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windisch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagla, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlenzig, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cynis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montag, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossner, S.</span><span> </span><span class="NLM_article-title">Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer’s disease-like pathology</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1106</span><span class="NLM_x">–</span> <span class="NLM_lpage">1111</span><span class="refDoi"> DOI: 10.1038/nm.1872</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1038%2Fnm.1872" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=18836460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Slu7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1106-1111&author=S.+Schillingauthor=U.+Zeitschelauthor=T.+Hoffmannauthor=U.+Heiserauthor=M.+Franckeauthor=A.+Kehlenauthor=M.+Holzerauthor=B.+Hutter-Paierauthor=M.+Prokeschauthor=M.+Windischauthor=W.+Jaglaauthor=D.+Schlenzigauthor=C.+Lindnerauthor=T.+Rudolphauthor=G.+Reuterauthor=H.+Cynisauthor=D.+Montagauthor=H.+U.+Demuthauthor=S.+Rossner&title=Glutaminyl+cyclase+inhibition+attenuates+pyroglutamate+Abeta+and+Alzheimer%E2%80%99s+disease-like+pathology&doi=10.1038%2Fnm.1872"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease-like pathology</span></div><div class="casAuthors">Schilling, Stephan; Zeitschel, Ulrike; Hoffmann, Torsten; Heiser, Ulrich; Francke, Mike; Kehlen, Astrid; Holzer, Max; Hutter-Paier, Birgit; Prokesch, Manuela; Windisch, Manfred; Jagla, Wolfgang; Schlenzig, Dagmar; Lindner, Christiane; Rudolph, Thomas; Reuter, Gunter; Cynis, Holger; Montag, Dirk; Demuth, Hans-Ulrich; Rossner, Steffen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1106-1111</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Because of their abundance, resistance to proteolysis, rapid aggregation and neurotoxicity, N-terminally truncated and, in particular, pyroglutamate (pE)-modified Aβ peptides have been suggested as being important in the initiation of pathol. cascades resulting in the development of Alzheimer's disease.  We found that the N-terminal pE-formation is catalyzed by glutaminyl cyclase in vivo.  Glutaminyl cyclase expression was upregulated in the cortices of individuals with Alzheimer's disease and correlated with the appearance of pE-modified Aβ.  Oral application of a glutaminyl cyclase inhibitor resulted in reduced Aβ3(pE)-42 burden in two different transgenic mouse models of Alzheimer's disease and in a new Drosophila model.  Treatment of mice was accompanied by redns. in Aβx-40/42, diminished plaque formation and gliosis and improved performance in context memory and spatial learning tests.  These observations are consistent with the hypothesis that Aβ3(pE)-42 acts as a seed for Aβ aggregation by self-aggregation and co-aggregation with Aβ1-40/42.  Therefore, Aβ3(pE)-40/42 peptides seem to represent Aβ forms with exceptional potency for disturbing neuronal function.  The redn. of brain pE-Aβ by inhibition of glutaminyl cyclase offers a new therapeutic option for the treatment of Alzheimer's disease and provides implications for other amyloidoses, such as familial Danish dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQl4XiuOJSmrVg90H21EOLACvtfcHk0ljNm7eZS8Bflw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Slu7zL&md5=30f8f53b27c6c9580fe71f867e1ab670</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnm.1872&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.1872%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DZeitschel%26aufirst%3DU.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DFrancke%26aufirst%3DM.%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DHolzer%26aufirst%3DM.%26aulast%3DHutter-Paier%26aufirst%3DB.%26aulast%3DProkesch%26aufirst%3DM.%26aulast%3DWindisch%26aufirst%3DM.%26aulast%3DJagla%26aufirst%3DW.%26aulast%3DSchlenzig%26aufirst%3DD.%26aulast%3DLindner%26aufirst%3DC.%26aulast%3DRudolph%26aufirst%3DT.%26aulast%3DReuter%26aufirst%3DG.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DMontag%26aufirst%3DD.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DRossner%26aufirst%3DS.%26atitle%3DGlutaminyl%2520cyclase%2520inhibition%2520attenuates%2520pyroglutamate%2520Abeta%2520and%2520Alzheimer%25E2%2580%2599s%2520disease-like%2520pathology%26jtitle%3DNat.%2520Med.%26date%3D2008%26volume%3D14%26spage%3D1106%26epage%3D1111%26doi%3D10.1038%2Fnm.1872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Jawhar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirths, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graubner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayer, T. A.</span><span> </span><span class="NLM_article-title">Overexpression of glutaminyl cyclase, the enzyme responsible for pyroglutamate A{beta} formation, induces behavioral deficits, and glutaminyl cyclase knock-out rescues the behavioral phenotype in 5XFAD mice</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">4454</span><span class="NLM_x">–</span> <span class="NLM_lpage">4460</span><span class="refDoi"> DOI: 10.1074/jbc.M110.185819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1074%2Fjbc.M110.185819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=21148560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFGltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=4454-4460&author=S.+Jawharauthor=O.+Wirthsauthor=S.+Schillingauthor=S.+Graubnerauthor=H.+U.+Demuthauthor=T.+A.+Bayer&title=Overexpression+of+glutaminyl+cyclase%2C+the+enzyme+responsible+for+pyroglutamate+A%7Bbeta%7D+formation%2C+induces+behavioral+deficits%2C+and+glutaminyl+cyclase+knock-out+rescues+the+behavioral+phenotype+in+5XFAD+mice&doi=10.1074%2Fjbc.M110.185819"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of Glutaminyl Cyclase, the Enzyme Responsible for Pyroglutamate Aβ Formation, Induces Behavioral Deficits, and Glutaminyl Cyclase Knock-out Rescues the Behavioral Phenotype in 5XFAD Mice</span></div><div class="casAuthors">Jawhar, Sadim; Wirths, Oliver; Schilling, Stephan; Graubner, Sigrid; Demuth, Hans-Ulrich; Bayer, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4454-4460</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Pyroglutamate-modified Aβ (AβpE3-42) peptides are gaining considerable attention as potential key players in the pathol. of Alzheimer disease (AD) due to their abundance in AD brain, high aggregation propensity, stability, and cellular toxicity.  Overexpressing AβpE3-42 induced a severe neuron loss and neurol. phenotype in TBA2 mice.  In vitro and in vivo expts. have recently proven that the enzyme glutaminyl cyclase (QC) catalyzes the formation of AβpE3-42.  The aim of the present work was to analyze the role of QC in an AD mouse model with abundant AβpE3-42 formation. 5XFAD mice were crossed with transgenic mice expressing human QC (hQC) under the control of the Thy1 promoter. 5XFAD/hQC bigenic mice showed significant elevation in TBS, SDS, and formic acid-sol. AβpE3-42 peptides and aggregation in plaques.  In 6-mo-old 5XFAD/hQC mice, a significant motor and working memory impairment developed compared with 5XFAD.  The contribution of endogenous QC was studied by generating 5XFAD/QC-KO mice (mouse QC knock-out). 5XFAD/QC-KO mice showed a significant rescue of the wild-type mice behavioral phenotype, demonstrating the important contribution of endogenous mouse QC and transgenic overexpressed QC.  These data clearly demonstrate that QC is crucial for modulating AβpE3-42 levels in vivo and prove on a genetic base the concept that redn. of QC activity is a promising new therapeutic approach for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMeSo62btLh7Vg90H21EOLACvtfcHk0ljNm7eZS8Bflw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFGltL8%253D&md5=7b704a92ffab37146126e9d101df9a1e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.185819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.185819%26sid%3Dliteratum%253Aachs%26aulast%3DJawhar%26aufirst%3DS.%26aulast%3DWirths%26aufirst%3DO.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DGraubner%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26atitle%3DOverexpression%2520of%2520glutaminyl%2520cyclase%252C%2520the%2520enzyme%2520responsible%2520for%2520pyroglutamate%2520A%257Bbeta%257D%2520formation%252C%2520induces%2520behavioral%2520deficits%252C%2520and%2520glutaminyl%2520cyclase%2520knock-out%2520rescues%2520the%2520behavioral%2520phenotype%2520in%25205XFAD%2520mice%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D4454%26epage%3D4460%26doi%3D10.1074%2Fjbc.M110.185819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cynis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagla, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Horsten, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span> </span><span class="NLM_article-title">Inhibition of glutaminyl cyclase prevents pGlu-Abeta formation after intracortical/hippocampal microinjection in vivo/in situ</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">1225</span><span class="NLM_x">–</span> <span class="NLM_lpage">1236</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2008.05471.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1111%2Fj.1471-4159.2008.05471.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=18627432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsFOis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2008&pages=1225-1236&author=S.+Schillingauthor=T.+Applauthor=T.+Hoffmannauthor=H.+Cynisauthor=K.+Schulzauthor=W.+Jaglaauthor=D.+Friedrichauthor=M.+Wermannauthor=M.+Buchholzauthor=U.+Heiserauthor=S.+von+Horstenauthor=H.+U.+Demuth&title=Inhibition+of+glutaminyl+cyclase+prevents+pGlu-Abeta+formation+after+intracortical%2Fhippocampal+microinjection+in+vivo%2Fin+situ&doi=10.1111%2Fj.1471-4159.2008.05471.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of glutaminyl cyclase prevents pGlu-Aβ formation after intracortical/hippocampal microinjection in vivo/in situ</span></div><div class="casAuthors">Schilling, Stephan; Appl, Thomas; Hoffmann, Torsten; Cynis, Holger; Schulz, Katrin; Jagla, Wolfgang; Friedrich, Daniel; Wermann, Michael; Buchholz, Mirko; Heiser, Ulrich; von Hoersten, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1225-1236</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Modified amyloid β (Aβ) peptides represent major constituents of the amyloid deposits in Alzheimer's disease and Down's syndrome.  In particular, N-terminal pyroglutamate (pGlu) following truncation renders Aβ more stable, increases hydrophobicity and the aggregation velocity.  Recent evidence based on in vitro studies suggests that the cyclization of glutamic acid, leading to pGlu-Aβ, is catalyzed by the enzyme glutaminyl cyclase (QC) following limited proteolysis of Aβ at the N-terminus.  Here, we studied the pGlu-formation by rat QC in vitro as well as after microinjection of Aβ(1-40) and Aβ(3-40) into the rat cortex in vivo/in situ with and without pharmacol. QC inhibition.  Significant pGlu-Aβ formation was obsd. following injection of Aβ(3-40) after 24 h, indicating a catalyzed process.  The generation of pGlu-Aβ from Aβ(3-40) was significantly inhibited by intracortical microinjection of a QC inhibitor.  The study provides first evidence that generation of pGlu-Aβ is a QC-catalyzed process in vivo.  The approach per se offers a strategy for a rapid evaluation of compds. targeting a redn. of pGlu formation at the N-terminus of amyloid peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIz9fnOIjlVbVg90H21EOLACvtfcHk0lg0kiddV2BPbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsFOis7Y%253D&md5=8450718510d281c928abaa1e20a870ad</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2008.05471.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2008.05471.x%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DAppl%26aufirst%3DT.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DSchulz%26aufirst%3DK.%26aulast%3DJagla%26aufirst%3DW.%26aulast%3DFriedrich%26aufirst%3DD.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3Dvon%2BHorsten%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DInhibition%2520of%2520glutaminyl%2520cyclase%2520prevents%2520pGlu-Abeta%2520formation%2520after%2520intracortical%252Fhippocampal%2520microinjection%2520in%2520vivo%252Fin%2520situ%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D106%26spage%3D1225%26epage%3D1236%26doi%3D10.1111%2Fj.1471-4159.2008.05471.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Lues, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bühring, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kühn-Wache, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manhart, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pokorny, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiesa, J.</span><span> </span><span class="NLM_article-title">A phase 1 study to evaluate the safety and pharmacokinetics of PQ912, a glutaminyl cyclase inhibitor, in healthy subjects</span> <span class="citation_source-journal">Alzheimer’s Dement.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span><span class="refDoi"> DOI: 10.1016/j.trci.2015.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1016%2Fj.trci.2015.08.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=182-195&author=I.+Luesauthor=F.+Weberauthor=A.+Meyerauthor=U.+B%C3%BChringauthor=T.+Hoffmannauthor=K.+K%C3%BChn-Wacheauthor=S.+Manhartauthor=U.+Heiserauthor=R.+Pokornyauthor=J.+Chiesa&title=A+phase+1+study+to+evaluate+the+safety+and+pharmacokinetics+of+PQ912%2C+a+glutaminyl+cyclase+inhibitor%2C+in+healthy+subjects&doi=10.1016%2Fj.trci.2015.08.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.trci.2015.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trci.2015.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DLues%26aufirst%3DI.%26aulast%3DWeber%26aufirst%3DF.%26aulast%3DMeyer%26aufirst%3DA.%26aulast%3DB%25C3%25BChring%26aufirst%3DU.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DK%25C3%25BChn-Wache%26aufirst%3DK.%26aulast%3DManhart%26aufirst%3DS.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DPokorny%26aufirst%3DR.%26aulast%3DChiesa%26aufirst%3DJ.%26atitle%3DA%2520phase%25201%2520study%2520to%2520evaluate%2520the%2520safety%2520and%2520pharmacokinetics%2520of%2520PQ912%252C%2520a%2520glutaminyl%2520cyclase%2520inhibitor%252C%2520in%2520healthy%2520subjects%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dement.%26date%3D2015%26volume%3D1%26spage%3D182%26epage%3D195%26doi%3D10.1016%2Fj.trci.2015.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Buchholz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aust, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohme, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span> </span><span class="NLM_article-title">Inhibitors for human glutaminyl cyclase by structure based design and bioisosteric replacement</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7069</span><span class="NLM_x">–</span> <span class="NLM_lpage">7080</span><span class="refDoi"> DOI: 10.1021/jm900969p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900969p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlagsbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7069-7080&author=M.+Buchholzauthor=A.+Hamannauthor=S.+Austauthor=W.+Brandtauthor=L.+Bohmeauthor=T.+Hoffmannauthor=S.+Schillingauthor=H.+U.+Demuthauthor=U.+Heiser&title=Inhibitors+for+human+glutaminyl+cyclase+by+structure+based+design+and+bioisosteric+replacement&doi=10.1021%2Fjm900969p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors for Human Glutaminyl Cyclase by Structure Based Design and Bioisosteric Replacement</span></div><div class="casAuthors">Buchholz, Mirko; Hamann, Antje; Aust, Susanne; Brandt, Wolfgang; Boehme, Livia; Hoffmann, Torsten; Schilling, Stephan; Demuth, Hans-Ulrich; Heiser, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7069-7080</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The inhibition of human glutaminyl cyclase (hQC) has come into focus as a new potential approach for the treatment of Alzheimer's disease.  The hallmark of this principle is the prevention of the formation of Aβ3,11(pE)-40,42, as these Aβ-species were shown to be of elevated neurotoxicity and likely to act as a seeding core leading to an accelerated formation of Aβ-oligomers and fibrils.  Starting from 1-(3-(1H-imidazol-1-yl)propyl)-3-(3,4-dimethoxyphenyl)thiourea, bioisosteric replacements led to the development of new classes of inhibitors.  The optimization of the metal-binding group was achieved by homol. modeling and afforded a first insight into the probable binding mode of the inhibitors in the hQC active site.  The efficacy assessment of the hQC inhibitors was performed in cell culture, directly monitoring the inhibition of Aβ3,11(pE)-40,42 formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZG_jswBXx2LVg90H21EOLACvtfcHk0lg0kiddV2BPbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlagsbnJ&md5=262248c3c91f344aacb530288aa46471</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm900969p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900969p%26sid%3Dliteratum%253Aachs%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DHamann%26aufirst%3DA.%26aulast%3DAust%26aufirst%3DS.%26aulast%3DBrandt%26aufirst%3DW.%26aulast%3DBohme%26aufirst%3DL.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DHeiser%26aufirst%3DU.%26atitle%3DInhibitors%2520for%2520human%2520glutaminyl%2520cyclase%2520by%2520structure%2520based%2520design%2520and%2520bioisosteric%2520replacement%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7069%26epage%3D7080%26doi%3D10.1021%2Fjm900969p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Buchholz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niestroj, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunkel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span> </span><span class="NLM_article-title">The first potent inhibitors for human glutaminyl cyclase: synthesis and structure-activity relationship</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">664</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span><span class="refDoi"> DOI: 10.1021/jm050756e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050756e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD28XotlWrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=664-677&author=M.+Buchholzauthor=U.+Heiserauthor=S.+Schillingauthor=A.+J.+Niestrojauthor=K.+Zunkelauthor=H.+U.+Demuth&title=The+first+potent+inhibitors+for+human+glutaminyl+cyclase%3A+synthesis+and+structure-activity+relationship&doi=10.1021%2Fjm050756e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The first potent inhibitors for human glutaminyl cyclase: synthesis and structure-activity relationship</span></div><div class="casAuthors">Buchholz, Mirko; Heiser, Ulrich; Schilling, Stephan; Niestroj, Andre J.; Zunkel, Katrin; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">664-677</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The first effective inhibitors for human glutaminyl cyclase (QC) are described.  The structures are developed by applying a ligand-based optimization approach starting from imidazole.  Screening of derivs. of that heterocycle led to compds. of the imidazol-1-yl-alkyl thiourea type as a lead scaffold.  A library of thiourea derivs. was synthesized, resulting in an inhibitory improvement by 2 orders of magnitude, leading to 1-(3-(1H-imidazol-1-yl)propyl)-3-(3,4-dimethoxyphenyl)thiourea as a potent inhibitor.  Systematic exploitation of the scaffold revealed a strong impact on the inhibitory efficacy and resulted in the development of imidazole-propyl-thioamides as another new class of potent inhibitors.  A flexible alignment of the most potent compds. of the thioamide and thiourea class and a QC substrate revealed a good match of characteristic features of the mols., which suggests a similar binding mode of both inhibitors and the substrate to the active site of QC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo88OPnC7vM57Vg90H21EOLACvtfcHk0liukG6ziWD6SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotlWrug%253D%253D&md5=584302fd2d356f680bb4df9e10f26b93</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm050756e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050756e%26sid%3Dliteratum%253Aachs%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DNiestroj%26aufirst%3DA.%2BJ.%26aulast%3DZunkel%26aufirst%3DK.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DThe%2520first%2520potent%2520inhibitors%2520for%2520human%2520glutaminyl%2520cyclase%253A%2520synthesis%2520and%2520structure-activity%2520relationship%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D664%26epage%3D677%26doi%3D10.1021%2Fjm050756e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span> </span><span class="NLM_article-title">Inhibitory effect of flavonoids on human glutaminyl cyclase</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2280</span><span class="NLM_x">–</span> <span class="NLM_lpage">2286</span><span class="refDoi"> DOI: 10.1016/j.bmc.2016.03.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1016%2Fj.bmc.2016.03.064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=27061673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsF2lsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=2280-2286&author=M.+Liauthor=Y.+Dongauthor=X.+Yuauthor=Y.+Zouauthor=Y.+Zhengauthor=X.+Buauthor=J.+Quanauthor=Z.+Heauthor=H.+Wu&title=Inhibitory+effect+of+flavonoids+on+human+glutaminyl+cyclase&doi=10.1016%2Fj.bmc.2016.03.064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory effect of flavonoids on human glutaminyl cyclase</span></div><div class="casAuthors">Li, Manman; Dong, Yao; Yu, Xi; Zou, Yongdong; Zheng, Yizhi; Bu, Xianzhang; Quan, Junmin; He, Zhendan; Wu, Haiqiang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2280-2286</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (QC) plays an important role in the pathogenesis of Alzheimer's disease (AD) and can be a potential target for the development of novel anti-AD agents.  However, the study of QC inhibitors are still less.  Here, phenol-4' (R1-), C5-OH (R2-) and C7-OH (R3-) modified apigenin derivs. were synthesized as a new class of human QC (hQC) inhibitors.  The efficacy investigation of these compds. was performed by spectrophotometric assessment and the structure-activity relationship (SAR) was evaluated.  Mol. docking was also carried out to analyze the binding mode of the synthesized flavonoid to the active site of hQC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjo3dENiH0N7Vg90H21EOLACvtfcHk0liukG6ziWD6SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsF2lsLk%253D&md5=86df2e8e2c427d483dea92e747ddf116</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.03.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.03.064%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DBu%26aufirst%3DX.%26aulast%3DQuan%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DH.%26atitle%3DInhibitory%2520effect%2520of%2520flavonoids%2520on%2520human%2520glutaminyl%2520cyclase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D2280%26epage%3D2286%26doi%3D10.1016%2Fj.bmc.2016.03.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Ramsbeck, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohme, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span> </span><span class="NLM_article-title">Structure-activity relationships of benzimidazole-based glutaminyl cyclase inhibitors featuring a heteroaryl scaffold</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">6613</span><span class="NLM_x">–</span> <span class="NLM_lpage">6625</span><span class="refDoi"> DOI: 10.1021/jm4001709</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4001709" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOltrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6613-6625&author=D.+Ramsbeckauthor=M.+Buchholzauthor=B.+Kochauthor=L.+Bohmeauthor=T.+Hoffmannauthor=H.+U.+Demuthauthor=U.+Heiser&title=Structure-activity+relationships+of+benzimidazole-based+glutaminyl+cyclase+inhibitors+featuring+a+heteroaryl+scaffold&doi=10.1021%2Fjm4001709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships of Benzimidazole-Based Glutaminyl Cyclase Inhibitors Featuring a Heteroaryl Scaffold</span></div><div class="casAuthors">Ramsbeck, Daniel; Buchholz, Mirko; Koch, Birgit; Boehme, Livia; Hoffmann, Torsten; Demuth, Hans-Ulrich; Heiser, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6613-6625</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (hQC) has emerged as a new potential target for the treatment of Alzheimer's disease (AD).  The inhibition of hQC prevents of the formation of the Aβ3(pE)-40,42 species which were shown to be of elevated neurotoxicity and are likely to act as a seeding core, leading to an accelerated formation of Aβ-oligomers and fibrils.  This work presents a new class of inhibitors of hQC, resulting from a pharmacophore-based screen.  Hit mols. were identified, contg. benzimidazole as the metal binding group connected to 1,3,4-oxadiazole as the central scaffold.  The subsequent optimization resulted in benzimidazolyl-1,3,4-thiadiazoles and -1,2,3-triazoles with an inhibitory potency in the nanomolar range.  Further investigation into the potential binding mode of the new compd. classes combined mol. docking and site directed mutagenesis studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj2cbdhUrX_bVg90H21EOLACvtfcHk0liukG6ziWD6SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOltrvL&md5=eaff2e3df3c955881a158b5efd012c0d</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm4001709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4001709%26sid%3Dliteratum%253Aachs%26aulast%3DRamsbeck%26aufirst%3DD.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DBohme%26aufirst%3DL.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DHeiser%26aufirst%3DU.%26atitle%3DStructure-activity%2520relationships%2520of%2520benzimidazole-based%2520glutaminyl%2520cyclase%2520inhibitors%2520featuring%2520a%2520heteroaryl%2520scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6613%26epage%3D6625%26doi%3D10.1021%2Fjm4001709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Tran, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoang, V. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorat, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nam, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mook-Jung, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span> </span><span class="NLM_article-title">Structure-activity relationship of human glutaminyl cyclase inhibitors having an N-(5-methyl-1H-imidazol-1-yl)propyl thiourea template</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3821</span><span class="NLM_x">–</span> <span class="NLM_lpage">3830</span><span class="refDoi"> DOI: 10.1016/j.bmc.2013.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1016%2Fj.bmc.2013.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=23643900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvF2mtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=3821-3830&author=P.+T.+Tranauthor=V.+H.+Hoangauthor=S.+A.+Thoratauthor=S.+E.+Kimauthor=J.+Annauthor=Y.+J.+Changauthor=D.+W.+Namauthor=H.+Songauthor=I.+Mook-Jungauthor=J.+Leeauthor=J.+Lee&title=Structure-activity+relationship+of+human+glutaminyl+cyclase+inhibitors+having+an+N-%285-methyl-1H-imidazol-1-yl%29propyl+thiourea+template&doi=10.1016%2Fj.bmc.2013.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship of human glutaminyl cyclase inhibitors having an N-(5-methyl-1H-imidazol-1-yl)propyl thiourea template</span></div><div class="casAuthors">Tran, Phuong-Thao; Hoang, Van-Hai; Thorat, Shivaji A.; Kim, Sung Eun; Ann, Jihyae; Chang, Yu Jin; Nam, Dong Woo; Song, Hyundong; Mook-Jung, Inhee; Lee, Jiyoun; Lee, Jeewoo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3821-3830</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In an effort to design inhibitors of human glutaminyl cyclase (QC), the authors have synthesized a library of N-aryl N-(5-methyl-1H-imidazol-1-yl)propyl thioureas and investigated the contribution of the aryl region of these compds. to their structure-activity relationships as cyclase inhibitors.  The authors' design was guided by the proposed binding mode of the preferred substrate for the cyclase.  In this series, 1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea (compd. 52) was identified as the most potent QC inhibitor with an IC50 value of 58 nM, which was two-fold more potent than the previously reported lead (II).  Compd. 52 is a most promising candidate for future evaluation to monitor its ability to reduce the formation of pGlu-Aβ and Aβ plaques in cells and transgenic animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5aCpSObyf3rVg90H21EOLACvtfcHk0lh1_dKJPOvNNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvF2mtL0%253D&md5=a8d7ad244e262c7bb26681c64393551a</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DP.%2BT.%26aulast%3DHoang%26aufirst%3DV.%2BH.%26aulast%3DThorat%26aufirst%3DS.%2BA.%26aulast%3DKim%26aufirst%3DS.%2BE.%26aulast%3DAnn%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DY.%2BJ.%26aulast%3DNam%26aufirst%3DD.%2BW.%26aulast%3DSong%26aufirst%3DH.%26aulast%3DMook-Jung%26aufirst%3DI.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%26atitle%3DStructure-activity%2520relationship%2520of%2520human%2520glutaminyl%2520cyclase%2520inhibitors%2520having%2520an%2520N-%25285-methyl-1H-imidazol-1-yl%2529propyl%2520thiourea%2520template%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D3821%26epage%3D3830%26doi%3D10.1016%2Fj.bmc.2013.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Efange, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelson, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knusel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hefti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boudreau, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tennison, J. R.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of radioiodinated N-2-(4-piperidyl)ethyl benzamides</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">527</span><span class="NLM_x">–</span> <span class="NLM_lpage">538</span><span class="refDoi"> DOI: 10.1016/0969-8051(93)90083-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1016%2F0969-8051%2893%2990083-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=8504292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADyaK3sXlsFCqurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1993&pages=527-538&author=S.+M.+Efangeauthor=R.+H.+Michelsonauthor=B.+Knuselauthor=F.+Heftiauthor=R.+J.+Boudreauauthor=J.+R.+Thomasauthor=J.+R.+Tennison&title=Synthesis+and+biological+evaluation+of+radioiodinated+N-2-%284-piperidyl%29ethyl+benzamides&doi=10.1016%2F0969-8051%2893%2990083-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of radioiodinated N-2-(4-piperidyl)ethylbenzamides</span></div><div class="casAuthors">Efange, S. M. N.; Michelson, R. H.; Knusel, B.; Hefti, F.; Boudreau, R. J.; Thomas, J. R.; Tennison, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">527-38</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0883-2897</span>.
    </div><div class="casAbstract">Three iodinated benzamides (I, R, R1, R2 = H, Cl, or I; R3 = H) analogs of the potent acetylcholinesterase inhibitor 1-benzyl-4-[N-[4'-(benzylsulfonyl)benzoyl-N-methylamino]ethyl]piperidine (I, R = PhCH2SO2, R1 = R2 = H, R3 = Me) were synthesized and evaluated as potential anticholinesterase agents.  All 3 compds. were 3 orders of magnitude less potent than the parent compd.  However, receptor screening revealed I show nanomolar affinity for the sigma binding site.  Both [125I]-I (R = R2 = R3 = H, R1 = 125I) and [125I]-I (R = R1 = Cl, R2 = 125I, R3 = H) were prepd. and evaluated in rats.  Following the i.v. administration of [125I]-I (R = R2 = R3 = H, R1 = 125I) into rats, 1.59% of the injected dose was found in the rat brain within 5 min.  The level of radioactivity in the brain remained steady for 2 h, the duration of the study.  In contrast, 0.42% of the injected dose was detected in the rat brain following the i.v. injection of [125I]-I (R = R1 = Cl, R2 = 125I, R3 = H).  Coadministration of either these 2 radioiodinated compds. with 0.5 μmol/kg of haloperidol resulted in a 56-73% redn. in the level of radioactivity in the rat brain, suggesting that these compds. bind to the sigma binding site in vivo.  Planar imaging studies with [125I]-I (R = R2 = R3 = H, R1 = 125I) revealed significant accumulation of radioactivity within the monkey brain, with a half-life of 6 h.  This compd. may be potentially useful for studying sigma receptor distribution in the human brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCcFe7wwMOy7Vg90H21EOLACvtfcHk0lh1_dKJPOvNNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlsFCqurk%253D&md5=8845c8409eb3974281240455f8ccbf68</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2F0969-8051%2893%2990083-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0969-8051%252893%252990083-7%26sid%3Dliteratum%253Aachs%26aulast%3DEfange%26aufirst%3DS.%2BM.%26aulast%3DMichelson%26aufirst%3DR.%2BH.%26aulast%3DKnusel%26aufirst%3DB.%26aulast%3DHefti%26aufirst%3DF.%26aulast%3DBoudreau%26aufirst%3DR.%2BJ.%26aulast%3DThomas%26aufirst%3DJ.%2BR.%26aulast%3DTennison%26aufirst%3DJ.%2BR.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520radioiodinated%2520N-2-%25284-piperidyl%2529ethyl%2520benzamides%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D1993%26volume%3D20%26spage%3D527%26epage%3D538%26doi%3D10.1016%2F0969-8051%2893%2990083-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Bautista-Aguilera, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chioua, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolic, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agbaba, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Andres, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcaro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsay, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortuso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span> </span><span class="NLM_article-title">N-Methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1H-indol-2- yl)methyl)prop-2-yn-1-amine, a new cholinesterase and monoamine oxidase dual inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">10455</span><span class="NLM_x">–</span> <span class="NLM_lpage">10463</span><span class="refDoi"> DOI: 10.1021/jm501501a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501501a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10455-10463&author=O.+M.+Bautista-Aguileraauthor=A.+Samadiauthor=M.+Chiouaauthor=K.+Nikolicauthor=S.+Filipicauthor=D.+Agbabaauthor=E.+Sorianoauthor=L.+de+Andresauthor=M.+I.+Rodriguez-Francoauthor=S.+Alcaroauthor=R.+R.+Ramsayauthor=F.+Ortusoauthor=M.+Yanezauthor=J.+Marco-Contelles&title=N-Methyl-N-%28%281-methyl-5-%283-%281-%282-methylbenzyl%29piperidin-4-yl%29propoxy%29-1H-indol-2-+yl%29methyl%29prop-2-yn-1-amine%2C+a+new+cholinesterase+and+monoamine+oxidase+dual+inhibitor&doi=10.1021%2Fjm501501a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm501501a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501501a%26sid%3Dliteratum%253Aachs%26aulast%3DBautista-Aguilera%26aufirst%3DO.%2BM.%26aulast%3DSamadi%26aufirst%3DA.%26aulast%3DChioua%26aufirst%3DM.%26aulast%3DNikolic%26aufirst%3DK.%26aulast%3DFilipic%26aufirst%3DS.%26aulast%3DAgbaba%26aufirst%3DD.%26aulast%3DSoriano%26aufirst%3DE.%26aulast%3Dde%2BAndres%26aufirst%3DL.%26aulast%3DRodriguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DRamsay%26aufirst%3DR.%2BR.%26aulast%3DOrtuso%26aufirst%3DF.%26aulast%3DYanez%26aufirst%3DM.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DN-Methyl-N-%2528%25281-methyl-5-%25283-%25281-%25282-methylbenzyl%2529piperidin-4-yl%2529propoxy%2529-1H-indol-2-%2520yl%2529methyl%2529prop-2-yn-1-amine%252C%2520a%2520new%2520cholinesterase%2520and%2520monoamine%2520oxidase%2520dual%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10455%26epage%3D10463%26doi%3D10.1021%2Fjm501501a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Kurosawa, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuyama, T.</span><span> </span><span class="NLM_article-title">Preparation of secondary amines from primary amines via 2-nitrobenzenesulfonamides: N-(4-methoxybenzyl)-3-phenylpropylamine</span> <span class="citation_source-journal">Org. Synth.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span><span class="refDoi"> DOI: 10.1002/0471264180.os079.22</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1002%2F0471264180.os079.22" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=186-186&author=W.+Kurosawaauthor=T.+Kanauthor=T.+Fukuyama&title=Preparation+of+secondary+amines+from+primary+amines+via+2-nitrobenzenesulfonamides%3A+N-%284-methoxybenzyl%29-3-phenylpropylamine&doi=10.1002%2F0471264180.os079.22"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2F0471264180.os079.22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F0471264180.os079.22%26sid%3Dliteratum%253Aachs%26aulast%3DKurosawa%26aufirst%3DW.%26aulast%3DKan%26aufirst%3DT.%26aulast%3DFukuyama%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520secondary%2520amines%2520from%2520primary%2520amines%2520via%25202-nitrobenzenesulfonamides%253A%2520N-%25284-methoxybenzyl%2529-3-phenylpropylamine%26jtitle%3DOrg.%2520Synth.%26date%3D2003%26spage%3D186%26epage%3D186%26doi%3D10.1002%2F0471264180.os079.22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Nettekoven, M.</span><span> </span><span class="NLM_article-title">Combinatorial synthesis of 5-aryl-[1, 2, 4]-triazolo-[1, 5-a]-pyridine derivatives as potential inhibitors of the adenosine 2a receptor</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2001</span><span class="NLM_x">, </span> <span class="NLM_fpage">1917</span><span class="NLM_x">–</span> <span class="NLM_lpage">1920</span><span class="refDoi"> DOI: 10.1055/s-2001-18758</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1055%2Fs-2001-18758" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2001&publication_year=2001&pages=1917-1920&author=M.+Nettekoven&title=Combinatorial+synthesis+of+5-aryl-%5B1%2C+2%2C+4%5D-triazolo-%5B1%2C+5-a%5D-pyridine+derivatives+as+potential+inhibitors+of+the+adenosine+2a+receptor&doi=10.1055%2Fs-2001-18758"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1055%2Fs-2001-18758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2001-18758%26sid%3Dliteratum%253Aachs%26aulast%3DNettekoven%26aufirst%3DM.%26atitle%3DCombinatorial%2520synthesis%2520of%25205-aryl-%255B1%252C%25202%252C%25204%255D-triazolo-%255B1%252C%25205-a%255D-pyridine%2520derivatives%2520as%2520potential%2520inhibitors%2520of%2520the%2520adenosine%25202a%2520receptor%26jtitle%3DSynlett%26date%3D2001%26volume%3D2001%26spage%3D1917%26epage%3D1920%26doi%3D10.1055%2Fs-2001-18758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasternack, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span> </span><span class="NLM_article-title">Continuous spectrometric assays for glutaminyl cyclase activity</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1006/abio.2001.5560</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1006%2Fabio.2001.5560" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=11906150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD38XitFeisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2002&pages=49-56&author=S.+Schillingauthor=T.+Hoffmannauthor=M.+Wermannauthor=U.+Heiserauthor=C.+Wasternackauthor=H.+U.+Demuth&title=Continuous+spectrometric+assays+for+glutaminyl+cyclase+activity&doi=10.1006%2Fabio.2001.5560"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Continuous Spectrometric Assays for Glutaminyl Cyclase Activity</span></div><div class="casAuthors">Schilling, Stephan; Hoffmann, Torsten; Wermann, Michael; Heiser, Ulrich; Wasternack, Claus; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-56</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">The enzymic conversion of one chromogenic substrate, L-glutamine-p-nitroanilide, and two fluorogenic substrates, L-glutaminyl-2-naphthylamide and L-glutaminyl-4-methylcoumarinylamide, into their resp. pyroglutamic acid derivs. by glutaminyl cyclase (QC) was estd. by introducing a new coupled assay using pyroglutamyl aminopeptidase as the auxiliary enzyme.  For the purified papaya QC, the kinetic parameters were found to be in the range of those previously reported for other glutaminyl peptides, such as Gln-Gln, Gln-Ala, or Gln-tert-Bu ester.  The assay can be performed in the presence of ammonia up to a concn. of 50 mM.  Increasing ionic strength, e.g., potassium chloride up to 300 mM, resulted in an increase in enzymic activity of about 20%.  This is the first report of a fast, continuous, and reliable detn. of QC activity, even in the presence of ammonium ions, during the course of protein purifn. and enzymic anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpQW4L1wwLqbVg90H21EOLACvtfcHk0ljpvA0qY79Y4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitFeisL0%253D&md5=18509903cf5017f855c3c3ea68dc9915</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1006%2Fabio.2001.5560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.2001.5560%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DWasternack%26aufirst%3DC.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DContinuous%2520spectrometric%2520assays%2520for%2520glutaminyl%2520cyclase%2520activity%26jtitle%3DAnal.%2520Biochem.%26date%3D2002%26volume%3D303%26spage%3D49%26epage%3D56%26doi%3D10.1006%2Fabio.2001.5560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Koch, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span> </span><span class="NLM_article-title">Probing secondary glutaminyl cyclase (QC) inhibitor interactions applying an in silico-modeling/site-directed mutagenesis approach: implications for drug development</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">937</span><span class="NLM_x">–</span> <span class="NLM_lpage">946</span><span class="refDoi"> DOI: 10.1111/cbdd.12046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1111%2Fcbdd.12046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=22967026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCmu7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2012&pages=937-946&author=B.+Kochauthor=M.+Buchholzauthor=M.+Wermannauthor=U.+Heiserauthor=S.+Schillingauthor=H.+U.+Demuth&title=Probing+secondary+glutaminyl+cyclase+%28QC%29+inhibitor+interactions+applying+an+in+silico-modeling%2Fsite-directed+mutagenesis+approach%3A+implications+for+drug+development&doi=10.1111%2Fcbdd.12046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Probing secondary glutaminyl cyclase (QC) inhibitor interactions applying an in silico-modeling/site-directed mutagenesis approach: implications for drug development</span></div><div class="casAuthors">Koch, Birgit; Buchholz, Mirko; Wermann, Michael; Heiser, Ulrich; Schilling, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">937-946</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Glutaminyl cyclases (QCs) catalyze the formation of pyroglutamate-modified amyloid peptides deposited in neurodegenerative disorders such as Alzheimer's disease.  Inhibitors of QC are currently in development as potential therapeutics.  The crystal structures of the potent inhibitor PBD150 bound to human and murine QC (hQC, mQC) have been described recently.  The binding modes of a dimethoxyphenyl moiety of the inhibitor are significantly different between the structures, which contrasts with a similar Ki value.  We show the conformation of PBD150 prone to disturbance by protein-protein interactions within the crystals.  Semi-empirical calcns. of the enzyme-inhibitor interaction within the crystal suggest significant differences in the dissocn. consts. between the binding modes.  To probe for interactions in soln., a site-directed mutagenesis on hQC was performed.  The replacement of F325 and I303 by alanine or asparagine resulted in a 800-fold lower activity of the inhibitor, whereas the exchange of S323 by alanine or valine led to a 20-fold higher activity of PBD150.  The results provide an example of deciphering the interaction mode between a target enzyme and lead substance in soln., if co-crystn. does not mirror such interactions properly.  Thus, the study might provide implications for rapid screening of binding modes also for other drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG1xHVETpdubVg90H21EOLACvtfcHk0ljpvA0qY79Y4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCmu7fE&md5=826cc42ff98381d0a09f6bec93f2a878</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12046%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DProbing%2520secondary%2520glutaminyl%2520cyclase%2520%2528QC%2529%2520inhibitor%2520interactions%2520applying%2520an%2520in%2520silico-modeling%252Fsite-directed%2520mutagenesis%2520approach%253A%2520implications%2520for%2520drug%2520development%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2012%26volume%3D80%26spage%3D937%26epage%3D946%26doi%3D10.1111%2Fcbdd.12046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Becker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eichentopf, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedlmeier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waniek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cynis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauscher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohlmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehlen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freyse, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osmand, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plank, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Horsten, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graubner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, S.</span><span> </span><span class="NLM_article-title">IsoQC (QPCTL) knock-out mice suggest differential substrate conversion by glutaminyl cyclase isoenzymes</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">397</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span><span class="refDoi"> DOI: 10.1515/hsz-2015-0192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1515%2Fhsz-2015-0192" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=26351917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKjtbrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=397&publication_year=2016&pages=45-55&author=A.+Beckerauthor=R.+Eichentopfauthor=R.+Sedlmeierauthor=A.+Waniekauthor=H.+Cynisauthor=B.+Kochauthor=A.+Stephanauthor=C.+Bauscherauthor=S.+Kohlmannauthor=T.+Hoffmannauthor=A.+Kehlenauthor=S.+Bergauthor=E.+J.+Freyseauthor=A.+Osmandauthor=A.+C.+Plankauthor=S.+Rossnerauthor=S.+von+Horstenauthor=S.+Graubnerauthor=H.+U.+Demuthauthor=S.+Schilling&title=IsoQC+%28QPCTL%29+knock-out+mice+suggest+differential+substrate+conversion+by+glutaminyl+cyclase+isoenzymes&doi=10.1515%2Fhsz-2015-0192"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">IsoQC (QPCTL) knock-out mice suggest differential substrate conversion by glutaminyl cyclase isoenzymes</span></div><div class="casAuthors">Becker, Andreas; Eichentopf, Rico; Sedlmeier, Reinhard; Waniek, Alexander; Cynis, Holger; Koch, Birgit; Stephan, Anett; Baeuscher, Christoph; Kohlmann, Stephanie; Hoffmann, Torsten; Kehlen, Astrid; Berg, Sabine; Freyse, Ernst-Joachim; Osmand, Alexander; Plank, Anne-Christine; Rossner, Steffen; von Hoersten, Stephan; Graubner, Sigrid; Demuth, Hans-Ulrich; Schilling, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">397</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-55</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH</span>)
        </div><div class="casAbstract">Secretory peptides and proteins are frequently modified by pyroglutamic acid (pE, pGlu) at their N-terminus.  This modification is catalyzed by the glutaminyl cyclases QC and isoQC.  Here, we decipher the roles of the isoenzymes by characterization of IsoQC-/- mice.  These mice show a significant redn. of glutaminyl cyclase activity in brain and peripheral tissue, suggesting ubiquitous expression of the isoQC enzyme.  An assay of substrate conversion in vivo reveals impaired generation of the pGlu-modified C-C chemokine ligand 2 (CCL2, MCP-1) in isoQC-/- mice.  The pGlu-formation was also impaired in primary neurons, which express significant levels of QC.  Interestingly, however, the formation of the neuropeptide hormone TSH-releasing hormone (TRH), assessed by immunohistochem. and hormonal anal. of hypothalamic-pituitary-thyroid axis, was not affected in isoQC-/-, which contrasts to QC-/-.  Thus, the results reveal differential functions of isoQC and QC in the formation of the pGlu-peptides CCL2 and TRH.  Substrates requiring extensive prohormone processing in secretory granules, such as TRH, are primarily converted by QC.  In contrast, protein substrates such as CCL2 appear to be primarily converted by isoQC.  The results provide a new example, how subtle differences in subcellular localization of enzymes and substrate precursor maturation might influence pGlu-product formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6FvRmQrpJjbVg90H21EOLACvtfcHk0li7FM7WskvWvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKjtbrN&md5=d49367e240255a8fa1546bae79865508</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1515%2Fhsz-2015-0192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fhsz-2015-0192%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DA.%26aulast%3DEichentopf%26aufirst%3DR.%26aulast%3DSedlmeier%26aufirst%3DR.%26aulast%3DWaniek%26aufirst%3DA.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DStephan%26aufirst%3DA.%26aulast%3DBauscher%26aufirst%3DC.%26aulast%3DKohlmann%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DFreyse%26aufirst%3DE.%2BJ.%26aulast%3DOsmand%26aufirst%3DA.%26aulast%3DPlank%26aufirst%3DA.%2BC.%26aulast%3DRossner%26aufirst%3DS.%26aulast%3Dvon%2BHorsten%26aufirst%3DS.%26aulast%3DGraubner%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DSchilling%26aufirst%3DS.%26atitle%3DIsoQC%2520%2528QPCTL%2529%2520knock-out%2520mice%2520suggest%2520differential%2520substrate%2520conversion%2520by%2520glutaminyl%2520cyclase%2520isoenzymes%26jtitle%3DBiol.%2520Chem.%26date%3D2016%26volume%3D397%26spage%3D45%26epage%3D55%26doi%3D10.1515%2Fhsz-2015-0192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Oakley, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maus, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craft, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillozet-Bongaarts, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Disterhoft, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Eldik, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassar, R.</span><span> </span><span class="NLM_article-title">Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer’s disease mutations: potential factors in amyloid plaque formation</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">10129</span><span class="NLM_x">–</span> <span class="NLM_lpage">10140</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.1202-06.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1523%2FJNEUROSCI.1202-06.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=17021169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVymurbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=10129-10140&author=H.+Oakleyauthor=S.+L.+Coleauthor=S.+Loganauthor=E.+Mausauthor=P.+Shaoauthor=J.+Craftauthor=A.+Guillozet-Bongaartsauthor=M.+Ohnoauthor=J.+Disterhoftauthor=L.+Van+Eldikauthor=R.+Berryauthor=R.+Vassar&title=Intraneuronal+beta-amyloid+aggregates%2C+neurodegeneration%2C+and+neuron+loss+in+transgenic+mice+with+five+familial+Alzheimer%E2%80%99s+disease+mutations%3A+potential+factors+in+amyloid+plaque+formation&doi=10.1523%2FJNEUROSCI.1202-06.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation</span></div><div class="casAuthors">Oakley, Holly; Cole, Sarah L.; Logan, Sreemathi; Maus, Erika; Shao, Pei; Craft, Jeffery; Guillozet-Bongaarts, Angela; Ohno, Masuo; Disterhoft, John; Van Eldik, Linda; Berry, Robert; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">10129-10140</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Mutations in the genes for amyloid precursor protein (APP) and presenilins (PS1, PS2) increase prodn. of β-amyloid 42 (Aβ42) and cause familial Alzheimer's disease (FAD).  Transgenic mice that express FAD mutant APP and PS1 overproduce Aβ42 and exhibit amyloid plaque pathol. similar to that found in AD, but most transgenic models develop plaques slowly.  To accelerate plaque development and investigate the effects of very high cerebral Aβ42 levels, we generated APP/PS1 double transgenic mice that coexpress five FAD mutations (5XFAD mice) and additively increase Aβ42 prodn.  5XFAD mice generate Aβ42 almost exclusively and rapidly accumulate massive cerebral Aβ42 levels.  Amyloid deposition (and gliosis) begins at 2 mo and reaches a very large burden, esp. in subiculum and deep cortical layers.  Intraneuronal Aβ42 accumulates in 5XFAD brain starting at 1.5 mo of age (before plaques form), is aggregated (as detd. by thioflavin S staining), and occurs within neuron soma and neurites.  Some amyloid deposits originate within morphol. abnormal neuron soma that contain intraneuronal Aβ.  Synaptic markers synaptophysin, syntaxin, and postsynaptic d.-95 decrease with age in 5XFAD brain, and large pyramidal neurons in cortical layer 5 and subiculum are lost.  In addn., levels of the activation subunit of cyclin-dependent kinase 5, p25, are elevated significantly at 9 mo in 5XFAD brain, although an upward trend is obsd. by 3 mo of age, before significant neurodegeneration or neuron loss.  Finally, 5XFAD mice have impaired memory in the Y-maze.  Thus, 5XFAD mice rapidly recapitulate major features of AD amyloid pathol. and may be useful models of intraneuronal Aβ42-induced neurodegeneration and amyloid plaque formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIhU1MNDa0RrVg90H21EOLACvtfcHk0li7FM7WskvWvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVymurbK&md5=a47a3bedd25b37812f9172ebca81fb1d</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1202-06.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1202-06.2006%26sid%3Dliteratum%253Aachs%26aulast%3DOakley%26aufirst%3DH.%26aulast%3DCole%26aufirst%3DS.%2BL.%26aulast%3DLogan%26aufirst%3DS.%26aulast%3DMaus%26aufirst%3DE.%26aulast%3DShao%26aufirst%3DP.%26aulast%3DCraft%26aufirst%3DJ.%26aulast%3DGuillozet-Bongaarts%26aufirst%3DA.%26aulast%3DOhno%26aufirst%3DM.%26aulast%3DDisterhoft%26aufirst%3DJ.%26aulast%3DVan%2BEldik%26aufirst%3DL.%26aulast%3DBerry%26aufirst%3DR.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DIntraneuronal%2520beta-amyloid%2520aggregates%252C%2520neurodegeneration%252C%2520and%2520neuron%2520loss%2520in%2520transgenic%2520mice%2520with%2520five%2520familial%2520Alzheimer%25E2%2580%2599s%2520disease%2520mutations%253A%2520potential%2520factors%2520in%2520amyloid%2520plaque%2520formation%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26spage%3D10129%26epage%3D10140%26doi%3D10.1523%2FJNEUROSCI.1202-06.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Hwang, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attia, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connelly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichterman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustinaite, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inglese, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guy, R. K.</span><span> </span><span class="NLM_article-title">Methylsulfonylnitrobenzoates, a new class of irreversible inhibitors of the interaction of the thyroid hormone receptor and its obligate coactivators that functionally antagonizes thyroid hormone</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">11895</span><span class="NLM_x">–</span> <span class="NLM_lpage">11908</span><span class="refDoi"> DOI: 10.1074/jbc.M110.200436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1074%2Fjbc.M110.200436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=21321127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVKqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=11895-11908&author=J.+Y.+Hwangauthor=W.+Huangauthor=L.+A.+Arnoldauthor=R.+Huangauthor=R.+R.+Attiaauthor=M.+Connellyauthor=J.+Wichtermanauthor=F.+Zhuauthor=I.+Augustinaiteauthor=C.+P.+Austinauthor=J.+Ingleseauthor=R.+L.+Johnsonauthor=R.+K.+Guy&title=Methylsulfonylnitrobenzoates%2C+a+new+class+of+irreversible+inhibitors+of+the+interaction+of+the+thyroid+hormone+receptor+and+its+obligate+coactivators+that+functionally+antagonizes+thyroid+hormone&doi=10.1074%2Fjbc.M110.200436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Methylsulfonylnitrobenzoates, a New Class of Irreversible Inhibitors of the Interaction of the Thyroid Hormone Receptor and its Obligate Coactivators that Functionally Antagonizes Thyroid Hormone</span></div><div class="casAuthors">Hwang, Jong-Yeon; Huang, Wen-Wei; Arnold, Leggy A.; Huang, Rui-Li; Attia, Ramy R.; Connelly, Michele; Wichterman, Jennifer; Zhu, Fang-Yi; Augustinaite, Indre; Austin, Christopher P.; Inglese, James; Johnson, Ronald L.; Guy, R. Kiplin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">11895-11908</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Thyroid hormone receptors (TRs) are members of the nuclear hormone receptor (NR) superfamily and regulate development, growth, and metab.  Upon binding thyroid hormone, TR undergoes a conformational change that allows the release of corepressors and the recruitment of coactivators, which in turn regulate target gene transcription.  Although a no. of TR antagonists have been developed, most are analogs of the endogenous hormone that inhibit ligand binding.  In a screen for inhibitors that block the assocn. of TRβ with steroid receptor coactivator 2 (SRC2), the authors identified a novel methylsulfonylnitrobenzoate (MSNB)-contg. series that blocks this interaction at micromolar concns.  Here the authors have studied a series of MSNB analogs and characterized their structure activity relationships.  MSNB members do not displace thyroid hormone T3 but instead act by direct displacement of SRC2.  MSNB series members are selective for the TR over the androgen, vitamin D, and PPARγ NR members, and they antagonize thyroid hormone-activated transcription action in cells.  The methylsulfonylnitro group is essential for TRβ antagonism.  Side-chain alkylamine substituents showed better inhibitory activity than arylamine substituents.  Mass spectrum anal. suggested that MSNB inhibitors bind irreversibly to Cys-298 within the AF-2 cleft of TRβ to disrupt SRC2 assocn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN6FEsDjbQsLVg90H21EOLACvtfcHk0li7FM7WskvWvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVKqtro%253D&md5=a968a083f7c5718c2e03d5ef0a3b25ae</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.200436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.200436%26sid%3Dliteratum%253Aachs%26aulast%3DHwang%26aufirst%3DJ.%2BY.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DArnold%26aufirst%3DL.%2BA.%26aulast%3DHuang%26aufirst%3DR.%26aulast%3DAttia%26aufirst%3DR.%2BR.%26aulast%3DConnelly%26aufirst%3DM.%26aulast%3DWichterman%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DF.%26aulast%3DAugustinaite%26aufirst%3DI.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DInglese%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DR.%2BL.%26aulast%3DGuy%26aufirst%3DR.%2BK.%26atitle%3DMethylsulfonylnitrobenzoates%252C%2520a%2520new%2520class%2520of%2520irreversible%2520inhibitors%2520of%2520the%2520interaction%2520of%2520the%2520thyroid%2520hormone%2520receptor%2520and%2520its%2520obligate%2520coactivators%2520that%2520functionally%2520antagonizes%2520thyroid%2520hormone%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D11895%26epage%3D11908%26doi%3D10.1074%2Fjbc.M110.200436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Huang, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liaw, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chia, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A. H.</span><span> </span><span class="NLM_article-title">Structures of human Golgi-resident glutaminyl cyclase and its complexes with inhibitors reveal a large loop movement upon inhibitor binding</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">12439</span><span class="NLM_x">–</span> <span class="NLM_lpage">12449</span><span class="refDoi"> DOI: 10.1074/jbc.M110.208595</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1074%2Fjbc.M110.208595" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=21288892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVKqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=12439-12449&author=K.+F.+Huangauthor=S.+S.+Liawauthor=W.+L.+Huangauthor=C.+Y.+Chiaauthor=Y.+C.+Loauthor=Y.+L.+Chenauthor=A.+H.+Wang&title=Structures+of+human+Golgi-resident+glutaminyl+cyclase+and+its+complexes+with+inhibitors+reveal+a+large+loop+movement+upon+inhibitor+binding&doi=10.1074%2Fjbc.M110.208595"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Golgi-resident Glutaminyl Cyclase and its Complexes with Inhibitors Reveal a Large Loop Movement upon Inhibitor Binding</span></div><div class="casAuthors">Huang, Kai-Fa; Liaw, Su-Sen; Huang, Wei-Lin; Chia, Cho-Yun; Lo, Yan-Chung; Chen, Yi-Ling; Wang, Andrew H.-J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">12439-12449</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Aberrant pyroglutamate formation at the N terminus of certain peptides and proteins, catalyzed by glutaminyl cyclases (QCs), is linked to some pathol. conditions, such as Alzheimer disease.  Recently, a glutaminyl cyclase (QC) inhibitor, PBD150, was shown to be able to reduce the deposition of pyroglutamate-modified amyloid-β peptides in brain of transgenic mouse models of Alzheimer disease, leading to a significant improvement of learning and memory in those transgenic animals.  Here, we report the 1.05-1.40 Å resoln. structures, solved by the sulfur single-wavelength anomalous dispersion phasing method, of the Golgi-luminal catalytic domain of the recently identified Golgi-resident QC (gQC) and its complex with PBD150.  We also describe the high-resoln. structures of secretory QC (sQC)-PBD150 complex and two other gQC-inhibitor complexes.  The gQC structure has a scaffold similar to that of sQC but with a relatively wider and neg. charged active site, suggesting a distinct substrate specificity from sQC.  Upon binding to PBD150, a large loop movement in gQC allows the inhibitor to be tightly held in its active site primarily by hydrophobic interactions.  Further comparisons of the inhibitor-bound structures revealed distinct interactions of the inhibitors with gQC and sQC, which are consistent with the results from our inhibitor assays reported here.  Because gQC and sQC may play different biol. roles in vivo, the different inhibitor binding modes allow the design of specific inhibitors toward gQC and sQC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeL8K3B1TxsLVg90H21EOLACvtfcHk0lhX-ztsdvs53A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVKqu7c%253D&md5=ef9018b9dc4ff40db7cac0ddac9fadb1</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.208595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.208595%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BF.%26aulast%3DLiaw%26aufirst%3DS.%2BS.%26aulast%3DHuang%26aufirst%3DW.%2BL.%26aulast%3DChia%26aufirst%3DC.%2BY.%26aulast%3DLo%26aufirst%3DY.%2BC.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DWang%26aufirst%3DA.%2BH.%26atitle%3DStructures%2520of%2520human%2520Golgi-resident%2520glutaminyl%2520cyclase%2520and%2520its%2520complexes%2520with%2520inhibitors%2520reveal%2520a%2520large%2520loop%2520movement%2520upon%2520inhibitor%2520binding%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D12439%26epage%3D12449%26doi%3D10.1074%2Fjbc.M110.208595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Cho, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guallar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berne, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R.</span><span> </span><span class="NLM_article-title">Importance of accurate charges in molecular docking: quantum mechanical/molecular mechanical (QM/MM) approach</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">915</span><span class="NLM_x">–</span> <span class="NLM_lpage">931</span><span class="refDoi"> DOI: 10.1002/jcc.20222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1002%2Fjcc.20222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=15841474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvF2ktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=915-931&author=A.+E.+Choauthor=V.+Guallarauthor=B.+J.+Berneauthor=R.+Friesner&title=Importance+of+accurate+charges+in+molecular+docking%3A+quantum+mechanical%2Fmolecular+mechanical+%28QM%2FMM%29+approach&doi=10.1002%2Fjcc.20222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Importance of accurate charges in molecular docking: Quantum mechanical/molecular mechanical (QM/MM) approach</span></div><div class="casAuthors">Cho, Art E.; Guallar, Victor; Berne, Bruce J.; Friesner, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">915-931</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The extent to which accuracy of elec. charges plays a role in protein-ligand docking is investigated through development of a docking algorithm, which incorporates quantum mech./mol. mech. (QM/MM) calcns.  In this algorithm, fixed charges of ligands obtained from force field parameterization are replaced by QM/MM calcns. in the protein environment, treating only the ligands as the quantum region.  The algorithm is tested on a set of 40 co-crystd. structures taken from the Protein Data Bank (PDB) and provides strong evidence that use of non-fixed charges is important.  An algorithm, dubbed Survival of the Fittest (SOF) algorithm, is implemented to incorporate QM/MM charge calcns. without any prior knowledge of native structures of the complexes.  Using an iterative protocol, this algorithm is able in many cases to converge to a native-like structure in systems where redocking of the ligand using a std. fixed charge force field exhibits non-trivial errors.  The results demonstrate that polarization effects can play a significant role in detg. the structures of protein-ligand complexes, and provide a promising start toward the development of more accurate docking methods for lead optimization applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUfbf04iv-0bVg90H21EOLACvtfcHk0lhX-ztsdvs53A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvF2ktLo%253D&md5=4ba42205c6857a4395850a488d3ba272</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20222%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DA.%2BE.%26aulast%3DGuallar%26aufirst%3DV.%26aulast%3DBerne%26aufirst%3DB.%2BJ.%26aulast%3DFriesner%26aufirst%3DR.%26atitle%3DImportance%2520of%2520accurate%2520charges%2520in%2520molecular%2520docking%253A%2520quantum%2520mechanical%252Fmolecular%2520mechanical%2520%2528QM%252FMM%2529%2520approach%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2005%26volume%3D26%26spage%3D915%26epage%3D931%26doi%3D10.1002%2Fjcc.20222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheraga, H. A.</span><span> </span><span class="NLM_article-title">Monte Carlo-minimization approach to the multiple-minima problem in protein folding</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">6611</span><span class="NLM_x">–</span> <span class="NLM_lpage">6615</span><span class="refDoi"> DOI: 10.1073/pnas.84.19.6611</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1073%2Fpnas.84.19.6611" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=3477791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADyaL1cXlt1emuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=1987&pages=6611-6615&author=Z.+Liauthor=H.+A.+Scheraga&title=Monte+Carlo-minimization+approach+to+the+multiple-minima+problem+in+protein+folding&doi=10.1073%2Fpnas.84.19.6611"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Monte Carlo-minimization approach to the multiple-minima problem in protein folding</span></div><div class="casAuthors">Li, Zhenqin; Scheraga, Harold A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6611-15</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">A Monte Carlo-minimization method was developed to overcome the multiple-min. problem.  The Metropolis Monte Carlo sampling, assisted by energy minimization, surmounted intervening barriers in moving through successive discrete local min. in the multidimensional energy surface.  The method located the lowest-energy min. thus far reported for the brain pentapeptide, methionine-enkephalin, in the absence of water.  Presumably it is the global min.-energy structure.  This supports the concept that protein folding may be a Markov process.  In the presence of water, the mols. appear to exist as an ensemble of different conformations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHepRW7gor_7Vg90H21EOLACvtfcHk0lhX-ztsdvs53A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXlt1emuw%253D%253D&md5=5a3aaea4f7ae84ed25b5ac2f7ac06a27</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1073%2Fpnas.84.19.6611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.84.19.6611%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DScheraga%26aufirst%3DH.%2BA.%26atitle%3DMonte%2520Carlo-minimization%2520approach%2520to%2520the%2520multiple-minima%2520problem%2520in%2520protein%2520folding%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1987%26volume%3D84%26spage%3D6611%26epage%3D6615%26doi%3D10.1073%2Fpnas.84.19.6611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 22 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jin Choi, Gabriele Laudadio, Edouard Godineau, <span class="NLM_string-name hlFld-ContribAuthor">Phil S. Baran</span>. </span><span class="cited-content_cbyCitation_article-title">Practical and Regioselective Synthesis of C-4-Alkylated Pyridines. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2021</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.1c05278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.1c05278%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DPractical%252Band%252BRegioselective%252BSynthesis%252Bof%252BC-4-Alkylated%252BPyridines%26aulast%3DChoi%26aufirst%3DJin%26date%3D2021%26date%3D2021%26date%3D21052021%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Chenshu Xu, Yi-nan Wang, <span class="NLM_string-name hlFld-ContribAuthor">Haiqiang Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (10)
                                     , 6549-6565. <a href="https://doi.org/10.1021/acs.jmedchem.1c00325" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00325</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00325%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGlutaminyl%252BCyclase%25252C%252BDiseases%25252C%252Band%252BDevelopment%252Bof%252BGlutaminyl%252BCyclase%252BInhibitors%26aulast%3DXu%26aufirst%3DChenshu%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D21022021%26date%3D18052021%26volume%3D64%26issue%3D10%26spage%3D6549%26epage%3D6565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Van-Hai Hoang, Van T. H. Ngo, Minghua Cui, Nguyen Van Manh, Phuong-Thao Tran, Jihyae Ann, Hee-Jin Ha, Hee Kim, Kwanghyun Choi, Young-Ho Kim, Hyerim Chang, Stephani Joy Y. Macalino, Jiyoun Lee, Sun Choi, <span class="NLM_string-name hlFld-ContribAuthor">Jeewoo Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimer’s Agents by Structure-Based Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (17)
                                     , 8011-8027. <a href="https://doi.org/10.1021/acs.jmedchem.9b00751" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00751</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00751%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BConformationally%252BRestricted%252BHuman%252BGlutaminyl%252BCyclase%252BInhibitors%252Bas%252BPotent%252BAnti-Alzheimer%2525E2%252580%252599s%252BAgents%252Bby%252BStructure-Based%252BDesign%26aulast%3DHoang%26aufirst%3DVan-Hai%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D08052019%26date%3D27082019%26date%3D14082019%26volume%3D62%26issue%3D17%26spage%3D8011%26epage%3D8027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Judite R.M.  Coimbra</span>, <span class="hlFld-ContribAuthor ">Jorge A.R.  Salvador</span>. </span><span class="cited-content_cbyCitation_article-title">A patent review of glutaminyl cyclase inhibitors (2004–present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>276 </em>, 1-28. <a href="https://doi.org/10.1080/13543776.2021.1917549" title="DOI URL">https://doi.org/10.1080/13543776.2021.1917549</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1917549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1917549%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DA%252Bpatent%252Breview%252Bof%252Bglutaminyl%252Bcyclase%252Binhibitors%252B%2525282004%2525E2%252580%252593present%252529%26aulast%3DCoimbra%26aufirst%3DJudite%2BR.M.%26date%3D2021%26date%3D2021%26volume%3D276%26spage%3D1%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sebastiaan  Lamers</span>, <span class="hlFld-ContribAuthor ">Qiaoli  Feng</span>, <span class="hlFld-ContribAuthor ">Yili  Cheng</span>, <span class="hlFld-ContribAuthor ">Sihong  Yu</span>, <span class="hlFld-ContribAuthor ">Bo  Sun</span>, <span class="hlFld-ContribAuthor ">Maxwell  Lukman</span>, <span class="hlFld-ContribAuthor ">Jie  Jiang</span>, <span class="hlFld-ContribAuthor ">David  Ruiz-Carrillo</span>. </span><span class="cited-content_cbyCitation_article-title">Structural and kinetic characterization of
              Porphyromonas gingivalis
              glutaminyl cyclase. </span><span class="cited-content_cbyCitation_journal-name">Biological Chemistry</span><span> <strong>2021,</strong> <em>402 </em>
                                    (7)
                                     , 759-768. <a href="https://doi.org/10.1515/hsz-2020-0298" title="DOI URL">https://doi.org/10.1515/hsz-2020-0298</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/hsz-2020-0298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fhsz-2020-0298%26sid%3Dliteratum%253Aachs%26jtitle%3DBiological%2520Chemistry%26atitle%3DStructural%252Band%252Bkinetic%252Bcharacterization%252Bof%252BPorphyromonas%252Bgingivalis%252Bglutaminyl%252Bcyclase%26aulast%3DLamers%26aufirst%3DSebastiaan%26date%3D2021%26date%3D2021%26volume%3D402%26issue%3D7%26spage%3D759%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Niklas  Baumann</span>, <span class="hlFld-ContribAuthor ">Thies  Rösner</span>, <span class="hlFld-ContribAuthor ">J. H. Marco  Jansen</span>, <span class="hlFld-ContribAuthor ">Chilam  Chan</span>, <span class="hlFld-ContribAuthor ">Klara  Marie Eichholz</span>, <span class="hlFld-ContribAuthor ">Katja  Klausz</span>, <span class="hlFld-ContribAuthor ">Dorothee  Winterberg</span>, <span class="hlFld-ContribAuthor ">Kristina  Müller</span>, <span class="hlFld-ContribAuthor ">Andreas  Humpe</span>, <span class="hlFld-ContribAuthor ">Renate  Burger</span>, <span class="hlFld-ContribAuthor ">Matthias  Peipp</span>, <span class="hlFld-ContribAuthor ">Denis M.  Schewe</span>, <span class="hlFld-ContribAuthor ">Christian  Kellner</span>, <span class="hlFld-ContribAuthor ">Jeanette H. W.  Leusen</span>, <span class="hlFld-ContribAuthor ">Thomas  Valerius</span>. </span><span class="cited-content_cbyCitation_article-title">Enhancement of epidermal growth factor receptor antibody tumor immunotherapy by glutaminyl cyclase inhibition to interfere with CD47/signal regulatory protein alpha interactions. </span><span class="cited-content_cbyCitation_journal-name">Cancer Science</span><span> <strong>2021,</strong> <em>29 </em><a href="https://doi.org/10.1111/cas.14999" title="DOI URL">https://doi.org/10.1111/cas.14999</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cas.14999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcas.14999%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Science%26atitle%3DEnhancement%252Bof%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor%252Bantibody%252Btumor%252Bimmunotherapy%252Bby%252Bglutaminyl%252Bcyclase%252Binhibition%252Bto%252Binterfere%252Bwith%252BCD47%25252Fsignal%252Bregulatory%252Bprotein%252Balpha%252Binteractions%26aulast%3DBaumann%26aufirst%3DNiklas%26date%3D2021%26date%3D2021%26volume%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandeep  Rulhania</span>, <span class="hlFld-ContribAuthor ">Shubham  Kumar</span>, <span class="hlFld-ContribAuthor ">Bhupender  Nehra</span>, <span class="hlFld-ContribAuthor ">GD  Gupta</span>, <span class="hlFld-ContribAuthor ">Vikramdeep  Monga</span>. </span><span class="cited-content_cbyCitation_article-title">An insight into the medicinal perspective of synthetic analogs of imidazole. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1232 </em>, 129982. <a href="https://doi.org/10.1016/j.molstruc.2021.129982" title="DOI URL">https://doi.org/10.1016/j.molstruc.2021.129982</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2021.129982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2021.129982%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DAn%252Binsight%252Binto%252Bthe%252Bmedicinal%252Bperspective%252Bof%252Bsynthetic%252Banalogs%252Bof%252Bimidazole%26aulast%3DRulhania%26aufirst%3DSandeep%26date%3D2021%26volume%3D1232%26spage%3D129982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haizhou  Zhu</span>, <span class="hlFld-ContribAuthor ">Venkateshwara  Dronamraju</span>, <span class="hlFld-ContribAuthor ">Wei  Xie</span>, <span class="hlFld-ContribAuthor ">Swati S.  More</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfur-containing therapeutics in the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (2)
                                     , 305-352. <a href="https://doi.org/10.1007/s00044-020-02687-1" title="DOI URL">https://doi.org/10.1007/s00044-020-02687-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02687-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02687-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSulfur-containing%252Btherapeutics%252Bin%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DZhu%26aufirst%3DHaizhou%26date%3D2021%26date%3D2021%26volume%3D30%26issue%3D2%26spage%3D305%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K.V.  Dileep</span>, <span class="hlFld-ContribAuthor ">Naoki  Sakai</span>, <span class="hlFld-ContribAuthor ">Kentaro  Ihara</span>, <span class="hlFld-ContribAuthor ">Miyuki  Kato-Murayama</span>, <span class="hlFld-ContribAuthor ">Akiko  Nakata</span>, <span class="hlFld-ContribAuthor ">Akihiro  Ito</span>, <span class="hlFld-ContribAuthor ">D.M.  Sivaraman</span>, <span class="hlFld-ContribAuthor ">Jay W.  Shin</span>, <span class="hlFld-ContribAuthor ">Minoru  Yoshida</span>, <span class="hlFld-ContribAuthor ">Mikako  Shirouzu</span>, <span class="hlFld-ContribAuthor ">Kam Y.J.  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Piperidine-4-carboxamide as a new scaffold for designing secretory glutaminyl cyclase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Biological Macromolecules</span><span> <strong>2021,</strong> <em>170 </em>, 415-423. <a href="https://doi.org/10.1016/j.ijbiomac.2020.12.118" title="DOI URL">https://doi.org/10.1016/j.ijbiomac.2020.12.118</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijbiomac.2020.12.118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijbiomac.2020.12.118%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Biological%2520Macromolecules%26atitle%3DPiperidine-4-carboxamide%252Bas%252Ba%252Bnew%252Bscaffold%252Bfor%252Bdesigning%252Bsecretory%252Bglutaminyl%252Bcyclase%252Binhibitors%26aulast%3DDileep%26aufirst%3DK.V.%26date%3D2021%26volume%3D170%26spage%3D415%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Son Tung  Ngo</span>. </span><span class="cited-content_cbyCitation_article-title">Estimating the
              ligand‐binding
              affinity via
              λ‐dependent
              umbrella sampling simulations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computational Chemistry</span><span> <strong>2021,</strong> <em>42 </em>
                                    (2)
                                     , 117-123. <a href="https://doi.org/10.1002/jcc.26439" title="DOI URL">https://doi.org/10.1002/jcc.26439</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcc.26439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcc.26439%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computational%2520Chemistry%26atitle%3DEstimating%252Bthe%252Bligand%2525E2%252580%252590binding%252Baffinity%252Bvia%252B%2525CE%2525BB%2525E2%252580%252590dependent%252Bumbrella%252Bsampling%252Bsimulations%26aulast%3DNgo%26aufirst%3DSon%2BTung%26date%3D2021%26date%3D2020%26volume%3D42%26issue%3D2%26spage%3D117%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Judite RM  Coimbra</span>, <span class="hlFld-ContribAuthor ">Pedro JM  Sobral</span>, <span class="hlFld-ContribAuthor ">Armanda E  Santos</span>, <span class="hlFld-ContribAuthor ">Paula I  Moreira</span>, <span class="hlFld-ContribAuthor ">Jorge AR  Salvador</span>. </span><span class="cited-content_cbyCitation_article-title">An overview of glutaminyl cyclase inhibitors for Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2019,</strong> <em>11 </em>
                                    (24)
                                     , 3179-3194. <a href="https://doi.org/10.4155/fmc-2019-0163" title="DOI URL">https://doi.org/10.4155/fmc-2019-0163</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2019-0163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2019-0163%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DAn%252Boverview%252Bof%252Bglutaminyl%252Bcyclase%252Binhibitors%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DCoimbra%26aufirst%3DJudite%2BRM%26date%3D2019%26volume%3D11%26issue%3D24%26spage%3D3179%26epage%3D3194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaojuan  Wang</span>, <span class="hlFld-ContribAuthor ">Li  Wang</span>, <span class="hlFld-ContribAuthor ">Xi  Yu</span>, <span class="hlFld-ContribAuthor ">Yue  Li</span>, <span class="hlFld-ContribAuthor ">Zhigang  Liu</span>, <span class="hlFld-ContribAuthor ">Yongdong  Zou</span>, <span class="hlFld-ContribAuthor ">Yizhi  Zheng</span>, <span class="hlFld-ContribAuthor ">Zhendan  He</span>, <span class="hlFld-ContribAuthor ">Haiqiang  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Glutaminyl cyclase inhibitor exhibits anti-inflammatory effects in both AD and LPS-induced inflammatory model mice. </span><span class="cited-content_cbyCitation_journal-name">International Immunopharmacology</span><span> <strong>2019,</strong> <em>75 </em>, 105770. <a href="https://doi.org/10.1016/j.intimp.2019.105770" title="DOI URL">https://doi.org/10.1016/j.intimp.2019.105770</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.intimp.2019.105770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.intimp.2019.105770%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Immunopharmacology%26atitle%3DGlutaminyl%252Bcyclase%252Binhibitor%252Bexhibits%252Banti-inflammatory%252Beffects%252Bin%252Bboth%252BAD%252Band%252BLPS-induced%252Binflammatory%252Bmodel%252Bmice%26aulast%3DWang%26aufirst%3DXiaojuan%26date%3D2019%26volume%3D75%26spage%3D105770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana  Xu</span>, <span class="hlFld-ContribAuthor ">Feng  He</span>, <span class="hlFld-ContribAuthor ">Chenggong  Yu</span>, <span class="hlFld-ContribAuthor ">Ying  Qu</span>, <span class="hlFld-ContribAuthor ">Qiuqiong  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiahui  Lv</span>, <span class="hlFld-ContribAuthor ">Xiangna  Zhang</span>, <span class="hlFld-ContribAuthor ">Yingying  Ran</span>, <span class="hlFld-ContribAuthor ">Chao  Wei</span>, <span class="hlFld-ContribAuthor ">Jingde  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">The Development of Small Molecule Inhibitors of Glutaminyl Cyclase and Isoglutaminyl Cyclase for Alzheimer's Disease. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (35)
                                     , 10591-10600. <a href="https://doi.org/10.1002/slct.201902852" title="DOI URL">https://doi.org/10.1002/slct.201902852</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201902852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201902852%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DThe%252BDevelopment%252Bof%252BSmall%252BMolecule%252BInhibitors%252Bof%252BGlutaminyl%252BCyclase%252Band%252BIsoglutaminyl%252BCyclase%252Bfor%252BAlzheimer%252527s%252BDisease%26aulast%3DXu%26aufirst%3DAna%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D35%26spage%3D10591%26epage%3D10600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Phuong-Thao  Tran</span>, <span class="hlFld-ContribAuthor ">Van-Hai  Hoang</span>, <span class="hlFld-ContribAuthor ">Jeewoo  Lee</span>, <span class="hlFld-ContribAuthor ">Tran Thi Thu  Hien</span>, <span class="hlFld-ContribAuthor ">Nguyen Thanh  Tung</span>, <span class="hlFld-ContribAuthor ">Son Tung  Ngo</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro
              and
              in silico
              determination of glutaminyl cyclase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2019,</strong> <em>9 </em>
                                    (51)
                                     , 29619-29627. <a href="https://doi.org/10.1039/C9RA05763C" title="DOI URL">https://doi.org/10.1039/C9RA05763C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9RA05763C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9RA05763C%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DIn%252Bvitro%252Band%252Bin%252Bsilico%252Bdetermination%252Bof%252Bglutaminyl%252Bcyclase%252Binhibitors%26aulast%3DTran%26aufirst%3DPhuong-Thao%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D51%26spage%3D29619%26epage%3D29627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dileep K.  Vijayan</span>, <span class="hlFld-ContribAuthor ">Kam Y.J.  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Human glutaminyl cyclase: Structure, function, inhibitors and involvement in Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2019,</strong> <em>147 </em>, 104342. <a href="https://doi.org/10.1016/j.phrs.2019.104342" title="DOI URL">https://doi.org/10.1016/j.phrs.2019.104342</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2019.104342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2019.104342%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DHuman%252Bglutaminyl%252Bcyclase%25253A%252BStructure%25252C%252Bfunction%25252C%252Binhibitors%252Band%252Binvolvement%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DVijayan%26aufirst%3DDileep%2BK.%26date%3D2019%26volume%3D147%26spage%3D104342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weicong  Lin</span>, <span class="hlFld-ContribAuthor ">Xiaojie  Zheng</span>, <span class="hlFld-ContribAuthor ">Danqing  Fang</span>, <span class="hlFld-ContribAuthor ">Shengfu  Zhou</span>, <span class="hlFld-ContribAuthor ">Wenjuan  Wu</span>, <span class="hlFld-ContribAuthor ">Kangcheng  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Identifying hQC Inhibitors of Alzheimer’s Disease by Effective Customized Pharmacophore-Based Virtual Screening, Molecular Dynamic Simulation, and Binding Free Energy Analysis. </span><span class="cited-content_cbyCitation_journal-name">Applied Biochemistry and Biotechnology</span><span> <strong>2019,</strong> <em>187 </em>
                                    (4)
                                     , 1173-1192. <a href="https://doi.org/10.1007/s12010-018-2780-9" title="DOI URL">https://doi.org/10.1007/s12010-018-2780-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12010-018-2780-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12010-018-2780-9%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Biochemistry%2520and%2520Biotechnology%26atitle%3DIdentifying%252BhQC%252BInhibitors%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%252Bby%252BEffective%252BCustomized%252BPharmacophore-Based%252BVirtual%252BScreening%25252C%252BMolecular%252BDynamic%252BSimulation%25252C%252Band%252BBinding%252BFree%252BEnergy%252BAnalysis%26aulast%3DLin%26aufirst%3DWeicong%26date%3D2019%26date%3D2018%26volume%3D187%26issue%3D4%26spage%3D1173%26epage%3D1192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cecilia  Pozzi</span>, <span class="hlFld-ContribAuthor ">Flavio  Di Pisa</span>, <span class="hlFld-ContribAuthor ">Manuela  Benvenuti</span>, <span class="hlFld-ContribAuthor ">Stefano  Mangani</span>. </span><span class="cited-content_cbyCitation_article-title">The structure of the human glutaminyl cyclase–SEN177 complex indicates routes for developing new potent inhibitors as possible agents for the treatment of neurological disorders. </span><span class="cited-content_cbyCitation_journal-name">JBIC Journal of Biological Inorganic Chemistry</span><span> <strong>2018,</strong> <em>23 </em>
                                    (8)
                                     , 1219-1226. <a href="https://doi.org/10.1007/s00775-018-1605-1" title="DOI URL">https://doi.org/10.1007/s00775-018-1605-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00775-018-1605-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00775-018-1605-1%26sid%3Dliteratum%253Aachs%26jtitle%3DJBIC%2520Journal%2520of%2520Biological%2520Inorganic%2520Chemistry%26atitle%3DThe%252Bstructure%252Bof%252Bthe%252Bhuman%252Bglutaminyl%252Bcyclase%2525E2%252580%252593SEN177%252Bcomplex%252Bindicates%252Broutes%252Bfor%252Bdeveloping%252Bnew%252Bpotent%252Binhibitors%252Bas%252Bpossible%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252Bneurological%252Bdisorders%26aulast%3DPozzi%26aufirst%3DCecilia%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D8%26spage%3D1219%26epage%3D1226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abha  Sharma</span>, <span class="hlFld-ContribAuthor ">Vidhu  Pachauri</span>, <span class="hlFld-ContribAuthor ">S. J. S.  Flora</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in Multi-Functional Ligands and the Need for Metal-Related Pharmacology for the Management of Alzheimer Disease. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2018,</strong> <em>9 </em><a href="https://doi.org/10.3389/fphar.2018.01247" title="DOI URL">https://doi.org/10.3389/fphar.2018.01247</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2018.01247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2018.01247%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DAdvances%252Bin%252BMulti-Functional%252BLigands%252Band%252Bthe%252BNeed%252Bfor%252BMetal-Related%252BPharmacology%252Bfor%252Bthe%252BManagement%252Bof%252BAlzheimer%252BDisease%26aulast%3DSharma%26aufirst%3DAbha%26date%3D2018%26date%3D2018%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephani Joy Y.  Macalino</span>, <span class="hlFld-ContribAuthor ">Shaherin  Basith</span>, <span class="hlFld-ContribAuthor ">Nina Abigail B.  Clavio</span>, <span class="hlFld-ContribAuthor ">Hyerim  Chang</span>, <span class="hlFld-ContribAuthor ">Soosung  Kang</span>, <span class="hlFld-ContribAuthor ">Sun  Choi</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution of In Silico Strategies for Protein-Protein Interaction Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (8)
                                     , 1963. <a href="https://doi.org/10.3390/molecules23081963" title="DOI URL">https://doi.org/10.3390/molecules23081963</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23081963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23081963%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DEvolution%252Bof%252BIn%252BSilico%252BStrategies%252Bfor%252BProtein-Protein%252BInteraction%252BDrug%252BDiscovery%26aulast%3DMacalino%26aufirst%3DStephani%2BJoy%2BY.%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D8%26spage%3D1963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Van T.H.  Ngo</span>, <span class="hlFld-ContribAuthor ">Van-Hai  Hoang</span>, <span class="hlFld-ContribAuthor ">Phuong-Thao  Tran</span>, <span class="hlFld-ContribAuthor ">Nguyen  Van Manh</span>, <span class="hlFld-ContribAuthor ">Jihyae  Ann</span>, <span class="hlFld-ContribAuthor ">Eunhye  Kim</span>, <span class="hlFld-ContribAuthor ">Minghua  Cui</span>, <span class="hlFld-ContribAuthor ">Sun  Choi</span>, <span class="hlFld-ContribAuthor ">Jiyoun  Lee</span>, <span class="hlFld-ContribAuthor ">Hee  Kim</span>, <span class="hlFld-ContribAuthor ">Hee-Jin  Ha</span>, <span class="hlFld-ContribAuthor ">Kwanghyun  Choi</span>, <span class="hlFld-ContribAuthor ">Young-Ho  Kim</span>, <span class="hlFld-ContribAuthor ">Jeewoo  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-activity relationship investigation of Phe-Arg mimetic region of human glutaminyl cyclase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (12)
                                     , 3133-3144. <a href="https://doi.org/10.1016/j.bmc.2018.04.040" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.04.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.04.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.04.040%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DStructure-activity%252Brelationship%252Binvestigation%252Bof%252BPhe-Arg%252Bmimetic%252Bregion%252Bof%252Bhuman%252Bglutaminyl%252Bcyclase%252Binhibitors%26aulast%3DNgo%26aufirst%3DVan%2BT.H.%26date%3D2018%26volume%3D26%26issue%3D12%26spage%3D3133%26epage%3D3144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Van T.H.  Ngo</span>, <span class="hlFld-ContribAuthor ">Van-Hai  Hoang</span>, <span class="hlFld-ContribAuthor ">Phuong-Thao  Tran</span>, <span class="hlFld-ContribAuthor ">Jihyae  Ann</span>, <span class="hlFld-ContribAuthor ">Minghua  Cui</span>, <span class="hlFld-ContribAuthor ">Gyungseo  Park</span>, <span class="hlFld-ContribAuthor ">Sun  Choi</span>, <span class="hlFld-ContribAuthor ">Jiyoun  Lee</span>, <span class="hlFld-ContribAuthor ">Hee  Kim</span>, <span class="hlFld-ContribAuthor ">Hee-Jin  Ha</span>, <span class="hlFld-ContribAuthor ">Kwanghyun  Choi</span>, <span class="hlFld-ContribAuthor ">Young-Ho  Kim</span>, <span class="hlFld-ContribAuthor ">Jeewoo  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Potent human glutaminyl cyclase inhibitors as potential anti-Alzheimer’s agents: Structure-activity relationship study of Arg-mimetic region. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (5)
                                     , 1035-1049. <a href="https://doi.org/10.1016/j.bmc.2018.01.015" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.01.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.01.015%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DPotent%252Bhuman%252Bglutaminyl%252Bcyclase%252Binhibitors%252Bas%252Bpotential%252Banti-Alzheimer%2525E2%252580%252599s%252Bagents%25253A%252BStructure-activity%252Brelationship%252Bstudy%252Bof%252BArg-mimetic%252Bregion%26aulast%3DNgo%26aufirst%3DVan%2BT.H.%26date%3D2018%26volume%3D26%26issue%3D5%26spage%3D1035%26epage%3D1049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sotirios  Katsamakas</span>, <span class="hlFld-ContribAuthor ">Dimitra  Hadjipavlou-Litina</span>. </span><span class="cited-content_cbyCitation_article-title">Computational Design of Multitarget Drugs Against Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 203-253. <a href="https://doi.org/10.1007/7653_2018_25" title="DOI URL">https://doi.org/10.1007/7653_2018_25</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7653_2018_25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7653_2018_25%26sid%3Dliteratum%253Aachs%26atitle%3DComputational%252BDesign%252Bof%252BMultitarget%252BDrugs%252BAgainst%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DKatsamakas%26aufirst%3DSotirios%26date%3D2018%26date%3D2018%26spage%3D203%26epage%3D253%26pub%3DSpringer%2520New%2520York%26atitle%3DMulti-Target%252BDrug%252BDesign%252BUsing%252BChem-Bioinformatic%252BApproaches%26aulast%3DRoy%26aufirst%3DKunal%26date%3D2019%26volume%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/medium/jm-2017-00098k_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00098&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/medium/jm-2017-00098k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Newly designed scaffold for QC inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00098&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/medium/jm-2017-00098k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the Alkyl D-Region<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00098&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) bromoalkyl derivatives, K<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C, 1 h for <b>25</b>, <b>26</b>, and <b>28</b>; (b) DMF, base (piperidine, morpholine, 1-methylpiperazine, or <i>N</i>-Boc piperazine), heat; (c) 4-(hydroxyalkyl)piperidine, DEAD, PPh<sub>3</sub>, DCM, r.t., 2 h; (d) TFA, DCM, r.t., overnight; (e) (HCHO)<sub>n</sub>, ZnCl<sub>2</sub>, DCM, r.t., 1 h; then NaBH<sub>4</sub>, reflux, overnight; (f) N<sub>2</sub>H<sub>4</sub>·H<sub>2</sub>O, EtOH, r.t., overnight; (g) 2-nitrobenzenesulfonyl chloride, TEA, DCM, r.t., 5 h; (h) CH<sub>3</sub>I, NaH, THF, r.t., overnight; (i) thiophenol, K<sub>2</sub>CO<sub>3</sub>, MeCN, r.t., overnight; (j) Boc<sub>2</sub>O, Et<sub>3</sub>N, DCM, r.t., 2 h; (k) HO(CH)<sub>2</sub>N(CH<sub>3</sub>)Boc, DEAD, PPh<sub>3</sub>, DCM, r.t., 2 h for <b>27</b>.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/medium/jm-2017-00098k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the Aryl D-Region<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00098&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CuI, Pd(PPh<sub>3</sub>)<sub>4</sub>, Et<sub>3</sub>N, DCM, 50 °C, overnight or alkyn-1-ol, DMF, Et<sub>3</sub>N, (Ph<sub>3</sub>P)<sub>2</sub>PdCl<sub>2</sub>, CuI, r.t., 15 h; (b) Pd/C, MeOH, H<sub>2</sub>, r.t., overnight; (c) 4-nitroguaiacol, DEAD, PPh<sub>3</sub>, DCM, r.t., 2 h; (d) HCOONH<sub>4</sub>, Zn, MeOH, r.t., 15 min; (e) 4-nitroguaiacol, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C; (f) Boc<sub>2</sub>O, Et<sub>3</sub>N, DCM, r.t., overnight.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/medium/jm-2017-00098k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the Aryl D-Region<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00098&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) bromoalkane derivatives or diethylcarbonate, <i>n</i>-BuLi, THF, −78 °C; (b) 4-nitroguaiacol, K<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C, 1 h or 4-nitroguaiacol, DEAD, Ph<sub>3</sub>P, DCM, r.t.; (c) Boc<sub>2</sub>O, <i>t</i>-BuOH, r.t., overnight; (d) TBAF, THF, r.t., 2 h; (e) LAH, THF, 0 °C, 1 h.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/medium/jm-2017-00098k_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0010.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Final QC Inhibitors<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00098&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd/C, H<sub>2</sub>, MeOH, r.t., overnight; (b) 3-(5-methyl-1<i>H</i>-imidazol-1-yl)propan-1-amine, TCDI, Et<sub>3</sub>N, DCM, r.t.–40 °C, overnight; (c) TFA, DCM, r.t., 2 h; (d) 2-chloropyrimidine derivatives, EtOH, Et<sub>3</sub>N, reflux, 2 days; (e) (HCHO)<sub>n</sub>, ZnCl<sub>2</sub>, DCM, r.t., 1 h; then NaBH<sub>4</sub>, reflux, overnight; (f) Ac<sub>2</sub>O, pyridine, MC, r.t., 4–5 h; (g) N<sub>2</sub>H<sub>4</sub>·H<sub>2</sub>O, EtOH, r.t., overnight; (h) 1<i>H</i>-pyrazole-1-carboxamidine-HCl, <i>i</i>Pr<sub>2</sub>EtN, MeOH, r.t.–50 °C, 2 h.</p></p></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/medium/jm-2017-00098k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Inhibition of QC in acute AD model mice showing percent inhibition of the formation of human Aβ<sub>N3pE−40</sub> levels in the brain after (a) deep cortical/hippocampus injection (10 mM); (b) i.p. injection of each inhibitor (25 mg/kg). Data were analyzed by One-way ANOVA with a Bonferroni posthoc test in SPSS. (*, <i>p</i> < 0.05; **, <i>p</i> < 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00098&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/medium/jm-2017-00098k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Inhibition of the formation of human Aβ<sub>N3pE−42</sub> and Aβ<sub>1–42</sub> in APP/PS1 mice. (a) Brain concentrations of Aβ<sub>N3pE−42</sub>; (b) brain concentrations of Aβ<sub>1–42</sub>. Data were analyzed by unpaired <i>t</i> test or one-way ANOVA. (ns, <i>p</i> > 0.05; *, <i>p</i> < 0.05; **, <i>p</i> < 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00098&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/medium/jm-2017-00098k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of compound <b>212</b> on the cognitive function of 5XFAD mice. (a) Escape latency of each group in the hidden-platform training of the Morris water maze. Data were analyzed by two-way repeated-measures ANOVA. (b) Percentage of time spent in the target quadrant. Data were analyzed by independent samples <i>t</i> test in SPSS. (ns, <i>p</i> > 0.05; *, <i>p</i> < 0.05).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00098&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/medium/jm-2017-00098k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Docked and refined structure of <b>191</b> in <i>h</i>QC. (A) Binding interactions of <b>191</b> at the active site of <i>h</i>QC. <b>191</b> is displayed as sticks with magenta carbon atoms, and Zn<sup>2+</sup> is a purple ball. The interacting residues are depicted as light blue sticks. Hydrogen bonds are depicted as black dashed lines. (B) 2D representation of the interactions of <b>191</b> with the active site residues of the <i>h</i>QC. Hydrophobic interactions are marked in light brown. Hydrogen bonds are shown as red-dotted arrows with their directionality. The π–π stacking interaction is marked as a blue disc and arrow, and the salt bridge interaction is displayed as a blue wedged line.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00098&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/medium/jm-2017-00098k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0006.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Docked and refined structures of <b>212</b> in <i>h</i>QC. Binding interactions of <b>212</b> in (A) neutral form and (B) protonated form at the active site of the <i>h</i>QC. <b>212</b> is represented in sticks with cyan carbon atoms, and Zn<sup>2+</sup> is a purple ball. The interacting residues are depicted as light blue sticks. Hydrogen bonds are depicted as black dashed lines. 2D representation of <b>212</b> interactions in (C) neutral form and (D) protonated form with the active site of <i>h</i>QC. Hydrophobic interactions are marked in light brown. Hydrogen bonds are shown as red- and green-dotted arrows with their directionality. The π–π stacking interaction is marked as a blue disc and arrow, and the salt bridge interaction is displayed as a blue wedged line.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.7b00098/20170317/images/large/jm-2017-00098k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00098&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i97">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27021" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27021" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 44 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span><span class="refDoi"> DOI: 10.1126/science.1072994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+progress+and+problems+on+the+road+to+therapeutics&doi=10.1126%2Fscience.1072994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0lhZ1kw0GDZZFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520progress%2520and%2520problems%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356%26doi%3D10.1126%2Fscience.1072994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Bishop, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, S. R.</span><span> </span><span class="NLM_article-title">Physiological roles of amyloid-beta and implications for its removal in Alzheimer’s disease</span> <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">630</span><span class="refDoi"> DOI: 10.2165/00002512-200421100-00001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.2165%2F00002512-200421100-00001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=15287821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvFOlu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2004&pages=621-630&author=G.+M.+Bishopauthor=S.+R.+Robinson&title=Physiological+roles+of+amyloid-beta+and+implications+for+its+removal+in+Alzheimer%E2%80%99s+disease&doi=10.2165%2F00002512-200421100-00001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Physiological roles of amyloid-β and implications for its removal in Alzheimer's disease</span></div><div class="casAuthors">Bishop, Glenda M.; Robinson, Stephen R.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & Aging</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">621-630</span>CODEN:
                <span class="NLM_cas:coden">DRAGE6</span>;
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review.  The underlying pathol. cause of Alzheimer's disease has been postulated to be an excess of amyloid-β (Aβ) which aggregates into toxic fibrillar deposits within the extracellular space of the brain, thereby disrupting neuronal and synaptic function and eventually leading to neuronal degeneration and dementia.  As a result, therapeutic strategies have been developed that are designed to remove Aβ from the brain.  Caution needs to be exercised concerning such strategies because, in addn. to its presence in neuritic plaques, Aβ has a widespread distribution through the brain and body, even in cognitively normal individuals.  Evidence indicates that instead of being a toxic peptide, sol. Aβ serves a variety of physiol. functions, including modulation of synaptic function, facilitation of neuronal growth and survival, protection against oxidative stress, and surveillance against neuroactive compds., toxins and pathogens.  These physiol. functions must be taken into account when strategies are developed to reduce Aβ load in Alzheimer's disease.  Ideally, such strategies should target forms of Aβ that are not bioavailable, such as fibrillar Aβ, or forms that are regarded to be overexpressed in Alzheimer's disease (such as oligomers) while leaving normal sol. Aβ1-40 and Aβ1-42 intact.  At present none of the available therapeutic strategies appears to have such selectivity.  Until these tech. limitations and the uncertainties regarding the effect of depletion of Aβ from the brain are resolved, it would not be prudent to begin further clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfnaDxhoWFObVg90H21EOLACvtfcHk0lhZ1kw0GDZZFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvFOlu7w%253D&md5=d00dcf814a383fecc05e767a6e54af1f</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2165%2F00002512-200421100-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002512-200421100-00001%26sid%3Dliteratum%253Aachs%26aulast%3DBishop%26aufirst%3DG.%2BM.%26aulast%3DRobinson%26aufirst%3DS.%2BR.%26atitle%3DPhysiological%2520roles%2520of%2520amyloid-beta%2520and%2520implications%2520for%2520its%2520removal%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DDrugs%2520Aging%26date%3D2004%26volume%3D21%26spage%3D621%26epage%3D630%26doi%3D10.2165%2F00002512-200421100-00001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Puzzo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span> </span><span class="NLM_article-title">Amyloid-beta peptide: Dr. Jekyll or Mr. Hyde?</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S111</span><span class="NLM_x">–</span> <span class="NLM_lpage">120</span><span class="refDoi"> DOI: 10.3233/JAD-2012-129033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.3233%2FJAD-2012-129033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=S111-120&issue=Suppl+1&author=D.+Puzzoauthor=O.+Arancio&title=Amyloid-beta+peptide%3A+Dr.+Jekyll+or+Mr.+Hyde%3F&doi=10.3233%2FJAD-2012-129033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3233%2FJAD-2012-129033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2012-129033%26sid%3Dliteratum%253Aachs%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DAmyloid-beta%2520peptide%253A%2520Dr.%2520Jekyll%2520or%2520Mr.%2520Hyde%253F%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2013%26volume%3D33%26issue%3DSuppl%25201%26spage%3DS111%26epage%3D120%26doi%3D10.3233%2FJAD-2012-129033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Lopez-Toledano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelanski, M. L.</span><span> </span><span class="NLM_article-title">Neurogenic effect of beta-amyloid peptide in the development of neural stem cells</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">5439</span><span class="NLM_x">–</span> <span class="NLM_lpage">5444</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.0974-04.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1523%2FJNEUROSCI.0974-04.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=15190117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltFCgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=5439-5444&author=M.+A.+Lopez-Toledanoauthor=M.+L.+Shelanski&title=Neurogenic+effect+of+beta-amyloid+peptide+in+the+development+of+neural+stem+cells&doi=10.1523%2FJNEUROSCI.0974-04.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Neurogenic effect of β-amyloid peptide in the development of neural stem cells</span></div><div class="casAuthors">Lopez-Toledano, Miguel A.; Shelanski, Michael L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5439-5444</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The adult mammalian brain contains neural stem cells (NSCs) with self-renewal and multilineage potential in the hippocampus and subventricular zone.  However, neurogenesis from these areas does not compensate for neuronal loss in age-related neurodegenerative disorders such as Alzheimer's disease (AD).  To test whether an impairment of neurogenesis could contribute to the pathogenesis of AD, we examd. the effects of amyloid-β peptide (Aβ) on the survival and neuronal differentiation of cultured NSCs from striatum and hippocampus.  We show that Aβ peptide does not impair the neurogenic rate in NSC progeny, but that it increases the total no. of neurons in vitro in a dose-dependent manner.  The neurogenic effect of Aβ peptide is not dependent on sol. factors released from the NSC progeny.  Neurogenesis is induced by Aβ42 and not Aβ40 or Aβ 25-35, and the activity appears to be a property of Aβ oligomers and not fibrils.  These results suggest that Aβ may have pos. as well as deleterious actions, and that a knowledge of the mechanisms involved in the former could be valuable in exploiting the regenerative and plastic potential of the brain in preventing and treating Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4XsvDahB767Vg90H21EOLACvtfcHk0lgnYvFQCbHZtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltFCgu78%253D&md5=904d3e58af4a01cb63667474f308f20b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0974-04.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0974-04.2004%26sid%3Dliteratum%253Aachs%26aulast%3DLopez-Toledano%26aufirst%3DM.%2BA.%26aulast%3DShelanski%26aufirst%3DM.%2BL.%26atitle%3DNeurogenic%2520effect%2520of%2520beta-amyloid%2520peptide%2520in%2520the%2520development%2520of%2520neural%2520stem%2520cells%26jtitle%3DJ.%2520Neurosci.%26date%3D2004%26volume%3D24%26spage%3D5439%26epage%3D5444%26doi%3D10.1523%2FJNEUROSCI.0974-04.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Yankner, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffy, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirschner, D. A.</span><span> </span><span class="NLM_article-title">Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">250</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span><span class="refDoi"> DOI: 10.1126/science.2218531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1126%2Fscience.2218531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=2218531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADyaK3MXlslansg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=250&publication_year=1990&pages=279-282&author=B.+A.+Yanknerauthor=L.+K.+Duffyauthor=D.+A.+Kirschner&title=Neurotrophic+and+neurotoxic+effects+of+amyloid+beta+protein%3A+reversal+by+tachykinin+neuropeptides&doi=10.1126%2Fscience.2218531"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotrophic and neurotoxic effects of amyloid β protein:  reversal by tachykinin neuropeptides</span></div><div class="casAuthors">Yankner, Bruce A.; Duffy, Lawrence K.; Kirschner, Daniel A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">250</span>
        (<span class="NLM_cas:issue">4978</span>),
    <span class="NLM_cas:pages">279-82</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">In culture, the amyloid β protein was neurotrophic to undifferentiated hippocampal neurons at low concns. and neurotoxic to mature neurons at higher concns.  In differentiated neurons, amyloid β protein caused dendritic and axonal retraction followed by neuronal death.  A portion of the amyloid β protein (amino acids 25 to 35) mediated both the trophic and toxic effects and was homologous to the tachykinin neuropeptide family.  The effects of the amyloid β protein were mimicked by tachykinin neuropeptide family.  The effects of the amyloid β protein were mimicked by tachykinin antagonists and completely reversed by specific tachykinin agonists.  Thus, the amyloid β protein could function as a neurotrophic factor for differentiating neurons, but at high concns. in mature neurons, as in Alzheimer's disease, could cause neuronal degeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJRCaiy24wQ7Vg90H21EOLACvtfcHk0lgnYvFQCbHZtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlslansg%253D%253D&md5=fbfae857924c6783ceeee51926a077a3</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.2218531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.2218531%26sid%3Dliteratum%253Aachs%26aulast%3DYankner%26aufirst%3DB.%2BA.%26aulast%3DDuffy%26aufirst%3DL.%2BK.%26aulast%3DKirschner%26aufirst%3DD.%2BA.%26atitle%3DNeurotrophic%2520and%2520neurotoxic%2520effects%2520of%2520amyloid%2520beta%2520protein%253A%2520reversal%2520by%2520tachykinin%2520neuropeptides%26jtitle%3DScience%26date%3D1990%26volume%3D250%26spage%3D279%26epage%3D282%26doi%3D10.1126%2Fscience.2218531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Giuffrida, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caraci, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pignataro, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cataldo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Bona, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molinaro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pappalardo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmigiano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garozzo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoletti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzarelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copani, A.</span><span> </span><span class="NLM_article-title">Beta-amyloid monomers are neuroprotective</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">10582</span><span class="NLM_x">–</span> <span class="NLM_lpage">10587</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.1736-09.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1523%2FJNEUROSCI.1736-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=19710311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVyntr3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=10582-10587&author=M.+L.+Giuffridaauthor=F.+Caraciauthor=B.+Pignataroauthor=S.+Cataldoauthor=P.+De+Bonaauthor=V.+Brunoauthor=G.+Molinaroauthor=G.+Pappalardoauthor=A.+Messinaauthor=A.+Palmigianoauthor=D.+Garozzoauthor=F.+Nicolettiauthor=E.+Rizzarelliauthor=A.+Copani&title=Beta-amyloid+monomers+are+neuroprotective&doi=10.1523%2FJNEUROSCI.1736-09.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">β-Amyloid monomers are neuroprotective</span></div><div class="casAuthors">Giuffrida, Maria Laura; Caraci, Filippo; Pignataro, Bruno; Cataldo, Sebastiano; De Bona, Paolo; Bruno, Valeria; Molinaro, Gemma; Pappalardo, Giuseppe; Messina, Angela; Palmigiano, Angelo; Garozzo, Domenico; Nicoletti, Ferdinando; Rizzarelli, Enrico; Copani, Agata</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">10582-10587</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The 42-aa-long β-amyloid protein-Aβ1-42-is thought to play a central role in the pathogenesis of Alzheimer's disease (AD).  Data from AD brain, transgenic APP (amyloid precursor protein)-overexpressing mice, and neuronal cultures treated with synthetic Aβ peptides indicate that self-assocn. of Aβ1-42 monomers into sol. oligomers is required for neurotoxicity.  The function of monomeric Aβ1-42 is unknown.  The evidence that Aβ1-42 is present in the brain and CSF of normal individuals suggests that the peptide is physiol. active.  Here we show that synthetic Aβ1-42 monomers support the survival of developing neurons under conditions of trophic deprivation and protect mature neurons against excitotoxic death, a process that contributes to the overall neurodegeneration assocd. with AD.  The neuroprotective action of Aβ1-42 monomers was mediated by the activation of the PI-3-K (phosphatidylinositol-3-kinase) pathway, and involved the stimulation of IGF-1 (insulin-like growth factor-1) receptors and/or other receptors of the insulin superfamily.  Interestingly, monomers of Aβ1-42 carrying the Arctic mutation (E22G) assocd. with familiar AD were not neuroprotective.  We suggest that pathol. aggregation of Aβ1-42 may also cause neurodegeneration by depriving neurons of the protective activity of Aβ1-42 monomers.  This "loss-of-function" hypothesis of neuronal death should be taken into consideration when designing therapies aimed at reducing Aβ burden.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSmQtdvzLazLVg90H21EOLACvtfcHk0lgnYvFQCbHZtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVyntr3I&md5=bd2dd3dbe1b024d9457a5a9cdac6376f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1736-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1736-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DGiuffrida%26aufirst%3DM.%2BL.%26aulast%3DCaraci%26aufirst%3DF.%26aulast%3DPignataro%26aufirst%3DB.%26aulast%3DCataldo%26aufirst%3DS.%26aulast%3DDe%2BBona%26aufirst%3DP.%26aulast%3DBruno%26aufirst%3DV.%26aulast%3DMolinaro%26aufirst%3DG.%26aulast%3DPappalardo%26aufirst%3DG.%26aulast%3DMessina%26aufirst%3DA.%26aulast%3DPalmigiano%26aufirst%3DA.%26aulast%3DGarozzo%26aufirst%3DD.%26aulast%3DNicoletti%26aufirst%3DF.%26aulast%3DRizzarelli%26aufirst%3DE.%26aulast%3DCopani%26aufirst%3DA.%26atitle%3DBeta-amyloid%2520monomers%2520are%2520neuroprotective%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D10582%26epage%3D10587%26doi%3D10.1523%2FJNEUROSCI.1736-09.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Giuffrida, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caraci, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Bona, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pappalardo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoletti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzarelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copani, A.</span><span> </span><span class="NLM_article-title">The monomer state of beta-amyloid: where the Alzheimer’s disease protein meets physiology</span> <span class="citation_source-journal">Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span><span class="refDoi"> DOI: 10.1515/REVNEURO.2010.21.2.83</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1515%2FREVNEURO.2010.21.2.83" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=20614800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosVSmsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=83-93&author=M.+L.+Giuffridaauthor=F.+Caraciauthor=P.+De+Bonaauthor=G.+Pappalardoauthor=F.+Nicolettiauthor=E.+Rizzarelliauthor=A.+Copani&title=The+monomer+state+of+beta-amyloid%3A+where+the+Alzheimer%E2%80%99s+disease+protein+meets+physiology&doi=10.1515%2FREVNEURO.2010.21.2.83"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The monomer state of beta-amyloid: where the Alzheimer's disease protein meets physiology</span></div><div class="casAuthors">Giuffrida, M. L.; Caraci, F.; de Bona, P.; Pappalardo, G.; Nicoletti, F.; Rizzarelli, E.; Copani, A.</div><div class="citationInfo"><span class="NLM_cas:title">Reviews in the Neurosciences (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">83-93</span>CODEN:
                <span class="NLM_cas:coden">RNEUEO</span>;
        ISSN:<span class="NLM_cas:issn">0334-1763</span>.
    
            (<span class="NLM_cas:orgname">Freund & Pettman</span>)
        </div><div class="casAbstract">A review.  One hundred years of study have identified beta-Amyloid (Aβ) as the most interesting feature of Alzheimer's disease (AD).  Since the discovery of Aβ as the principal component of amyloid plaques, the central challenge in AD research has been the understanding of Aβ involvement in the neurodegenerative process of the disease.  The ability of Aβ to undergo conformational changes and subsequent aggregation has always been a limiting factor in finding out the activities of the peptide.  Extensive research has been carried out to study the mol. mechanisms of amyloid self-assembly.  The finding that sol. Aβ concns. in the brain are correlated with the severity of AD, whereas fibrillar d. is not /40,42/, has pointed attention toward the oligomeric forms of Aβ, which are generally considered the most toxic and, therefore, the most important species to be addressed.  Despite great efforts in basic AD research, none of the currently available treatments is able to treat the devastating effects of the disease, leading to the consideration that there is more to reason than just Aβ prodn. and aggregation.  Here we summarize the emerging evidence for the physiol. functions of Aβ, including our recent demonstration that Aβ monomers are endowed with neuroprotective activity, and propose that Aβ aggregation might contribute to AD pathol. through a "loss-of-function" process.  Finally, we discuss the current therapeutics targeting the cerebral load of Aβ and possible new ones aimed at preserving the biol. functions of Aβ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD_O2Wutn2VLVg90H21EOLACvtfcHk0ljCJvVfLrU0HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosVSmsb0%253D&md5=067db06db21cc4a0e987267b99e6ca0e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1515%2FREVNEURO.2010.21.2.83&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FREVNEURO.2010.21.2.83%26sid%3Dliteratum%253Aachs%26aulast%3DGiuffrida%26aufirst%3DM.%2BL.%26aulast%3DCaraci%26aufirst%3DF.%26aulast%3DDe%2BBona%26aufirst%3DP.%26aulast%3DPappalardo%26aufirst%3DG.%26aulast%3DNicoletti%26aufirst%3DF.%26aulast%3DRizzarelli%26aufirst%3DE.%26aulast%3DCopani%26aufirst%3DA.%26atitle%3DThe%2520monomer%2520state%2520of%2520beta-amyloid%253A%2520where%2520the%2520Alzheimer%25E2%2580%2599s%2520disease%2520protein%2520meets%2520physiology%26jtitle%3DRev.%2520Neurosci.%26date%3D2010%26volume%3D21%26spage%3D83%26epage%3D93%26doi%3D10.1515%2FREVNEURO.2010.21.2.83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Butterfield, D. A.</span><span> </span><span class="NLM_article-title">Amyloid beta-peptide (1–42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer’s disease brain. A review</span> <span class="citation_source-journal">Free Radical Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1307</span><span class="NLM_x">–</span> <span class="NLM_lpage">1313</span><span class="refDoi"> DOI: 10.1080/1071576021000049890</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1080%2F1071576021000049890" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=12607822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslamtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2002&pages=1307-1313&author=D.+A.+Butterfield&title=Amyloid+beta-peptide+%281%E2%80%9342%29-induced+oxidative+stress+and+neurotoxicity%3A+implications+for+neurodegeneration+in+Alzheimer%E2%80%99s+disease+brain.+A+review&doi=10.1080%2F1071576021000049890"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid β-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review</span></div><div class="casAuthors">Butterfield, D. Allan</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1307-1313</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1071-5762</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Oxidative stress, manifested by protein oxidn., lipid peroxidn., DNA oxidn. and 3-nitrotyrosine formation, among other indexes, is obsd. in Alzheimer's disease (AD) brain.  Amyloid β-peptide (1-42) [Aβ(1-42)] may be central to the pathogenesis of AD.  Our lab. and others have implicated Aβ(1-42)-induced free radical oxidative stress in the neurodegeneration obsd. in AD brain.  This paper reviews some of these studies from our lab.  Recently, we showed both in-vitro and in-vivo that methionine residue 35 (Met-35) of Aβ(1-42) was crit. to its oxidative stress and neurotoxic properties.  Because the C-terminal region of Aβ(1-42) is helical, and invoking the i + 4 rule of helixes, we hypothesized that the carboxyl oxygen of lle-31, known to be within a van der Waals distance of the S atom of Met-35, would interact with the latter.  This interaction could alter the susceptibility for oxidn. of Met-35, i.e. free radical formation.  Consistent with this hypothesis, substitution of lle-31 by the helix-breaking amino acid, proline, completely abrogated the oxidative stress and neurotoxic properties of Aβ(1-42).  Removal of the Met-35 residue from the lipid bilayer by substitution of the neg. charged Asp for Gly-37 abrogated oxidative stress and neurotoxic properties of Aβ(1-42).  The free radical scavenger vitamin E prevented Aβ (1-42)-induced ROS formation, protein oxidn., lipid peroxidn., and neurotoxicity in hippocampal neurons, consistent with our model for Aβ-assocd. free radical oxidative stress induced neurodegeneration in AD.  ApoE, allele 4, is a risk factor for AD.  Synaptosomes from apoE knock-out mice are more vulnerable to Aβ-induced oxidative stress (protein oxidn., lipid peroxidn., and ROS generation) than are those from wild-type mice.  We also studied synaptosomes from allele-specific human apoE knock-in mice.  Brain membranes from human apoE4 mice have greater vulnerability to Aβ(1-42)-induced oxidative stress than brain membranes from apoE2 or E3, assessed by the same indexes, consistent with the notion of a coupling of the oxidative environment in AD brain and increased risk of developing this disorder.  Using immunopptn. of proteins from AD and control brain obtained no longer than 4 h PMI, selective oxidized proteins were identified in the AD brain.  Creatine kinase (CK) and β-actin have increased carbonyl groups, an index of protein oxidn., and Glt-1, the principal glutamate transporter, has increased binding of the lipid peroxidn. product, 4-hydroxy-2-nonenal (HNE).  Aβ inhibits CK and causes lipid peroxidn., leading to HNE formation.  Implications of these findings relate to decreased energy utilization, altered assembly of cytoskeletal proteins, and increased excitotoxicity to neurons by glutamate, all reported for AD.  Other oxidatively modified proteins have been identified in AD brain by proteomics anal., and these oxidatively-modified proteins may be related to increased excitotoxicity (glutamine synthetase), aberrant proteasomal degrdn. of damaged or aggregated proteins (ubiquitin C-terminal hydrolase L-1), altered energy prodn. (α-enolase), and diminished growth cone elongation and directionality (dihydropyrimindase-related protein 2).  Taken together, these studies outlined above suggest that Met-35 is key to the oxidative stress and neurotoxic properties of Aβ(1-42) and may help explain the apoE allele dependence on risk for AD, some of the functional and structural alterations in AD brain, and strongly support a causative role of Aβ(1-42)-induced oxidative stress and neurodegeneration in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovbtGvhIQlIrVg90H21EOLACvtfcHk0ljCJvVfLrU0HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslamtA%253D%253D&md5=ad37b360cb8245ded7a9acad99e15b5e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1080%2F1071576021000049890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F1071576021000049890%26sid%3Dliteratum%253Aachs%26aulast%3DButterfield%26aufirst%3DD.%2BA.%26atitle%3DAmyloid%2520beta-peptide%2520%25281%25E2%2580%259342%2529-induced%2520oxidative%2520stress%2520and%2520neurotoxicity%253A%2520implications%2520for%2520neurodegeneration%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520brain.%2520A%2520review%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2002%26volume%3D36%26spage%3D1307%26epage%3D1313%26doi%3D10.1080%2F1071576021000049890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Baruch-Suchodolsky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, B.</span><span> </span><span class="NLM_article-title">Abeta40, either soluble or aggregated, is a remarkably potent antioxidant in cell-free oxidative systems</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4354</span><span class="NLM_x">–</span> <span class="NLM_lpage">4370</span><span class="refDoi"> DOI: 10.1021/bi802361k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi802361k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=4354-4370&author=R.+Baruch-Suchodolskyauthor=B.+Fischer&title=Abeta40%2C+either+soluble+or+aggregated%2C+is+a+remarkably+potent+antioxidant+in+cell-free+oxidative+systems&doi=10.1021%2Fbi802361k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fbi802361k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi802361k%26sid%3Dliteratum%253Aachs%26aulast%3DBaruch-Suchodolsky%26aufirst%3DR.%26aulast%3DFischer%26aufirst%3DB.%26atitle%3DAbeta40%252C%2520either%2520soluble%2520or%2520aggregated%252C%2520is%2520a%2520remarkably%2520potent%2520antioxidant%2520in%2520cell-free%2520oxidative%2520systems%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D4354%26epage%3D4370%26doi%3D10.1021%2Fbi802361k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Soscia, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washicosky, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingelsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, R. D.</span><span> </span><span class="NLM_article-title">The Alzheimer’s disease-associated amyloid beta-protein is an antimicrobial peptide</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e9505</span><span class="refDoi"> DOI: 10.1371/journal.pone.0009505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1371%2Fjournal.pone.0009505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=20209079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A280%3ADC%252BC3c7mtlCmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e9505&author=S.+J.+Sosciaauthor=J.+E.+Kirbyauthor=K.+J.+Washicoskyauthor=S.+M.+Tuckerauthor=M.+Ingelssonauthor=B.+Hymanauthor=M.+A.+Burtonauthor=L.+E.+Goldsteinauthor=S.+Duongauthor=R.+E.+Tanziauthor=R.+D.+Moir&title=The+Alzheimer%E2%80%99s+disease-associated+amyloid+beta-protein+is+an+antimicrobial+peptide&doi=10.1371%2Fjournal.pone.0009505"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide</span></div><div class="casAuthors">Soscia Stephanie J; Kirby James E; Washicosky Kevin J; Tucker Stephanie M; Ingelsson Martin; Hyman Bradley; Burton Mark A; Goldstein Lee E; Duong Scott; Tanzi Rudolph E; Moir Robert D</div><div class="citationInfo"><span class="NLM_cas:title">PloS one</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e9505</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The amyloid beta-protein (Abeta) is believed to be the key mediator of Alzheimer's disease (AD) pathology.  Abeta is most often characterized as an incidental catabolic byproduct that lacks a normal physiological role.  However, Abeta has been shown to be a specific ligand for a number of different receptors and other molecules, transported by complex trafficking pathways, modulated in response to a variety of environmental stressors, and able to induce pro-inflammatory activities.  METHODOLOGY/PRINCIPAL FINDINGS:  Here, we provide data supporting an in vivo function for Abeta as an antimicrobial peptide (AMP).  Experiments used established in vitro assays to compare antimicrobial activities of Abeta and LL-37, an archetypical human AMP.  Findings reveal that Abeta exerts antimicrobial activity against eight common and clinically relevant microorganisms with a potency equivalent to, and in some cases greater than, LL-37.  Furthermore, we show that AD whole brain homogenates have significantly higher antimicrobial activity than aged matched non-AD samples and that AMP action correlates with tissue Abeta levels.  Consistent with Abeta-mediated activity, the increased antimicrobial action was ablated by immunodepletion of AD brain homogenates with anti-Abeta antibodies.  CONCLUSIONS/SIGNIFICANCE:  Our findings suggest Abeta is a hitherto unrecognized AMP that may normally function in the innate immune system.  This finding stands in stark contrast to current models of Abeta-mediated pathology and has important implications for ongoing and future AD treatment strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRXGndyYusJ4Y2y4bB4mnvYfW6udTcc2eZhtwqBejnNh7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7mtlCmsA%253D%253D&md5=74845535cf4f072df2baa4bb7ab08bf8</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0009505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0009505%26sid%3Dliteratum%253Aachs%26aulast%3DSoscia%26aufirst%3DS.%2BJ.%26aulast%3DKirby%26aufirst%3DJ.%2BE.%26aulast%3DWashicosky%26aufirst%3DK.%2BJ.%26aulast%3DTucker%26aufirst%3DS.%2BM.%26aulast%3DIngelsson%26aufirst%3DM.%26aulast%3DHyman%26aufirst%3DB.%26aulast%3DBurton%26aufirst%3DM.%2BA.%26aulast%3DGoldstein%26aufirst%3DL.%2BE.%26aulast%3DDuong%26aufirst%3DS.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DMoir%26aufirst%3DR.%2BD.%26atitle%3DThe%2520Alzheimer%25E2%2580%2599s%2520disease-associated%2520amyloid%2520beta-protein%2520is%2520an%2520antimicrobial%2520peptide%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26spage%3De9505%26doi%3D10.1371%2Fjournal.pone.0009505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Larner, A. J.</span><span> </span><span class="NLM_article-title">Hypothesis: amyloid beta-peptides truncated at the N-terminus contribute to the pathogenesis of Alzheimer’s disease</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span><span class="refDoi"> DOI: 10.1016/S0197-4580(99)00014-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1016%2FS0197-4580%2899%2900014-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10466895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADyaK1MXlvVKnurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=65-69&author=A.+J.+Larner&title=Hypothesis%3A+amyloid+beta-peptides+truncated+at+the+N-terminus+contribute+to+the+pathogenesis+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0197-4580%2899%2900014-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Hypothesis: amyloid β-peptides truncated at the N-terminus contribute to the pathogenesis of Alzheimer's disease</span></div><div class="casAuthors">Larner, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-69</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Fragments of amyloid β-peptide truncated at the N-terminus are present in AD brain early in the course of Alzheimer's disease.  It is proposed that these species contribute to the pathogenesis of AD, possibly through destabilization of elements of the neuronal cytoskeleton by small fibrillar deposits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVBDWqVDUChLVg90H21EOLACvtfcHk0liZ1ssPQoUBZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvVKnurw%253D&md5=c6fc637848837e8d6b797073966df531</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0197-4580%2899%2900014-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0197-4580%252899%252900014-7%26sid%3Dliteratum%253Aachs%26aulast%3DLarner%26aufirst%3DA.%2BJ.%26atitle%3DHypothesis%253A%2520amyloid%2520beta-peptides%2520truncated%2520at%2520the%2520N-terminus%2520contribute%2520to%2520the%2520pathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D1999%26volume%3D20%26spage%3D65%26epage%3D69%26doi%3D10.1016%2FS0197-4580%2899%2900014-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Kumar-Singh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Jonghe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruts, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderstichele, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lofgren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderhoeven, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backhovens, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanmechelen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroisel, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Broeckhoven, C.</span><span> </span><span class="NLM_article-title">Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase site mutation points to an essential role for N-truncated A beta(42) in Alzheimer’s disease</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2589</span><span class="NLM_x">–</span> <span class="NLM_lpage">2598</span><span class="refDoi"> DOI: 10.1093/hmg/9.18.2589</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1093%2Fhmg%2F9.18.2589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=11063718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVKktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2000&pages=2589-2598&author=S.+Kumar-Singhauthor=C.+De+Jongheauthor=M.+Crutsauthor=R.+Kleinertauthor=R.+Wangauthor=M.+Merckenauthor=B.+De+Strooperauthor=H.+Vandersticheleauthor=A.+Lofgrenauthor=I.+Vanderhoevenauthor=H.+Backhovensauthor=E.+Vanmechelenauthor=P.+M.+Kroiselauthor=C.+Van+Broeckhoven&title=Nonfibrillar+diffuse+amyloid+deposition+due+to+a+gamma%2842%29-secretase+site+mutation+points+to+an+essential+role+for+N-truncated+A+beta%2842%29+in+Alzheimer%E2%80%99s+disease&doi=10.1093%2Fhmg%2F9.18.2589"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Nonfibrillar diffuse amyloid deposition due to a γ42-secretase site mutation points to an essential role for N-truncated Aβ42 in Alzheimer's disease</span></div><div class="casAuthors">Kumar-Singh, Samir; De Jonghe, Chris; Cruts, Marc; Kleinert, Reinhold; Wang, Rong; Mercken, Marc; De Strooper, Bart; Vanderstichele, Hugo; Lofgren, Ann; Vanderhoeven, Inge; Backhovens, Hubert; Vanmechelen, Eugeen; Kroisel, Peter M.; Van Broeckhoven, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2589-2598</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Amyloidogenic processing of the amyloid precursor protein (APP) with deposition in brain of the 42-amino acid long amyloid β-peptide (Aβ42) is considered central to Alzheimer's disease (AD) pathol.  However, it is generally believed that nonfibrillar pre-amyloid Aβ42 deposits have to mature in the presence of Aβ40 into fibrillar amyloid plaques to cause neurodegeneration.  Here, an aggressive form of AD is shown to be caused by a novel missense mutation in APP (T714I) directly involving γ-secretase cleavages of APP.  The mutation had the most drastic effect on Aβ42/Aβ40 ratio in vitro of ∼11-fold, simultaneously increasing Aβ42 and decreasing Aβ40 secretion, as measured by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.  This coincided in brain with deposition of abundant and predominant nonfibrillar pre-amyloid plaques composed primarily of N-truncated Aβ42 in complete absence of Aβ40.  These data indicate that N-truncated Aβ42 as diffuse nonfibrillar plaques has an essential but undermined role in AD pathol.  Importantly, inhibiting secretion of full-length Aβ42 by therapeutic targeting of APP processing should not result in secretion of an equally toxic N-truncated Aβ42.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbZLr8Yf4DdbVg90H21EOLACvtfcHk0liZ1ssPQoUBZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVKktL0%253D&md5=49e857dfb99cefd1e71df74cfd407fd1</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F9.18.2589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F9.18.2589%26sid%3Dliteratum%253Aachs%26aulast%3DKumar-Singh%26aufirst%3DS.%26aulast%3DDe%2BJonghe%26aufirst%3DC.%26aulast%3DCruts%26aufirst%3DM.%26aulast%3DKleinert%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DVanderstichele%26aufirst%3DH.%26aulast%3DLofgren%26aufirst%3DA.%26aulast%3DVanderhoeven%26aufirst%3DI.%26aulast%3DBackhovens%26aufirst%3DH.%26aulast%3DVanmechelen%26aufirst%3DE.%26aulast%3DKroisel%26aufirst%3DP.%2BM.%26aulast%3DVan%2BBroeckhoven%26aufirst%3DC.%26atitle%3DNonfibrillar%2520diffuse%2520amyloid%2520deposition%2520due%2520to%2520a%2520gamma%252842%2529-secretase%2520site%2520mutation%2520points%2520to%2520an%2520essential%2520role%2520for%2520N-truncated%2520A%2520beta%252842%2529%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2000%26volume%3D9%26spage%3D2589%26epage%3D2598%26doi%3D10.1093%2Fhmg%2F9.18.2589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Miravalle, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calero, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roher, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghetti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, R.</span><span> </span><span class="NLM_article-title">Amino-terminally truncated Abeta peptide species are the main component of cotton wool plaques</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">10810</span><span class="NLM_x">–</span> <span class="NLM_lpage">10821</span><span class="refDoi"> DOI: 10.1021/bi0508237</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0508237" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsVynsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=10810-10821&author=L.+Miravalleauthor=M.+Caleroauthor=M.+Takaoauthor=A.+E.+Roherauthor=B.+Ghettiauthor=R.+Vidal&title=Amino-terminally+truncated+Abeta+peptide+species+are+the+main+component+of+cotton+wool+plaques&doi=10.1021%2Fbi0508237"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Amino-Terminally Truncated Aβ Peptide Species Are the Main Component of Cotton Wool Plaques</span></div><div class="casAuthors">Miravalle, Leticia; Calero, Miguel; Takao, Masaki; Roher, Alex E.; Ghetti, Bernardino; Vidal, Ruben</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">10810-10821</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cotton wool plaques (CWPs) are round lesions that lack a central amyloid core.  CWPs have been obsd. in individuals affected by early-onset familial Alzheimer disease (FAD) assocd. with mutations in the presenilin 1 (PSEN1) gene.  Here we present the characterization of the amyloid-β (Aβ) peptides deposited in the brain of an individual affected by FAD carrying the novel missense (V261I) mutation in the PSEN1 gene.  Matrix-assisted laser desorption ionization time-of-flight mass spectrometry was used to det. the Aβ peptide species present in the cerebral and cerebellar cortexes, in leptomeningeal vessels, and in CWPs isolated by laser microdissection (LMD).  Our results indicate that amino-terminally truncated Aβ peptide species ending at residues 42 and 43 are the main Aβ peptides deposited in brain parenchyma and LMD-CWPs in assocn. with the PSEN1 V261I mutation.  Full-length Aβ1-42 and Aβ1-43 peptide species were underrepresented.  CWPs were not found to be assocd. with vessels and did not contain Aβ1-40 peptides, the main component of the vascular deposits.  Although Aβ deposits were present mostly in the form of CWPs in the cerebral cortex and as diffuse deposits in the cerebellar cortex, a similar array of amino-terminally truncated Aβ peptide species was seen in both cases.  The biochem. data support the concept that parenchymal and vascular amyloid deposits are assocd. with a different array of Aβ peptide species.  The generation and parenchymal deposition of highly insol. amino-terminally truncated Aβ peptides may play an important role in the pathogenesis of AD and must be taken into consideration in developing new diagnostic and therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAq_XS9LmMPrVg90H21EOLACvtfcHk0ljwAzvaCcg0KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsVynsrY%253D&md5=15b5a7a7cc10e2f4013b40f344988c81</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fbi0508237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0508237%26sid%3Dliteratum%253Aachs%26aulast%3DMiravalle%26aufirst%3DL.%26aulast%3DCalero%26aufirst%3DM.%26aulast%3DTakao%26aufirst%3DM.%26aulast%3DRoher%26aufirst%3DA.%2BE.%26aulast%3DGhetti%26aufirst%3DB.%26aulast%3DVidal%26aufirst%3DR.%26atitle%3DAmino-terminally%2520truncated%2520Abeta%2520peptide%2520species%2520are%2520the%2520main%2520component%2520of%2520cotton%2520wool%2520plaques%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D10810%26epage%3D10821%26doi%3D10.1021%2Fbi0508237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Jawhar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirths, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayer, T. A.</span><span> </span><span class="NLM_article-title">Pyroglutamate amyloid-beta (Abeta): a hatchet man in Alzheimer disease</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">38825</span><span class="NLM_x">–</span> <span class="NLM_lpage">38832</span><span class="refDoi"> DOI: 10.1074/jbc.R111.288308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1074%2Fjbc.R111.288308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=21965666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSqt7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=38825-38832&author=S.+Jawharauthor=O.+Wirthsauthor=T.+A.+Bayer&title=Pyroglutamate+amyloid-beta+%28Abeta%29%3A+a+hatchet+man+in+Alzheimer+disease&doi=10.1074%2Fjbc.R111.288308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamate amyloid-β (Aβ): a hatchet man in Alzheimer disease</span></div><div class="casAuthors">Jawhar, Sadim; Wirths, Oliver; Bayer, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">38825-38832</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  Pyroglutamate-modified amyloid-β (AβpE3) peptides are gaining considerable attention as potential key participants in the pathol. of Alzheimer disease (AD) due to their abundance in AD brain, high aggregation propensity, stability, and cellular toxicity.  Transgenic mice that produce high levels of AβpE3-42 show severe neuron loss.  Recent in vitro and in vivo expts. have proven that the enzyme glutaminyl cyclase catalyzes the formation of AβpE3.  In this minireview, we summarize the current knowledge on AβpE3, discussing its discovery, biochem. properties, mol. events detg. formation, prevalence in the brains of AD patients, Alzheimer mouse models, and potential as a target for therapy and as a diagnostic marker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9SRHPGwO6ErVg90H21EOLACvtfcHk0lisFBOQY-Uo0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSqt7vE&md5=e7b0363724dd2e7cbbfc2071abdc8241</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R111.288308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R111.288308%26sid%3Dliteratum%253Aachs%26aulast%3DJawhar%26aufirst%3DS.%26aulast%3DWirths%26aufirst%3DO.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26atitle%3DPyroglutamate%2520amyloid-beta%2520%2528Abeta%2529%253A%2520a%2520hatchet%2520man%2520in%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D38825%26epage%3D38832%26doi%3D10.1074%2Fjbc.R111.288308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Saido, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawashima, S.</span><span> </span><span class="NLM_article-title">Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">466</span><span class="refDoi"> DOI: 10.1016/0896-6273(95)90301-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1016%2F0896-6273%2895%2990301-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=7857653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADyaK2MXjvFejsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1995&pages=457-466&author=T.+C.+Saidoauthor=T.+Iwatsuboauthor=D.+M.+Mannauthor=H.+Shimadaauthor=Y.+Iharaauthor=S.+Kawashima&title=Dominant+and+differential+deposition+of+distinct+beta-amyloid+peptide+species%2C+A+beta+N3%28pE%29%2C+in+senile+plaques&doi=10.1016%2F0896-6273%2895%2990301-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Dominant and differential deposition of distinct β-amyloid peptide species, AβN3(pE), in senile plaques</span></div><div class="casAuthors">Saido, Takaomi C.; Iwatsubo, Takeshi; Mann, David M. A.; Shimada, Hiroyuki; Ihara, Yasuo; Kawashima, Selichi</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">457-66</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We analyzed an amino-terminal modification of β-amyloid (Aβ) peptide in brain, using anti-Aβ antibodies that distinguish distinct mol. species.  Examn. of cortical sections from 28 aged individuals with a wide range in senile plaque d. revealed that a mol. species distinct from the std. Aβ is deposited in the brain in a dominant and differential manner.  This modified Aβ peptide (AβN3(pE)) starts at the 3rd amino-terminal residue of the std. αβ, glutamate, converted to pyroglutamate through intramol. dehydration.  Because plaques composed of αβN3(pE) are present in equiv. or greater densities than those composed of std. Aβ bearing the first amino-terminal residue (AβN1) and because deposition of the former species appears to precede deposition of the latter, as confirmed with specimens from Down's syndrome patients, the processes involved in AβNe(pE) prodn. and retention may play an early and crit. role in senile plaque formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEs7XnR_KCcbVg90H21EOLACvtfcHk0lisFBOQY-Uo0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjvFejsLk%253D&md5=8405ddfabcebe721ccd5b1dc1e222069</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2F0896-6273%2895%2990301-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0896-6273%252895%252990301-1%26sid%3Dliteratum%253Aachs%26aulast%3DSaido%26aufirst%3DT.%2BC.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DMann%26aufirst%3DD.%2BM.%26aulast%3DShimada%26aufirst%3DH.%26aulast%3DIhara%26aufirst%3DY.%26aulast%3DKawashima%26aufirst%3DS.%26atitle%3DDominant%2520and%2520differential%2520deposition%2520of%2520distinct%2520beta-amyloid%2520peptide%2520species%252C%2520A%2520beta%2520N3%2528pE%2529%252C%2520in%2520senile%2520plaques%26jtitle%3DNeuron%26date%3D1995%26volume%3D14%26spage%3D457%26epage%3D466%26doi%3D10.1016%2F0896-6273%2895%2990301-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Schlenzig, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manhart, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cinar, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinschmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hause, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willbold, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funke, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span> </span><span class="NLM_article-title">Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7072</span><span class="NLM_x">–</span> <span class="NLM_lpage">7078</span><span class="refDoi"> DOI: 10.1021/bi900818a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi900818a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnvFWkurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=7072-7078&author=D.+Schlenzigauthor=S.+Manhartauthor=Y.+Cinarauthor=M.+Kleinschmidtauthor=G.+Hauseauthor=D.+Willboldauthor=S.+A.+Funkeauthor=S.+Schillingauthor=H.+U.+Demuth&title=Pyroglutamate+formation+influences+solubility+and+amyloidogenicity+of+amyloid+peptides&doi=10.1021%2Fbi900818a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamate Formation Influences Solubility and Amyloidogenicity of Amyloid Peptides</span></div><div class="casAuthors">Schlenzig, Dagmar; Manhart, Susanne; Cinar, Yeliz; Kleinschmidt, Martin; Hause, Gerd; Willbold, Dieter; Funke, Susanne Aileen; Schilling, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">7072-7078</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Terminally truncated and pyroglutamate (pGlu) modified amyloid β (Aβ) peptides are major constituents of amyloid deposits in sporadic and inherited Alzheimer's disease (AD).  Formation of pGlu at the N-terminus confers resistance against cleavage by most aminopeptidases, increases toxicity of the peptides, and may seed Aβ aggregate formation.  Similarly, the deposited amyloid peptides ABri and ADan, which cause a very similar histopathol. in familial British dementia (FBD) and familial Danish dementia (FDD), are N-terminally blocked by pGlu.  Triggered by the coincidence of pGlu-modified amyloid peptides and similar pathol. in AD, FBD, and FDD, we investigated the impact of N-terminal pGlu on biochem. and biophys. properties of Aβ, ABri, and ADan.  N-Terminal pGlu increases the hydrophobicity and changes the pH-dependent soly. profile, rendering the pGlu-modified peptides less sol. in the basic pH range.  The pGlu residue increases the aggregation propensity of all amyloid peptides as evidenced by ThT fluorescence assays and dynamic light scattering.  The far-UV CD spectroscopic anal. points toward an enhanced β-sheet structure of the pGlu-Aβ.  Importantly, changes in fibril morphol. are clearly caused by the N-terminal pGlu, resulting in the formation of short fibers, which are frequently arranged in bundles.  The effect of pGlu on the morphol. is virtually indistinguishable between ABri, ADan, and Aβ.  The data provide evidence for a comparable influence of the pGlu modification on the aggregation process of structurally different amyloid peptides, thus likely contributing to the molecularly distinct neurodegenerative diseases AD, FBD, and FDD.  The main driving force for the aggregation is apparently an increase in the hydrophobicity and thus an accelerated seed formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo01m64gYKSRLVg90H21EOLACvtfcHk0lisFBOQY-Uo0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnvFWkurk%253D&md5=f32a500d5c6e5f44fa2809256c8a90ca</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fbi900818a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi900818a%26sid%3Dliteratum%253Aachs%26aulast%3DSchlenzig%26aufirst%3DD.%26aulast%3DManhart%26aufirst%3DS.%26aulast%3DCinar%26aufirst%3DY.%26aulast%3DKleinschmidt%26aufirst%3DM.%26aulast%3DHause%26aufirst%3DG.%26aulast%3DWillbold%26aufirst%3DD.%26aulast%3DFunke%26aufirst%3DS.%2BA.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DPyroglutamate%2520formation%2520influences%2520solubility%2520and%2520amyloidogenicity%2520of%2520amyloid%2520peptides%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D7072%26epage%3D7078%26doi%3D10.1021%2Fbi900818a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Russo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Violani, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venezia, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolcini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damonte, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benatti, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arrigo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrone, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schettini, G.</span><span> </span><span class="NLM_article-title">Pyroglutamate-modified amyloid beta-peptides--AbetaN3(pE)--strongly affect cultured neuron and astrocyte survival</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">1480</span><span class="NLM_x">–</span> <span class="NLM_lpage">1489</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.2002.01107.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1046%2Fj.1471-4159.2002.01107.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=12354296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsV2hs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2002&pages=1480-1489&author=C.+Russoauthor=E.+Violaniauthor=S.+Salisauthor=V.+Veneziaauthor=V.+Dolciniauthor=G.+Damonteauthor=U.+Benattiauthor=C.+D%E2%80%99Arrigoauthor=E.+Patroneauthor=P.+Carloauthor=G.+Schettini&title=Pyroglutamate-modified+amyloid+beta-peptides%2D%2DAbetaN3%28pE%29%2D%2Dstrongly+affect+cultured+neuron+and+astrocyte+survival&doi=10.1046%2Fj.1471-4159.2002.01107.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamate-modified amyloid β-peptides - AβN3(pE) -strongly affect cultured neuron and astrocyte survival</span></div><div class="casAuthors">Russo, Claudio; Violani, Elisabetta; Salis, Serena; Venezia, Valentina; Dolcini, Virginia; Damonte, Gianluca; Benatti, Umberto; D'Arrigo, Cristina; Patrone, Eligio; Carlo, Pia; Schettini, Gennaro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1480-1489</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">N-terminally truncated amyloid-β (Aβ) peptides are present in early and diffuse plaques of individuals with Alzheimer's disease (AD), are overproduced in early onset familial AD and their amt. seems to be directly correlated to the severity and the progression of the disease in AD and Down's syndrome (DS).  The pyroglutamate-contg. isoforms at position 3 [AβN3(pE)-40/42] represent the prominent form among the N-truncated species, and may account for more than 50% of Aβ accumulated in plaques.  In this study, the authors compared the toxic properties, fibrillogenic capabilities, and in vitro degrdn. profile of Aβ1-40, Aβ1-42, AβN3(pE)-40 and AβN3(pE)-42.  The authors' data show that fiber morphol. of Aβ peptides is greatly influenced by the C-terminus while toxicity, interaction with cell membranes and degrdn. are influenced by the N-terminus.  AβN3(pE)-40 induced significantly more cell loss than the other species both in neuronal and glial cell cultures.  Aggregated AβN3(pE) peptides were heavily distributed on plasma membrane and within the cytoplasm of treated cells.  AβN3(pE)-40/42 peptides showed a significant resistance to degrdn. by cultured astrocytes, while full-length peptides resulted partially degraded.  These findings suggest that formation of N-terminally modified peptides may enhance β-amyloid aggregation and toxicity, likely worsening the onset and progression of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR0uvn5GQRVLVg90H21EOLACvtfcHk0ljQYqeMK8H1xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsV2hs7g%253D&md5=41ad79cbdbb8f5debcec7c93035a709d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2002.01107.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2002.01107.x%26sid%3Dliteratum%253Aachs%26aulast%3DRusso%26aufirst%3DC.%26aulast%3DViolani%26aufirst%3DE.%26aulast%3DSalis%26aufirst%3DS.%26aulast%3DVenezia%26aufirst%3DV.%26aulast%3DDolcini%26aufirst%3DV.%26aulast%3DDamonte%26aufirst%3DG.%26aulast%3DBenatti%26aufirst%3DU.%26aulast%3DD%25E2%2580%2599Arrigo%26aufirst%3DC.%26aulast%3DPatrone%26aufirst%3DE.%26aulast%3DCarlo%26aufirst%3DP.%26aulast%3DSchettini%26aufirst%3DG.%26atitle%3DPyroglutamate-modified%2520amyloid%2520beta-peptides--AbetaN3%2528pE%2529--strongly%2520affect%2520cultured%2520neuron%2520and%2520astrocyte%2520survival%26jtitle%3DJ.%2520Neurochem.%26date%3D2002%26volume%3D82%26spage%3D1480%26epage%3D1489%26doi%3D10.1046%2Fj.1471-4159.2002.01107.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">He, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrow, C. J.</span><span> </span><span class="NLM_article-title">The A beta 3-pyroglutamyl and 11-pyroglutamyl peptides found in senile plaque have greater beta-sheet forming and aggregation propensities in vitro than full-length A beta</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">10871</span><span class="NLM_x">–</span> <span class="NLM_lpage">10877</span><span class="refDoi"> DOI: 10.1021/bi990563r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi990563r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADyaK1MXltFSltbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=10871-10877&author=W.+Heauthor=C.+J.+Barrow&title=The+A+beta+3-pyroglutamyl+and+11-pyroglutamyl+peptides+found+in+senile+plaque+have+greater+beta-sheet+forming+and+aggregation+propensities+in+vitro+than+full-length+A+beta&doi=10.1021%2Fbi990563r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The Aβ 3-Pyroglutamyl and 11-Pyroglutamyl Peptides Found in Senile Plaque Have Greater β-Sheet Forming and Aggregation Propensities in Vitro than Full-Length Aβ</span></div><div class="casAuthors">He, Weilan; Barrow, Colin J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">10871-10877</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aβ isolated from neuritic plaque and vascular walls of the brains of patients with Alzheimer's disease has been shown to contain significant quantities of Aβ peptides which begin at residue 3Glu or 11Glu in the form of pyroglutamyl residues (Aβ3pE and Aβ11pE).  To investigate the effects of these N-terminal modifications on the biophys. properties of Aβ, peptides Aβ1-40, Aβ3pE-40, Aβ11pE-40, Aβ1-28, Aβ3pE-28, and Aβ11pE-28 were synthesized.  Using CD spectroscopy, we detd. that the pyroglutamyl-contg. peptides form β-sheet structure more readily than the corresponding full-length Aβ peptides, both in aq. solns. and in 10% SDS micelles.  Trifluoroethanol spectra indicated that the relative β-sheet to α-helical stability is higher for the pyroglutamyl-contg. peptides.  Sedimentation expts. show that the pyroglutamyl-contg. peptides have greater aggregation propensities than the corresponding full-length peptides.  Comparison between the Aβ40 and the Aβ28 series indicated that the greater β-sheet forming and aggregation propensities of the pyroglutamyl peptides are not simply due to an increase in hydrophobicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5xcOsA5djELVg90H21EOLACvtfcHk0ljQYqeMK8H1xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltFSltbk%253D&md5=edb7b92c11ef110e8d87d397b7531a8d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fbi990563r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi990563r%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DW.%26aulast%3DBarrow%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520A%2520beta%25203-pyroglutamyl%2520and%252011-pyroglutamyl%2520peptides%2520found%2520in%2520senile%2520plaque%2520have%2520greater%2520beta-sheet%2520forming%2520and%2520aggregation%2520propensities%2520in%2520vitro%2520than%2520full-length%2520A%2520beta%26jtitle%3DBiochemistry%26date%3D1999%26volume%3D38%26spage%3D10871%26epage%3D10877%26doi%3D10.1021%2Fbi990563r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Nussbaum, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cynis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wangsanut, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tayler, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiltgen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronicke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reymann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutter-Paier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexandru, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagla, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graubner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glabe, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloom, G. S.</span><span> </span><span class="NLM_article-title">Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-beta</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">485</span><span class="NLM_x">, </span> <span class="NLM_fpage">651</span><span class="NLM_x">–</span> <span class="NLM_lpage">655</span><span class="refDoi"> DOI: 10.1038/nature11060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1038%2Fnature11060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=22660329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVymsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=485&publication_year=2012&pages=651-655&author=J.+M.+Nussbaumauthor=S.+Schillingauthor=H.+Cynisauthor=A.+Silvaauthor=E.+Swansonauthor=T.+Wangsanutauthor=K.+Taylerauthor=B.+Wiltgenauthor=A.+Hatamiauthor=R.+Ronickeauthor=K.+Reymannauthor=B.+Hutter-Paierauthor=A.+Alexandruauthor=W.+Jaglaauthor=S.+Graubnerauthor=C.+G.+Glabeauthor=H.+U.+Demuthauthor=G.+S.+Bloom&title=Prion-like+behaviour+and+tau-dependent+cytotoxicity+of+pyroglutamylated+amyloid-beta&doi=10.1038%2Fnature11060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Prion-like behavior and tau-dependent cytotoxicity of pyroglutamylated amyloid-β</span></div><div class="casAuthors">Nussbaum, Justin M.; Schilling, Stephan; Cynis, Holger; Silva, Antonia; Swanson, Eric; Wangsanut, Tanaporn; Tayler, Kaycie; Wiltgen, Brian; Hatami, Asa; Roenicke, Raik; Reymann, Klaus; Hutter-Paier, Birgit; Alexandru, Anca; Jagla, Wolfgang; Graubner, Sigrid; Glabe, Charles G.; Demuth, Hans-Ulrich; Bloom, George S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">485</span>
        (<span class="NLM_cas:issue">7400</span>),
    <span class="NLM_cas:pages">651-655</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Extracellular plaques of amyloid-β and intraneuronal neurofibrillary tangles made from tau are the histopathol. signatures of Alzheimer's disease.  Plaques comprise amyloid-β fibrils that assemble from monomeric and oligomeric intermediates, and are prognostic indicators of Alzheimer's disease.  Despite the importance of plaques to Alzheimer's disease, oligomers are considered to be the principal toxic forms of amyloid-β.  Interestingly, many adverse responses to amyloid-β, such as cytotoxicity, microtubule loss, impaired memory and learning, and neuritic degeneration, are greatly amplified by tau expression.  Amino-terminally truncated, pyroglutamylated (pE) forms of amyloid-β are strongly assocd. with Alzheimer's disease, are more toxic than amyloid-β, residues 1-42 (Aβ1-42) and Aβ1-40, and have been proposed as initiators of Alzheimer's disease pathogenesis.  Here we report a mechanism by which pE-Aβ may trigger Alzheimer's disease.  Aβ3(pE)-42 co-oligomerizes with excess Aβ1-42 to form metastable low-n oligomers (LNOs) that are structurally distinct and far more cytotoxic to cultured neurons than comparable LNOs made from Aβ1-42 alone.  Tau is required for cytotoxicity, and LNOs comprising 5% Aβ3(pE)-42 plus 95% Aβ1-42 (5% pE-Aβ) seed new cytotoxic LNOs through multiple serial dilns. into Aβ1-42 monomers in the absence of addnl. Aβ3(pE)-42.  LNOs isolated from human Alzheimer's disease brain contained Aβ3(pE)-42, and enhanced Aβ3(pE)-42 formation in mice triggered neuron loss and gliosis at 3 mo, but not in a tau-null background.  We conclude that Aβ3(pE)-42 confers tau-dependent neuronal death and causes template-induced misfolding of Aβ1-42 into structurally distinct LNOs that propagate by a prion-like mechanism.  Our results raise the possibility that Aβ3(pE)-42 acts similarly at a primary step in Alzheimer's disease pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotg6vra9ty9rVg90H21EOLACvtfcHk0ljQYqeMK8H1xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVymsbc%253D&md5=67ba093a16fe5db1bea9f3873bd92ee5</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnature11060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11060%26sid%3Dliteratum%253Aachs%26aulast%3DNussbaum%26aufirst%3DJ.%2BM.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DSilva%26aufirst%3DA.%26aulast%3DSwanson%26aufirst%3DE.%26aulast%3DWangsanut%26aufirst%3DT.%26aulast%3DTayler%26aufirst%3DK.%26aulast%3DWiltgen%26aufirst%3DB.%26aulast%3DHatami%26aufirst%3DA.%26aulast%3DRonicke%26aufirst%3DR.%26aulast%3DReymann%26aufirst%3DK.%26aulast%3DHutter-Paier%26aufirst%3DB.%26aulast%3DAlexandru%26aufirst%3DA.%26aulast%3DJagla%26aufirst%3DW.%26aulast%3DGraubner%26aufirst%3DS.%26aulast%3DGlabe%26aufirst%3DC.%2BG.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DBloom%26aufirst%3DG.%2BS.%26atitle%3DPrion-like%2520behaviour%2520and%2520tau-dependent%2520cytotoxicity%2520of%2520pyroglutamylated%2520amyloid-beta%26jtitle%3DNature%26date%3D2012%26volume%3D485%26spage%3D651%26epage%3D655%26doi%3D10.1038%2Fnature11060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Busby, W. H.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humm, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youngblood, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kizer, J. S.</span><span> </span><span class="NLM_article-title">An enzyme(s) that converts glutaminyl-peptides into pyroglutamyl-peptides. Presence in pituitary, brain, adrenal medulla, and lymphocytes</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">262</span><span class="NLM_x">, </span> <span class="NLM_fpage">8532</span><span class="NLM_x">–</span> <span class="NLM_lpage">8536</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=3597387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADyaL2sXlt12lsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=262&publication_year=1987&pages=8532-8536&author=W.+H.+Busbyauthor=G.+E.+Quackenbushauthor=J.+Hummauthor=W.+W.+Youngbloodauthor=J.+S.+Kizer&title=An+enzyme%28s%29+that+converts+glutaminyl-peptides+into+pyroglutamyl-peptides.+Presence+in+pituitary%2C+brain%2C+adrenal+medulla%2C+and+lymphocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">An enzyme(s) that converts glutaminyl-peptides into pyroglutamyl-peptides.  Presence in pituitary, brain, adrenal medulla, and lymphocytes</span></div><div class="casAuthors">Busby, Walker H., Jr.; Quackenbush, Gail E.; Humm, Jane; Youngblood, William W.; Kizer, John S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">262</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8532-6</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The mechanism for the post-translational conversion of glutamine to pyroglutamic acid on the N-terminus of newly synthesized peptides and proteins is unknown.  An assay is reported here that permits measurement of the rate of conversion of Gln-His-Pro-NH2 to <Glu-His-Pro-NH2 (TRH), where <Glu is pyroglutamate.  Using this assay, it was demonstrated that the spontaneous cyclization of the N-terminal glutamine of this peptide occurs only slowly under physiol. conditions.  Furthermore, the presence in rat brain, porcine pituitary, and human B lymphocytes of a glutaminyl-peptide cyclase which converts Gln-His-Pro-NH2 into <Glu-His-Pro-NH2, is described.  The enzyme(s) appears to be a glycoprotein, is maximally active at neutral pH, has a mol. wt. of 55,000, and contains catalytically significant SH groups.  The product of the enzymic reaction was confirmed by high-resoln. fast atom bombardment-mass spectrometry.  In preliminary studies, it was found that >90% of the enzyme in bovine adrenal medulla is contained in the sol. chromaffin vesicle fraction.  These findings indicate that in vivo the post-translational conversion of a glutaminyl-peptide into a pyroglutamyl-peptide is neither spontaneous nor abiotic as has been previously proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRgXDyJEuhjrVg90H21EOLACvtfcHk0lhivtH_HNftuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXlt12lsLs%253D&md5=8a8b35c61b2c94f4437fd06fc400656e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBusby%26aufirst%3DW.%2BH.%26aulast%3DQuackenbush%26aufirst%3DG.%2BE.%26aulast%3DHumm%26aufirst%3DJ.%26aulast%3DYoungblood%26aufirst%3DW.%2BW.%26aulast%3DKizer%26aufirst%3DJ.%2BS.%26atitle%3DAn%2520enzyme%2528s%2529%2520that%2520converts%2520glutaminyl-peptides%2520into%2520pyroglutamyl-peptides.%2520Presence%2520in%2520pituitary%252C%2520brain%252C%2520adrenal%2520medulla%252C%2520and%2520lymphocytes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1987%26volume%3D262%26spage%3D8532%26epage%3D8536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Bockers, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreutz, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pohl, T.</span><span> </span><span class="NLM_article-title">Glutaminyl-cyclase expression in the bovine/porcine hypothalamus and pituitary</span> <span class="citation_source-journal">J. Neuroendocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">–</span> <span class="NLM_lpage">453</span><span class="refDoi"> DOI: 10.1111/j.1365-2826.1995.tb00780.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1111%2Fj.1365-2826.1995.tb00780.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=7550291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A280%3ADyaK28%252FgvVSkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1995&pages=445-453&author=T.+M.+Bockersauthor=M.+R.+Kreutzauthor=T.+Pohl&title=Glutaminyl-cyclase+expression+in+the+bovine%2Fporcine+hypothalamus+and+pituitary&doi=10.1111%2Fj.1365-2826.1995.tb00780.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl-cyclase expression in the bovine/porcine hypothalamus and pituitary</span></div><div class="casAuthors">Bockers T M; Kreutz M R; Pohl T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroendocrinology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">445-53</span>
        ISSN:<span class="NLM_cas:issn">0953-8194</span>.
    </div><div class="casAbstract">The expression of the glutaminyl cyclase (QC), an enzyme responsible for the post-translational modification of N-terminal pyroglutamyl residues of neuropeptide precursors, was examined in bovine/porcine hypothalamic and pituitary tissue by means of immunocytochemistry and in situ hybridization.  In the anterior pituitary a distinct pattern of QC immunoreactivity and mRNA expression was found associated exclusively with somatotrophs.  In corticotrophs of the pars intermedia QC expression was undetectable, whereas a small portion of putative pars tuberalis cells in the rostral part of the pars distalis were heavily labelled.  The neurointermediate lobe was devoid of signals for QC mRNA, but showed significant QC-immunoreactivity on secretory granules of axonal nerve endings.  Also nuclei of the hypothalamus were found to be positive for QC-immunoreactivity.  Intense labelling was observed in the nucleus supraopticus and nucleus paraventricularis.  Staining of the nucleus periventricularis was found to be moderate, whereas no labelling of perikarya in the nucleus arcuatus, the preoptic area and the nucleus suprachiasmaticus was detectable.  Moreover, varicose fibers stained positive for QC-immunoreactivity and could be identified in the main transport route from the hypothalamus to the pars neuronalis (tractus hypothalamo hypophysialis).  These results suggest that the enzyme is transported via the same routes as its substrate/product to the median eminence or the neural lobe.  Furthermore, the mapping of the cellular QC distribution reveals a strikingly distinctive expression pattern, that should be useful for the identification of yet undiscovered places of peptide synthesis and processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTvTdinpe-TVvEeosoOnpOLfW6udTcc2eY4uQsaPyHjvrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28%252FgvVSkuw%253D%253D&md5=623044c0c3d4e838cf9b833b04722f41</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2826.1995.tb00780.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2826.1995.tb00780.x%26sid%3Dliteratum%253Aachs%26aulast%3DBockers%26aufirst%3DT.%2BM.%26aulast%3DKreutz%26aufirst%3DM.%2BR.%26aulast%3DPohl%26aufirst%3DT.%26atitle%3DGlutaminyl-cyclase%2520expression%2520in%2520the%2520bovine%252Fporcine%2520hypothalamus%2520and%2520pituitary%26jtitle%3DJ.%2520Neuroendocrinol.%26date%3D1995%26volume%3D7%26spage%3D445%26epage%3D453%26doi%3D10.1111%2Fj.1365-2826.1995.tb00780.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Pohl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mugele, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiess, J.</span><span> </span><span class="NLM_article-title">Primary structure and functional expression of a glutaminyl cyclase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">10059</span><span class="NLM_x">–</span> <span class="NLM_lpage">10063</span><span class="refDoi"> DOI: 10.1073/pnas.88.22.10059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1073%2Fpnas.88.22.10059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1946423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADyaK3sXhvVCnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1991&pages=10059-10063&author=T.+Pohlauthor=M.+Zimmerauthor=K.+Mugeleauthor=J.+Spiess&title=Primary+structure+and+functional+expression+of+a+glutaminyl+cyclase&doi=10.1073%2Fpnas.88.22.10059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Primary structure and functional expression of a glutaminyl cyclase</span></div><div class="casAuthors">Pohl, Thomas; Zimmer, Michael; Mugele, Katrin; Spiess, Joachim</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10059-63</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">A glutaminyl cyclase (QC) that is probably involved in the biosynthesis of pyroglutamyl peptides such as gonadotropin-releasing hormone and TSH-releasing hormone has been purified to homogeneity from bovine anterior pituitary.  On the basis of N-terminal sequence anal., a 2088-base-pair cDNA clone was isolated from a bovine anterior pituitary library.  From the nucleotide sequence of this clone, the primary structure of a 330-residue protein and a preceding 31-residue prepropeptide sequence was deduced.  By transfection of COS-7 monkey cells with a QC cDNA/pCDM8 vector construct, QC activity was expressed.  Hybridization with mRNAs of various bovine tissues revealed expression of QC mainly in brain tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdQGThtNPlPLVg90H21EOLACvtfcHk0lhivtH_HNftuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhvVCnsQ%253D%253D&md5=3d0e422d9b00b1184d8646c5a12bf353</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1073%2Fpnas.88.22.10059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.88.22.10059%26sid%3Dliteratum%253Aachs%26aulast%3DPohl%26aufirst%3DT.%26aulast%3DZimmer%26aufirst%3DM.%26aulast%3DMugele%26aufirst%3DK.%26aulast%3DSpiess%26aufirst%3DJ.%26atitle%3DPrimary%2520structure%2520and%2520functional%2520expression%2520of%2520a%2520glutaminyl%2520cyclase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1991%26volume%3D88%26spage%3D10059%26epage%3D10063%26doi%3D10.1073%2Fpnas.88.22.10059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Morawski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreuzberger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waniek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jager, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cynis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehlen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arendt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartlage-Rubsamen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossner, S.</span><span> </span><span class="NLM_article-title">Glutaminyl cyclase in human cortex: correlation with (pGlu)-amyloid-beta load and cognitive decline in Alzheimer’s disease</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.3233%2FJAD-131535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=24164736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFKls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=385-400&author=M.+Morawskiauthor=S.+Schillingauthor=M.+Kreuzbergerauthor=A.+Waniekauthor=C.+Jagerauthor=B.+Kochauthor=H.+Cynisauthor=A.+Kehlenauthor=T.+Arendtauthor=M.+Hartlage-Rubsamenauthor=H.+U.+Demuthauthor=S.+Rossner&title=Glutaminyl+cyclase+in+human+cortex%3A+correlation+with+%28pGlu%29-amyloid-beta+load+and+cognitive+decline+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl Cyclase in Human Cortex: Correlation with (pGlu)-Amyloid-β Load and Cognitive Decline in Alzheimer's Disease</span></div><div class="casAuthors">Morawski, Markus; Schilling, Stephan; Kreuzberger, Moritz; Waniek, Alexander; Jaeger, Carsten; Koch, Birgit; Cynis, Holger; Kehlen, Astrid; Arendt, Thomas; Hartlage-Ruebsamen, Maike; Demuth, Hans-Ulrich; Rossner, Steffen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">385-400</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Brains of Alzheimer's disease (AD) patients are characterized in part by the formation of high mol. wt. aggregates of amyloid-β (Aβ) peptides, which interfere with neuronal function and provoke neuronal cell death.  The pyroglutamate (pGlu) modification of Aβ was demonstrated to be catalyzed by the enzyme glutaminyl cyclase (QC) and to enhance pathogenicity and neurotoxicity.  Here, we addressed the role of QC in AD pathogenesis in human cortex.  Two sets of human postmortem brain tissue from a total of 13 non-demented controls and 11 AD cases were analyzed by immunohistochem. and unbiased stereol., quant. RT-PCR, and enzymic activity assays for the expression level of QC in temporal and entorhinal cortex.  Addnl., cortical Aβ and pGlu-Aβ concns. were quantified by ELISA.  Data on QC expression and Aβ peptide concns. were correlated with each other and with the Mini-Mental State Examn. (MMSE) of individual cases.  In control cases, QC expression was higher in the more vulnerable entorhinal cortex than in temporal cortex.  In AD brains, QC mRNA expression and the immunoreactivity of QC were increased in both cortical regions and frequently assocd. with pGlu-Aβ deposits.  The analyses of individual cases revealed significant correlations between QC mRNA levels and the concn. of insol. pGlu-Aβ aggregates, but not of unmodified Aβ peptides.  Elevated pGlu-Aβ load showed a better correlation with the decline in MMSE than elevated concn. of unmodified Aβ.  Our observations provide evidence for an involvement of QC in AD pathogenesis and cognitive decline by QC-catalyzed pGlu-Aβ formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS8tVHNEV2BbVg90H21EOLACvtfcHk0lhIRIeAQ_Rnjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFKls7k%253D&md5=6500fe542f7ccbc6b61c9a4c862cde6d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.3233%2FJAD-131535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-131535%26sid%3Dliteratum%253Aachs%26aulast%3DMorawski%26aufirst%3DM.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DKreuzberger%26aufirst%3DM.%26aulast%3DWaniek%26aufirst%3DA.%26aulast%3DJager%26aufirst%3DC.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DArendt%26aufirst%3DT.%26aulast%3DHartlage-Rubsamen%26aufirst%3DM.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DRossner%26aufirst%3DS.%26atitle%3DGlutaminyl%2520cyclase%2520in%2520human%2520cortex%253A%2520correlation%2520with%2520%2528pGlu%2529-amyloid-beta%2520load%2520and%2520cognitive%2520decline%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2014%26volume%3D39%26spage%3D385%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeitschel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehlen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutter-Paier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokesch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windisch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagla, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlenzig, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cynis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montag, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossner, S.</span><span> </span><span class="NLM_article-title">Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer’s disease-like pathology</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1106</span><span class="NLM_x">–</span> <span class="NLM_lpage">1111</span><span class="refDoi"> DOI: 10.1038/nm.1872</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1038%2Fnm.1872" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=18836460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Slu7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1106-1111&author=S.+Schillingauthor=U.+Zeitschelauthor=T.+Hoffmannauthor=U.+Heiserauthor=M.+Franckeauthor=A.+Kehlenauthor=M.+Holzerauthor=B.+Hutter-Paierauthor=M.+Prokeschauthor=M.+Windischauthor=W.+Jaglaauthor=D.+Schlenzigauthor=C.+Lindnerauthor=T.+Rudolphauthor=G.+Reuterauthor=H.+Cynisauthor=D.+Montagauthor=H.+U.+Demuthauthor=S.+Rossner&title=Glutaminyl+cyclase+inhibition+attenuates+pyroglutamate+Abeta+and+Alzheimer%E2%80%99s+disease-like+pathology&doi=10.1038%2Fnm.1872"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease-like pathology</span></div><div class="casAuthors">Schilling, Stephan; Zeitschel, Ulrike; Hoffmann, Torsten; Heiser, Ulrich; Francke, Mike; Kehlen, Astrid; Holzer, Max; Hutter-Paier, Birgit; Prokesch, Manuela; Windisch, Manfred; Jagla, Wolfgang; Schlenzig, Dagmar; Lindner, Christiane; Rudolph, Thomas; Reuter, Gunter; Cynis, Holger; Montag, Dirk; Demuth, Hans-Ulrich; Rossner, Steffen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1106-1111</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Because of their abundance, resistance to proteolysis, rapid aggregation and neurotoxicity, N-terminally truncated and, in particular, pyroglutamate (pE)-modified Aβ peptides have been suggested as being important in the initiation of pathol. cascades resulting in the development of Alzheimer's disease.  We found that the N-terminal pE-formation is catalyzed by glutaminyl cyclase in vivo.  Glutaminyl cyclase expression was upregulated in the cortices of individuals with Alzheimer's disease and correlated with the appearance of pE-modified Aβ.  Oral application of a glutaminyl cyclase inhibitor resulted in reduced Aβ3(pE)-42 burden in two different transgenic mouse models of Alzheimer's disease and in a new Drosophila model.  Treatment of mice was accompanied by redns. in Aβx-40/42, diminished plaque formation and gliosis and improved performance in context memory and spatial learning tests.  These observations are consistent with the hypothesis that Aβ3(pE)-42 acts as a seed for Aβ aggregation by self-aggregation and co-aggregation with Aβ1-40/42.  Therefore, Aβ3(pE)-40/42 peptides seem to represent Aβ forms with exceptional potency for disturbing neuronal function.  The redn. of brain pE-Aβ by inhibition of glutaminyl cyclase offers a new therapeutic option for the treatment of Alzheimer's disease and provides implications for other amyloidoses, such as familial Danish dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQl4XiuOJSmrVg90H21EOLACvtfcHk0lhIRIeAQ_Rnjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Slu7zL&md5=30f8f53b27c6c9580fe71f867e1ab670</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnm.1872&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.1872%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DZeitschel%26aufirst%3DU.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DFrancke%26aufirst%3DM.%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DHolzer%26aufirst%3DM.%26aulast%3DHutter-Paier%26aufirst%3DB.%26aulast%3DProkesch%26aufirst%3DM.%26aulast%3DWindisch%26aufirst%3DM.%26aulast%3DJagla%26aufirst%3DW.%26aulast%3DSchlenzig%26aufirst%3DD.%26aulast%3DLindner%26aufirst%3DC.%26aulast%3DRudolph%26aufirst%3DT.%26aulast%3DReuter%26aufirst%3DG.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DMontag%26aufirst%3DD.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DRossner%26aufirst%3DS.%26atitle%3DGlutaminyl%2520cyclase%2520inhibition%2520attenuates%2520pyroglutamate%2520Abeta%2520and%2520Alzheimer%25E2%2580%2599s%2520disease-like%2520pathology%26jtitle%3DNat.%2520Med.%26date%3D2008%26volume%3D14%26spage%3D1106%26epage%3D1111%26doi%3D10.1038%2Fnm.1872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Jawhar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirths, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graubner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayer, T. A.</span><span> </span><span class="NLM_article-title">Overexpression of glutaminyl cyclase, the enzyme responsible for pyroglutamate A{beta} formation, induces behavioral deficits, and glutaminyl cyclase knock-out rescues the behavioral phenotype in 5XFAD mice</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">4454</span><span class="NLM_x">–</span> <span class="NLM_lpage">4460</span><span class="refDoi"> DOI: 10.1074/jbc.M110.185819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1074%2Fjbc.M110.185819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=21148560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFGltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=4454-4460&author=S.+Jawharauthor=O.+Wirthsauthor=S.+Schillingauthor=S.+Graubnerauthor=H.+U.+Demuthauthor=T.+A.+Bayer&title=Overexpression+of+glutaminyl+cyclase%2C+the+enzyme+responsible+for+pyroglutamate+A%7Bbeta%7D+formation%2C+induces+behavioral+deficits%2C+and+glutaminyl+cyclase+knock-out+rescues+the+behavioral+phenotype+in+5XFAD+mice&doi=10.1074%2Fjbc.M110.185819"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of Glutaminyl Cyclase, the Enzyme Responsible for Pyroglutamate Aβ Formation, Induces Behavioral Deficits, and Glutaminyl Cyclase Knock-out Rescues the Behavioral Phenotype in 5XFAD Mice</span></div><div class="casAuthors">Jawhar, Sadim; Wirths, Oliver; Schilling, Stephan; Graubner, Sigrid; Demuth, Hans-Ulrich; Bayer, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4454-4460</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Pyroglutamate-modified Aβ (AβpE3-42) peptides are gaining considerable attention as potential key players in the pathol. of Alzheimer disease (AD) due to their abundance in AD brain, high aggregation propensity, stability, and cellular toxicity.  Overexpressing AβpE3-42 induced a severe neuron loss and neurol. phenotype in TBA2 mice.  In vitro and in vivo expts. have recently proven that the enzyme glutaminyl cyclase (QC) catalyzes the formation of AβpE3-42.  The aim of the present work was to analyze the role of QC in an AD mouse model with abundant AβpE3-42 formation. 5XFAD mice were crossed with transgenic mice expressing human QC (hQC) under the control of the Thy1 promoter. 5XFAD/hQC bigenic mice showed significant elevation in TBS, SDS, and formic acid-sol. AβpE3-42 peptides and aggregation in plaques.  In 6-mo-old 5XFAD/hQC mice, a significant motor and working memory impairment developed compared with 5XFAD.  The contribution of endogenous QC was studied by generating 5XFAD/QC-KO mice (mouse QC knock-out). 5XFAD/QC-KO mice showed a significant rescue of the wild-type mice behavioral phenotype, demonstrating the important contribution of endogenous mouse QC and transgenic overexpressed QC.  These data clearly demonstrate that QC is crucial for modulating AβpE3-42 levels in vivo and prove on a genetic base the concept that redn. of QC activity is a promising new therapeutic approach for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMeSo62btLh7Vg90H21EOLACvtfcHk0liud02jO-oarA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFGltL8%253D&md5=7b704a92ffab37146126e9d101df9a1e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.185819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.185819%26sid%3Dliteratum%253Aachs%26aulast%3DJawhar%26aufirst%3DS.%26aulast%3DWirths%26aufirst%3DO.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DGraubner%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26atitle%3DOverexpression%2520of%2520glutaminyl%2520cyclase%252C%2520the%2520enzyme%2520responsible%2520for%2520pyroglutamate%2520A%257Bbeta%257D%2520formation%252C%2520induces%2520behavioral%2520deficits%252C%2520and%2520glutaminyl%2520cyclase%2520knock-out%2520rescues%2520the%2520behavioral%2520phenotype%2520in%25205XFAD%2520mice%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D4454%26epage%3D4460%26doi%3D10.1074%2Fjbc.M110.185819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cynis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagla, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Horsten, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span> </span><span class="NLM_article-title">Inhibition of glutaminyl cyclase prevents pGlu-Abeta formation after intracortical/hippocampal microinjection in vivo/in situ</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">1225</span><span class="NLM_x">–</span> <span class="NLM_lpage">1236</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2008.05471.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1111%2Fj.1471-4159.2008.05471.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=18627432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsFOis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2008&pages=1225-1236&author=S.+Schillingauthor=T.+Applauthor=T.+Hoffmannauthor=H.+Cynisauthor=K.+Schulzauthor=W.+Jaglaauthor=D.+Friedrichauthor=M.+Wermannauthor=M.+Buchholzauthor=U.+Heiserauthor=S.+von+Horstenauthor=H.+U.+Demuth&title=Inhibition+of+glutaminyl+cyclase+prevents+pGlu-Abeta+formation+after+intracortical%2Fhippocampal+microinjection+in+vivo%2Fin+situ&doi=10.1111%2Fj.1471-4159.2008.05471.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of glutaminyl cyclase prevents pGlu-Aβ formation after intracortical/hippocampal microinjection in vivo/in situ</span></div><div class="casAuthors">Schilling, Stephan; Appl, Thomas; Hoffmann, Torsten; Cynis, Holger; Schulz, Katrin; Jagla, Wolfgang; Friedrich, Daniel; Wermann, Michael; Buchholz, Mirko; Heiser, Ulrich; von Hoersten, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1225-1236</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Modified amyloid β (Aβ) peptides represent major constituents of the amyloid deposits in Alzheimer's disease and Down's syndrome.  In particular, N-terminal pyroglutamate (pGlu) following truncation renders Aβ more stable, increases hydrophobicity and the aggregation velocity.  Recent evidence based on in vitro studies suggests that the cyclization of glutamic acid, leading to pGlu-Aβ, is catalyzed by the enzyme glutaminyl cyclase (QC) following limited proteolysis of Aβ at the N-terminus.  Here, we studied the pGlu-formation by rat QC in vitro as well as after microinjection of Aβ(1-40) and Aβ(3-40) into the rat cortex in vivo/in situ with and without pharmacol. QC inhibition.  Significant pGlu-Aβ formation was obsd. following injection of Aβ(3-40) after 24 h, indicating a catalyzed process.  The generation of pGlu-Aβ from Aβ(3-40) was significantly inhibited by intracortical microinjection of a QC inhibitor.  The study provides first evidence that generation of pGlu-Aβ is a QC-catalyzed process in vivo.  The approach per se offers a strategy for a rapid evaluation of compds. targeting a redn. of pGlu formation at the N-terminus of amyloid peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIz9fnOIjlVbVg90H21EOLACvtfcHk0liud02jO-oarA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsFOis7Y%253D&md5=8450718510d281c928abaa1e20a870ad</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2008.05471.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2008.05471.x%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DAppl%26aufirst%3DT.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DSchulz%26aufirst%3DK.%26aulast%3DJagla%26aufirst%3DW.%26aulast%3DFriedrich%26aufirst%3DD.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3Dvon%2BHorsten%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DInhibition%2520of%2520glutaminyl%2520cyclase%2520prevents%2520pGlu-Abeta%2520formation%2520after%2520intracortical%252Fhippocampal%2520microinjection%2520in%2520vivo%252Fin%2520situ%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D106%26spage%3D1225%26epage%3D1236%26doi%3D10.1111%2Fj.1471-4159.2008.05471.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Lues, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bühring, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kühn-Wache, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manhart, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pokorny, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiesa, J.</span><span> </span><span class="NLM_article-title">A phase 1 study to evaluate the safety and pharmacokinetics of PQ912, a glutaminyl cyclase inhibitor, in healthy subjects</span> <span class="citation_source-journal">Alzheimer’s Dement.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span><span class="refDoi"> DOI: 10.1016/j.trci.2015.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1016%2Fj.trci.2015.08.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=182-195&author=I.+Luesauthor=F.+Weberauthor=A.+Meyerauthor=U.+B%C3%BChringauthor=T.+Hoffmannauthor=K.+K%C3%BChn-Wacheauthor=S.+Manhartauthor=U.+Heiserauthor=R.+Pokornyauthor=J.+Chiesa&title=A+phase+1+study+to+evaluate+the+safety+and+pharmacokinetics+of+PQ912%2C+a+glutaminyl+cyclase+inhibitor%2C+in+healthy+subjects&doi=10.1016%2Fj.trci.2015.08.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.trci.2015.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trci.2015.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DLues%26aufirst%3DI.%26aulast%3DWeber%26aufirst%3DF.%26aulast%3DMeyer%26aufirst%3DA.%26aulast%3DB%25C3%25BChring%26aufirst%3DU.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DK%25C3%25BChn-Wache%26aufirst%3DK.%26aulast%3DManhart%26aufirst%3DS.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DPokorny%26aufirst%3DR.%26aulast%3DChiesa%26aufirst%3DJ.%26atitle%3DA%2520phase%25201%2520study%2520to%2520evaluate%2520the%2520safety%2520and%2520pharmacokinetics%2520of%2520PQ912%252C%2520a%2520glutaminyl%2520cyclase%2520inhibitor%252C%2520in%2520healthy%2520subjects%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dement.%26date%3D2015%26volume%3D1%26spage%3D182%26epage%3D195%26doi%3D10.1016%2Fj.trci.2015.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Buchholz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aust, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohme, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span> </span><span class="NLM_article-title">Inhibitors for human glutaminyl cyclase by structure based design and bioisosteric replacement</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7069</span><span class="NLM_x">–</span> <span class="NLM_lpage">7080</span><span class="refDoi"> DOI: 10.1021/jm900969p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900969p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlagsbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7069-7080&author=M.+Buchholzauthor=A.+Hamannauthor=S.+Austauthor=W.+Brandtauthor=L.+Bohmeauthor=T.+Hoffmannauthor=S.+Schillingauthor=H.+U.+Demuthauthor=U.+Heiser&title=Inhibitors+for+human+glutaminyl+cyclase+by+structure+based+design+and+bioisosteric+replacement&doi=10.1021%2Fjm900969p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors for Human Glutaminyl Cyclase by Structure Based Design and Bioisosteric Replacement</span></div><div class="casAuthors">Buchholz, Mirko; Hamann, Antje; Aust, Susanne; Brandt, Wolfgang; Boehme, Livia; Hoffmann, Torsten; Schilling, Stephan; Demuth, Hans-Ulrich; Heiser, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7069-7080</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The inhibition of human glutaminyl cyclase (hQC) has come into focus as a new potential approach for the treatment of Alzheimer's disease.  The hallmark of this principle is the prevention of the formation of Aβ3,11(pE)-40,42, as these Aβ-species were shown to be of elevated neurotoxicity and likely to act as a seeding core leading to an accelerated formation of Aβ-oligomers and fibrils.  Starting from 1-(3-(1H-imidazol-1-yl)propyl)-3-(3,4-dimethoxyphenyl)thiourea, bioisosteric replacements led to the development of new classes of inhibitors.  The optimization of the metal-binding group was achieved by homol. modeling and afforded a first insight into the probable binding mode of the inhibitors in the hQC active site.  The efficacy assessment of the hQC inhibitors was performed in cell culture, directly monitoring the inhibition of Aβ3,11(pE)-40,42 formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZG_jswBXx2LVg90H21EOLACvtfcHk0lgdeFnIdEpRFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlagsbnJ&md5=262248c3c91f344aacb530288aa46471</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm900969p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900969p%26sid%3Dliteratum%253Aachs%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DHamann%26aufirst%3DA.%26aulast%3DAust%26aufirst%3DS.%26aulast%3DBrandt%26aufirst%3DW.%26aulast%3DBohme%26aufirst%3DL.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DHeiser%26aufirst%3DU.%26atitle%3DInhibitors%2520for%2520human%2520glutaminyl%2520cyclase%2520by%2520structure%2520based%2520design%2520and%2520bioisosteric%2520replacement%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7069%26epage%3D7080%26doi%3D10.1021%2Fjm900969p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Buchholz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niestroj, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunkel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span> </span><span class="NLM_article-title">The first potent inhibitors for human glutaminyl cyclase: synthesis and structure-activity relationship</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">664</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span><span class="refDoi"> DOI: 10.1021/jm050756e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050756e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD28XotlWrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=664-677&author=M.+Buchholzauthor=U.+Heiserauthor=S.+Schillingauthor=A.+J.+Niestrojauthor=K.+Zunkelauthor=H.+U.+Demuth&title=The+first+potent+inhibitors+for+human+glutaminyl+cyclase%3A+synthesis+and+structure-activity+relationship&doi=10.1021%2Fjm050756e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The first potent inhibitors for human glutaminyl cyclase: synthesis and structure-activity relationship</span></div><div class="casAuthors">Buchholz, Mirko; Heiser, Ulrich; Schilling, Stephan; Niestroj, Andre J.; Zunkel, Katrin; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">664-677</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The first effective inhibitors for human glutaminyl cyclase (QC) are described.  The structures are developed by applying a ligand-based optimization approach starting from imidazole.  Screening of derivs. of that heterocycle led to compds. of the imidazol-1-yl-alkyl thiourea type as a lead scaffold.  A library of thiourea derivs. was synthesized, resulting in an inhibitory improvement by 2 orders of magnitude, leading to 1-(3-(1H-imidazol-1-yl)propyl)-3-(3,4-dimethoxyphenyl)thiourea as a potent inhibitor.  Systematic exploitation of the scaffold revealed a strong impact on the inhibitory efficacy and resulted in the development of imidazole-propyl-thioamides as another new class of potent inhibitors.  A flexible alignment of the most potent compds. of the thioamide and thiourea class and a QC substrate revealed a good match of characteristic features of the mols., which suggests a similar binding mode of both inhibitors and the substrate to the active site of QC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo88OPnC7vM57Vg90H21EOLACvtfcHk0lgdeFnIdEpRFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotlWrug%253D%253D&md5=584302fd2d356f680bb4df9e10f26b93</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm050756e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050756e%26sid%3Dliteratum%253Aachs%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DNiestroj%26aufirst%3DA.%2BJ.%26aulast%3DZunkel%26aufirst%3DK.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DThe%2520first%2520potent%2520inhibitors%2520for%2520human%2520glutaminyl%2520cyclase%253A%2520synthesis%2520and%2520structure-activity%2520relationship%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D664%26epage%3D677%26doi%3D10.1021%2Fjm050756e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span> </span><span class="NLM_article-title">Inhibitory effect of flavonoids on human glutaminyl cyclase</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2280</span><span class="NLM_x">–</span> <span class="NLM_lpage">2286</span><span class="refDoi"> DOI: 10.1016/j.bmc.2016.03.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1016%2Fj.bmc.2016.03.064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=27061673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsF2lsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=2280-2286&author=M.+Liauthor=Y.+Dongauthor=X.+Yuauthor=Y.+Zouauthor=Y.+Zhengauthor=X.+Buauthor=J.+Quanauthor=Z.+Heauthor=H.+Wu&title=Inhibitory+effect+of+flavonoids+on+human+glutaminyl+cyclase&doi=10.1016%2Fj.bmc.2016.03.064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory effect of flavonoids on human glutaminyl cyclase</span></div><div class="casAuthors">Li, Manman; Dong, Yao; Yu, Xi; Zou, Yongdong; Zheng, Yizhi; Bu, Xianzhang; Quan, Junmin; He, Zhendan; Wu, Haiqiang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2280-2286</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (QC) plays an important role in the pathogenesis of Alzheimer's disease (AD) and can be a potential target for the development of novel anti-AD agents.  However, the study of QC inhibitors are still less.  Here, phenol-4' (R1-), C5-OH (R2-) and C7-OH (R3-) modified apigenin derivs. were synthesized as a new class of human QC (hQC) inhibitors.  The efficacy investigation of these compds. was performed by spectrophotometric assessment and the structure-activity relationship (SAR) was evaluated.  Mol. docking was also carried out to analyze the binding mode of the synthesized flavonoid to the active site of hQC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjo3dENiH0N7Vg90H21EOLACvtfcHk0lgdeFnIdEpRFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsF2lsLk%253D&md5=86df2e8e2c427d483dea92e747ddf116</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.03.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.03.064%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DBu%26aufirst%3DX.%26aulast%3DQuan%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DH.%26atitle%3DInhibitory%2520effect%2520of%2520flavonoids%2520on%2520human%2520glutaminyl%2520cyclase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D2280%26epage%3D2286%26doi%3D10.1016%2Fj.bmc.2016.03.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Ramsbeck, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohme, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span> </span><span class="NLM_article-title">Structure-activity relationships of benzimidazole-based glutaminyl cyclase inhibitors featuring a heteroaryl scaffold</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">6613</span><span class="NLM_x">–</span> <span class="NLM_lpage">6625</span><span class="refDoi"> DOI: 10.1021/jm4001709</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4001709" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOltrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6613-6625&author=D.+Ramsbeckauthor=M.+Buchholzauthor=B.+Kochauthor=L.+Bohmeauthor=T.+Hoffmannauthor=H.+U.+Demuthauthor=U.+Heiser&title=Structure-activity+relationships+of+benzimidazole-based+glutaminyl+cyclase+inhibitors+featuring+a+heteroaryl+scaffold&doi=10.1021%2Fjm4001709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships of Benzimidazole-Based Glutaminyl Cyclase Inhibitors Featuring a Heteroaryl Scaffold</span></div><div class="casAuthors">Ramsbeck, Daniel; Buchholz, Mirko; Koch, Birgit; Boehme, Livia; Hoffmann, Torsten; Demuth, Hans-Ulrich; Heiser, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6613-6625</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (hQC) has emerged as a new potential target for the treatment of Alzheimer's disease (AD).  The inhibition of hQC prevents of the formation of the Aβ3(pE)-40,42 species which were shown to be of elevated neurotoxicity and are likely to act as a seeding core, leading to an accelerated formation of Aβ-oligomers and fibrils.  This work presents a new class of inhibitors of hQC, resulting from a pharmacophore-based screen.  Hit mols. were identified, contg. benzimidazole as the metal binding group connected to 1,3,4-oxadiazole as the central scaffold.  The subsequent optimization resulted in benzimidazolyl-1,3,4-thiadiazoles and -1,2,3-triazoles with an inhibitory potency in the nanomolar range.  Further investigation into the potential binding mode of the new compd. classes combined mol. docking and site directed mutagenesis studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj2cbdhUrX_bVg90H21EOLACvtfcHk0ljBTaCuNAzWqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOltrvL&md5=eaff2e3df3c955881a158b5efd012c0d</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm4001709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4001709%26sid%3Dliteratum%253Aachs%26aulast%3DRamsbeck%26aufirst%3DD.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DBohme%26aufirst%3DL.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DHeiser%26aufirst%3DU.%26atitle%3DStructure-activity%2520relationships%2520of%2520benzimidazole-based%2520glutaminyl%2520cyclase%2520inhibitors%2520featuring%2520a%2520heteroaryl%2520scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6613%26epage%3D6625%26doi%3D10.1021%2Fjm4001709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Tran, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoang, V. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorat, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nam, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mook-Jung, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span> </span><span class="NLM_article-title">Structure-activity relationship of human glutaminyl cyclase inhibitors having an N-(5-methyl-1H-imidazol-1-yl)propyl thiourea template</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3821</span><span class="NLM_x">–</span> <span class="NLM_lpage">3830</span><span class="refDoi"> DOI: 10.1016/j.bmc.2013.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1016%2Fj.bmc.2013.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=23643900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvF2mtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=3821-3830&author=P.+T.+Tranauthor=V.+H.+Hoangauthor=S.+A.+Thoratauthor=S.+E.+Kimauthor=J.+Annauthor=Y.+J.+Changauthor=D.+W.+Namauthor=H.+Songauthor=I.+Mook-Jungauthor=J.+Leeauthor=J.+Lee&title=Structure-activity+relationship+of+human+glutaminyl+cyclase+inhibitors+having+an+N-%285-methyl-1H-imidazol-1-yl%29propyl+thiourea+template&doi=10.1016%2Fj.bmc.2013.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship of human glutaminyl cyclase inhibitors having an N-(5-methyl-1H-imidazol-1-yl)propyl thiourea template</span></div><div class="casAuthors">Tran, Phuong-Thao; Hoang, Van-Hai; Thorat, Shivaji A.; Kim, Sung Eun; Ann, Jihyae; Chang, Yu Jin; Nam, Dong Woo; Song, Hyundong; Mook-Jung, Inhee; Lee, Jiyoun; Lee, Jeewoo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3821-3830</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In an effort to design inhibitors of human glutaminyl cyclase (QC), the authors have synthesized a library of N-aryl N-(5-methyl-1H-imidazol-1-yl)propyl thioureas and investigated the contribution of the aryl region of these compds. to their structure-activity relationships as cyclase inhibitors.  The authors' design was guided by the proposed binding mode of the preferred substrate for the cyclase.  In this series, 1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea (compd. 52) was identified as the most potent QC inhibitor with an IC50 value of 58 nM, which was two-fold more potent than the previously reported lead (II).  Compd. 52 is a most promising candidate for future evaluation to monitor its ability to reduce the formation of pGlu-Aβ and Aβ plaques in cells and transgenic animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5aCpSObyf3rVg90H21EOLACvtfcHk0ljBTaCuNAzWqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvF2mtL0%253D&md5=a8d7ad244e262c7bb26681c64393551a</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DP.%2BT.%26aulast%3DHoang%26aufirst%3DV.%2BH.%26aulast%3DThorat%26aufirst%3DS.%2BA.%26aulast%3DKim%26aufirst%3DS.%2BE.%26aulast%3DAnn%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DY.%2BJ.%26aulast%3DNam%26aufirst%3DD.%2BW.%26aulast%3DSong%26aufirst%3DH.%26aulast%3DMook-Jung%26aufirst%3DI.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%26atitle%3DStructure-activity%2520relationship%2520of%2520human%2520glutaminyl%2520cyclase%2520inhibitors%2520having%2520an%2520N-%25285-methyl-1H-imidazol-1-yl%2529propyl%2520thiourea%2520template%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D3821%26epage%3D3830%26doi%3D10.1016%2Fj.bmc.2013.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Efange, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelson, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knusel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hefti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boudreau, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tennison, J. R.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of radioiodinated N-2-(4-piperidyl)ethyl benzamides</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">527</span><span class="NLM_x">–</span> <span class="NLM_lpage">538</span><span class="refDoi"> DOI: 10.1016/0969-8051(93)90083-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1016%2F0969-8051%2893%2990083-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=8504292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADyaK3sXlsFCqurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1993&pages=527-538&author=S.+M.+Efangeauthor=R.+H.+Michelsonauthor=B.+Knuselauthor=F.+Heftiauthor=R.+J.+Boudreauauthor=J.+R.+Thomasauthor=J.+R.+Tennison&title=Synthesis+and+biological+evaluation+of+radioiodinated+N-2-%284-piperidyl%29ethyl+benzamides&doi=10.1016%2F0969-8051%2893%2990083-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of radioiodinated N-2-(4-piperidyl)ethylbenzamides</span></div><div class="casAuthors">Efange, S. M. N.; Michelson, R. H.; Knusel, B.; Hefti, F.; Boudreau, R. J.; Thomas, J. R.; Tennison, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">527-38</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0883-2897</span>.
    </div><div class="casAbstract">Three iodinated benzamides (I, R, R1, R2 = H, Cl, or I; R3 = H) analogs of the potent acetylcholinesterase inhibitor 1-benzyl-4-[N-[4'-(benzylsulfonyl)benzoyl-N-methylamino]ethyl]piperidine (I, R = PhCH2SO2, R1 = R2 = H, R3 = Me) were synthesized and evaluated as potential anticholinesterase agents.  All 3 compds. were 3 orders of magnitude less potent than the parent compd.  However, receptor screening revealed I show nanomolar affinity for the sigma binding site.  Both [125I]-I (R = R2 = R3 = H, R1 = 125I) and [125I]-I (R = R1 = Cl, R2 = 125I, R3 = H) were prepd. and evaluated in rats.  Following the i.v. administration of [125I]-I (R = R2 = R3 = H, R1 = 125I) into rats, 1.59% of the injected dose was found in the rat brain within 5 min.  The level of radioactivity in the brain remained steady for 2 h, the duration of the study.  In contrast, 0.42% of the injected dose was detected in the rat brain following the i.v. injection of [125I]-I (R = R1 = Cl, R2 = 125I, R3 = H).  Coadministration of either these 2 radioiodinated compds. with 0.5 μmol/kg of haloperidol resulted in a 56-73% redn. in the level of radioactivity in the rat brain, suggesting that these compds. bind to the sigma binding site in vivo.  Planar imaging studies with [125I]-I (R = R2 = R3 = H, R1 = 125I) revealed significant accumulation of radioactivity within the monkey brain, with a half-life of 6 h.  This compd. may be potentially useful for studying sigma receptor distribution in the human brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCcFe7wwMOy7Vg90H21EOLACvtfcHk0ljBTaCuNAzWqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlsFCqurk%253D&md5=8845c8409eb3974281240455f8ccbf68</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2F0969-8051%2893%2990083-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0969-8051%252893%252990083-7%26sid%3Dliteratum%253Aachs%26aulast%3DEfange%26aufirst%3DS.%2BM.%26aulast%3DMichelson%26aufirst%3DR.%2BH.%26aulast%3DKnusel%26aufirst%3DB.%26aulast%3DHefti%26aufirst%3DF.%26aulast%3DBoudreau%26aufirst%3DR.%2BJ.%26aulast%3DThomas%26aufirst%3DJ.%2BR.%26aulast%3DTennison%26aufirst%3DJ.%2BR.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520radioiodinated%2520N-2-%25284-piperidyl%2529ethyl%2520benzamides%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D1993%26volume%3D20%26spage%3D527%26epage%3D538%26doi%3D10.1016%2F0969-8051%2893%2990083-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Bautista-Aguilera, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chioua, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolic, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agbaba, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Andres, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcaro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsay, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortuso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span> </span><span class="NLM_article-title">N-Methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1H-indol-2- yl)methyl)prop-2-yn-1-amine, a new cholinesterase and monoamine oxidase dual inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">10455</span><span class="NLM_x">–</span> <span class="NLM_lpage">10463</span><span class="refDoi"> DOI: 10.1021/jm501501a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501501a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10455-10463&author=O.+M.+Bautista-Aguileraauthor=A.+Samadiauthor=M.+Chiouaauthor=K.+Nikolicauthor=S.+Filipicauthor=D.+Agbabaauthor=E.+Sorianoauthor=L.+de+Andresauthor=M.+I.+Rodriguez-Francoauthor=S.+Alcaroauthor=R.+R.+Ramsayauthor=F.+Ortusoauthor=M.+Yanezauthor=J.+Marco-Contelles&title=N-Methyl-N-%28%281-methyl-5-%283-%281-%282-methylbenzyl%29piperidin-4-yl%29propoxy%29-1H-indol-2-+yl%29methyl%29prop-2-yn-1-amine%2C+a+new+cholinesterase+and+monoamine+oxidase+dual+inhibitor&doi=10.1021%2Fjm501501a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm501501a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501501a%26sid%3Dliteratum%253Aachs%26aulast%3DBautista-Aguilera%26aufirst%3DO.%2BM.%26aulast%3DSamadi%26aufirst%3DA.%26aulast%3DChioua%26aufirst%3DM.%26aulast%3DNikolic%26aufirst%3DK.%26aulast%3DFilipic%26aufirst%3DS.%26aulast%3DAgbaba%26aufirst%3DD.%26aulast%3DSoriano%26aufirst%3DE.%26aulast%3Dde%2BAndres%26aufirst%3DL.%26aulast%3DRodriguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DRamsay%26aufirst%3DR.%2BR.%26aulast%3DOrtuso%26aufirst%3DF.%26aulast%3DYanez%26aufirst%3DM.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DN-Methyl-N-%2528%25281-methyl-5-%25283-%25281-%25282-methylbenzyl%2529piperidin-4-yl%2529propoxy%2529-1H-indol-2-%2520yl%2529methyl%2529prop-2-yn-1-amine%252C%2520a%2520new%2520cholinesterase%2520and%2520monoamine%2520oxidase%2520dual%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10455%26epage%3D10463%26doi%3D10.1021%2Fjm501501a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Kurosawa, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuyama, T.</span><span> </span><span class="NLM_article-title">Preparation of secondary amines from primary amines via 2-nitrobenzenesulfonamides: N-(4-methoxybenzyl)-3-phenylpropylamine</span> <span class="citation_source-journal">Org. Synth.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span><span class="refDoi"> DOI: 10.1002/0471264180.os079.22</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1002%2F0471264180.os079.22" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=186-186&author=W.+Kurosawaauthor=T.+Kanauthor=T.+Fukuyama&title=Preparation+of+secondary+amines+from+primary+amines+via+2-nitrobenzenesulfonamides%3A+N-%284-methoxybenzyl%29-3-phenylpropylamine&doi=10.1002%2F0471264180.os079.22"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2F0471264180.os079.22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F0471264180.os079.22%26sid%3Dliteratum%253Aachs%26aulast%3DKurosawa%26aufirst%3DW.%26aulast%3DKan%26aufirst%3DT.%26aulast%3DFukuyama%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520secondary%2520amines%2520from%2520primary%2520amines%2520via%25202-nitrobenzenesulfonamides%253A%2520N-%25284-methoxybenzyl%2529-3-phenylpropylamine%26jtitle%3DOrg.%2520Synth.%26date%3D2003%26spage%3D186%26epage%3D186%26doi%3D10.1002%2F0471264180.os079.22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Nettekoven, M.</span><span> </span><span class="NLM_article-title">Combinatorial synthesis of 5-aryl-[1, 2, 4]-triazolo-[1, 5-a]-pyridine derivatives as potential inhibitors of the adenosine 2a receptor</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2001</span><span class="NLM_x">, </span> <span class="NLM_fpage">1917</span><span class="NLM_x">–</span> <span class="NLM_lpage">1920</span><span class="refDoi"> DOI: 10.1055/s-2001-18758</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1055%2Fs-2001-18758" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2001&publication_year=2001&pages=1917-1920&author=M.+Nettekoven&title=Combinatorial+synthesis+of+5-aryl-%5B1%2C+2%2C+4%5D-triazolo-%5B1%2C+5-a%5D-pyridine+derivatives+as+potential+inhibitors+of+the+adenosine+2a+receptor&doi=10.1055%2Fs-2001-18758"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1055%2Fs-2001-18758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2001-18758%26sid%3Dliteratum%253Aachs%26aulast%3DNettekoven%26aufirst%3DM.%26atitle%3DCombinatorial%2520synthesis%2520of%25205-aryl-%255B1%252C%25202%252C%25204%255D-triazolo-%255B1%252C%25205-a%255D-pyridine%2520derivatives%2520as%2520potential%2520inhibitors%2520of%2520the%2520adenosine%25202a%2520receptor%26jtitle%3DSynlett%26date%3D2001%26volume%3D2001%26spage%3D1917%26epage%3D1920%26doi%3D10.1055%2Fs-2001-18758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasternack, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span> </span><span class="NLM_article-title">Continuous spectrometric assays for glutaminyl cyclase activity</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1006/abio.2001.5560</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1006%2Fabio.2001.5560" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=11906150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD38XitFeisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2002&pages=49-56&author=S.+Schillingauthor=T.+Hoffmannauthor=M.+Wermannauthor=U.+Heiserauthor=C.+Wasternackauthor=H.+U.+Demuth&title=Continuous+spectrometric+assays+for+glutaminyl+cyclase+activity&doi=10.1006%2Fabio.2001.5560"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Continuous Spectrometric Assays for Glutaminyl Cyclase Activity</span></div><div class="casAuthors">Schilling, Stephan; Hoffmann, Torsten; Wermann, Michael; Heiser, Ulrich; Wasternack, Claus; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-56</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">The enzymic conversion of one chromogenic substrate, L-glutamine-p-nitroanilide, and two fluorogenic substrates, L-glutaminyl-2-naphthylamide and L-glutaminyl-4-methylcoumarinylamide, into their resp. pyroglutamic acid derivs. by glutaminyl cyclase (QC) was estd. by introducing a new coupled assay using pyroglutamyl aminopeptidase as the auxiliary enzyme.  For the purified papaya QC, the kinetic parameters were found to be in the range of those previously reported for other glutaminyl peptides, such as Gln-Gln, Gln-Ala, or Gln-tert-Bu ester.  The assay can be performed in the presence of ammonia up to a concn. of 50 mM.  Increasing ionic strength, e.g., potassium chloride up to 300 mM, resulted in an increase in enzymic activity of about 20%.  This is the first report of a fast, continuous, and reliable detn. of QC activity, even in the presence of ammonium ions, during the course of protein purifn. and enzymic anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpQW4L1wwLqbVg90H21EOLACvtfcHk0lioUge3_oGCPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitFeisL0%253D&md5=18509903cf5017f855c3c3ea68dc9915</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1006%2Fabio.2001.5560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.2001.5560%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DWasternack%26aufirst%3DC.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DContinuous%2520spectrometric%2520assays%2520for%2520glutaminyl%2520cyclase%2520activity%26jtitle%3DAnal.%2520Biochem.%26date%3D2002%26volume%3D303%26spage%3D49%26epage%3D56%26doi%3D10.1006%2Fabio.2001.5560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Koch, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span> </span><span class="NLM_article-title">Probing secondary glutaminyl cyclase (QC) inhibitor interactions applying an in silico-modeling/site-directed mutagenesis approach: implications for drug development</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">937</span><span class="NLM_x">–</span> <span class="NLM_lpage">946</span><span class="refDoi"> DOI: 10.1111/cbdd.12046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1111%2Fcbdd.12046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=22967026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCmu7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2012&pages=937-946&author=B.+Kochauthor=M.+Buchholzauthor=M.+Wermannauthor=U.+Heiserauthor=S.+Schillingauthor=H.+U.+Demuth&title=Probing+secondary+glutaminyl+cyclase+%28QC%29+inhibitor+interactions+applying+an+in+silico-modeling%2Fsite-directed+mutagenesis+approach%3A+implications+for+drug+development&doi=10.1111%2Fcbdd.12046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Probing secondary glutaminyl cyclase (QC) inhibitor interactions applying an in silico-modeling/site-directed mutagenesis approach: implications for drug development</span></div><div class="casAuthors">Koch, Birgit; Buchholz, Mirko; Wermann, Michael; Heiser, Ulrich; Schilling, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">937-946</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Glutaminyl cyclases (QCs) catalyze the formation of pyroglutamate-modified amyloid peptides deposited in neurodegenerative disorders such as Alzheimer's disease.  Inhibitors of QC are currently in development as potential therapeutics.  The crystal structures of the potent inhibitor PBD150 bound to human and murine QC (hQC, mQC) have been described recently.  The binding modes of a dimethoxyphenyl moiety of the inhibitor are significantly different between the structures, which contrasts with a similar Ki value.  We show the conformation of PBD150 prone to disturbance by protein-protein interactions within the crystals.  Semi-empirical calcns. of the enzyme-inhibitor interaction within the crystal suggest significant differences in the dissocn. consts. between the binding modes.  To probe for interactions in soln., a site-directed mutagenesis on hQC was performed.  The replacement of F325 and I303 by alanine or asparagine resulted in a 800-fold lower activity of the inhibitor, whereas the exchange of S323 by alanine or valine led to a 20-fold higher activity of PBD150.  The results provide an example of deciphering the interaction mode between a target enzyme and lead substance in soln., if co-crystn. does not mirror such interactions properly.  Thus, the study might provide implications for rapid screening of binding modes also for other drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG1xHVETpdubVg90H21EOLACvtfcHk0lgkvem05iK2Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCmu7fE&md5=826cc42ff98381d0a09f6bec93f2a878</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12046%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DProbing%2520secondary%2520glutaminyl%2520cyclase%2520%2528QC%2529%2520inhibitor%2520interactions%2520applying%2520an%2520in%2520silico-modeling%252Fsite-directed%2520mutagenesis%2520approach%253A%2520implications%2520for%2520drug%2520development%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2012%26volume%3D80%26spage%3D937%26epage%3D946%26doi%3D10.1111%2Fcbdd.12046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Becker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eichentopf, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedlmeier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waniek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cynis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauscher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohlmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehlen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freyse, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osmand, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plank, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Horsten, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graubner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, S.</span><span> </span><span class="NLM_article-title">IsoQC (QPCTL) knock-out mice suggest differential substrate conversion by glutaminyl cyclase isoenzymes</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">397</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span><span class="refDoi"> DOI: 10.1515/hsz-2015-0192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1515%2Fhsz-2015-0192" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=26351917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKjtbrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=397&publication_year=2016&pages=45-55&author=A.+Beckerauthor=R.+Eichentopfauthor=R.+Sedlmeierauthor=A.+Waniekauthor=H.+Cynisauthor=B.+Kochauthor=A.+Stephanauthor=C.+Bauscherauthor=S.+Kohlmannauthor=T.+Hoffmannauthor=A.+Kehlenauthor=S.+Bergauthor=E.+J.+Freyseauthor=A.+Osmandauthor=A.+C.+Plankauthor=S.+Rossnerauthor=S.+von+Horstenauthor=S.+Graubnerauthor=H.+U.+Demuthauthor=S.+Schilling&title=IsoQC+%28QPCTL%29+knock-out+mice+suggest+differential+substrate+conversion+by+glutaminyl+cyclase+isoenzymes&doi=10.1515%2Fhsz-2015-0192"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">IsoQC (QPCTL) knock-out mice suggest differential substrate conversion by glutaminyl cyclase isoenzymes</span></div><div class="casAuthors">Becker, Andreas; Eichentopf, Rico; Sedlmeier, Reinhard; Waniek, Alexander; Cynis, Holger; Koch, Birgit; Stephan, Anett; Baeuscher, Christoph; Kohlmann, Stephanie; Hoffmann, Torsten; Kehlen, Astrid; Berg, Sabine; Freyse, Ernst-Joachim; Osmand, Alexander; Plank, Anne-Christine; Rossner, Steffen; von Hoersten, Stephan; Graubner, Sigrid; Demuth, Hans-Ulrich; Schilling, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">397</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-55</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH</span>)
        </div><div class="casAbstract">Secretory peptides and proteins are frequently modified by pyroglutamic acid (pE, pGlu) at their N-terminus.  This modification is catalyzed by the glutaminyl cyclases QC and isoQC.  Here, we decipher the roles of the isoenzymes by characterization of IsoQC-/- mice.  These mice show a significant redn. of glutaminyl cyclase activity in brain and peripheral tissue, suggesting ubiquitous expression of the isoQC enzyme.  An assay of substrate conversion in vivo reveals impaired generation of the pGlu-modified C-C chemokine ligand 2 (CCL2, MCP-1) in isoQC-/- mice.  The pGlu-formation was also impaired in primary neurons, which express significant levels of QC.  Interestingly, however, the formation of the neuropeptide hormone TSH-releasing hormone (TRH), assessed by immunohistochem. and hormonal anal. of hypothalamic-pituitary-thyroid axis, was not affected in isoQC-/-, which contrasts to QC-/-.  Thus, the results reveal differential functions of isoQC and QC in the formation of the pGlu-peptides CCL2 and TRH.  Substrates requiring extensive prohormone processing in secretory granules, such as TRH, are primarily converted by QC.  In contrast, protein substrates such as CCL2 appear to be primarily converted by isoQC.  The results provide a new example, how subtle differences in subcellular localization of enzymes and substrate precursor maturation might influence pGlu-product formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6FvRmQrpJjbVg90H21EOLACvtfcHk0lgkvem05iK2Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKjtbrN&md5=d49367e240255a8fa1546bae79865508</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1515%2Fhsz-2015-0192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fhsz-2015-0192%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DA.%26aulast%3DEichentopf%26aufirst%3DR.%26aulast%3DSedlmeier%26aufirst%3DR.%26aulast%3DWaniek%26aufirst%3DA.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DStephan%26aufirst%3DA.%26aulast%3DBauscher%26aufirst%3DC.%26aulast%3DKohlmann%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DFreyse%26aufirst%3DE.%2BJ.%26aulast%3DOsmand%26aufirst%3DA.%26aulast%3DPlank%26aufirst%3DA.%2BC.%26aulast%3DRossner%26aufirst%3DS.%26aulast%3Dvon%2BHorsten%26aufirst%3DS.%26aulast%3DGraubner%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DSchilling%26aufirst%3DS.%26atitle%3DIsoQC%2520%2528QPCTL%2529%2520knock-out%2520mice%2520suggest%2520differential%2520substrate%2520conversion%2520by%2520glutaminyl%2520cyclase%2520isoenzymes%26jtitle%3DBiol.%2520Chem.%26date%3D2016%26volume%3D397%26spage%3D45%26epage%3D55%26doi%3D10.1515%2Fhsz-2015-0192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Oakley, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maus, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craft, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillozet-Bongaarts, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Disterhoft, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Eldik, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassar, R.</span><span> </span><span class="NLM_article-title">Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer’s disease mutations: potential factors in amyloid plaque formation</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">10129</span><span class="NLM_x">–</span> <span class="NLM_lpage">10140</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.1202-06.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1523%2FJNEUROSCI.1202-06.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=17021169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVymurbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=10129-10140&author=H.+Oakleyauthor=S.+L.+Coleauthor=S.+Loganauthor=E.+Mausauthor=P.+Shaoauthor=J.+Craftauthor=A.+Guillozet-Bongaartsauthor=M.+Ohnoauthor=J.+Disterhoftauthor=L.+Van+Eldikauthor=R.+Berryauthor=R.+Vassar&title=Intraneuronal+beta-amyloid+aggregates%2C+neurodegeneration%2C+and+neuron+loss+in+transgenic+mice+with+five+familial+Alzheimer%E2%80%99s+disease+mutations%3A+potential+factors+in+amyloid+plaque+formation&doi=10.1523%2FJNEUROSCI.1202-06.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation</span></div><div class="casAuthors">Oakley, Holly; Cole, Sarah L.; Logan, Sreemathi; Maus, Erika; Shao, Pei; Craft, Jeffery; Guillozet-Bongaarts, Angela; Ohno, Masuo; Disterhoft, John; Van Eldik, Linda; Berry, Robert; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">10129-10140</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Mutations in the genes for amyloid precursor protein (APP) and presenilins (PS1, PS2) increase prodn. of β-amyloid 42 (Aβ42) and cause familial Alzheimer's disease (FAD).  Transgenic mice that express FAD mutant APP and PS1 overproduce Aβ42 and exhibit amyloid plaque pathol. similar to that found in AD, but most transgenic models develop plaques slowly.  To accelerate plaque development and investigate the effects of very high cerebral Aβ42 levels, we generated APP/PS1 double transgenic mice that coexpress five FAD mutations (5XFAD mice) and additively increase Aβ42 prodn.  5XFAD mice generate Aβ42 almost exclusively and rapidly accumulate massive cerebral Aβ42 levels.  Amyloid deposition (and gliosis) begins at 2 mo and reaches a very large burden, esp. in subiculum and deep cortical layers.  Intraneuronal Aβ42 accumulates in 5XFAD brain starting at 1.5 mo of age (before plaques form), is aggregated (as detd. by thioflavin S staining), and occurs within neuron soma and neurites.  Some amyloid deposits originate within morphol. abnormal neuron soma that contain intraneuronal Aβ.  Synaptic markers synaptophysin, syntaxin, and postsynaptic d.-95 decrease with age in 5XFAD brain, and large pyramidal neurons in cortical layer 5 and subiculum are lost.  In addn., levels of the activation subunit of cyclin-dependent kinase 5, p25, are elevated significantly at 9 mo in 5XFAD brain, although an upward trend is obsd. by 3 mo of age, before significant neurodegeneration or neuron loss.  Finally, 5XFAD mice have impaired memory in the Y-maze.  Thus, 5XFAD mice rapidly recapitulate major features of AD amyloid pathol. and may be useful models of intraneuronal Aβ42-induced neurodegeneration and amyloid plaque formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIhU1MNDa0RrVg90H21EOLACvtfcHk0lirRzsxvuDhOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVymurbK&md5=a47a3bedd25b37812f9172ebca81fb1d</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1202-06.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1202-06.2006%26sid%3Dliteratum%253Aachs%26aulast%3DOakley%26aufirst%3DH.%26aulast%3DCole%26aufirst%3DS.%2BL.%26aulast%3DLogan%26aufirst%3DS.%26aulast%3DMaus%26aufirst%3DE.%26aulast%3DShao%26aufirst%3DP.%26aulast%3DCraft%26aufirst%3DJ.%26aulast%3DGuillozet-Bongaarts%26aufirst%3DA.%26aulast%3DOhno%26aufirst%3DM.%26aulast%3DDisterhoft%26aufirst%3DJ.%26aulast%3DVan%2BEldik%26aufirst%3DL.%26aulast%3DBerry%26aufirst%3DR.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DIntraneuronal%2520beta-amyloid%2520aggregates%252C%2520neurodegeneration%252C%2520and%2520neuron%2520loss%2520in%2520transgenic%2520mice%2520with%2520five%2520familial%2520Alzheimer%25E2%2580%2599s%2520disease%2520mutations%253A%2520potential%2520factors%2520in%2520amyloid%2520plaque%2520formation%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26spage%3D10129%26epage%3D10140%26doi%3D10.1523%2FJNEUROSCI.1202-06.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Hwang, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attia, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connelly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichterman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustinaite, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inglese, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guy, R. K.</span><span> </span><span class="NLM_article-title">Methylsulfonylnitrobenzoates, a new class of irreversible inhibitors of the interaction of the thyroid hormone receptor and its obligate coactivators that functionally antagonizes thyroid hormone</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">11895</span><span class="NLM_x">–</span> <span class="NLM_lpage">11908</span><span class="refDoi"> DOI: 10.1074/jbc.M110.200436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1074%2Fjbc.M110.200436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=21321127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVKqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=11895-11908&author=J.+Y.+Hwangauthor=W.+Huangauthor=L.+A.+Arnoldauthor=R.+Huangauthor=R.+R.+Attiaauthor=M.+Connellyauthor=J.+Wichtermanauthor=F.+Zhuauthor=I.+Augustinaiteauthor=C.+P.+Austinauthor=J.+Ingleseauthor=R.+L.+Johnsonauthor=R.+K.+Guy&title=Methylsulfonylnitrobenzoates%2C+a+new+class+of+irreversible+inhibitors+of+the+interaction+of+the+thyroid+hormone+receptor+and+its+obligate+coactivators+that+functionally+antagonizes+thyroid+hormone&doi=10.1074%2Fjbc.M110.200436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Methylsulfonylnitrobenzoates, a New Class of Irreversible Inhibitors of the Interaction of the Thyroid Hormone Receptor and its Obligate Coactivators that Functionally Antagonizes Thyroid Hormone</span></div><div class="casAuthors">Hwang, Jong-Yeon; Huang, Wen-Wei; Arnold, Leggy A.; Huang, Rui-Li; Attia, Ramy R.; Connelly, Michele; Wichterman, Jennifer; Zhu, Fang-Yi; Augustinaite, Indre; Austin, Christopher P.; Inglese, James; Johnson, Ronald L.; Guy, R. Kiplin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">11895-11908</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Thyroid hormone receptors (TRs) are members of the nuclear hormone receptor (NR) superfamily and regulate development, growth, and metab.  Upon binding thyroid hormone, TR undergoes a conformational change that allows the release of corepressors and the recruitment of coactivators, which in turn regulate target gene transcription.  Although a no. of TR antagonists have been developed, most are analogs of the endogenous hormone that inhibit ligand binding.  In a screen for inhibitors that block the assocn. of TRβ with steroid receptor coactivator 2 (SRC2), the authors identified a novel methylsulfonylnitrobenzoate (MSNB)-contg. series that blocks this interaction at micromolar concns.  Here the authors have studied a series of MSNB analogs and characterized their structure activity relationships.  MSNB members do not displace thyroid hormone T3 but instead act by direct displacement of SRC2.  MSNB series members are selective for the TR over the androgen, vitamin D, and PPARγ NR members, and they antagonize thyroid hormone-activated transcription action in cells.  The methylsulfonylnitro group is essential for TRβ antagonism.  Side-chain alkylamine substituents showed better inhibitory activity than arylamine substituents.  Mass spectrum anal. suggested that MSNB inhibitors bind irreversibly to Cys-298 within the AF-2 cleft of TRβ to disrupt SRC2 assocn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN6FEsDjbQsLVg90H21EOLACvtfcHk0lirRzsxvuDhOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVKqtro%253D&md5=a968a083f7c5718c2e03d5ef0a3b25ae</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.200436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.200436%26sid%3Dliteratum%253Aachs%26aulast%3DHwang%26aufirst%3DJ.%2BY.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DArnold%26aufirst%3DL.%2BA.%26aulast%3DHuang%26aufirst%3DR.%26aulast%3DAttia%26aufirst%3DR.%2BR.%26aulast%3DConnelly%26aufirst%3DM.%26aulast%3DWichterman%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DF.%26aulast%3DAugustinaite%26aufirst%3DI.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DInglese%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DR.%2BL.%26aulast%3DGuy%26aufirst%3DR.%2BK.%26atitle%3DMethylsulfonylnitrobenzoates%252C%2520a%2520new%2520class%2520of%2520irreversible%2520inhibitors%2520of%2520the%2520interaction%2520of%2520the%2520thyroid%2520hormone%2520receptor%2520and%2520its%2520obligate%2520coactivators%2520that%2520functionally%2520antagonizes%2520thyroid%2520hormone%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D11895%26epage%3D11908%26doi%3D10.1074%2Fjbc.M110.200436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Huang, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liaw, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chia, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A. H.</span><span> </span><span class="NLM_article-title">Structures of human Golgi-resident glutaminyl cyclase and its complexes with inhibitors reveal a large loop movement upon inhibitor binding</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">12439</span><span class="NLM_x">–</span> <span class="NLM_lpage">12449</span><span class="refDoi"> DOI: 10.1074/jbc.M110.208595</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1074%2Fjbc.M110.208595" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=21288892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVKqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=12439-12449&author=K.+F.+Huangauthor=S.+S.+Liawauthor=W.+L.+Huangauthor=C.+Y.+Chiaauthor=Y.+C.+Loauthor=Y.+L.+Chenauthor=A.+H.+Wang&title=Structures+of+human+Golgi-resident+glutaminyl+cyclase+and+its+complexes+with+inhibitors+reveal+a+large+loop+movement+upon+inhibitor+binding&doi=10.1074%2Fjbc.M110.208595"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Golgi-resident Glutaminyl Cyclase and its Complexes with Inhibitors Reveal a Large Loop Movement upon Inhibitor Binding</span></div><div class="casAuthors">Huang, Kai-Fa; Liaw, Su-Sen; Huang, Wei-Lin; Chia, Cho-Yun; Lo, Yan-Chung; Chen, Yi-Ling; Wang, Andrew H.-J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">12439-12449</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Aberrant pyroglutamate formation at the N terminus of certain peptides and proteins, catalyzed by glutaminyl cyclases (QCs), is linked to some pathol. conditions, such as Alzheimer disease.  Recently, a glutaminyl cyclase (QC) inhibitor, PBD150, was shown to be able to reduce the deposition of pyroglutamate-modified amyloid-β peptides in brain of transgenic mouse models of Alzheimer disease, leading to a significant improvement of learning and memory in those transgenic animals.  Here, we report the 1.05-1.40 Å resoln. structures, solved by the sulfur single-wavelength anomalous dispersion phasing method, of the Golgi-luminal catalytic domain of the recently identified Golgi-resident QC (gQC) and its complex with PBD150.  We also describe the high-resoln. structures of secretory QC (sQC)-PBD150 complex and two other gQC-inhibitor complexes.  The gQC structure has a scaffold similar to that of sQC but with a relatively wider and neg. charged active site, suggesting a distinct substrate specificity from sQC.  Upon binding to PBD150, a large loop movement in gQC allows the inhibitor to be tightly held in its active site primarily by hydrophobic interactions.  Further comparisons of the inhibitor-bound structures revealed distinct interactions of the inhibitors with gQC and sQC, which are consistent with the results from our inhibitor assays reported here.  Because gQC and sQC may play different biol. roles in vivo, the different inhibitor binding modes allow the design of specific inhibitors toward gQC and sQC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeL8K3B1TxsLVg90H21EOLACvtfcHk0lirRzsxvuDhOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVKqu7c%253D&md5=ef9018b9dc4ff40db7cac0ddac9fadb1</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.208595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.208595%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BF.%26aulast%3DLiaw%26aufirst%3DS.%2BS.%26aulast%3DHuang%26aufirst%3DW.%2BL.%26aulast%3DChia%26aufirst%3DC.%2BY.%26aulast%3DLo%26aufirst%3DY.%2BC.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DWang%26aufirst%3DA.%2BH.%26atitle%3DStructures%2520of%2520human%2520Golgi-resident%2520glutaminyl%2520cyclase%2520and%2520its%2520complexes%2520with%2520inhibitors%2520reveal%2520a%2520large%2520loop%2520movement%2520upon%2520inhibitor%2520binding%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D12439%26epage%3D12449%26doi%3D10.1074%2Fjbc.M110.208595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Cho, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guallar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berne, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R.</span><span> </span><span class="NLM_article-title">Importance of accurate charges in molecular docking: quantum mechanical/molecular mechanical (QM/MM) approach</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">915</span><span class="NLM_x">–</span> <span class="NLM_lpage">931</span><span class="refDoi"> DOI: 10.1002/jcc.20222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1002%2Fjcc.20222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=15841474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvF2ktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=915-931&author=A.+E.+Choauthor=V.+Guallarauthor=B.+J.+Berneauthor=R.+Friesner&title=Importance+of+accurate+charges+in+molecular+docking%3A+quantum+mechanical%2Fmolecular+mechanical+%28QM%2FMM%29+approach&doi=10.1002%2Fjcc.20222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Importance of accurate charges in molecular docking: Quantum mechanical/molecular mechanical (QM/MM) approach</span></div><div class="casAuthors">Cho, Art E.; Guallar, Victor; Berne, Bruce J.; Friesner, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">915-931</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The extent to which accuracy of elec. charges plays a role in protein-ligand docking is investigated through development of a docking algorithm, which incorporates quantum mech./mol. mech. (QM/MM) calcns.  In this algorithm, fixed charges of ligands obtained from force field parameterization are replaced by QM/MM calcns. in the protein environment, treating only the ligands as the quantum region.  The algorithm is tested on a set of 40 co-crystd. structures taken from the Protein Data Bank (PDB) and provides strong evidence that use of non-fixed charges is important.  An algorithm, dubbed Survival of the Fittest (SOF) algorithm, is implemented to incorporate QM/MM charge calcns. without any prior knowledge of native structures of the complexes.  Using an iterative protocol, this algorithm is able in many cases to converge to a native-like structure in systems where redocking of the ligand using a std. fixed charge force field exhibits non-trivial errors.  The results demonstrate that polarization effects can play a significant role in detg. the structures of protein-ligand complexes, and provide a promising start toward the development of more accurate docking methods for lead optimization applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUfbf04iv-0bVg90H21EOLACvtfcHk0ljWtaMru_uWCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvF2ktLo%253D&md5=4ba42205c6857a4395850a488d3ba272</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20222%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DA.%2BE.%26aulast%3DGuallar%26aufirst%3DV.%26aulast%3DBerne%26aufirst%3DB.%2BJ.%26aulast%3DFriesner%26aufirst%3DR.%26atitle%3DImportance%2520of%2520accurate%2520charges%2520in%2520molecular%2520docking%253A%2520quantum%2520mechanical%252Fmolecular%2520mechanical%2520%2528QM%252FMM%2529%2520approach%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2005%26volume%3D26%26spage%3D915%26epage%3D931%26doi%3D10.1002%2Fjcc.20222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheraga, H. A.</span><span> </span><span class="NLM_article-title">Monte Carlo-minimization approach to the multiple-minima problem in protein folding</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">6611</span><span class="NLM_x">–</span> <span class="NLM_lpage">6615</span><span class="refDoi"> DOI: 10.1073/pnas.84.19.6611</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=10.1073%2Fpnas.84.19.6611" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=3477791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;key=1%3ACAS%3A528%3ADyaL1cXlt1emuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=1987&pages=6611-6615&author=Z.+Liauthor=H.+A.+Scheraga&title=Monte+Carlo-minimization+approach+to+the+multiple-minima+problem+in+protein+folding&doi=10.1073%2Fpnas.84.19.6611"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Monte Carlo-minimization approach to the multiple-minima problem in protein folding</span></div><div class="casAuthors">Li, Zhenqin; Scheraga, Harold A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6611-15</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">A Monte Carlo-minimization method was developed to overcome the multiple-min. problem.  The Metropolis Monte Carlo sampling, assisted by energy minimization, surmounted intervening barriers in moving through successive discrete local min. in the multidimensional energy surface.  The method located the lowest-energy min. thus far reported for the brain pentapeptide, methionine-enkephalin, in the absence of water.  Presumably it is the global min.-energy structure.  This supports the concept that protein folding may be a Markov process.  In the presence of water, the mols. appear to exist as an ensemble of different conformations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHepRW7gor_7Vg90H21EOLACvtfcHk0ljWtaMru_uWCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXlt1emuw%253D%253D&md5=5a3aaea4f7ae84ed25b5ac2f7ac06a27</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1073%2Fpnas.84.19.6611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.84.19.6611%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DScheraga%26aufirst%3DH.%2BA.%26atitle%3DMonte%2520Carlo-minimization%2520approach%2520to%2520the%2520multiple-minima%2520problem%2520in%2520protein%2520folding%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1987%26volume%3D84%26spage%3D6611%26epage%3D6615%26doi%3D10.1073%2Fpnas.84.19.6611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBB','PDB','3PBB'); return false;">PDB: 3PBB</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i93"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00098">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_15645"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00098">10.1021/acs.jmedchem.7b00098</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular modeling and the HPLC purities of all final compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00098/suppl_file/jm7b00098_si_001.pdf">PDF</a>)</p></li><li><p class="inline">SMILES data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00098/suppl_file/jm7b00098_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00098/suppl_file/jm7b00098_si_001.pdf">jm7b00098_si_001.pdf (1.32 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00098/suppl_file/jm7b00098_si_002.csv">jm7b00098_si_002.csv (3.15 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00098%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-6" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00098" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799187b4ba8221c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
